[
    {
        "Source": "GAS",
        "Type": "Non-Grey",
        "Date Access": "2022-05-27 00:00:00",
        "URL": "\"\"http://btdenton.engin.umich.edu/wp-content/uploads/sites/138/2016/08/Price-2016.pdf\"\";\"\"wait...\"\";\"\"wait...\"\";\"\"1",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Include",
        "Exclusion Reason Final Level 2": "",
        "Title": "Operations research models and methods in the screening ...",
        "Theme": "Guidelines",
        "Research Paper Type": "Review",
        "Country/ Organisation": "United States"
    },
    {
        "Source": "GAS",
        "Type": "Grey",
        "Date Access": "2022-05-27 00:00:00",
        "URL": "\"\"http://prostatecanceradvisorycouncil.org/education/prostate-cancer-early-detection-guidelines-for-floridians/\"\";\"\"96\"\";\"\"1183\"\";\"\"43 \"\";\"\"n/a\"\";\"\"42744572\"\";\"\"1\"\";\"\"1\"\"",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Include",
        "Exclusion Reason Final Level 2": "",
        "Title": "Prostate Cancer Early Detection Guidelines for Floridians",
        "Theme": "Guidelines",
        "Research Paper Type": "Guidelines/Recommendations",
        "Country/ Organisation": "Florida, United States"
    },
    {
        "Source": "GAS",
        "Type": "Non-Grey",
        "Date Access": "2022-05-24 00:00:00",
        "URL": "https://doi.org/10.1016/j.eururo.2021.07.024",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Include",
        "Exclusion Reason Final Level 2": "",
        "Title": "Prostate-specific Antigen Testing as Part of a Risk-Adapted Early Detection Strategy for Prostate Cancer: European Association of Urology Position and Recommendations for 2021",
        "Theme": "Guidelines",
        "Research Paper Type": "Guidelines/Recommendations",
        "Country/ Organisation": "European Association of Urology"
    },
    {
        "Source": "GAS",
        "Type": "Non-Grey",
        "Date Access": "2022-05-27 00:00:00",
        "URL": "\"\"http://www.bccancer.bc.ca/family-oncology-network-site/Documents/Melburn%20Conscensus.pdf\"\";\"\"0\"\";\"\"162488\"\";\"\"10",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Include",
        "Exclusion Reason Final Level 2": "",
        "Title": "The Melbourne Consensus Statement on the early detection ...",
        "Theme": "Guidelines",
        "Research Paper Type": "Guidelines/Recommendations",
        "Country/ Organisation": "BJU International,USA"
    },
    {
        "Source": "GAS",
        "Type": "Non-Grey",
        "Date Access": "2022-05-27 00:00:00",
        "URL": "\"\"http://www.parcdesalutmar.cat/media/upload/arxius/unitats/cancer_urologic/protocols/NCCN/prostate_cancer_early_detection.pdf\"\";\"\"2\"\";\"\"101334\"\";\"\"7",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Include",
        "Exclusion Reason Final Level 2": "",
        "Title": "NCCN Clinical Practice Guidelines in Oncology (NCCN GuidelinesÂ¨) Prostate Cancer Early Detection",
        "Theme": "Guidelines",
        "Research Paper Type": "Guidelines/Recommendations",
        "Country/ Organisation": "National Comprehensive Cancer Network"
    },
    {
        "Source": "GAS",
        "Type": "Grey",
        "Date Access": "2022-05-27 00:00:00",
        "URL": "\"\"https://bpac.org.nz/2020/prostate.aspx\"\";\"\"92\"\";\"\"83688\"\";\"\"4",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Include",
        "Exclusion Reason Final Level 2": "",
        "Title": "Testing for prostate cancer: helping patients to decide - bpacnz",
        "Theme": "Guidelines, decision aids",
        "Research Paper Type": "Guidelines/Recommendations",
        "Country/ Organisation": "New Zealand"
    },
    {
        "Source": "GAS",
        "Type": "Grey",
        "Date Access": "2022-05-27 00:00:00",
        "URL": "\"\"https://canadiantaskforce.ca/canadian-task-force-recommends-against-screening-for-prostate-cancer/\"\";\"\"49\"\";\"\"28290\"\";\"\"4",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Include",
        "Exclusion Reason Final Level 2": "",
        "Title": "Canadian Task Force recommends against screening for ...",
        "Theme": "Guidelines",
        "Research Paper Type": "Guidelines/Recommendations",
        "Country/ Organisation": "Canadian Medical Association "
    },
    {
        "Source": "GAS",
        "Type": "Non-Grey",
        "Date Access": "2022-05-27 00:00:00",
        "URL": "\"\"https://cuaj.ca/index.php/journal/article/download/4888/3304/\"\";\"\"0\"\";\"\"7731\"\";\"\"4",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Include",
        "Exclusion Reason Final Level 2": "",
        "Title": "cua guideline - Canadian Urological Association Journal",
        "Theme": "Guidelines, risk calculators",
        "Research Paper Type": "Guidelines/Recommendations",
        "Country/ Organisation": "Canadian Urological Association, Canada"
    },
    {
        "Source": "GAS",
        "Type": "Grey",
        "Date Access": "2022-05-10 00:00:00",
        "URL": "\"\"https://prostatecanceruk.org/about-us/projects-and-policies/consensus-on-psa-testing\"\";\"\"75\"\";\"\"825078\"\";\"\"12",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Include",
        "Exclusion Reason Final Level 2": "",
        "Title": "Consensus on PSA testing | Prostate Cancer UK",
        "Theme": "Guidelines",
        "Research Paper Type": "Guidelines/Recommendations",
        "Country/ Organisation": "Prostate Cancer United Kingdom"
    },
    {
        "Source": "GAS",
        "Type": "Grey",
        "Date Access": "2022-05-27 00:00:00",
        "URL": "https://prostatecanceruk.org/media/zvypxfhm/best-practice-pathway-prereferral.pdf",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Include",
        "Exclusion Reason Final Level 2": "",
        "Title": "best-practice-pathway-prereferral.pdf - Prostate Cancer UK",
        "Theme": "Guidelines",
        "Research Paper Type": "Guidelines/Recommendations",
        "Country/ Organisation": "United Kingdom"
    },
    {
        "Source": "GAS",
        "Type": "Non-Grey",
        "Date Access": "2022-05-23 00:00:00",
        "URL": "\"\"https://pubmed.ncbi.nlm.nih.gov/23856038/\"\";\"\"11\"\";\"\"268171754\"\";\"\"218",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Include",
        "Exclusion Reason Final Level 2": "",
        "Title": "Early detection of prostate cancer: European Association of ...",
        "Theme": "Guidelines",
        "Research Paper Type": "Guidelines/Recommendations",
        "Country/ Organisation": "European Association of Urology"
    },
    {
        "Source": "GAS",
        "Type": "Non-Grey",
        "Date Access": "2022-05-23 00:00:00",
        "URL": "\"\"https://pubmed.ncbi.nlm.nih.gov/25190691/\"\";\"\"33\"\";\"\"268171754\"\";\"\"218",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Include",
        "Exclusion Reason Final Level 2": "",
        "Title": "Prostate cancer early detection, version 1.2014. Featured ...",
        "Theme": "Guidelines",
        "Research Paper Type": "Guidelines/Recommendations",
        "Country/ Organisation": "National Comprehensive Cancer Network (NCCN)"
    },
    {
        "Source": "GAS",
        "Type": "Non-Grey",
        "Date Access": "2022-05-23 00:00:00",
        "URL": "\"\"https://pubmed.ncbi.nlm.nih.gov/26656522/\"\";\"\"84\"\";\"\"268171754\"\";\"\"218",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Include",
        "Exclusion Reason Final Level 2": "",
        "Title": "NCCN Clinical Practice Guidelines Prostate Cancer Early ...",
        "Theme": "Guidelines",
        "Research Paper Type": "Guidelines",
        "Country/ Organisation": "National Comprehensive Cancer Network JNCCN"
    },
    {
        "Source": "GAS",
        "Type": "Non-Grey",
        "Date Access": "2022-05-27 00:00:00",
        "URL": "\"\"https://www.aafp.org/afp/2014/0115/p137.html\"\";\"\"193\"\";\"\"24559875\"\";\"\"56",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Include",
        "Exclusion Reason Final Level 2": "",
        "Title": "AUA Releases Guideline on Early Detection of Prostate Cancer",
        "Theme": "Guidelines",
        "Research Paper Type": "Guidelines/Recommendations",
        "Country/ Organisation": "American Urological Association"
    },
    {
        "Source": "GAS",
        "Type": "Non-Grey",
        "Date Access": "2022-05-27 00:00:00",
        "URL": "\"\"https://www.aafp.org/afp/2018/1015/od1.html\"\";\"\"349\"\";\"\"22618203\"\";\"\"56",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Include",
        "Exclusion Reason Final Level 2": "",
        "Title": "Screening for Prostate Cancer: Recommendation Statement",
        "Theme": "Guidelines",
        "Research Paper Type": "Recommendation",
        "Country/ Organisation": "U.S. PREVENTIVE SERVICES TASK FORCE"
    },
    {
        "Source": "GAS",
        "Type": "Grey",
        "Date Access": "2022-05-27 00:00:00",
        "URL": "\"\"https://www.albertahealthservices.ca/assets/info/hp/cancer/if-hp-cancer-guide-gu004-prostate.pdf\"\";\"\"31\"\";\"\"25138843\"\";\"\"74",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Include",
        "Exclusion Reason Final Level 2": "",
        "Title": "Prostate Cancer - Alberta Health Services",
        "Theme": "Guidelines",
        "Research Paper Type": "Guidelines",
        "Country/ Organisation": "Alberta Health Service"
    },
    {
        "Source": "GAS",
        "Type": "Non-Grey",
        "Date Access": "2022-05-10 00:00:00",
        "URL": "\"\"https://www.annalsofoncology.org/article/S0923-7534(19)31488-7/fulltext\"\";\"\"18\"\";\"\"124477\"\";\"\"46",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Include",
        "Exclusion Reason Final Level 2": "",
        "Title": "Do prostate cancer risk models improve the predictive ...",
        "Theme": "Risk prediction tool",
        "Research Paper Type": "Review",
        "Country/ Organisation": "Oxford University Press"
    },
    {
        "Source": "GAS",
        "Type": "Non-Grey",
        "Date Access": "2022-05-27 00:00:00",
        "URL": "\"\"https://www.annalsofoncology.org/article/S0923-7534(20)39898-7/fulltext\"\";\"\"179\"\";\"\"126425\"\";\"\"46",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Include",
        "Exclusion Reason Final Level 2": "",
        "Title": "Prostate cancer: ESMO Clinical Practice Guidelines for ...",
        "Theme": "Guidelines",
        "Research Paper Type": "Guidelines/Recommendations",
        "Country/ Organisation": "European Society for Medical Oncology, United Kingdom"
    },
    {
        "Source": "GAS",
        "Type": "Grey",
        "Date Access": "2022-05-23 00:00:00",
        "URL": "\"\"https://www.cancer.org/health-care-professionals/american-cancer-society-prevention-early-detection-guidelines.html\"\";\"\"1168\"\";\"\"14177707\"\";\"\"28",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Include",
        "Exclusion Reason Final Level 2": "",
        "Title": "Prevention and Early Detection Guidelines - American Cancer",
        "Theme": "Guidelines",
        "Research Paper Type": "Guidelines/Recommendations",
        "Country/ Organisation": "American Cancer Society"
    },
    {
        "Source": "GAS",
        "Type": "Grey",
        "Date Access": "2022-05-27 00:00:00",
        "URL": "\"\"https://www.chp.gov.hk/files/pdf/prostate_cancer_professional_hp.pdf\"\";\"\"12\"\";\"\"852651\"\";\"\"25",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Include",
        "Exclusion Reason Final Level 2": "",
        "Title": "Recommendations on Prevention and Screening for Prostate ...",
        "Theme": "Guidelines",
        "Research Paper Type": "Guidelines/Recommendations",
        "Country/ Organisation": "Centre for Health Protection"
    },
    {
        "Source": "GAS",
        "Type": "Grey",
        "Date Access": "2022-05-27 00:00:00",
        "URL": "https://www.ontario.ca/page/prostate-cancer-screening",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Include",
        "Exclusion Reason Final Level 2": "",
        "Title": "Ontario Prostate Specific Antigen (PSA) Clinical Guidelines ...",
        "Theme": "Guidelines",
        "Research Paper Type": "Guidelines/Recommendations",
        "Country/ Organisation": "Ontario, Canada"
    },
    {
        "Source": "GAS",
        "Type": "Grey",
        "Date Access": "2022-05-10 00:00:00",
        "URL": "\"\"https://www.health.govt.nz/system/files/documents/publications/diagnosis-management-prostate-cancer-nz-men.doc\"\";\"\"1\"\";\"\"1236186\"\";\"\"29",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Include",
        "Exclusion Reason Final Level 2": "",
        "Title": "diagnosis-management-prostate-cancer-nz-men.doc - Ministry ...",
        "Theme": "Guidelines, policy",
        "Research Paper Type": "Guidelines/Recommendations",
        "Country/ Organisation": "New Zealand"
    },
    {
        "Source": "GAS",
        "Type": "Grey",
        "Date Access": "2022-05-27 00:00:00",
        "URL": "\"\"https://www.health.govt.nz/system/files/documents/publications/prostate-cancer-awareness-and-quality-improvement-programme-v2.pdf\"\";\"\"0\"\";\"\"1338580\"\";\"\"29",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Include",
        "Exclusion Reason Final Level 2": "",
        "Title": "Prostate Cancer Awareness and Quality Improvement ...",
        "Theme": "Programme",
        "Research Paper Type": "Guidelines/Recommendations",
        "Country/ Organisation": "New Zealand MOH"
    },
    {
        "Source": "GAS",
        "Type": "Grey",
        "Date Access": "2022-05-27 00:00:00",
        "URL": "\"\"https://www.health.govt.nz/system/files/documents/publications/prostate-cancer-management-referral-guidance_sept15-c.pdf\"\";\"\"118\"\";\"\"1338580\"\";\"\"29",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Include",
        "Exclusion Reason Final Level 2": "",
        "Title": "Prostate Cancer Management and Referral Guidance",
        "Theme": "Guidelines",
        "Research Paper Type": "Guidelines/Recommendations",
        "Country/ Organisation": "New Zealand MOH"
    },
    {
        "Source": "GAS",
        "Type": "Grey",
        "Date Access": "2022-05-27 00:00:00",
        "URL": "\"\"https://www.health.pa.gov/topics/Documents/Diseases%20and%20Conditions/Cancer/Prostate%20Cancer%20Task%20Force%20Report-final.pdf\"\";\"\"wait...\"\";\"\"wait...\"\";\"\"20",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Include",
        "Exclusion Reason Final Level 2": "",
        "Title": "Prostate Cancer - Pennsylvania Department of Health",
        "Theme": "Guidelines, decision aids, policy",
        "Research Paper Type": "Guidelines/policy",
        "Country/ Organisation": "Pennsylvania Dept. of Health"
    },
    {
        "Source": "GAS",
        "Type": "Grey",
        "Date Access": "2022-05-27 00:00:00",
        "URL": "\"\"https://www.iccp-portal.org/system/files/plans/NCCSP%20Final%20Version%20Zambia.pdf\"\";\"\"wait...\"\";\"\"wait...\"\";\"\"wait...\"\";\"\"wait...\"\";\"\"wait...\"\";\"\"wait...\"\";\"\"wait...\"\"",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Include",
        "Exclusion Reason Final Level 2": "",
        "Title": "National Cancer Control Strategic Plan - ICCP Portal",
        "Theme": "Programme",
        "Research Paper Type": "Strategic Plan (Programme)",
        "Country/ Organisation": "Ministry of Heath Republic of Zambia"
    },
    {
        "Source": "GAS",
        "Type": "Grey",
        "Date Access": "2022-05-24 00:00:00",
        "URL": "\"\"https://www.krebsdaten.de/Krebs/EN/Content/Cancer_sites/Prostate_cancer/prostate_cancer_node.html\"\";\"\"12\"\";\"\"19956\"\";\"\"2",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Include",
        "Exclusion Reason Final Level 2": "",
        "Title": "Prostate cancer - Krebs",
        "Theme": "Programme",
        "Research Paper Type": "Programme",
        "Country/ Organisation": "Germany"
    },
    {
        "Source": "GAS",
        "Type": "Grey",
        "Date Access": "2022-05-10 00:00:00",
        "URL": "\"\"https://www.moh.gov.bn/Shared%20Documents/MOH_National%20Health%20Screening%20Guideline%20on%20NCDs_23%20Jul%202020.pdf\"\";\"\"0\"\";\"\"22640\"\";\"\"11",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Include",
        "Exclusion Reason Final Level 2": "",
        "Title": "National Health Screening Guideline on Noncommunicable ...",
        "Theme": "Guidelines, decision aids",
        "Research Paper Type": "Recommendation",
        "Country/ Organisation": "Noncommunicable Diseases (NCDs) Prevention Unit, Ministry of Health"
    },
    {
        "Source": "GAS",
        "Type": "Non-Grey",
        "Date Access": "2022-05-23 00:00:00",
        "URL": "\"\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5861291/\"\";\"\"36\"\";\"\"2289175364\"\";\"\"172",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Include",
        "Exclusion Reason Final Level 2": "",
        "Title": "Prostate cancer screeningÂÃÃwhen to start and how to screen?",
        "Theme": "Guidelines, biomarkers",
        "Research Paper Type": "Review",
        "Country/ Organisation": "Translational Anrology and Urology"
    },
    {
        "Source": "GAS",
        "Type": "Grey",
        "Date Access": "2022-05-27 00:00:00",
        "URL": "\"\"https://www.pcf.org/news/new-recommendations-offer-guidance-for-clinicians-patients-on-implementing-genetic-testing-for-prostate-cancer/\"\";\"\"65\"\";\"\"135466\"\";\"\"4",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Include",
        "Exclusion Reason Final Level 2": "",
        "Title": "New Recommendations Offer Guidance for Clinicians ...",
        "Theme": "Guidelines",
        "Research Paper Type": "Recommendation",
        "Country/ Organisation": "Prostate cancer Foundation Australia Santa Monica, CA "
    },
    {
        "Source": "GAS",
        "Type": "Grey",
        "Date Access": "2022-05-27 00:00:00",
        "URL": "\"\"https://www.prostate.org.au/awareness/for-healthcare-professionals/clinical-practice-guidelines-on-psa-testing/\"\";\"\"287\"\";\"\"402436\"\";\"\"3",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Include",
        "Exclusion Reason Final Level 2": "",
        "Title": "Clinical Practice Guidelines on PSA Testing | PCFA",
        "Theme": "Guidelines",
        "Research Paper Type": "Guidelines/Recommendations",
        "Country/ Organisation": "Prostate Cancer Foundation of Australia"
    },
    {
        "Source": "GAS",
        "Type": "Grey",
        "Date Access": "2022-05-24 00:00:00",
        "URL": "\"\"https://www.racgp.org.au/clinical-resources/clinical-guidelines/key-racgp-guidelines/view-all-racgp-guidelines/national-guide/chapter-15-prevention-and-early-detection-of-cance/early-detection-of-prostate-cancer\"\";\"\"13\"\";\"\"1693656\"\";\"\"26",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Include",
        "Exclusion Reason Final Level 2": "",
        "Title": "Early detection of prostate cancer - RACGP",
        "Theme": "Guidelines",
        "Research Paper Type": "Guidelines",
        "Country/ Organisation": "Royal Australian College of General Practitioners"
    },
    {
        "Source": "GAS",
        "Type": "Non-Grey",
        "Date Access": "2022-05-10 00:00:00",
        "URL": "\"\"https://www.researchgate.net/publication/327510872_Prostate_cancer_screening_with_prostate-specific_antigen_PSA_test_A_clinical_practice_guideline\"\";\"\"4\"\";\"\"504149507\"\";\"\"8",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Include",
        "Exclusion Reason Final Level 2": "",
        "Title": "Prostate cancer screening with prostate-specific antigen (PSA ...",
        "Theme": "Guidelines",
        "Research Paper Type": "Guidelines/Recommendations",
        "Country/ Organisation": "The BMJ"
    },
    {
        "Source": "GAS",
        "Type": "Grey",
        "Date Access": "2022-05-10 00:00:00",
        "URL": "\"\"https://www.rogelcancercenter.org/prostate-cancer/screening\"\";\"\"35\"\";\"\"93862\"\";\"\"5",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Include",
        "Exclusion Reason Final Level 2": "",
        "Title": "Screening for Prostate Cancer",
        "Theme": "Guidelines",
        "Research Paper Type": "Guidelines",
        "Country/ Organisation": "Rogel Cancer Centre"
    },
    {
        "Source": "GAS",
        "Type": "Non-Grey",
        "Date Access": "2022-05-27 00:00:00",
        "URL": "\"\"https://www.scirp.org/journal/paperinformation.aspx?paperid=84462\"\";\"\"39\"\";\"\"1862708\"\";\"\"417",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Include",
        "Exclusion Reason Final Level 2": "",
        "Title": "PSA Screening for Prostate Cancer in Men under the Age of 65",
        "Theme": "Guidelines",
        "Research Paper Type": "Review",
        "Country/ Organisation": "Open Journal for Urology"
    },
    {
        "Source": "GAS",
        "Type": "Grey",
        "Date Access": "2022-05-27 00:00:00",
        "URL": "\"\"https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/prostate-cancer-screening\"\";\"\"3288\"\";\"\"367254\"\";\"\"9",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Include",
        "Exclusion Reason Final Level 2": "",
        "Title": "Prostate Cancer: Screening",
        "Theme": "Guidelines",
        "Research Paper Type": "",
        "Country/ Organisation": "US Preventive Services Task Force"
    },
    {
        "Source": "GAS",
        "Type": "Grey",
        "Date Access": "2022-05-27 00:00:00",
        "URL": "\"\"https://www2.gov.bc.ca/gov/content/health/practitioner-professional-resources/bc-guidelines/prostate-cancer-part-1\"\";\"\"32\"\";\"\"5982848\"\";\"\"89",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Include",
        "Exclusion Reason Final Level 2": "",
        "Title": "Prostate Cancer Part 1: Diagnosis and Referral in Primary Care",
        "Theme": "Guidelines",
        "Research Paper Type": "Recommendation",
        "Country/ Organisation": "British Columbia"
    },
    {
        "Source": "GAS",
        "Type": "Grey",
        "Date Access": "2022-05-27 00:00:00",
        "URL": "\"\"https://www2.tri-kobe.org/nccn/guideline/urological/english/prostate_detection.pdf\"\";\"\"364\"\";\"\"39491\"\";\"\"4",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Include",
        "Exclusion Reason Final Level 2": "",
        "Title": "Prostate Cancer Early Detection",
        "Theme": "Guidelines",
        "Research Paper Type": "Guidelines/Recommendations",
        "Country/ Organisation": "National Comprehensive Cancer Network"
    },
    {
        "Source": "GAS",
        "Type": "Grey",
        "Date Access": "2022-05-23 00:00:00",
        "URL": "\"\"https://dhss.delaware.gov/dph/dpc/sfl.html\"\";\"\"3\"\";\"\"146238\"\";\"\"54",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Include",
        "Exclusion Reason Final Level 2": "",
        "Title": "Screening for Life - Delaware Health and Social Services",
        "Theme": "Programme",
        "Research Paper Type": "Programme",
        "Country/ Organisation": "Delaware"
    },
    {
        "Source": "GAS",
        "Type": "Grey",
        "Date Access": "2022-05-23 00:00:00",
        "URL": "\"\"https://www.betterhealth.vic.gov.au/health/conditionsandtreatments/prostate-cancer-testing\"\";\"\"223\"\";\"\"2125542\"\";\"\"9",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Include",
        "Exclusion Reason Final Level 2": "",
        "Title": "Prostate cancer testing - Better Health Channel",
        "Theme": "Programme",
        "Research Paper Type": "Programme",
        "Country/ Organisation": "Better Health Channel"
    },
    {
        "Source": "GAS",
        "Type": "Grey",
        "Date Access": "2022-05-27 00:00:00",
        "URL": "\"\"https://www.cancerresearchuk.org/about-cancer/prostate-cancer/getting-diagnosed/screening\"\";\"\"458\"\";\"\"12833948\"\";\"\"167",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Include",
        "Exclusion Reason Final Level 2": "",
        "Title": "Screening for prostate cancer",
        "Theme": "Programme",
        "Research Paper Type": "",
        "Country/ Organisation": "Cancer Research UK"
    },
    {
        "Source": "GAS",
        "Type": "Grey",
        "Date Access": "2022-05-27 00:00:00",
        "URL": "\"\"https://www.gov.uk/government/publications/prostate-specific-antigen-testing-explanation-and-implementation/advising-well-men-about-the-psa-test-for-prostate-cancer-information-for-gps\"\";\"\"wait...\"\";\"\"380242834\"\";\"\"1",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Include",
        "Exclusion Reason Final Level 2": "",
        "Title": "Guidance - Advising men without symptoms of prostate disease who ask about the PSA test",
        "Theme": "Guidelines, programme",
        "Research Paper Type": "Guidance",
        "Country/ Organisation": "Office for Health Improvement and Disparities, Gov UK"
    },
    {
        "Source": "GAS",
        "Type": "Grey",
        "Date Access": "2022-05-24 00:00:00",
        "URL": "\"\"https://www.health.gov.au/health-topics/cancer/screening-for-cancer\"\";\"\"340\"\";\"\"7928436\"\";\"\"73",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Include",
        "Exclusion Reason Final Level 2": "",
        "Title": "Screening for cancer",
        "Theme": "Programme",
        "Research Paper Type": "Programme",
        "Country/ Organisation": "Department of Health and Aged Care Australia"
    },
    {
        "Source": "GAS",
        "Type": "Grey",
        "Date Access": "2022-05-23 00:00:00",
        "URL": "\"\"https://www.nhs.uk/conditions/prostate-cancer/psa-testing/\"\";\"\"wait...\"\";\"\"wait...\"\";\"\"808",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Include",
        "Exclusion Reason Final Level 2": "",
        "Title": "PSA testing - - - Prostate cancer - NHS",
        "Theme": "Programme",
        "Research Paper Type": "",
        "Country/ Organisation": "nhs UK"
    },
    {
        "Source": "GAS",
        "Type": "Grey",
        "Date Access": "2022-05-24 00:00:00",
        "URL": "\"\"https://www.sussex.nj.us/cn/webpage.cfm?tpid=14930\"\";\"\"1\"\";\"\"78942\"\";\"\"4",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Include",
        "Exclusion Reason Final Level 2": "",
        "Title": "NJCEED (NJ Cancer Education and Early Detection) - Sussex",
        "Theme": "Programme",
        "Research Paper Type": "Programme",
        "Country/ Organisation": "Division of Health, Sussex County, New Jersey"
    },
    {
        "Source": "GAS",
        "Type": "Grey",
        "Date Access": "2022-05-10 00:00:00",
        "URL": "\"\"https://www.gov.uk/guidance/prostate-cancer-risk-management-programme-overview\"\";\"\"333\"\";\"\"380242834\"\";\"\"1",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Include",
        "Exclusion Reason Final Level 2": "",
        "Title": "Guidance - Prostate cancer risk management programme: overview",
        "Theme": "Programme",
        "Research Paper Type": "",
        "Country/ Organisation": "GOV.UK"
    },
    {
        "Source": "GAS",
        "Type": "Grey",
        "Date Access": "2022-05-27 00:00:00",
        "URL": "\"\"http://prostatecanceradvisorycouncil.org/education/physicians-and-care-providers/localized-prostate-cancer-initial-evaluation-and-management-options/\"\";\"\"wait...\"\";\"\"wait...\"\";\"\"wait...\"\";\"\"wait...\"\";\"\"wait...\"\";\"\"wait...\"\";\"\"wait...\"\"",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Exclude",
        "Exclusion Reason Final Level 2": "Management and/or treatment",
        "Title": "Localized Prostate Cancer: Initial Evaluation and ...",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "Non-Grey",
        "Date Access": "2022-05-24 00:00:00",
        "URL": "\"\"https://aacrjournals.org/cebp/article-pdf/29/12/2454/1944466/2454.pdf\"\";\"\"0\"\";\"\"1367595\"\";\"\"163",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Exclude",
        "Exclusion Reason Final Level 2": "Management and/or treatment",
        "Title": "Prostate Cancer Biomarker Development: National Cancer Institute's Early Detection Research Network Prostate Cancer Collaborative Group Review",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "Grey",
        "Date Access": "2022-05-10 00:00:00",
        "URL": "\"\"https://apps.who.int/iris/bitstream/handle/10665/330829/9789289054782-eng.pdf\"\";\"\"763\"\";\"\"6096974\"\";\"\"314",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Exclude",
        "Exclusion Reason Final Level 2": "Summary study, not guideline, no screening details, no details, no analysis",
        "Title": "Screening programmes: a short guide - WHO | World Health ...",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "Non-Grey",
        "Date Access": "2022-05-24 00:00:00",
        "URL": "\"\"https://ascopubs.org/doi/10.14694/EdBook_AM.2015.35.57\"\";\"\"33\"\";\"\"1707714\"\";\"\"264",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Exclude",
        "Exclusion Reason Final Level 2": "Primary study or not systematic review",
        "Title": "Early Detection of Cancer: Past, Present, and Future",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "Grey",
        "Date Access": "2022-05-27 00:00:00",
        "URL": "\"\"https://assets.gov.ie/11609/f4bac55a659a4b0c876386f55d88fc9d.pdf\"\";\"\"wait...\"\";\"\"wait...\"\";\"\"wait...\"\";\"\"wait...\"\";\"\"wait...\"\";\"\"wait...\"\";\"\"wait...\"\"",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Exclude",
        "Exclusion Reason Final Level 2": "Management and/or treatment",
        "Title": "Diagnosis, staging and treatment of patients with prostate cancer",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "Non-Grey",
        "Date Access": "2022-05-10 00:00:00",
        "URL": "\"\"https://bcmj.org/articles/psa-and-beyond-biomarkers-prostate-cancer\"\";\"\"177\"\";\"\"50335\"\";\"\"9",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Exclude",
        "Exclusion Reason Final Level 2": "Management and/or treatment",
        "Title": "PSA and beyond: Biomarkers in prostate cancer - British ...",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "Non-Grey",
        "Date Access": "2022-05-10 00:00:00",
        "URL": "\"\"https://bjgpopen.org/content/4/2/bjgpopen20X101039\"\";\"\"50\"\";\"\"51780\"\";\"\"2",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Exclude",
        "Exclusion Reason Final Level 2": "Not research study objectives - ie not prostate cancer-related or decision aid or guideline or programme related to prostate cancer",
        "Title": "A genetic risk assessment for prostate cancer influences ...",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "Grey",
        "Date Access": "2022-05-27 00:00:00",
        "URL": "\"\"https://cansa.org.za/files/2021/04/Fact-Sheet-on-Prostate-Cancer-NCR-2017-web-March-2021.pdf\"\";\"\"wait...\"\";\"\"wait...\"\";\"\"wait...\"\";\"\"wait...\"\";\"\"wait...\"\";\"\"wait...\"\";\"\"wait...\"\"",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Exclude",
        "Exclusion Reason Final Level 2": "For public consumption, patient info/guide, trial information",
        "Title": "Fact-Sheet-on-Prostate-Cancer-NCR-2017-web-March-2021.pdf",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "Grey",
        "Date Access": "2022-05-27 00:00:00",
        "URL": "\"\"https://doh.gov.ph/philippine-cancer-control-program\"\";\"\"wait...\"\";\"\"wait...\"\";\"\"wait...\"\";\"\"wait...\"\";\"\"wait...\"\";\"\"wait...\"\";\"\"wait...\"\"",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Exclude",
        "Exclusion Reason Final Level 2": "Not research study objectives - ie not prostate cancer-related or decision aid or guideline or programme related to prostate cancer",
        "Title": "Philippine Cancer Control Program - Department of Health ...",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "Grey",
        "Date Access": "2022-05-27 00:00:00",
        "URL": "\"\"https://ec.europa.eu/assets/sante/health/funding/wp2022_en.pdf\"\";\"\"wait...\"\";\"\"wait...\"\";\"\"4",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Exclude",
        "Exclusion Reason Final Level 2": "News, lecturer note, thesis, draft, proposal, module, stimulation, presscast, fact sheet, opinion, editorial",
        "Title": "21 11 19 Annex I - track changes - European Commission",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "Grey",
        "Date Access": "2022-05-10 00:00:00",
        "URL": "\"\"https://effectivehealthcare.ahrq.gov/sites/default/files/pdf/prostate-cancer-risk-assessment-genes_research.pdf\"\";\"\"44\"\";\"\"141895\"\";\"\"9",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Exclude",
        "Exclusion Reason Final Level 2": "Not research study objectives - ie not prostate cancer-related or decision aid or guideline or programme related to prostate cancer",
        "Title": "Multigene Panels in Prostate Cancer Risk Assessment",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "Non-Grey",
        "Date Access": "2022-05-27 00:00:00",
        "URL": "\"\"https://elifesciences.org/articles/50936\"\";\"\"wait...\"\";\"\"wait...\"\";\"\"49",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Exclude",
        "Exclusion Reason Final Level 2": "Not research study objectives - ie not prostate cancer-related or decision aid or guideline or programme related to prostate cancer",
        "Title": "Identifying prostate cancer and its clinical risk in asymptomatic ...",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "Grey",
        "Date Access": "2022-05-24 00:00:00",
        "URL": "\"\"https://iopscience.iop.org/article/10.1088/1757-899X/1022/1/012073/pdf\"\";\"\"1\"\";\"\"67683121\"\";\"\"1",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Exclude",
        "Exclusion Reason Final Level 2": "Primary study or not systematic review",
        "Title": "Detection of Prostate Cancer Using Deep Learning Framework",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "Grey",
        "Date Access": "2022-05-27 00:00:00",
        "URL": "\"\"https://itif.org/publications/2021/04/19/seizing-transformative-opportunity-multi-cancer-early-detection\"\";\"\"wait...\"\";\"\"wait...\"\";\"\"6",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Exclude",
        "Exclusion Reason Final Level 2": "Management and/or treatment",
        "Title": "Seizing the Transformative Opportunity of Multi-cancer Early ...",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "Non-Grey",
        "Date Access": "2022-05-24 00:00:00",
        "URL": "https://pubmed.ncbi.nlm.nih.gov/31747161",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Exclude",
        "Exclusion Reason Final Level 2": "Others",
        "Title": "Moscow program of early detection and treatment of prostate cancer",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "Non-Grey",
        "Date Access": "2022-05-27 00:00:00",
        "URL": "\"\"https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0066855\"\";\"\"6605\"\";\"\"72890378\"\";\"\"453",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Exclude",
        "Exclusion Reason Final Level 2": "Management and/or treatment",
        "Title": "Discovery and Validation of a Prostate Cancer Genomic ...",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "Grey",
        "Date Access": "2022-05-27 00:00:00",
        "URL": "\"\"https://lup.lub.lu.se/luur/download?func=downloadFile&recordOId=8923049&fileOId=8923572\"\";\"\"wait...\"\";\"\"wait...\"\";\"\"wait...\"\";\"\"wait...\"\";\"\"wait...\"\";\"\"wait...\"\";\"\"wait...\"\"",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Exclude",
        "Exclusion Reason Final Level 2": "News, lecturer note, thesis, draft, proposal, module, stimulation, presscast, fact sheet, opinion, editorial",
        "Title": "Evaluation of the Cost-Effectiveness of Novel Tests in the ...",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "Non-Grey",
        "Date Access": "2022-05-10 00:00:00",
        "URL": "https://www.ons.org/onf/43/1/facilitating-shared-decision-making-about-prostate-cancer-screening-among-african-american#:~:text=Nurses%20can%20facilitate%20shared%20decision,for%20men%20facing%20screening%20decisions.",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Exclude",
        "Exclusion Reason Final Level 2": "Primary study or not systematic review",
        "Title": "Facilitating Shared Decision Making About Prostate Cancer ...",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "Grey",
        "Date Access": "2022-05-27 00:00:00",
        "URL": "https://prostatematters.co.uk/screening/future-screening-the-prostgram/",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Exclude",
        "Exclusion Reason Final Level 2": "For public consumption, patient info/guide, trial information",
        "Title": "Future screening - The Prostgram - Prostate Matters",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "Non-Grey",
        "Date Access": "2022-05-23 00:00:00",
        "URL": "\"\"https://pubmed.ncbi.nlm.nih.gov/33384200/\"\";\"\"22\"\";\"\"268171754\"\";\"\"218",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Exclude",
        "Exclusion Reason Final Level 2": "Not by country health authorities or medical organisation",
        "Title": "Early Detection of Prostate Cancer in 2020 and Beyond",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "Non-Grey",
        "Date Access": "2022-05-27 00:00:00",
        "URL": "\"\"https://pubmed.ncbi.nlm.nih.gov/35073647/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1x9bY_ZPGMIhWPqiUsK2sa8rJXYKMRQLABbF8TBW2939vGjYby&fc=20201208113519&ff=20220125140425&v=2.17.5\"\";\"\"0\"\";\"\"255613545\"\";\"\"228",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Exclude",
        "Exclusion Reason Final Level 2": "Others",
        "Title": "China guideline for the screening and early detection of ...",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "Non-Grey",
        "Date Access": "2022-05-24 00:00:00",
        "URL": "\"\"https://pubs.acs.org/doi/10.1021/acsomega.1c06479\"\";\"\"0\"\";\"\"214776436\"\";\"\"57",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Exclude",
        "Exclusion Reason Final Level 2": "Primary study or not systematic review",
        "Title": "Plasmonic-Based Biosensor for the Early Diagnosis of ...",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "Grey",
        "Date Access": "2022-05-27 00:00:00",
        "URL": "https://www.stonybrookmedicine.edu/patientcare/urology/prostate-cancer-program",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Exclude",
        "Exclusion Reason Final Level 2": "For public consumption, patient info/guide, trial information",
        "Title": "Prostate Care Program",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "Grey",
        "Date Access": "2022-05-10 00:00:00",
        "URL": "\"\"https://sphweb.bumc.bu.edu/otlt/mph-modules/bs/bs704_probability/bs704_probability4.html\"\";\"\"6\"\";\"\"827227\"\";\"\"17",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Exclude",
        "Exclusion Reason Final Level 2": "News, lecturer note, thesis, draft, proposal, module, stimulation, presscast, fact sheet, opinion, editorial",
        "Title": "Evaluating Screening Tests - SPH",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "Grey",
        "Date Access": "2022-05-27 00:00:00",
        "URL": "\"\"https://sphweb.bumc.bu.edu/otlt/mph-modules/ep/ep713_screening/EP713_Screening_print.html\"\";\"\"wait...\"\";\"\"wait...\"\";\"\"17",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Exclude",
        "Exclusion Reason Final Level 2": "News, lecturer note, thesis, draft, proposal, module, stimulation, presscast, fact sheet, opinion, editorial",
        "Title": "Screening for Disease - SPH",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "Grey",
        "Date Access": "2022-05-27 00:00:00",
        "URL": "\"\"https://urology.ucsf.edu/sites/urology.ucsf.edu/files/uploaded-files/attachments/sduro0081_localized_prostate_cancer_and_its_treatment-_a_patient_guide.pdf\"\";\"\"wait...\"\";\"\"wait...\"\";\"\"wait...\"\";\"\"wait...\"\";\"\"wait...\"\";\"\"wait...\"\";\"\"wait...\"\"",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Exclude",
        "Exclusion Reason Final Level 2": "For public consumption, patient info/guide, trial information",
        "Title": "Localized Prostate Cancer and Its Treatment: A Patient Guide",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "Grey",
        "Date Access": "2022-05-10 00:00:00",
        "URL": "\"\"https://uroweb.org/prostate-cancer-risk-calculator-offers-men-individual-risk-assessment\"\";\"\"22\"\";\"\"770634\"\";\"\"14",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Exclude",
        "Exclusion Reason Final Level 2": "News, lecturer note, thesis, draft, proposal, module, stimulation, presscast, fact sheet, opinion, editorial",
        "Title": "Prostate Cancer Risk Calculator offers men 'individual risk ...",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "Non-Grey",
        "Date Access": "2022-05-10 00:00:00",
        "URL": "\"\"https://wjmh.org/DOIx.php?id=10.5534/wjmh.210076\"\";\"\"18\"\";\"\"19339\"\";\"\"2",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Exclude",
        "Exclusion Reason Final Level 2": "Primary study or not systematic review",
        "Title": "New Prostate Cancer Screening Options - :: WJMH :: The ...",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "Grey",
        "Date Access": "2022-05-27 00:00:00",
        "URL": "https://www.myadlm.org/advocacy-and-outreach/adlm-policy-reports/2015/laboratory-medicine-advancing-quality-in-patient-care",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Exclude",
        "Exclusion Reason Final Level 2": "News, lecturer note, thesis, draft, proposal, module, stimulation, presscast, fact sheet, opinion, editorial",
        "Title": "Laboratory Medicine: Advancing Quality in Patient Care",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "Non-Grey",
        "Date Access": "2022-05-23 00:00:00",
        "URL": "\"\"https://www.aafp.org/afp/2014/1101/p625.html\"\";\"\"27\"\";\"\"23680096\"\";\"\"58",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Exclude",
        "Exclusion Reason Final Level 2": "Not by country health authorities or medical organisation",
        "Title": "Screening for Cancer: Concepts and Controversies",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "Grey",
        "Date Access": "2022-05-27 00:00:00",
        "URL": "https://www.expertmedical.berlin/en/services/advanced-cancer-prevention/",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Exclude",
        "Exclusion Reason Final Level 2": "For public consumption, patient info/guide, trial information",
        "Title": "Advanced cancer screening - Privatpraxis fÃ_r Urologie ...",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "Non-Grey",
        "Date Access": "2022-05-24 00:00:00",
        "URL": "\"\"https://www.annalsofglobalhealth.org/articles/10.5334/aogh.3519/\"\";\"\"0\"\";\"\"15195\"\";\"\"2",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Exclude",
        "Exclusion Reason Final Level 2": "Not research study objectives - ie not prostate cancer-related or decision aid or guideline or programme related to prostate cancer",
        "Title": "Strengthening Capacity for Prostate Cancer Early Diagnosis in West Africa Amidst the COVID-19 Pandemic: A Realist Approach to Rethinking and Operationalizing the World Health Organization 2017 Guide to Cancer Early Diagnosis",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "Non-Grey",
        "Date Access": "2022-05-27 00:00:00",
        "URL": "\"\"https://www.asco.org/about-asco/press-center/news-releases/increased-psa-screening-linked-lower-risk-advanced-prostate\"\";\"\"wait...\"\";\"\"wait...\"\";\"\"6",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Exclude",
        "Exclusion Reason Final Level 2": "News, lecturer note, thesis, draft, proposal, module, stimulation, presscast, fact sheet, opinion, editorial",
        "Title": "Increased PSA Screening Linked to Lower Risk of Advanced ...",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "Grey",
        "Date Access": "2022-05-27 00:00:00",
        "URL": "\"\"https://www.auanet.org/guidelines/guidelines/prostate-cancer-clinically-localized-guideline\"\";\"\"1190\"\";\"\"2728490\"\";\"\"7",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Exclude",
        "Exclusion Reason Final Level 2": "News, lecturer note, thesis, draft, proposal, module, stimulation, presscast, fact sheet, opinion, editorial",
        "Title": "Prostate Cancer: Clinically Localized Guideline - American ...",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "Grey",
        "Date Access": "2022-05-24 00:00:00",
        "URL": "\"\"https://www.auanet.org/guidelines/guidelines/prostate-specific-antigen-(psa)-best-practice-statement\"\";\"\"219\"\";\"\"2746093\"\";\"\"7",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Exclude",
        "Exclusion Reason Final Level 2": "Management and/or treatment",
        "Title": "PSA Testing for the Pretreatment Staging and Posttreatment ...",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "Non-Grey",
        "Date Access": "2022-05-27 00:00:00",
        "URL": "\"\"https://www.bjmo.be/app/uploads/2020/02/09-2015-D.-Mortier-MD.pdf\"\";\"\"3\"\";\"\"2784\"\";\"\"1",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Exclude",
        "Exclusion Reason Final Level 2": "Not by country health authorities or medical organisation",
        "Title": "Early detection of prostate cancer: the EAU versus the AUA ...",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "Grey",
        "Date Access": "2022-05-27 00:00:00",
        "URL": "\"\"https://www.bop.gov/resources/pdfs/phc.pdf\"\";\"\"wait...\"\";\"\"wait...\"\";\"\"wait...\"\";\"\"wait...\"\";\"\"wait...\"\";\"\"wait...\"\";\"\"wait...\"\"",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Exclude",
        "Exclusion Reason Final Level 2": "Not by country health authorities or medical organisation",
        "Title": "Preventive Health Care Screening - Federal Bureau of Prisons",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "Grey",
        "Date Access": "2022-05-27 00:00:00",
        "URL": "\"\"https://www.cancer.gov/types/prostate/hp/prostate-screening-pdq\"\";\"\"966\"\";\"\"9847600\"\";\"\"63",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Exclude",
        "Exclusion Reason Final Level 2": "Summary study, not guideline, no screening details, no details, no analysis",
        "Title": "Prostate Cancer Screening (PDQÃ¥Â¨)ÂÃÃHealth Professional ...",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "Grey",
        "Date Access": "2022-05-23 00:00:00",
        "URL": "\"\"https://www.cancer.gov/types/prostate/psa-fact-sheet\"\";\"\"15767\"\";\"\"9847600\"\";\"\"63",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Exclude",
        "Exclusion Reason Final Level 2": "Summary study, not guideline, no screening details, no details, no analysis",
        "Title": "Prostate-Specific Antigen (PSA) Test - NCI",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "Grey",
        "Date Access": "2022-05-23 00:00:00",
        "URL": "\"\"https://www.cancer.gov/types/prostate/research\"\";\"\"1635\"\";\"\"9847600\"\";\"\"63",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Exclude",
        "Exclusion Reason Final Level 2": "Management and/or treatment",
        "Title": "Advances in Prostate Cancer Research - NCI",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "Grey",
        "Date Access": "2022-05-27 00:00:00",
        "URL": "\"\"https://www.cancer.org/cancer/prostate-cancer/detection-diagnosis-staging/acs-recommendations.html\"\";\"\"7470\"\";\"\"14659475\"\";\"\"28",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Exclude",
        "Exclusion Reason Final Level 2": "For public consumption, patient info/guide, trial information",
        "Title": "American Cancer Society Recommendations for Prostate ...",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "Grey",
        "Date Access": "2022-05-23 00:00:00",
        "URL": "\"\"https://www.cancer.org/cancer/prostate-cancer/detection-diagnosis-staging/detection.html\"\";\"\"501\"\";\"\"14896038\"\";\"\"28",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Exclude",
        "Exclusion Reason Final Level 2": "For public consumption, patient info/guide, trial information",
        "Title": "Can Prostate Cancer Be Found Early?",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "Grey",
        "Date Access": "2022-05-23 00:00:00",
        "URL": "\"\"https://www.cancer.org/cancer/prostate-cancer/treating/watchful-waiting.html\"\";\"\"wait...\"\";\"\"14896038\"\";\"\"28",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Exclude",
        "Exclusion Reason Final Level 2": "Management and/or treatment",
        "Title": "Observation or Active Surveillance for Prostate Cancer",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "Grey",
        "Date Access": "2022-05-27 00:00:00",
        "URL": "\"\"https://www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-statistics/annual-cancer-facts-and-figures/2018/cancer-facts-and-figures-2018.pdf\"\";\"\"4777\"\";\"\"14659475\"\";\"\"28",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Exclude",
        "Exclusion Reason Final Level 2": "Not research study objectives - ie not prostate cancer-related or decision aid or guideline or programme related to prostate cancer",
        "Title": "Cancer Facts & Figures 2018 - American Cancer Society",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "Grey",
        "Date Access": "2022-05-23 00:00:00",
        "URL": "\"\"https://www.cancer.org/content/dam/CRC/PDF/Public/8795.00.pdf\"\";\"\"wait...\"\";\"\"14896038\"\";\"\"28",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Exclude",
        "Exclusion Reason Final Level 2": "For public consumption, patient info/guide, trial information",
        "Title": "Prostate Cancer Early Detection, Diagnosis, and Staging",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "Grey",
        "Date Access": "2022-05-23 00:00:00",
        "URL": "\"\"https://www.cancerresearchuk.org/health-professional/diagnosis/early-diagnosis-initiative\"\";\"\"wait...\"\";\"\"12644307\"\";\"\"162",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Exclude",
        "Exclusion Reason Final Level 2": "Not research study objectives - ie not prostate cancer-related or decision aid or guideline or programme related to prostate cancer",
        "Title": "Early Diagnosis Initiative | Cancer Research UK",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "Grey",
        "Date Access": "2022-05-27 00:00:00",
        "URL": "Cannot access",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Exclude",
        "Exclusion Reason Final Level 2": "For public consumption, patient info/guide, trial information",
        "Title": "American Society of Clinical Oncology | Choosing Wisely",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "Grey",
        "Date Access": "2022-05-27 00:00:00",
        "URL": "\"\"https://www.cms.gov/medicare-coverage-database/view/lcd.aspx?lcdid=37733&ver=7&\"\";\"\"23\"\";\"\"24447045\"\";\"\"162",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Exclude",
        "Exclusion Reason Final Level 2": "For public consumption, patient info/guide, trial information",
        "Title": "Biomarker Testing (Prior to Initial Biopsy) for Prostate Cancer ...",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "Grey",
        "Date Access": "2022-05-10 00:00:00",
        "URL": "\"\"https://www.dana-farber.org/prostate-cancer/diagnosis/\"\";\"\"wait...\"\";\"\"wait...\"\";\"\"wait...\"\";\"\"wait...\"\";\"\"wait...\"\";\"\"wait...\"\";\"\"wait...\"\"",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Exclude",
        "Exclusion Reason Final Level 2": "For public consumption, patient info/guide, trial information",
        "Title": "How We Diagnose Prostate Cancer | Boston, MA",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "Grey",
        "Date Access": "2022-05-27 00:00:00",
        "URL": "\"\"https://www.england.nhs.uk/wp-content/uploads/2019/02/report-of-the-independent-review-of-adult-screening-programme-in-england.pdf\"\";\"\"wait...\"\";\"\"9868337\"\";\"\"139",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Exclude",
        "Exclusion Reason Final Level 2": "Not research study objectives - ie not prostate cancer-related or decision aid or guideline or programme related to prostate cancer",
        "Title": "report-of-the-independent-review-of-adult-screening ...",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "Grey",
        "Date Access": "2022-05-27 00:00:00",
        "URL": "https://who-sandbox.squiz.cloud/en/health-topics/noncommunicable-diseases/cancer/policy/screening-and-early-detection",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Exclude",
        "Exclusion Reason Final Level 2": "Not research study objectives - ie not prostate cancer-related or decision aid or guideline or programme related to prostate cancer",
        "Title": "Screening and early detection - WHO/Europe",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "Grey",
        "Date Access": "2022-05-27 00:00:00",
        "URL": "\"\"https://www.europeancancer.org/index.php?option=com_attachments&task=download&id=695:ECO_Earlier-is-Better-Advancing-Cancer-Screening-and-Early-Detection_2021\"\";\"\"0\"\";\"\"585287\"\";\"\"2",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Exclude",
        "Exclusion Reason Final Level 2": "Summary study, not guideline, no screening details, no details, no analysis",
        "Title": "Advancing Cancer Screening and Early Detection",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "Non-Grey",
        "Date Access": "2022-05-23 00:00:00",
        "URL": "\"\"https://www.frontiersin.org/articles/10.3389/fimmu.2021.786828/full\"\";\"\"5\"\";\"\"2412176732\"\";\"\"789",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Exclude",
        "Exclusion Reason Final Level 2": "Primary study or not systematic review",
        "Title": "Prostate Cancer: Early Detection and Assessing Clinical Risk ...",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "Non-Grey",
        "Date Access": "2022-05-27 00:00:00",
        "URL": "\"\"https://www.frontiersin.org/articles/10.3389/fonc.2019.01263/full\"\";\"\"52\"\";\"\"2344426527\"\";\"\"711",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Exclude",
        "Exclusion Reason Final Level 2": "Management and/or treatment",
        "Title": "A New Era of Prostate Cancer Precision Medicine - Frontiers",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "Non-Grey",
        "Date Access": "2022-05-27 00:00:00",
        "URL": "\"\"https://www.frontiersin.org/articles/10.3389/fonc.2020.00582/full\"\";\"\"167\"\";\"\"2344426527\"\";\"\"711",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Exclude",
        "Exclusion Reason Final Level 2": "Primary study or not systematic review",
        "Title": "New Screening Test Improves Detection of Prostate Cancer ...",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "Non-Grey",
        "Date Access": "2022-05-24 00:00:00",
        "URL": "\"\"https://www.goldjournal.net/article/S0090-4295(99)80252-0/fulltext\"\";\"\"0\"\";\"\"98520\"\";\"\"5",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Exclude",
        "Exclusion Reason Final Level 2": "Others",
        "Title": "Screening, early detection, and treatment of prostate cancer",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "Grey",
        "Date Access": "2022-05-27 00:00:00",
        "URL": "\"\"https://www.gov.scot/publications/recovery-redesign-action-plan-cancer-services/pages/7/\"\";\"\"wait...\"\";\"\"wait...\"\";\"\"wait...\"\";\"\"wait...\"\";\"\"wait...\"\";\"\"wait...\"\";\"\"wait...\"\"",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Exclude",
        "Exclusion Reason Final Level 2": "Not research study objectives - ie not prostate cancer-related or decision aid or guideline or programme related to prostate cancer",
        "Title": "Recovery and redesign: cancer services - action plan - gov.scot",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "Grey",
        "Date Access": "2022-05-27 00:00:00",
        "URL": "\"\"https://www.guidelinesinpractice.co.uk/cancer/key-learning-points-nice-prostate-cancer/454919.article\"\";\"\"wait...\"\";\"\"wait...\"\";\"\"3",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Exclude",
        "Exclusion Reason Final Level 2": "Not by country health authorities or medical organisation",
        "Title": "Key learning points: NICE prostate cancer - Guidelines in ...",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "Grey",
        "Date Access": "2022-05-27 00:00:00",
        "URL": "\"\"https://www.hardingcenter.de/en/early-detection-of-cancer/early-detection-of-prostate-cancer-with-psa-testing\"\";\"\"67\"\";\"\"18762\"\";\"\"1",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Exclude",
        "Exclusion Reason Final Level 2": "For public consumption, patient info/guide, trial information",
        "Title": "Early detection of prostate cancer with PSA testing - Harding ...",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "Grey",
        "Date Access": "2022-05-27 00:00:00",
        "URL": "\"\"https://www.healthknowledge.org.uk/public-health-textbook/disease-causation-diagnostic/2c-diagnosis-screening/planning-operation-evaluation\"\";\"\"14\"\";\"\"50282\"\";\"\"3",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Exclude",
        "Exclusion Reason Final Level 2": "Not research study objectives - ie not prostate cancer-related or decision aid or guideline or programme related to prostate cancer",
        "Title": "Planning, operation and evaluation of screening programmes",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "Grey",
        "Date Access": "2022-05-10 00:00:00",
        "URL": "\"\"https://www.ipaac.eu/res/file/outputs/wp5/new-openings-cancer-screening-europe.pdf\"\";\"\"wait...\"\";\"\"wait...\"\";\"\"757 \"\";\"\"12897814\"\";\"\"20848704\"\";\"\"1\"\";\"\"1\"\"",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Exclude",
        "Exclusion Reason Final Level 2": "Summary study, not guideline, no screening details, no details, no analysis",
        "Title": "New openings of cancer screening in Europe - iPAAC",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "Non-Grey",
        "Date Access": "2022-05-10 00:00:00",
        "URL": "\"\"https://www.mja.com.au/journal/2013/198/10/risk-assessment-guide-prostate-cancer-screening-decisions-cost-effectiveness\"\";\"\"3\"\";\"\"690917\"\";\"\"28",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Exclude",
        "Exclusion Reason Final Level 2": "Primary study or not systematic review",
        "Title": "Risk assessment to guide prostate cancer screening decisions",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "Grey",
        "Date Access": "2022-05-10 00:00:00",
        "URL": "\"\"https://www.moh.gov.my/index.php/dl/554756755a584a6961585268626938794d4445334c314a31616e567259573476546d46306157397559577866553352795958526c5a326c6a5831427359573566516d39766131396d61573568624541794e564e46554651794d4445334c6e426b5a673d3d\"\";\"\"13\"\";\"\"730301\"\";\"\"25",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Exclude",
        "Exclusion Reason Final Level 2": "Not research study objectives - ie not prostate cancer-related or decision aid or guideline or programme related to prostate cancer",
        "Title": "NATIONAL STRATEGIC PLAN FOR CANCER CONTROL ...",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "Non-Grey",
        "Date Access": "2022-05-27 00:00:00",
        "URL": "\"\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1502372/\"\";\"\"22\"\";\"\"2206557410\"\";\"\"193",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Exclude",
        "Exclusion Reason Final Level 2": "Not research study objectives - ie not prostate cancer-related or decision aid or guideline or programme related to prostate cancer",
        "Title": "Prostate Cancer: Epidemiology and Screening - PMC - NCBI",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "Non-Grey",
        "Date Access": "2022-05-23 00:00:00",
        "URL": "\"\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4203149/\"\";\"\"377\"\";\"\"2289175364\"\";\"\"172",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Exclude",
        "Exclusion Reason Final Level 2": "Not research study objectives - ie not prostate cancer-related or decision aid or guideline or programme related to prostate cancer",
        "Title": "Prevention and Early Detection of Prostate Cancer - PMC - NCBI",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "Non-Grey",
        "Date Access": "2022-05-23 00:00:00",
        "URL": "\"\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5467686/\"\";\"\"168\"\";\"\"2206557410\"\";\"\"193",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Exclude",
        "Exclusion Reason Final Level 2": "Not research study objectives - ie not prostate cancer-related or decision aid or guideline or programme related to prostate cancer",
        "Title": "Cancer screening and early detection in the 21st century - NCBI",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "Non-Grey",
        "Date Access": "2022-05-23 00:00:00",
        "URL": "\"\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5935113/\"\";\"\"wait...\"\";\"\"2289175364\"\";\"\"172",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Exclude",
        "Exclusion Reason Final Level 2": "Not research study objectives - ie not prostate cancer-related or decision aid or guideline or programme related to prostate cancer",
        "Title": "Prostate Cancer Screening - PMC - NCBI",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "Non-Grey",
        "Date Access": "2022-05-23 00:00:00",
        "URL": "\"\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6139871/\"\";\"\"2\"\";\"\"2289175364\"\";\"\"172",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Exclude",
        "Exclusion Reason Final Level 2": "Primary study or not systematic review",
        "Title": "Prostate Cancer: Update on Early Detection and New ... - NCBI",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "Grey",
        "Date Access": "2022-05-10 00:00:00",
        "URL": "\"\"https://www.nccn.org/guidelines/guidelines-process/transparency-process-and-recommendations/GetFileFromFileManager?fileManagerId=11673\"\";\"\"0\"\";\"\"579212\"\";\"\"50",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Exclude",
        "Exclusion Reason Final Level 2": "News, lecturer note, thesis, draft, proposal, module, stimulation, presscast, fact sheet, opinion, editorial",
        "Title": "NCCN Guidelines for Prostate Cancer Early Detection V.1.2021",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "Non-Grey",
        "Date Access": "2022-05-27 00:00:00",
        "URL": "\"\"https://www.nejm.org/doi/full/10.1056/nejmoa1311593\"\";\"\"11\"\";\"\"16153342\"\";\"\"250",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Exclude",
        "Exclusion Reason Final Level 2": "Primary study or not systematic review",
        "Title": "Radical Prostatectomy or Watchful Waiting in Early Prostate ...",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "Non-Grey",
        "Date Access": "2022-05-27 00:00:00",
        "URL": "\"\"https://www.nejm.org/doi/full/10.1056/NEJMoa1910038\"\";\"\"wait...\"\";\"\"wait...\"\";\"\"250",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Exclude",
        "Exclusion Reason Final Level 2": "Primary study or not systematic review",
        "Title": "MRI-Targeted, Systematic, and Combined Biopsy for Prostate ...",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "Grey",
        "Date Access": "2022-05-27 00:00:00",
        "URL": "\"\"https://www.nice.org.uk/guidance/ng131/chapter/recommendations\"\";\"\"0\"\";\"\"32763161\"\";\"\"287",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Exclude",
        "Exclusion Reason Final Level 2": "Not research study objectives - ie not prostate cancer-related or decision aid or guideline or programme related to prostate cancer",
        "Title": "Prostate cancer: diagnosis and management | Guidance | NICE",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "Non-Grey",
        "Date Access": "2022-05-24 00:00:00",
        "URL": "\"\"https://www.phrp.com.au/issues/july-2017-volume-27-issue-3/psa-testing-for-men-at-average-risk-of-prostate-cancer/\"\";\"\"1\"\";\"\"101597\"\";\"\"3",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Exclude",
        "Exclusion Reason Final Level 2": "News, lecturer note, thesis, draft, proposal, module, stimulation, presscast, fact sheet, opinion, editorial",
        "Title": "PSA testing for men at average risk of prostate cancer | PHRP",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "Grey",
        "Date Access": "2022-05-10 00:00:00",
        "URL": "\"\"https://www.research.va.gov/currents/0122-VA-clinicians-testing-new-radioactive-tracer-drug-to-track-prostate-cancer-in-the-body.cfm\"\";\"\"wait...\"\";\"\"wait...\"\";\"\"wait...\"\";\"\"wait...\"\";\"\"wait...\"\";\"\"wait...\"\";\"\"wait...\"\"",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Exclude",
        "Exclusion Reason Final Level 2": "Not research study objectives - ie not prostate cancer-related or decision aid or guideline or programme related to prostate cancer",
        "Title": "VA clinicians testing new radioactive tracer drug to track ...",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "Non-Grey",
        "Date Access": "2022-05-27 00:00:00",
        "URL": "\"\"https://www.researchgate.net/publication/330272750_Key_indicators_of_organized_cancer_screening_programs_Results_from_a_Delphi_study\"\";\"\"0\"\";\"\"504149507\"\";\"\"8",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Exclude",
        "Exclusion Reason Final Level 2": "Primary study or not systematic review",
        "Title": "Key indicators of organized cancer screening programs",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "Non-Grey",
        "Date Access": "2022-05-27 00:00:00",
        "URL": "\"\"https://www.scielo.br/j/ibju/a/mSJjNPk5pjJdzY39NjhSD9Q/?lang=en\"\";\"\"0\"\";\"\"42079295\"\";\"\"2",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Exclude",
        "Exclusion Reason Final Level 2": "Primary study or not systematic review",
        "Title": "Metastatic prostate cancer in the modern era of PSA screening",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "Non-Grey",
        "Date Access": "2022-05-10 00:00:00",
        "URL": "\"\"https://www.scirp.org/journal/paperinformation.aspx?paperid=114608\"\";\"\"36\"\";\"\"1798676\"\";\"\"420",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Exclude",
        "Exclusion Reason Final Level 2": "Primary study or not systematic review",
        "Title": "Prostate Cancer Screening by General Practitioners in LomÃÂ© ...",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "Grey",
        "Date Access": "2022-05-23 00:00:00",
        "URL": "\"\"https://www.seattlecca.org/prevention/prostate-cancer-early-detection\"\";\"\"23\"\";\"\"66219\"\";\"\"4",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Exclude",
        "Exclusion Reason Final Level 2": "Not by country health authorities or medical organisation",
        "Title": "Prostate cancer screening and early detection",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "Grey",
        "Date Access": "2022-05-27 00:00:00",
        "URL": "\"\"https://www.selectscience.net/editorial-articles/early-detection-of-prostate-cancer-through-game-changing-molecular-biomarkers/?artID=52161\"\";\"\"wait...\"\";\"\"wait...\"\";\"\"wait...\"\";\"\"wait...\"\";\"\"wait...\"\";\"\"wait...\"\";\"\"wait...\"\"",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Exclude",
        "Exclusion Reason Final Level 2": "News, lecturer note, thesis, draft, proposal, module, stimulation, presscast, fact sheet, opinion, editorial",
        "Title": "Early detection of prostate cancer with RNA ISH technology",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "Grey",
        "Date Access": "2022-05-27 00:00:00",
        "URL": "\"\"https://www.strategyunitwm.nhs.uk/sites/default/files/2021-04/20210407%20Early%20diagnosis%20of%20cancer_FINAL_0.pdf\"\";\"\"wait...\"\";\"\"wait...\"\";\"\"wait...\"\";\"\"wait...\"\";\"\"wait...\"\";\"\"1\"\";\"\"1\"\"",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Exclude",
        "Exclusion Reason Final Level 2": "Not research study objectives - ie not prostate cancer-related or decision aid or guideline or programme related to prostate cancer",
        "Title": "Evidence Review: Early diagnosis of cancer - The Strategy Unit",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "Grey",
        "Date Access": "2022-05-27 00:00:00",
        "URL": "\"\"https://www.ucl.ac.uk/cancer/aced-funded-research-projects-ucl\"\";\"\"1\"\";\"\"13466809\"\";\"\"347",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Exclude",
        "Exclusion Reason Final Level 2": "Not research study objectives - ie not prostate cancer-related or decision aid or guideline or programme related to prostate cancer",
        "Title": "ACED Funded Research Projects at UCL | UCL Cancer Institute",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "Grey",
        "Date Access": "2022-05-27 00:00:00",
        "URL": "https://www.uclahealth.org/cancer/cancer-services/prostate-cancer/diagnosis-prostate-cancer",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Exclude",
        "Exclusion Reason Final Level 2": "For public consumption, patient info/guide, trial information",
        "Title": "Prostate Cancer Diagnosis - UCLA Health",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "Grey",
        "Date Access": "2022-05-10 00:00:00",
        "URL": "https://www.ucsfhealth.org/conditions/prostate-cancer-localized",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Exclude",
        "Exclusion Reason Final Level 2": "For public consumption, patient info/guide, trial information",
        "Title": "Diagnosis & Assessment | Prostate Cancer | UCSF Health",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "Grey",
        "Date Access": "2022-05-27 00:00:00",
        "URL": "\"\"https://www.uspreventiveservicestaskforce.org/Home/GetFile/1/16811/prostate-cancer-final-evidence-review/pdf\"\";\"\"wait...\"\";\"\"wait...\"\";\"\"wait...\"\";\"\"wait...\"\";\"\"wait...\"\";\"\"wait...\"\";\"\"wait...\"\"",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Exclude",
        "Exclusion Reason Final Level 2": "Summary study, not guideline, no screening details, no details, no analysis",
        "Title": "Prostate-Specific AntigenÂÃÃBased Screening for Prostate Cancer",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "Grey",
        "Date Access": "2022-05-27 00:00:00",
        "URL": "\"\"https://www2.tri-kobe.org/nccn/guideline/archive/urological2016-2017/english/prostate.pdf\"\";\"\"337\"\";\"\"39491\"\";\"\"",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Exclude",
        "Exclusion Reason Final Level 2": "Not research study objectives - ie not prostate cancer-related or decision aid or guideline or programme related to prostate cancer",
        "Title": "NCCN Guidelines Version 1.2016 Prostate Cancer",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "Grey",
        "Date Access": "2022-05-23 00:00:00",
        "URL": "\"\"https://uroweb.org/epad19-european-psa-screening-programme-is-on-its-way-part-2\"\";\"\"0\"\";\"\"1114359\"\";\"\"15",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Exclude",
        "Exclusion Reason Final Level 2": "News, lecturer note, thesis, draft, proposal, module, stimulation, presscast, fact sheet, opinion, editorial",
        "Title": "68EPAD19: European PSA screening programme is on its way",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "Grey",
        "Date Access": "2022-05-23 00:00:00",
        "URL": "\"\"http://www.bccancer.bc.ca/health-info/types-of-cancer/pelvic-area/prostate\"\";\"\"175\"\";\"\"156117\"\";\"\"10",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Exclude",
        "Exclusion Reason Final Level 2": "For public consumption, patient info/guide, trial information",
        "Title": "Prostate - BC Cancer",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "Grey",
        "Date Access": "2022-05-10 00:00:00",
        "URL": "\"\"https://advances.massgeneral.org/digestive-health/article.aspx?id=1350\"\";\"\"0\"\";\"\"32669\"\";\"\"5",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Exclude",
        "Exclusion Reason Final Level 2": "Not by country health authorities or medical organisation",
        "Title": "ADVANCING GENETIC TESTING FOR PROSTATE CANCER",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "Non-Grey",
        "Date Access": "2022-05-23 00:00:00",
        "URL": "\"\"https://bjgp.org/content/64/629/e783\"\";\"\"7\"\";\"\"3113224\"\";\"\"12",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Exclude",
        "Exclusion Reason Final Level 2": "Primary study or not systematic review",
        "Title": "Digital rectal examination in primary care is important for early ...",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "Grey",
        "Date Access": "2022-05-27 00:00:00",
        "URL": "\"\"https://cancer.ca/en/about-us/prostate-cancer\"\";\"\"16277\"\";\"\"544444\"\";\"\"31",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Exclude",
        "Exclusion Reason Final Level 2": "For public consumption, patient info/guide, trial information",
        "Title": "Prostate cancer",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "Grey",
        "Date Access": "2022-05-27 00:00:00",
        "URL": "\"\"https://cancer.ca/en/treatments/tests-and-procedures/prostate-specific-antigen-psa-test\"\";\"\"494\"\";\"\"504823\"\";\"\"27",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Exclude",
        "Exclusion Reason Final Level 2": "For public consumption, patient info/guide, trial information",
        "Title": "Prostate-specific antigen (PSA) test",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "Grey",
        "Date Access": "2022-05-10 00:00:00",
        "URL": "\"\"https://cansa.org.za/cansas-care-support/cancer-risk-reduction-screening/\"\";\"\"11\"\";\"\"8709\"\";\"\"2",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Exclude",
        "Exclusion Reason Final Level 2": "For public consumption, patient info/guide, trial information",
        "Title": "Cancer Risk-Reduction Screening",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "Grey",
        "Date Access": "2022-05-24 00:00:00",
        "URL": "\"\"https://evidence.nejm.org/doi/full/10.1056/EVIDoa2200031\"\";\"\"5\"\";\"\"75865\"\";\"\"11",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Exclude",
        "Exclusion Reason Final Level 2": "Primary study or not systematic review",
        "Title": "Harm-to-Benefit of Three Decades of Prostate Cancer Screening in Black Men",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "Grey",
        "Date Access": "2022-05-27 00:00:00",
        "URL": "\"\"https://evidence.nihr.ac.uk/alert/active-monitoring-early-prostate-cancer-prevents-death-effectively-as-surgery-radiotherapy/\"\";\"\"1\"\";\"\"21160\"\";\"\"3",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Exclude",
        "Exclusion Reason Final Level 2": "Primary study or not systematic review",
        "Title": "Active monitoring in early prostate cancer prevents as many deaths as surgery or radiotherapy, new research shows",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "Grey",
        "Date Access": "2022-05-27 00:00:00",
        "URL": "\"\"https://fqc.qc.ca/en/information/the-cancer/cancer-screening\"\";\"\"wait...\"\";\"\"wait...\"\";\"\"wait...\"\";\"\"wait...\"\";\"\"wait...\"\";\"\"wait...\"\";\"\"wait...\"\"",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Exclude",
        "Exclusion Reason Final Level 2": "For public consumption, patient info/guide, trial information",
        "Title": "Cancer screening",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "Grey",
        "Date Access": "2022-05-23 00:00:00",
        "URL": "\"\"https://iris.paho.org/bitstream/handle/10665.2/34934/pahonmh18009.pdf?sequence=1&isAllowed=y\"\";\"\"0\"\";\"\"526177\"\";\"\"85",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Exclude",
        "Exclusion Reason Final Level 2": "Summary study, not guideline, no screening details, no details, no analysis",
        "Title": "Expert Consultation on Prostate Cancer Screening and Early ...",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "Grey",
        "Date Access": "2022-05-10 00:00:00",
        "URL": "\"\"https://lifelabs.azureedge.net/lifelabs-wp-cdn/wp-content/uploads/2018/08/psa.pdf\"\";\"\"25\"\";\"\"6209\"\";\"\"7",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Exclude",
        "Exclusion Reason Final Level 2": "Others",
        "Title": "Prostate-Specific Antigen (PSA) Test",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "Grey",
        "Date Access": "2022-05-27 00:00:00",
        "URL": "\"\"https://med.mahidol.ac.th/cancer_center/sites/default/files/public/DownloadSlide/ProstateCancerMasterClass2017/1.Pocharapong-Prostate%20Cancer%20Screening%20Guidelines%20in%202017.pdf\"\";\"\"6\"\";\"\"3682793\"\";\"\"15",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Exclude",
        "Exclusion Reason Final Level 2": "News, lecturer note, thesis, draft, proposal, module, stimulation, presscast, fact sheet, opinion, editorial",
        "Title": "Prostate Cancer Screening Guidelines in 2017",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "Grey",
        "Date Access": "2022-05-24 00:00:00",
        "URL": "\"\"https://medlineplus.gov/genetics/condition/prostate-cancer/\"\";\"\"1244\"\";\"\"72500753\"\";\"\"88",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Exclude",
        "Exclusion Reason Final Level 2": "For public consumption, patient info/guide, trial information",
        "Title": "Prostate cancer - Genetics - MedlinePlus",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "Grey",
        "Date Access": "2022-05-10 00:00:00",
        "URL": "\"\"https://medlineplus.gov/lab-tests/tumor-marker-tests/\"\";\"\"wait...\"\";\"\"wait...\"\";\"\"86",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Exclude",
        "Exclusion Reason Final Level 2": "For public consumption, patient info/guide, trial information",
        "Title": "Tumor Marker Tests",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "Grey",
        "Date Access": "2022-05-23 00:00:00",
        "URL": "\"\"https://medlineplus.gov/prostatecancerscreening.html\"\";\"\"wait...\"\";\"\"72500753\"\";\"\"88",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Exclude",
        "Exclusion Reason Final Level 2": "For public consumption, patient info/guide, trial information",
        "Title": "Prostate Cancer Screening | PSA Test | MedlinePlus",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "Non-Grey",
        "Date Access": "2022-05-27 00:00:00",
        "URL": "\"\"https://mhealth.jmir.org/2017/12/e187/\"\";\"\"6\"\";\"\"wait...\"\";\"\"12",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Exclude",
        "Exclusion Reason Final Level 2": "Not research study objectives - ie not prostate cancer-related or decision aid or guideline or programme related to prostate cancer",
        "Title": "Mobile Phone Apps for Quality of Life and Well-Being ...",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "Grey",
        "Date Access": "2022-05-27 00:00:00",
        "URL": "\"\"https://prostatecancerinfolink.net/diagnosis/screening-diagnosis/\"\";\"\"5\"\";\"\"57675\"\";\"\"4",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Exclude",
        "Exclusion Reason Final Level 2": "For public consumption, patient info/guide, trial information",
        "Title": "Prostate cancer screening and early detection",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "Non-Grey",
        "Date Access": "2022-05-27 00:00:00",
        "URL": "\"\"https://smw.ch/article/doi/smw.2018.14584\"\";\"\"wait...\"\";\"\"wait...\"\";\"\"wait...\"\";\"\"wait...\"\";\"\"wait...\"\";\"\"wait...\"\";\"\"wait...\"\"",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Exclude",
        "Exclusion Reason Final Level 2": "Summary study, not guideline, no screening details, no details, no analysis",
        "Title": "Shared decision-making for prostate cancer screening and treatment: a systematic review of randomised controlled trials",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "Grey",
        "Date Access": "2022-05-24 00:00:00",
        "URL": "\"\"https://stanfordhealthcare.org/campaigns/preventive-screenings.html\"\";\"\"148\"\";\"\"4181918\"\";\"\"101",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Exclude",
        "Exclusion Reason Final Level 2": "Not by country health authorities or medical organisation",
        "Title": "Cancer Preventive Screening and Early Detection",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "Grey",
        "Date Access": "2022-05-27 00:00:00",
        "URL": "\"\"https://ufhealth.org/prostate-cancer\"\";\"\"wait...\"\";\"\"wait...\"\";\"\"wait...\"\";\"\"wait...\"\";\"\"wait...\"\";\"\"wait...\"\";\"\"wait...\"\"",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Exclude",
        "Exclusion Reason Final Level 2": "Not by country health authorities or medical organisation",
        "Title": "Prostate cancer",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "Grey",
        "Date Access": "2022-05-10 00:00:00",
        "URL": "\"\"https://www.cadth.ca/overview-liquid-biopsy-screening-and-early-detection-cancer\"\";\"\"7\"\";\"\"646241\"\";\"\"20",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Exclude",
        "Exclusion Reason Final Level 2": "Summary study, not guideline, no screening details, no details, no analysis",
        "Title": "An Overview of Liquid Biopsy for Screening and Early Detection of Cancer",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "Grey",
        "Date Access": "2022-05-23 00:00:00",
        "URL": "\"\"https://www.cancer.gov/about-cancer/screening/screening-tests\"\";\"\"6038\"\";\"\"10120836\"\";\"\"63",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Exclude",
        "Exclusion Reason Final Level 2": "For public consumption, patient info/guide, trial information",
        "Title": "What Cancer Screening Tests Check for Cancer? - NCI",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "Grey",
        "Date Access": "2022-05-27 00:00:00",
        "URL": "\"\"https://www.cancer.org.au/cancer-information/causes-and-prevention/early-detection-and-screening\"\";\"\"154\"\";\"\"2176777\"\";\"\"10",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Exclude",
        "Exclusion Reason Final Level 2": "Summary study, not guideline, no screening details, no details, no analysis",
        "Title": "Early detection and screening | Cancer Council",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "Grey",
        "Date Access": "2022-05-23 00:00:00",
        "URL": "\"\"https://www.cancer.org.au/cancer-information/causes-and-prevention/early-detection-and-screening/early-detection-of-prostate-cancer\"\";\"\"805\"\";\"\"2176777\"\";\"\"10",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Exclude",
        "Exclusion Reason Final Level 2": "Summary study, not guideline, no screening details, no details, no analysis",
        "Title": "Early detection of prostate cancer",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "Grey",
        "Date Access": "2022-05-10 00:00:00",
        "URL": "\"\"https://www.canceraustralia.gov.au/impacted-cancer/check-your-cancer-risk-online\"\";\"\"219\"\";\"\"64281\"\";\"\"7",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Exclude",
        "Exclusion Reason Final Level 2": "Not research study objectives - ie not prostate cancer-related or decision aid or guideline or programme related to prostate cancer",
        "Title": "Cancer risk online assessment tools",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "Grey",
        "Date Access": "2022-05-23 00:00:00",
        "URL": "\"\"https://www.cancercouncil.com.au/cancer-prevention/screening/reducing-your-risk-of-prostate-cancer/\"\";\"\"20\"\";\"\"125778\"\";\"\"7",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Exclude",
        "Exclusion Reason Final Level 2": "For public consumption, patient info/guide, trial information",
        "Title": "Testing for Prostate Cancer",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "Grey",
        "Date Access": "2022-05-23 00:00:00",
        "URL": "\"\"https://www.cancerresearchuk.org/about-cancer/screening\"\";\"\"wait...\"\";\"\"12644307\"\";\"\"162",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Exclude",
        "Exclusion Reason Final Level 2": "For public consumption, patient info/guide, trial information",
        "Title": "Screening for cancer | Cancer Research UK",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "Grey",
        "Date Access": "2022-05-27 00:00:00",
        "URL": "\"\"https://www.cancervic.org.au/cancer-information/types-of-cancer/prostate_cancer/diagnosing_prostate_cancer.html\"\";\"\"84\"\";\"\"88989\"\";\"\"4",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Exclude",
        "Exclusion Reason Final Level 2": "For public consumption, patient info/guide, trial information",
        "Title": "Prostate cancer",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "Grey",
        "Date Access": "2022-05-27 00:00:00",
        "URL": "https://www.cdc.gov/cancer/dcpc/about/index.htm",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Exclude",
        "Exclusion Reason Final Level 2": "Not research study objectives - ie not prostate cancer-related or decision aid or guideline or programme related to prostate cancer",
        "Title": "Programs to Prevent and Control Cancer | CDC",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "Grey",
        "Date Access": "2022-05-23 00:00:00",
        "URL": "\"\"https://www.cdc.gov/cancer/prostate/basic_info/screening.htm\"\";\"\"wait...\"\";\"\"194701036\"\";\"\"1",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Exclude",
        "Exclusion Reason Final Level 2": "For public consumption, patient info/guide, trial information",
        "Title": "What Is Screening for Prostate Cancer? | CDC",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "Grey",
        "Date Access": "2022-05-27 00:00:00",
        "URL": "\"\"https://www.choosingwisely.org/patient-resources/imaging-tests-for-early-prostate-cancer/\"\";\"\"319\"\";\"\"176186\"\";\"\"6",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Exclude",
        "Exclusion Reason Final Level 2": "For public consumption, patient info/guide, trial information",
        "Title": "Imaging Tests for Early Prostate Cancer | Choosing Wisely",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "Grey",
        "Date Access": "2022-05-27 00:00:00",
        "URL": "\"\"https://www.cinj.org/patient-care/cancer-prevention-and-screening-resource-center\"\";\"\"0\"\";\"\"93260\"\";\"\"6",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Exclude",
        "Exclusion Reason Final Level 2": "For public consumption, patient info/guide, trial information",
        "Title": "Cancer Prevention and Screening Resource Center",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "Grey",
        "Date Access": "2022-05-27 00:00:00",
        "URL": "\"\"https://www.hse.ie/eng/services/list/5/cancer/pubs/intelligence/kpis.html\"\";\"\"14\"\";\"\"wait...\"\";\"\"63",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Exclude",
        "Exclusion Reason Final Level 2": "Summary study, not guideline, no screening details, no details, no analysis",
        "Title": "Cancer Key Performance Indicators",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "Grey",
        "Date Access": "2022-05-27 00:00:00",
        "URL": "\"\"https://www.indigenoushpf.gov.au/measures/3-04-early-detection-early-treatment\"\";\"\"wait...\"\";\"\"wait...\"\";\"\"wait...\"\";\"\"wait...\"\";\"\"wait...\"\";\"\"wait...\"\";\"\"wait...\"\"",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Exclude",
        "Exclusion Reason Final Level 2": "Not research study objectives - ie not prostate cancer-related or decision aid or guideline or programme related to prostate cancer",
        "Title": "3.04 Early detection and early treatment - AIHW Indigenous HPF",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "Grey",
        "Date Access": "2022-05-27 00:00:00",
        "URL": "Cannot access",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Exclude",
        "Exclusion Reason Final Level 2": "For public consumption, patient info/guide, trial information",
        "Title": "Prostate cancer",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "Exclude in Level 1",
        "Exclusion Reason Final Level 2": "",
        "Title": "prostate cancer awareness, knowledge, perception - Kenyatta ...",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "Exclude in Level 1",
        "Exclusion Reason Final Level 2": "",
        "Title": "Implementation of Germline Testing for Prostate Cancer",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Intervention/ primary study/erratum/ conference abstract/ commentary/ clinic trial/ newsletter/ magazine/protocol/ literature review",
        "Final Level 2 Consensus": "Exclude in Level 1",
        "Exclusion Reason Final Level 2": "",
        "Title": "Early Detection of Prostate Cancer (PROLIPSY) - Clinical Trials",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Intervention/ primary study/erratum/ conference abstract/ commentary/ clinic trial/ newsletter/ magazine/protocol/ literature review",
        "Final Level 2 Consensus": "Exclude in Level 1",
        "Exclusion Reason Final Level 2": "",
        "Title": "RESEARCH PLAN: ProScreen (Prostate Cancer Screening ...",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not by country health authorities or medical organisation",
        "Final Level 2 Consensus": "Exclude in Level 1",
        "Exclusion Reason Final Level 2": "",
        "Title": "General Cancer Screening Guidelines - Cleveland Clinic",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "Exclude in Level 1",
        "Exclusion Reason Final Level 2": "",
        "Title": "Incidence of prostate cancer in Lithuania after introduction of ...",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "Exclude in Level 1",
        "Exclusion Reason Final Level 2": "",
        "Title": "Strategy for detection of prostate cancer based on relation between prostate specific antigen at age 40-55 and long term risk of metastasis: case-control study",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "Exclude in Level 1",
        "Exclusion Reason Final Level 2": "",
        "Title": "A European Model for an Organised Risk-stratified Early ...",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "Exclude in Level 1",
        "Exclusion Reason Final Level 2": "",
        "Title": "Imaging Diagnosis and Follow-up of Advanced Prostate Cancer",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Intervention/ primary study/erratum/ conference abstract/ commentary/ clinic trial/ newsletter/ magazine/protocol/ literature review",
        "Final Level 2 Consensus": "Exclude in Level 1",
        "Exclusion Reason Final Level 2": "",
        "Title": "A randomized trial of early detection of clinically significant ...",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Intervention/ primary study/erratum/ conference abstract/ commentary/ clinic trial/ newsletter/ magazine/protocol/ literature review",
        "Final Level 2 Consensus": "Exclude in Level 1",
        "Exclusion Reason Final Level 2": "",
        "Title": "PSA-Testing: Risk-Adjusted Screening for Prostate Cancer",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "Exclude in Level 1",
        "Exclusion Reason Final Level 2": "",
        "Title": "Clinical Utility of 4Kscore Ã¥Â¨, ExosomeDxÂÃ£Â¢ and Magnetic Resonance Imaging for the Early Detection of High Grade Prostate Cancer",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "Exclude in Level 1",
        "Exclusion Reason Final Level 2": "",
        "Title": "Victorian cancer plan 2020ÂÃÃ2024 - Improving cancer outcomes for all Victorians",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "Exclude in Level 1",
        "Exclusion Reason Final Level 2": "",
        "Title": "JCO Global Oncology",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "Exclude in Level 1",
        "Exclusion Reason Final Level 2": "",
        "Title": "History - BC Cancer",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Public consumption /patient info/ patient guide",
        "Final Level 2 Consensus": "Exclude in Level 1",
        "Exclusion Reason Final Level 2": "",
        "Title": "DonÂÃÂªt Delay Routine Health Care During the Pandemic",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "Exclude in Level 1",
        "Exclusion Reason Final Level 2": "",
        "Title": "Our research funding portfolio | Canadian Cancer Society",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Intervention/ primary study/erratum/ conference abstract/ commentary/ clinic trial/ newsletter/ magazine/protocol/ literature review",
        "Final Level 2 Consensus": "Exclude in Level 1",
        "Exclusion Reason Final Level 2": "",
        "Title": "PSA population screening is back in favour: here's why",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Intervention/ primary study/erratum/ conference abstract/ commentary/ clinic trial/ newsletter/ magazine/protocol/ literature review",
        "Final Level 2 Consensus": "Exclude in Level 1",
        "Exclusion Reason Final Level 2": "",
        "Title": "Centre for Cancer Genetic Epidemiology",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "Exclude in Level 1",
        "Exclusion Reason Final Level 2": "",
        "Title": "Early Detection of Prostate Cancer (PROLIPSY) - Clinical Trials",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Intervention/ primary study/erratum/ conference abstract/ commentary/ clinic trial/ newsletter/ magazine/protocol/ literature review",
        "Final Level 2 Consensus": "Exclude in Level 1",
        "Exclusion Reason Final Level 2": "",
        "Title": "Call for proposals to monitor and strengthen the implementation of innovative approaches to prostate, lung and gastric cancer screening at Union level",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Intervention/ primary study/erratum/ conference abstract/ commentary/ clinic trial/ newsletter/ magazine/protocol/ literature review",
        "Final Level 2 Consensus": "Exclude in Level 1",
        "Exclusion Reason Final Level 2": "",
        "Title": "Improving citizensÂÃÂª participation in cancer screening programmes and extending them to more types of cancer will help saving lives, EU Chief Scientific Advisors recommend",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Intervention/ primary study/erratum/ conference abstract/ commentary/ clinic trial/ newsletter/ magazine/protocol/ literature review",
        "Final Level 2 Consensus": "Exclude in Level 1",
        "Exclusion Reason Final Level 2": "",
        "Title": "Prostate cancer and PSA testing - an ongoing conundrum",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Intervention/ primary study/erratum/ conference abstract/ commentary/ clinic trial/ newsletter/ magazine/protocol/ literature review",
        "Final Level 2 Consensus": "Exclude in Level 1",
        "Exclusion Reason Final Level 2": "",
        "Title": "Prostate cancer",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Public consumption /patient info/ patient guide",
        "Final Level 2 Consensus": "Exclude in Level 1",
        "Exclusion Reason Final Level 2": "",
        "Title": "Prostate Cancer | Pros & Cons of PSA Testing",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "Exclude in Level 1",
        "Exclusion Reason Final Level 2": "",
        "Title": "Listen: Men can get breast cancer, too. That awareness is key",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "Exclude in Level 1",
        "Exclusion Reason Final Level 2": "",
        "Title": "Integrating genetic testing into the prostate cancer pathway to ...",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Intervention/ primary study/erratum/ conference abstract/ commentary/ clinic trial/ newsletter/ magazine/protocol/ literature review",
        "Final Level 2 Consensus": "Exclude in Level 1",
        "Exclusion Reason Final Level 2": "",
        "Title": "Detecting Prostate Cancer: PSA Screening Still Best Method to Find Prostate Cancer Early",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "Exclude in Level 1",
        "Exclusion Reason Final Level 2": "",
        "Title": "Early Detection of CKD: Implications for Low-Income, Middle ...",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "Exclude in Level 1",
        "Exclusion Reason Final Level 2": "",
        "Title": "Plasma-Derived Exosomal Survivin, a Plausible Biomarker for ...",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Intervention/ primary study/erratum/ conference abstract/ commentary/ clinic trial/ newsletter/ magazine/protocol/ literature review",
        "Final Level 2 Consensus": "Exclude in Level 1",
        "Exclusion Reason Final Level 2": "",
        "Title": "KHN Morning Briefing - Summaries of health policy coverage from major news organizations",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Intervention/ primary study/erratum/ conference abstract/ commentary/ clinic trial/ newsletter/ magazine/protocol/ literature review",
        "Final Level 2 Consensus": "Exclude in Level 1",
        "Exclusion Reason Final Level 2": "",
        "Title": "Study: New Prostate Cancer Test Could Avoid Unnecessary Biopsies",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Intervention/ primary study/erratum/ conference abstract/ commentary/ clinic trial/ newsletter/ magazine/protocol/ literature review",
        "Final Level 2 Consensus": "Exclude in Level 1",
        "Exclusion Reason Final Level 2": "",
        "Title": "Cancer Center | Loma Linda University Health",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Public consumption /patient info/ patient guide",
        "Final Level 2 Consensus": "Exclude in Level 1",
        "Exclusion Reason Final Level 2": "",
        "Title": "What Are the Five Warning Signs of Prostate Cancer?",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Public consumption /patient info/ patient guide",
        "Final Level 2 Consensus": "Exclude in Level 1",
        "Exclusion Reason Final Level 2": "",
        "Title": "Executive Health Programs | Cleveland Clinic Canada",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Public consumption /patient info/ patient guide",
        "Final Level 2 Consensus": "Exclude in Level 1",
        "Exclusion Reason Final Level 2": "",
        "Title": "Prostate Cancer",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Intervention/ primary study/erratum/ conference abstract/ commentary/ clinic trial/ newsletter/ magazine/protocol/ literature review",
        "Final Level 2 Consensus": "Exclude in Level 1",
        "Exclusion Reason Final Level 2": "",
        "Title": "Prostate Cancer Patient Hopes His Story Encourages Early Detection for Others",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Intervention/ primary study/erratum/ conference abstract/ commentary/ clinic trial/ newsletter/ magazine/protocol/ literature review",
        "Final Level 2 Consensus": "Exclude in Level 1",
        "Exclusion Reason Final Level 2": "",
        "Title": "Black men should start prostate-cancer screening at age 45",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "Exclude in Level 1",
        "Exclusion Reason Final Level 2": "",
        "Title": "Clinical trial: Using MRI for prostate cancer diagnosis equals ...",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Public consumption /patient info/ patient guide",
        "Final Level 2 Consensus": "Exclude in Level 1",
        "Exclusion Reason Final Level 2": "",
        "Title": "Distress Screening for Prostate Cancer - UTS Open",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not by country health authorities or medical organisation",
        "Final Level 2 Consensus": "Exclude in Level 1",
        "Exclusion Reason Final Level 2": "",
        "Title": "Prostate Cancer - Causes, Symptoms and Treatment",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Public consumption /patient info/ patient guide",
        "Final Level 2 Consensus": "Exclude in Level 1",
        "Exclusion Reason Final Level 2": "",
        "Title": "Prostate Cancer | Patient Power",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "Exclude in Level 1",
        "Exclusion Reason Final Level 2": "",
        "Title": "PSA screening and deaths from prostate cancer after diagnosis",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "Exclude in Level 1",
        "Exclusion Reason Final Level 2": "",
        "Title": "Cost-effectiveness of prostate cancer screening: a simulation ...",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "Exclude in Level 1",
        "Exclusion Reason Final Level 2": "",
        "Title": "Opportunistic testing versus organized prostate-specific ...",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "Exclude in Level 1",
        "Exclusion Reason Final Level 2": "",
        "Title": "Age-Adjusted PSA Levels in Prostate Cancer Prediction",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "Exclude in Level 1",
        "Exclusion Reason Final Level 2": "",
        "Title": "Role of Magnetic Resonance Imaging in Prostate Cancer ...",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "Exclude in Level 1",
        "Exclusion Reason Final Level 2": "",
        "Title": "Screening for Prostate Cancer Starting at Age 50-54 Years. A ...",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "Exclude in Level 1",
        "Exclusion Reason Final Level 2": "",
        "Title": "Diagnostic and Therapeutic Strategies for Prostate Cancer",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "Exclude in Level 1",
        "Exclusion Reason Final Level 2": "",
        "Title": "Two-Stage Biomarker Protocols for Improving the Precision of ...",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "Exclude in Level 1",
        "Exclusion Reason Final Level 2": "",
        "Title": "TOP2A and EZH2 Provide Early Detection of an Aggressive ...",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "Exclude in Level 1",
        "Exclusion Reason Final Level 2": "",
        "Title": "how to manage indeterminate or equivocal PI-RADS 3 lesions?",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "Exclude in Level 1",
        "Exclusion Reason Final Level 2": "",
        "Title": "Does a novel diagnostic pathway including blood-based risk ...",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "Exclude in Level 1",
        "Exclusion Reason Final Level 2": "",
        "Title": "Proteomic Tissue-Based Classifier for Early Prediction of ...",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "Exclude in Level 1",
        "Exclusion Reason Final Level 2": "",
        "Title": "Serum Prostate-Specific Antigen Testing for Early Detection of ...",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "Exclude in Level 1",
        "Exclusion Reason Final Level 2": "",
        "Title": "Benefit, Harm, and Cost-effectiveness Associated With ...",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "Exclude in Level 1",
        "Exclusion Reason Final Level 2": "",
        "Title": "Prostate Cancer Early Detection",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Non-english",
        "Final Level 2 Consensus": "Exclude in Level 1",
        "Exclusion Reason Final Level 2": "",
        "Title": "Intelligent early prostate cancer detection in 2021 - PubMed",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "Exclude in Level 1",
        "Exclusion Reason Final Level 2": "",
        "Title": "The Impact of Intensifying Prostate Cancer Screening in Black ...",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "Exclude in Level 1",
        "Exclusion Reason Final Level 2": "",
        "Title": "Examining developments in multicancer early detection",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "Exclude in Level 1",
        "Exclusion Reason Final Level 2": "",
        "Title": "MR Imaging of Prostate Cancer in Radiation Oncology - RSNA ...",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "Exclude in Level 1",
        "Exclusion Reason Final Level 2": "",
        "Title": "BRCA-associated Cancers: Role of Imaging in Screening, Diagnosis, and Management",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "Exclude in Level 1",
        "Exclusion Reason Final Level 2": "",
        "Title": "Prostate cancer",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "Exclude in Level 1",
        "Exclusion Reason Final Level 2": "",
        "Title": "Progress and prospects of early detection in lung cancer",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "Exclude in Level 1",
        "Exclusion Reason Final Level 2": "",
        "Title": "Earlier is not necessarily better",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Public consumption /patient info/ patient guide",
        "Final Level 2 Consensus": "Exclude in Level 1",
        "Exclusion Reason Final Level 2": "",
        "Title": "Prostate cancer care",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not by country health authorities or medical organisation",
        "Final Level 2 Consensus": "Exclude in Level 1",
        "Exclusion Reason Final Level 2": "",
        "Title": "When to Get Screened for Prostate Cancer",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not by country health authorities or medical organisation",
        "Final Level 2 Consensus": "Exclude in Level 1",
        "Exclusion Reason Final Level 2": "",
        "Title": "Ovarian Cancer Screening Program | UK Healthcare",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Public consumption /patient info/ patient guide",
        "Final Level 2 Consensus": "Exclude in Level 1",
        "Exclusion Reason Final Level 2": "",
        "Title": "EAU: Focused strategy to encourage timely detection PCa",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Intervention/ primary study/erratum/ conference abstract/ commentary/ clinic trial/ newsletter/ magazine/protocol/ literature review",
        "Final Level 2 Consensus": "Exclude in Level 1",
        "Exclusion Reason Final Level 2": "",
        "Title": "Genetic testing for prostate cancer: What men and their families should know",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "Exclude in Level 1",
        "Exclusion Reason Final Level 2": "",
        "Title": "Hereditary Cancer Syndromes and Risk Assessment | ACOG",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "Exclude in Level 1",
        "Exclusion Reason Final Level 2": "",
        "Title": "Breast Cancer Risk Assessment and Screening in Average-Risk Women",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "Exclude in Level 1",
        "Exclusion Reason Final Level 2": "",
        "Title": "Imaging-based prostate cancer screening among BRCA mutation carriersÂÃÃresults from the first round of screening",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Intervention/ primary study/erratum/ conference abstract/ commentary/ clinic trial/ newsletter/ magazine/protocol/ literature review",
        "Final Level 2 Consensus": "Exclude in Level 1",
        "Exclusion Reason Final Level 2": "",
        "Title": "Prostate Cancer Early Detection ÂÃÃ Arab Association of Urology",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "Exclude in Level 1",
        "Exclusion Reason Final Level 2": "",
        "Title": "Rapid Antigen COVID-19 Tests May Not Be Keeping Pace with Variants of Concern, Researchers Find",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Intervention/ primary study/erratum/ conference abstract/ commentary/ clinic trial/ newsletter/ magazine/protocol/ literature review",
        "Final Level 2 Consensus": "Exclude in Level 1",
        "Exclusion Reason Final Level 2": "",
        "Title": "Getting Genetic Test Results",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not by country health authorities or medical organisation",
        "Final Level 2 Consensus": "Exclude in Level 1",
        "Exclusion Reason Final Level 2": "",
        "Title": "Prostate Cancer - Brigham and Women's Hospital",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Intervention/ primary study/erratum/ conference abstract/ commentary/ clinic trial/ newsletter/ magazine/protocol/ literature review",
        "Final Level 2 Consensus": "Exclude in Level 1",
        "Exclusion Reason Final Level 2": "",
        "Title": "Prostate Cancer: Statistics | Cancer.Net",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Intervention/ primary study/erratum/ conference abstract/ commentary/ clinic trial/ newsletter/ magazine/protocol/ literature review",
        "Final Level 2 Consensus": "Exclude in Level 1",
        "Exclusion Reason Final Level 2": "",
        "Title": "Prostate Cancer: Types of Treatment",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "Exclude in Level 1",
        "Exclusion Reason Final Level 2": "",
        "Title": "Cancer Screening",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Public consumption /patient info/ patient guide",
        "Final Level 2 Consensus": "Exclude in Level 1",
        "Exclusion Reason Final Level 2": "",
        "Title": "What's New in Prostate Cancer Research?",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Intervention/ primary study/erratum/ conference abstract/ commentary/ clinic trial/ newsletter/ magazine/protocol/ literature review",
        "Final Level 2 Consensus": "Exclude in Level 1",
        "Exclusion Reason Final Level 2": "",
        "Title": "Can Prostate Cancer Be Prevented?",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "Exclude in Level 1",
        "Exclusion Reason Final Level 2": "",
        "Title": "Hormone Therapy for Prostate Cancer",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "Exclude in Level 1",
        "Exclusion Reason Final Level 2": "",
        "Title": "Early detection of breast cancer",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Public consumption /patient info/ patient guide",
        "Final Level 2 Consensus": "Exclude in Level 1",
        "Exclusion Reason Final Level 2": "",
        "Title": "Prostate Cancer: What You Should Know About Screening and Diagnosis",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Intervention/ primary study/erratum/ conference abstract/ commentary/ clinic trial/ newsletter/ magazine/protocol/ literature review",
        "Final Level 2 Consensus": "Exclude in Level 1",
        "Exclusion Reason Final Level 2": "",
        "Title": "Balancing Early-Stage Prostate Cancer Decisions",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "Exclude in Level 1",
        "Exclusion Reason Final Level 2": "",
        "Title": "Cancer Continuing Medical Education (CME) Courses | CDC",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "Exclude in Level 1",
        "Exclusion Reason Final Level 2": "",
        "Title": "Projected estimates of cancer in Canada in 2022",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "Exclude in Level 1",
        "Exclusion Reason Final Level 2": "",
        "Title": "Screening for Lung Cancer with Low Dose Computed ... - CMS",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Intervention/ primary study/erratum/ conference abstract/ commentary/ clinic trial/ newsletter/ magazine/protocol/ literature review",
        "Final Level 2 Consensus": "Exclude in Level 1",
        "Exclusion Reason Final Level 2": "",
        "Title": "New method to determine before surgery which prostate ...",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not by country health authorities or medical organisation",
        "Final Level 2 Consensus": "Exclude in Level 1",
        "Exclusion Reason Final Level 2": "",
        "Title": "Cancer Early Detection Programs",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not by country health authorities or medical organisation",
        "Final Level 2 Consensus": "Exclude in Level 1",
        "Exclusion Reason Final Level 2": "",
        "Title": "Cancer Mythbusters: Early Cancer Detection and Risk",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Intervention/ primary study/erratum/ conference abstract/ commentary/ clinic trial/ newsletter/ magazine/protocol/ literature review",
        "Final Level 2 Consensus": "Exclude in Level 1",
        "Exclusion Reason Final Level 2": "",
        "Title": "Multiparametric methods for early detection of prostate cancer",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "Exclude in Level 1",
        "Exclusion Reason Final Level 2": "",
        "Title": "Improved screening can be beneficial for mothers with ... - dtnext",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "Exclude in Level 1",
        "Exclusion Reason Final Level 2": "",
        "Title": "Early detection | EdCaN",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "Exclude in Level 1",
        "Exclusion Reason Final Level 2": "",
        "Title": "Research and Clinical Trials",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Intervention/ primary study/erratum/ conference abstract/ commentary/ clinic trial/ newsletter/ magazine/protocol/ literature review",
        "Final Level 2 Consensus": "Exclude in Level 1",
        "Exclusion Reason Final Level 2": "",
        "Title": "Prostate Cancer Screening: What is the PCA3 Test?",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "Exclude in Level 1",
        "Exclusion Reason Final Level 2": "",
        "Title": "Why is Breast Cancer Awareness so Important?",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Intervention/ primary study/erratum/ conference abstract/ commentary/ clinic trial/ newsletter/ magazine/protocol/ literature review",
        "Final Level 2 Consensus": "Exclude in Level 1",
        "Exclusion Reason Final Level 2": "",
        "Title": "Prostate Cancer Screening Guidelines Puts Patient Choice First",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "Exclude in Level 1",
        "Exclusion Reason Final Level 2": "",
        "Title": "Why is Breast Cancer Awareness so Important?",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not by country health authorities or medical organisation",
        "Final Level 2 Consensus": "Exclude in Level 1",
        "Exclusion Reason Final Level 2": "",
        "Title": "Why Should You Take a Prostate Exam?",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "Exclude in Level 1",
        "Exclusion Reason Final Level 2": "",
        "Title": "Newborn Bloodspot Screening ÂÃÃ National Policy Framework",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Intervention/ primary study/erratum/ conference abstract/ commentary/ clinic trial/ newsletter/ magazine/protocol/ literature review",
        "Final Level 2 Consensus": "Exclude in Level 1",
        "Exclusion Reason Final Level 2": "",
        "Title": "Are early detection and treatment always best?",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Intervention/ primary study/erratum/ conference abstract/ commentary/ clinic trial/ newsletter/ magazine/protocol/ literature review",
        "Final Level 2 Consensus": "Exclude in Level 1",
        "Exclusion Reason Final Level 2": "",
        "Title": "Understanding medical tests: sensitivity, specificity, and positive predictive value",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not by country health authorities or medical organisation",
        "Final Level 2 Consensus": "Exclude in Level 1",
        "Exclusion Reason Final Level 2": "",
        "Title": "Prostate Cancer: Advancements in Screenings",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not by country health authorities or medical organisation",
        "Final Level 2 Consensus": "Exclude in Level 1",
        "Exclusion Reason Final Level 2": "",
        "Title": "Prostate Cancer: Prevention | Johns Hopkins Medicine",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not by country health authorities or medical organisation",
        "Final Level 2 Consensus": "Exclude in Level 1",
        "Exclusion Reason Final Level 2": "",
        "Title": "Hunterdon County Cancer Education and Early Detection ...",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Intervention/ primary study/erratum/ conference abstract/ commentary/ clinic trial/ newsletter/ magazine/protocol/ literature review",
        "Final Level 2 Consensus": "Exclude in Level 1",
        "Exclusion Reason Final Level 2": "",
        "Title": "How To Check For Prostate Cancer At Home",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "Exclude in Level 1",
        "Exclusion Reason Final Level 2": "",
        "Title": "Polygenic hazard score to guide screening for aggressive prostate cancer",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Intervention/ primary study/erratum/ conference abstract/ commentary/ clinic trial/ newsletter/ magazine/protocol/ literature review",
        "Final Level 2 Consensus": "Exclude in Level 1",
        "Exclusion Reason Final Level 2": "",
        "Title": "When Should You Start Having Annual Prostate Exams?",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Public consumption /patient info/ patient guide",
        "Final Level 2 Consensus": "Exclude in Level 1",
        "Exclusion Reason Final Level 2": "",
        "Title": "When Detected Early, Prostate Cancer is a Very Treatable Disease",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "Exclude in Level 1",
        "Exclusion Reason Final Level 2": "",
        "Title": "Cancer - NHS Long Term Plan",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not by country health authorities or medical organisation",
        "Final Level 2 Consensus": "Exclude in Level 1",
        "Exclusion Reason Final Level 2": "",
        "Title": "Why there is no prostate cancer screening programme - Marie ...",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Public consumption /patient info/ patient guide",
        "Final Level 2 Consensus": "Exclude in Level 1",
        "Exclusion Reason Final Level 2": "",
        "Title": "Prostate cancer",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Intervention/ primary study/erratum/ conference abstract/ commentary/ clinic trial/ newsletter/ magazine/protocol/ literature review",
        "Final Level 2 Consensus": "Exclude in Level 1",
        "Exclusion Reason Final Level 2": "",
        "Title": "MD Anderson Research Highlights for May 4, 2022",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not by country health authorities or medical organisation",
        "Final Level 2 Consensus": "Exclude in Level 1",
        "Exclusion Reason Final Level 2": "",
        "Title": "Prostate Cancer | Department of Urology - UNC School of ...",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "Exclude in Level 1",
        "Exclusion Reason Final Level 2": "",
        "Title": "NATIONAL GUIDELINES FOR EARLY DIAGNOSIS OF BREAST CANCER IN ZAMBIA",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not by country health authorities or medical organisation",
        "Final Level 2 Consensus": "Exclude in Level 1",
        "Exclusion Reason Final Level 2": "",
        "Title": "Detecting Prostate Cancer Early",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not by country health authorities or medical organisation",
        "Final Level 2 Consensus": "Exclude in Level 1",
        "Exclusion Reason Final Level 2": "",
        "Title": "Mount Sinai Robert F. Smith Mobile Prostate Cancer Screening",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not by country health authorities or medical organisation",
        "Final Level 2 Consensus": "Exclude in Level 1",
        "Exclusion Reason Final Level 2": "",
        "Title": "Prostate Cancer Screening",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not by country health authorities or medical organisation",
        "Final Level 2 Consensus": "Exclude in Level 1",
        "Exclusion Reason Final Level 2": "",
        "Title": "Finding Hidden Cancer Cells: FDA Approval of New Imaging Tool Could Transform Treatment Decisions for Advanced Prostate Cancer",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not by country health authorities or medical organisation",
        "Final Level 2 Consensus": "Exclude in Level 1",
        "Exclusion Reason Final Level 2": "",
        "Title": "MSK Expert Explains New Prostate Cancer Screening Guideline",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not by country health authorities or medical organisation",
        "Final Level 2 Consensus": "Exclude in Level 1",
        "Exclusion Reason Final Level 2": "",
        "Title": "What Every Man Should Know about Radiation Therapy for ...",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Intervention/ primary study/erratum/ conference abstract/ commentary/ clinic trial/ newsletter/ magazine/protocol/ literature review",
        "Final Level 2 Consensus": "Exclude in Level 1",
        "Exclusion Reason Final Level 2": "",
        "Title": "Prostate Cancer - StatPearls - NCBI Bookshelf",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Intervention/ primary study/erratum/ conference abstract/ commentary/ clinic trial/ newsletter/ magazine/protocol/ literature review",
        "Final Level 2 Consensus": "Exclude in Level 1",
        "Exclusion Reason Final Level 2": "",
        "Title": "Trends in Prostate Cancer in the United States - PMC - NCBI",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "Exclude in Level 1",
        "Exclusion Reason Final Level 2": "",
        "Title": "Overdiagnosis and Overtreatment of Prostate Cancer - PMC",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Intervention/ primary study/erratum/ conference abstract/ commentary/ clinic trial/ newsletter/ magazine/protocol/ literature review",
        "Final Level 2 Consensus": "Exclude in Level 1",
        "Exclusion Reason Final Level 2": "",
        "Title": "Evidence-Based Versus Personalized Prostate Cancer ... - NCBI",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "Exclude in Level 1",
        "Exclusion Reason Final Level 2": "",
        "Title": "Knowledge of Prostate Cancer and Screening Among Young ...",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Intervention/ primary study/erratum/ conference abstract/ commentary/ clinic trial/ newsletter/ magazine/protocol/ literature review",
        "Final Level 2 Consensus": "Exclude in Level 1",
        "Exclusion Reason Final Level 2": "",
        "Title": "Screening for prostate cancer: are organized screening ... - NCBI",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Intervention/ primary study/erratum/ conference abstract/ commentary/ clinic trial/ newsletter/ magazine/protocol/ literature review",
        "Final Level 2 Consensus": "Exclude in Level 1",
        "Exclusion Reason Final Level 2": "",
        "Title": "Cancer prevention and screening: the next step in the era of ...",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "Exclude in Level 1",
        "Exclusion Reason Final Level 2": "",
        "Title": "Epidemiology of Prostate Cancer - PMC - NCBI",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not by country health authorities or medical organisation",
        "Final Level 2 Consensus": "Exclude in Level 1",
        "Exclusion Reason Final Level 2": "",
        "Title": "Prostate Cancer Care - Northwest Community Healthcare",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not by country health authorities or medical organisation",
        "Final Level 2 Consensus": "Exclude in Level 1",
        "Exclusion Reason Final Level 2": "",
        "Title": "Prostate cancer is treatable especially with early screenings",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Intervention/ primary study/erratum/ conference abstract/ commentary/ clinic trial/ newsletter/ magazine/protocol/ literature review",
        "Final Level 2 Consensus": "Exclude in Level 1",
        "Exclusion Reason Final Level 2": "",
        "Title": "New multi-marker risk algorithm could improve the accuracy of prostate cancer screening",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Intervention/ primary study/erratum/ conference abstract/ commentary/ clinic trial/ newsletter/ magazine/protocol/ literature review",
        "Final Level 2 Consensus": "Exclude in Level 1",
        "Exclusion Reason Final Level 2": "",
        "Title": "Diagnosis -Prostate cancer",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Intervention/ primary study/erratum/ conference abstract/ commentary/ clinic trial/ newsletter/ magazine/protocol/ literature review",
        "Final Level 2 Consensus": "Exclude in Level 1",
        "Exclusion Reason Final Level 2": "",
        "Title": "Diagnosis and treatment of prostate cancer | Nursing Times",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not by country health authorities or medical organisation",
        "Final Level 2 Consensus": "Exclude in Level 1",
        "Exclusion Reason Final Level 2": "",
        "Title": "Screening and Early Detection - Prostate Cancer Foundation",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not by country health authorities or medical organisation",
        "Final Level 2 Consensus": "Exclude in Level 1",
        "Exclusion Reason Final Level 2": "",
        "Title": "Prostate Cancer Survival Rates",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Public consumption /patient info/ patient guide",
        "Final Level 2 Consensus": "Exclude in Level 1",
        "Exclusion Reason Final Level 2": "",
        "Title": "The 3 Screenings All Men Should Have Today",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Intervention/ primary study/erratum/ conference abstract/ commentary/ clinic trial/ newsletter/ magazine/protocol/ literature review",
        "Final Level 2 Consensus": "Exclude in Level 1",
        "Exclusion Reason Final Level 2": "",
        "Title": "How mRNA Vaccines Help Fight Cancer Tumors, Too - Penn ...",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "Exclude in Level 1",
        "Exclusion Reason Final Level 2": "",
        "Title": "Downloads",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "Exclude in Level 1",
        "Exclusion Reason Final Level 2": "",
        "Title": "Global Cancer Biomarkers Market Size Worth $31695.03 Mn by 2028 at 16.90% CAGR - Industry Share, Trends, Forecast Report by Zion Market Research",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "Exclude in Level 1",
        "Exclusion Reason Final Level 2": "",
        "Title": "Psychosocial Care Model for Men with Prostate Cancer",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "Exclude in Level 1",
        "Exclusion Reason Final Level 2": "",
        "Title": "Schedule a Screening Today - Prostate On-Site Project",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not by country health authorities or medical organisation",
        "Final Level 2 Consensus": "Exclude in Level 1",
        "Exclusion Reason Final Level 2": "",
        "Title": "Early Detection & Prevention - Prostate Conditions Education ...",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Intervention/ primary study/erratum/ conference abstract/ commentary/ clinic trial/ newsletter/ magazine/protocol/ literature review",
        "Final Level 2 Consensus": "Exclude in Level 1",
        "Exclusion Reason Final Level 2": "",
        "Title": "Innovation at Purdue News",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Intervention/ primary study/erratum/ conference abstract/ commentary/ clinic trial/ newsletter/ magazine/protocol/ literature review",
        "Final Level 2 Consensus": "Exclude in Level 1",
        "Exclusion Reason Final Level 2": "",
        "Title": "Early Screening and Detection of Prostate Cancer Saves Local ManÂÃÂªs Life",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "Exclude in Level 1",
        "Exclusion Reason Final Level 2": "",
        "Title": "Breast Cancer",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Public consumption /patient info/ patient guide",
        "Final Level 2 Consensus": "Exclude in Level 1",
        "Exclusion Reason Final Level 2": "",
        "Title": "Prostate Cancer",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Intervention/ primary study/erratum/ conference abstract/ commentary/ clinic trial/ newsletter/ magazine/protocol/ literature review",
        "Final Level 2 Consensus": "Exclude in Level 1",
        "Exclusion Reason Final Level 2": "",
        "Title": "New AI tech for early detection of prostate cancer - RMIT ...",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not by country health authorities or medical organisation",
        "Final Level 2 Consensus": "Exclude in Level 1",
        "Exclusion Reason Final Level 2": "",
        "Title": "Frequently Asked Questions about the PSA Blood Test",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not by country health authorities or medical organisation",
        "Final Level 2 Consensus": "Exclude in Level 1",
        "Exclusion Reason Final Level 2": "",
        "Title": "Catching cancer extremely early",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "Exclude in Level 1",
        "Exclusion Reason Final Level 2": "",
        "Title": "Prostate cancer - symptoms, diagnosis, treatment",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Intervention/ primary study/erratum/ conference abstract/ commentary/ clinic trial/ newsletter/ magazine/protocol/ literature review",
        "Final Level 2 Consensus": "Exclude in Level 1",
        "Exclusion Reason Final Level 2": "",
        "Title": "New diagnostic tool ÂÃÃ·could help reduce prostate cancer deathsÂÃÂª",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Public consumption /patient info/ patient guide",
        "Final Level 2 Consensus": "Exclude in Level 1",
        "Exclusion Reason Final Level 2": "",
        "Title": "Prostate Cancer Program | Stony Brook Medicine",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Intervention/ primary study/erratum/ conference abstract/ commentary/ clinic trial/ newsletter/ magazine/protocol/ literature review",
        "Final Level 2 Consensus": "Exclude in Level 1",
        "Exclusion Reason Final Level 2": "",
        "Title": "StudyFinds Blotter: Other Notable Health Studies & Research From May 5, 2022",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Intervention/ primary study/erratum/ conference abstract/ commentary/ clinic trial/ newsletter/ magazine/protocol/ literature review",
        "Final Level 2 Consensus": "Exclude in Level 1",
        "Exclusion Reason Final Level 2": "",
        "Title": "New AI tech for early detection of prostate cancer",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not by country health authorities or medical organisation",
        "Final Level 2 Consensus": "Exclude in Level 1",
        "Exclusion Reason Final Level 2": "",
        "Title": "Prostate Cancer Screening & Diagnosis - UChicago Medicine",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not by country health authorities or medical organisation",
        "Final Level 2 Consensus": "Exclude in Level 1",
        "Exclusion Reason Final Level 2": "",
        "Title": "International Alliance for Cancer Early Detection",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Intervention/ primary study/erratum/ conference abstract/ commentary/ clinic trial/ newsletter/ magazine/protocol/ literature review",
        "Final Level 2 Consensus": "Exclude in Level 1",
        "Exclusion Reason Final Level 2": "",
        "Title": "New risk algorithm would improve screening for prostate cancer",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not by country health authorities or medical organisation",
        "Final Level 2 Consensus": "Exclude in Level 1",
        "Exclusion Reason Final Level 2": "",
        "Title": "UCLA Prostate Cancer Program - Los Angeles",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not by country health authorities or medical organisation",
        "Final Level 2 Consensus": "Exclude in Level 1",
        "Exclusion Reason Final Level 2": "",
        "Title": "What is Prostate Cancer",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not by country health authorities or medical organisation",
        "Final Level 2 Consensus": "Exclude in Level 1",
        "Exclusion Reason Final Level 2": "",
        "Title": "Localized Prostate Cancer | Conditions | UCSF Health",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not by country health authorities or medical organisation",
        "Final Level 2 Consensus": "Exclude in Level 1",
        "Exclusion Reason Final Level 2": "",
        "Title": "Radical Prostatectomy | Conditions & Treatments | UCSF Health",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Intervention/ primary study/erratum/ conference abstract/ commentary/ clinic trial/ newsletter/ magazine/protocol/ literature review",
        "Final Level 2 Consensus": "Exclude in Level 1",
        "Exclusion Reason Final Level 2": "",
        "Title": "Prostate Cancer Awareness Campaign | UICC",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not by country health authorities or medical organisation",
        "Final Level 2 Consensus": "Exclude in Level 1",
        "Exclusion Reason Final Level 2": "",
        "Title": "Prostate Cancer Screening",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Public consumption /patient info/ patient guide",
        "Final Level 2 Consensus": "Exclude in Level 1",
        "Exclusion Reason Final Level 2": "",
        "Title": "Educational-Resources",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Intervention/ primary study/erratum/ conference abstract/ commentary/ clinic trial/ newsletter/ magazine/protocol/ literature review",
        "Final Level 2 Consensus": "Exclude in Level 1",
        "Exclusion Reason Final Level 2": "",
        "Title": "Early-stage Prostate Cancer Basics - Urology Care Foundation",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "Exclude in Level 1",
        "Exclusion Reason Final Level 2": "",
        "Title": "What is Benign Prostatic Hyperplasia (BPH)?",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "Exclude in Level 1",
        "Exclusion Reason Final Level 2": "",
        "Title": "Hematuria : Symptoms, Diagnosis & Treatment - Urology Care",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Intervention/ primary study/erratum/ conference abstract/ commentary/ clinic trial/ newsletter/ magazine/protocol/ literature review",
        "Final Level 2 Consensus": "Exclude in Level 1",
        "Exclusion Reason Final Level 2": "",
        "Title": "Sens. Moran, Tester Introduce Bill to Expand Treatment & Research for Prostate Cancer in Veterans",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "Exclude in Level 1",
        "Exclusion Reason Final Level 2": "",
        "Title": "Screening for Benign Prostatic Hyperplasia (BPH)",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Intervention/ primary study/erratum/ conference abstract/ commentary/ clinic trial/ newsletter/ magazine/protocol/ literature review",
        "Final Level 2 Consensus": "Exclude in Level 1",
        "Exclusion Reason Final Level 2": "",
        "Title": "Regional Experts Discuss Approaches for Prostate Cancer ...",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Public consumption /patient info/ patient guide",
        "Final Level 2 Consensus": "Exclude in Level 1",
        "Exclusion Reason Final Level 2": "",
        "Title": "Early Detection | ZERO - The End of Prostate Cancer",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "GAS",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Intervention/ primary study/erratum/ conference abstract/ commentary/ clinic trial/ newsletter/ magazine/protocol/ literature review",
        "Final Level 2 Consensus": "Exclude in Level 1",
        "Exclusion Reason Final Level 2": "",
        "Title": "Early detection of prostate cancer is essential, and insurers must cover screening costs",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "2022-07-08 00:00:00",
        "URL": "",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Include",
        "Exclusion Reason Final Level 2": "",
        "Title": "Age-Adjusted Reference Values for Prostate Specific Antigen - A Systematic Review and Meta-Analysis",
        "Theme": "Psa testing",
        "Research Paper Type": "Review",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "2022-07-08 00:00:00",
        "URL": "NMA",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Include",
        "Exclusion Reason Final Level 2": "",
        "Title": "Assessing the effectiveness of decision aids for decision making in prostate cancer testing: a systematic review",
        "Theme": "Decision aids",
        "Research Paper Type": "Decision aid",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "2022-07-08 00:00:00",
        "URL": "",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Include",
        "Exclusion Reason Final Level 2": "",
        "Title": "Assessment of prostate-specific antigen screening: an evidence-based report by the German Institute for Quality and Efficiency in Health Care",
        "Theme": "Psa testing",
        "Research Paper Type": "Evidence-Based Report",
        "Country/ Organisation": "German Institute forQuality and EfÃciency in Health Care"
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "2022-07-08 00:00:00",
        "URL": "",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Include",
        "Exclusion Reason Final Level 2": "",
        "Title": "Association between RASSF1A promoter methylation and prostate cancer: a systematic review and meta-analysis",
        "Theme": "Biomarkers",
        "Research Paper Type": "Systematic Review & Meta-Analysis",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "2022-07-08 00:00:00",
        "URL": "",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Include",
        "Exclusion Reason Final Level 2": "",
        "Title": "Blood and urine biomarkers in prostate cancer: Are we ready for reflex testing in men with an elevated prostate-specific antigen?",
        "Theme": "Biomarkers",
        "Research Paper Type": "Review",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "2022-07-26 00:00:00",
        "URL": "https://rd.springer.com/journal/12301//https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emed22&AN=2010525029//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:&id=doi:10.1186%2Fs12301-021-00129-x&issn=1110-5704&isbn=&volume=27&issue=1&spage=32&pages=&date=2021&title=African+Journal+of+Urology&atitle=Clinical+diagnosis+of+prostate+cancer+using+digital+rectal+examination+and+prostate-specific+antigen+tests%3A+a+systematic+review+and+meta-analysis+of+sensitivity+and+specificity&aulast=Okpua&pid=%3Cauthor%3EOkpua+N.C.%3BOkekpa+S.I.%3BNjaka+S.%3BEmeh+A.N.%3C%2Fauthor%3E%3CAN%3E2010525029%3C%2FAN%3E%3CDT%3EReview%3C%2FDT%3E",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Include",
        "Exclusion Reason Final Level 2": "",
        "Title": "Clinical diagnosis of prostate cancer using digital rectal examination and prostate-specific antigen tests: a systematic review and meta-analysis of sensitivity and specificity",
        "Theme": "",
        "Research Paper Type": "Screening tool",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "2022-07-08 00:00:00",
        "URL": "",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Include",
        "Exclusion Reason Final Level 2": "",
        "Title": "Clinical utility of the (-2)proPSA and evaluation of the evidence: a systematic review",
        "Theme": "Biomarkers",
        "Research Paper Type": "Systematic Review",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "2022-07-08 00:00:00",
        "URL": "",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Include",
        "Exclusion Reason Final Level 2": "",
        "Title": "Consensus on Screening, Diagnosis, and Staging Tools for Prostate Cancer in Developing Countries: A Report From the First Prostate Cancer Consensus Conference for Developing Countries (PCCCDC)",
        "Theme": "Guidelines",
        "Research Paper Type": "Report from consensus",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "2022-07-08 00:00:00",
        "URL": "",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Include",
        "Exclusion Reason Final Level 2": "",
        "Title": "Current guidelines for prostate cancer screening: A systematic review and minimal core proposal",
        "Theme": "Guidelines",
        "Research Paper Type": "Guidelines",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "2022-07-08 00:00:00",
        "URL": "NMA",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Include",
        "Exclusion Reason Final Level 2": "",
        "Title": "Decision Aids for Prostate Cancer Screening Choice: A Systematic Review and Meta-analysis",
        "Theme": "Decision aids",
        "Research Paper Type": "Review",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "2022-07-08 00:00:00",
        "URL": "",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Include",
        "Exclusion Reason Final Level 2": "",
        "Title": "EAU guidelines on prostate cancer. part 1: screening, diagnosis, and local treatment with curative intent-update 2013",
        "Theme": "Guidelines",
        "Research Paper Type": "Guidelines",
        "Country/ Organisation": "European Association of Urology"
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "2022-07-08 00:00:00",
        "URL": "",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Include",
        "Exclusion Reason Final Level 2": "",
        "Title": "EAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer-2020 Update. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent",
        "Theme": "Guidelines",
        "Research Paper Type": "Guidelines",
        "Country/ Organisation": "EAU-EANM-ESTRO-ESUR-SIOG"
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "2022-07-08 00:00:00",
        "URL": "",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Include",
        "Exclusion Reason Final Level 2": "",
        "Title": "EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent",
        "Theme": "Guidelines",
        "Research Paper Type": "Guidelines",
        "Country/ Organisation": "EAU-ESTRO-SIOG"
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "2022-07-08 00:00:00",
        "URL": "NMA",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Include",
        "Exclusion Reason Final Level 2": "",
        "Title": "Interventions to improve decision making and reduce racial and ethnic disparities in the management of prostate cancer: a systematic review",
        "Theme": "Decision aids",
        "Research Paper Type": "Systematic Review",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "2022-07-26 00:00:00",
        "URL": "http://www.ijcem.com/files/ijcem0060345.pdf//https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emed19&AN=620499563//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:&id=doi:&issn=1940-5901&isbn=&volume=11&issue=1&spage=1&pages=1-11&date=2018&title=International+Journal+of+Clinical+and+Experimental+Medicine&atitle=Number+of+screening+rounds+and+risk+of+prostate+cancer%3A+A+systematic+review+and+meta-analysis&aulast=Deng&pid=%3Cauthor%3EDeng+T.%3BZhang+M.%3BFeng+S.%3BDuan+X.%3BZhang+T.%3BCai+C.%3BLan+Y.%3BWu+W.%3BZeng+G.%3C%2Fauthor%3E%3CAN%3E620499563%3C%2FAN%3E%3CDT%3EReview%3C%2FDT%3E",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Include",
        "Exclusion Reason Final Level 2": "",
        "Title": "Number of screening rounds and risk of prostate cancer: A systematic review and meta-analysis",
        "Theme": "Guidelines",
        "Research Paper Type": "Systematic Review & Meta-Analysis",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "2022-07-08 00:00:00",
        "URL": "",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Include",
        "Exclusion Reason Final Level 2": "",
        "Title": "Prostate Cancer Risk Calculators for Healthy Populations: Systematic Review",
        "Theme": "Risk prediction tool",
        "Research Paper Type": "Review",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "2022-07-08 00:00:00",
        "URL": "NMA",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Include",
        "Exclusion Reason Final Level 2": "",
        "Title": "Prostate Cancer Screening Patient Decision Aids: A Systematic Review and Meta-analysis",
        "Theme": "Decision aids",
        "Research Paper Type": "Decision aids/tools",
        "Country/ Organisation": "Oregon Health and Science University"
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "2022-07-08 00:00:00",
        "URL": "",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Include",
        "Exclusion Reason Final Level 2": "",
        "Title": "Prostate cancer screening: guidelines review and laboratory issues",
        "Theme": "Guidelines",
        "Research Paper Type": "Review",
        "Country/ Organisation": "Spain"
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "2022-07-08 00:00:00",
        "URL": "",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Include",
        "Exclusion Reason Final Level 2": "",
        "Title": "Prostate-Specific Antigen (PSA)-Based Population Screening for Prostate Cancer: An Evidence-Based Analysis",
        "Theme": "Programme",
        "Research Paper Type": "Review",
        "Country/ Organisation": "Ontario, Canada"
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "2022-07-08 00:00:00",
        "URL": "",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Include",
        "Exclusion Reason Final Level 2": "",
        "Title": "PSA velocity: a systematic review of clinical applications",
        "Theme": "Biomarkers",
        "Research Paper Type": "Systematic Review",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "2022-07-08 00:00:00",
        "URL": "",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Include",
        "Exclusion Reason Final Level 2": "",
        "Title": "Screening Coverage Needed to Reduce Mortality from Prostate Cancer: A Living Systematic Review",
        "Theme": "Programme",
        "Research Paper Type": "Review",
        "Country/ Organisation": "Denmark"
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "2022-07-08 00:00:00",
        "URL": "NMA",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Include",
        "Exclusion Reason Final Level 2": "",
        "Title": "The effects of shared decision-making compared to usual care for prostate cancer screening decisions: a systematic review and meta-analysis",
        "Theme": "Decision aids",
        "Research Paper Type": "Decision aid",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "2022-07-08 00:00:00",
        "URL": "NMA",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Include",
        "Exclusion Reason Final Level 2": "",
        "Title": "Web-Based Versus Usual Care and Other Formats of Decision Aids to Support Prostate Cancer Screening Decisions: Systematic Review and Meta-Analysis",
        "Theme": "Decision aids",
        "Research Paper Type": "Decision aid",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "2022-07-08 00:00:00",
        "URL": "",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Include",
        "Exclusion Reason Final Level 2": "",
        "Title": "Prostate cancer screening with prostate-specific antigen (PSA) test: a clinical practice guideline",
        "Theme": "Guidelines",
        "Research Paper Type": "Guidelines",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "2022-07-26 00:00:00",
        "URL": "https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emexb&AN=638431214//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:35801699&id=doi:10.7554%2FeLife.78304&issn=2050-084X&isbn=&volume=11&issue=&spage=&pages=&date=2022&title=eLife&atitle=Validation+of+a+multi-ancestry+polygenic+risk+score+and+age-specific+risks+of+prostate+cancer%3A+a+meta-analysis+within+diverse+populations&aulast=Chen&pid=%3Cauthor%3EChen+F.%3BDarst+B.F.%3BMadduri+R.K.%3BRodriguez+A.A.%3BSheng+X.%3BRentsch+C.T.%3BAndrews+C.%3BTang+W.%3BKibel+A.S.%3BPlym+A.%3BCho+K.%3BJalloh+M.%3BGueye+S.M.%3BNiang+L.%3BOgunbiyi+O.J.%3BPopoola+O.%3BAdebiyi+A.O.%3BAisuodionoe-Shadrach+O.I.%3BAjibola+H.O.%3BJamda+M.A.%3BOluwole+O.P.%3BNwegbu+M.%3BAdusei+B.%3BMante+S.%3BDarkwa-Abrahams+A.%3BMensah+J.E.%3BAdjei+A.A.%3BDiop+H.%3BLachance+J.%3BRebbeck+T.R.%3BAmbs+S.%3BGaziano+J.M.%3BJustice+A.C.%3BConti+D.V.%3BHaiman+C.A.%3C%2Fauthor%3E%3CAN%3E638431214%3C%2FAN%3E%3CDT%3EArticle%3C%2FDT%3E",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Include",
        "Exclusion Reason Final Level 2": "",
        "Title": "Validation of a multi-ancestry polygenic risk score and age-specific risks of prostate cancer: a meta-analysis within diverse populations",
        "Theme": "Risk prediction tool",
        "Research Paper Type": "Meta-analysis",
        "Country/ Organisation": "United States"
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "2023-07-12 00:00:00",
        "URL": "",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Include",
        "Exclusion Reason Final Level 2": "",
        "Title": "Early Detection of Prostate Cancer: AUA/SUO Guideline Part I: Prostate Cancer Screening",
        "Theme": "Guidelines",
        "Research Paper Type": "Guidelines",
        "Country/ Organisation": "AUA/SUO"
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "2023-07-12 00:00:00",
        "URL": "",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Include",
        "Exclusion Reason Final Level 2": "",
        "Title": "French AFU Cancer Committee Guidelines - Update 2022-2024: prostate cancer - Diagnosis and management of localised disease",
        "Theme": "Guidelines",
        "Research Paper Type": "",
        "Country/ Organisation": "French"
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "2022-07-08 00:00:00",
        "URL": "",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Exclude",
        "Exclusion Reason Final Level 2": "Others",
        "Title": "[Early detection of prostate cancer: harm verified, benefit not verifiable]",
        "Theme": "",
        "Research Paper Type": "Guidelines",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "2022-07-26 00:00:00",
        "URL": "https://www.journals.elsevier.com/european-urology-oncology//https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emexb&AN=2013930642//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:34364829&id=doi:10.1016%2Fj.euo.2021.06.006&issn=2588-9311&isbn=&volume=4&issue=5&spage=731&pages=731-739&date=2021&title=European+Urology+Oncology&atitle=A+European+Model+for+an+Organised+Risk-stratified+Early+Detection+Programme+for+Prostate+Cancer&aulast=Van+Poppel&pid=%3Cauthor%3EVan+Poppel+H.%3BHogenhout+R.%3BAlbers+P.%3Bvan+den+Bergh+R.C.N.%3BBarentsz+J.O.%3BRoobol+M.J.%3C%2Fauthor%3E%3CAN%3E2013930642%3C%2FAN%3E%3CDT%3EReview%3C%2FDT%3E",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Exclude",
        "Exclusion Reason Final Level 2": "Not by country health authorities or medical organisation",
        "Title": "A European Model for an Organised Risk-stratified Early Detection Programme for Prostate Cancer",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "2022-07-08 00:00:00",
        "URL": "",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Exclude",
        "Exclusion Reason Final Level 2": "Cost effectiveness",
        "Title": "A literature review of cost-effectiveness analyses of prostate-specific antigen test in prostate cancer screening",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "2022-07-26 00:00:00",
        "URL": "https://jtd.amegroups.com/article/view/52728/html//https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emexa&AN=2013312547//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:&id=doi:10.21037%2Fjtd-21-87&issn=2072-1439&isbn=&volume=13&issue=6&spage=3827&pages=3827-3843&date=2021&title=Journal+of+Thoracic+Disease&atitle=A+narrative+review+of+sociodemographic+risk+and+disparities+in+screening%2C+diagnosis%2C+treatment%2C+and+outcomes+of+the+most+common+extrathoracic+malignancies+in+the+United+States&aulast=Singh&pid=%3Cauthor%3ESingh+S.%3BSridhar+P.%3C%2Fauthor%3E%3CAN%3E2013312547%3C%2FAN%3E%3CDT%3EReview%3C%2FDT%3E",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Exclude",
        "Exclusion Reason Final Level 2": "Summary study, not guideline, no screening details, no details, no analysis",
        "Title": "A narrative review of sociodemographic risk and disparities in screening, diagnosis, treatment, and outcomes of the most common extrathoracic malignancies in the United States",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "2022-07-26 00:00:00",
        "URL": "https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emed13&AN=71026395//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:&id=doi:10.1111%2Fj.1743-7563.2012.01575.x&issn=1743-7555&isbn=&volume=8&issue=SUPPL.+1&spage=34&pages=34&date=2012&title=Asia-Pacific+Journal+of+Clinical+Oncology&atitle=A+novel+diagnostic+tool+for+detecting+prostate+cancer&aulast=Velonas&pid=%3Cauthor%3EVelonas+V.M.%3BAssinder+S.%3BWoo+H.%3BGrimwood+D.%3BHo+J.W.K.%3BDos+Remedios+C.%3C%2Fauthor%3E%3CAN%3E71026395%3C%2FAN%3E%3CDT%3EConference+Abstract%3C%2FDT%3E",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Exclude",
        "Exclusion Reason Final Level 2": "Conference abstract",
        "Title": "A novel diagnostic tool for detecting prostate cancer",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "2022-07-26 00:00:00",
        "URL": "https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emed18&AN=618193738//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:&id=doi:10.1016%2FS1569-9056%252817%252930312-3&issn=1569-9056&isbn=&volume=16&issue=3&spage=e429&pages=e429-e430&date=2017&title=European+Urology%2C+Supplements&atitle=A+positive+digital+rectal+examination+%28DRE%29+does+not+predict+prostate+cancer+in+45+yr+old+men-results+from+the+German+risk-adapted+PCA+Screening+Trial+%28PROBASE%29&aulast=Arsov&pid=%3Cauthor%3EArsov+C.%3BBecker+N.%3BHerkommer+K.%3BGschwend+J.%3BImkamp+F.%3BKuczyk+M.%3BHadaschik+B.%3BHohenfellner+M.%3BSiener+R.%3BKristiansen+G.%3BAntoch+G.%3BAlbers+P.%3C%2Fauthor%3E%3CAN%3E618193738%3C%2FAN%3E%3CDT%3EConference+Abstract%3C%2FDT%3E",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Exclude",
        "Exclusion Reason Final Level 2": "Conference abstract",
        "Title": "A positive digital rectal examination (DRE) does not predict prostate cancer in 45 yr old men-results from the German risk-adapted PCA Screening Trial (PROBASE)",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "2022-07-08 00:00:00",
        "URL": "",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Exclude",
        "Exclusion Reason Final Level 2": "Others",
        "Title": "A qualitative meta-synthesis examining the role of women in African American men's prostate cancer screening and treatment decision making",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "2022-07-26 00:00:00",
        "URL": "http://www.elsevier.com/inca/publications/store/6/2/2/9/3/4/index.htt//https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emexb&AN=2015680323//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:34798197&id=doi:10.1016%2Fj.ypmed.2021.106892&issn=0091-7435&isbn=&volume=154&issue=&spage=106892&pages=&date=2022&title=Preventive+Medicine&atitle=A+scoping+review+of+social+relationships+and+prostate+cancer+screening&aulast=Salmon&pid=%3Cauthor%3ESalmon+C.%3BParent+M.-E.%3BQuesnel-Vallee+A.%3BBarnett+T.A.%3C%2Fauthor%3E%3CAN%3E2015680323%3C%2FAN%3E%3CDT%3EReview%3C%2FDT%3E",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Exclude",
        "Exclusion Reason Final Level 2": "Others",
        "Title": "A scoping review of social relationships and prostate cancer screening",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "2022-07-26 00:00:00",
        "URL": "https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emed20&AN=629468135//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:&id=doi:10.1097%2F01.JU.0000555454.99604.a0&issn=1527-3792&isbn=&volume=201&issue=4+Supplement+1&spage=e267&pages=e267&date=2019&title=Journal+of+Urology&atitle=Age-adjusted+reference+values+for+prostate+specific+antigen%3A+A+systematic+review+and+meta-analysis&aulast=Matti&pid=%3Cauthor%3EMatti+B.%3BXia+W.%3BZargar-Shoshtari+K.%3C%2Fauthor%3E%3CAN%3E629468135%3C%2FAN%3E%3CDT%3EConference+Abstract%3C%2FDT%3E",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Exclude",
        "Exclusion Reason Final Level 2": "Conference abstract",
        "Title": "Age-adjusted reference values for prostate specific antigen: A systematic review and meta-analysis",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "2022-07-08 00:00:00",
        "URL": "",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Exclude",
        "Exclusion Reason Final Level 2": "Not by country health authorities or medical organisation",
        "Title": "APC gene hypermethylation and prostate cancer: a systematic review and meta-analysis",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "2022-07-26 00:00:00",
        "URL": "https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emed19&AN=623767261//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:&id=doi:&issn=1464-410X&isbn=&volume=122&issue=Supplement+2&spage=13&pages=13&date=2018&title=BJU+International&atitle=Are+current+prostate+cancer+risk+calculators+accurate%3F+A+review+of+the+literature&aulast=Omran&pid=%3Cauthor%3EOmran+G.%3BBolton+D.%3BLawrentschuk+N.%3C%2Fauthor%3E%3CAN%3E623767261%3C%2FAN%3E%3CDT%3EConference+Abstract%3C%2FDT%3E",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Exclude",
        "Exclusion Reason Final Level 2": "Conference abstract",
        "Title": "Are current prostate cancer risk calculators accurate? A review of the literature",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "2022-07-26 00:00:00",
        "URL": "http://www.wkap.nl/journalhome.htm/0393-2990//https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emed21&AN=2006155786//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:32929645&id=doi:10.1007%2Fs10654-020-00684-7&issn=0393-2990&isbn=&volume=35&issue=10&spage=891&pages=891-897&date=2020&title=European+Journal+of+Epidemiology&atitle=Assessment+of+cancer+screening+effectiveness+in+the+era+of+screening+programs&aulast=Adami&pid=%3Cauthor%3EAdami+H.-O.%3BBretthauer+M.%3BKalager+M.%3C%2Fauthor%3E%3CAN%3E2006155786%3C%2FAN%3E%3CDT%3EArticle%3C%2FDT%3E",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Exclude",
        "Exclusion Reason Final Level 2": "Primary study or not systematic review",
        "Title": "Assessment of cancer screening effectiveness in the era of screening programs",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "2022-07-26 00:00:00",
        "URL": "https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emed13&AN=51581805//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:21862205&id=doi:10.1016%2Fj.eururo.2011.07.067&issn=0302-2838&isbn=&volume=61&issue=1&spage=1&pages=1-7&date=2012&title=European+Urology&atitle=Baseline+prostate-specific+antigen+testing+at+a+young+age&aulast=Loeb&pid=%3Cauthor%3ELoeb+S.%3BCarter+H.B.%3BCatalona+W.J.%3BMoul+J.W.%3BSchroder+F.H.%3C%2Fauthor%3E%3CAN%3E51581805%3C%2FAN%3E%3CDT%3EReview%3C%2FDT%3E",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Exclude",
        "Exclusion Reason Final Level 2": "Primary study or not systematic review",
        "Title": "Baseline prostate-specific antigen testing at a young age",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "2022-07-26 00:00:00",
        "URL": "https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emed14&AN=71037724//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:&id=doi:10.1111%2Fbju.12069&issn=1464-4096&isbn=&volume=111&issue=SUPPL.+1&spage=108&pages=108&date=2013&title=BJU+International&atitle=Blood-based+biomarkers+for+prostate+cancer&aulast=Velonas&pid=%3Cauthor%3EVelonas+V.M.%3BRemedios+C.D.%3BWoo+H.%3BHo+J.W.K.%3BAssinder+S.%3C%2Fauthor%3E%3CAN%3E71037724%3C%2FAN%3E%3CDT%3EConference+Abstract%3C%2FDT%3E",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Exclude",
        "Exclusion Reason Final Level 2": "Conference abstract",
        "Title": "Blood-based biomarkers for prostate cancer",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "2022-07-26 00:00:00",
        "URL": "https://www.journals.elsevier.com/genetics-in-medicine//https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emexb&AN=2018220156//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:35575786&id=doi:10.1016%2Fj.gim.2022.04.020&issn=1098-3600&isbn=&volume=&issue=&spage=&pages=&date=2022&title=Genetics+in+Medicine&atitle=Can+polygenic+risk+scores+contribute+to+cost-effective+cancer+screening%3F+A+systematic+review&aulast=Dixon&pid=%3Cauthor%3EDixon+P.%3BKeeney+E.%3BTaylor+J.C.%3BWordsworth+S.%3BMartin+R.M.%3C%2Fauthor%3E%3CAN%3E2018220156%3C%2FAN%3E%3CDT%3EReview%3C%2FDT%3E",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Exclude",
        "Exclusion Reason Final Level 2": "Cost effectiveness",
        "Title": "Can polygenic risk scores contribute to cost-effective cancer screening? A systematic review",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "2022-07-26 00:00:00",
        "URL": "http://www.elsevier.com/locate/pateducou//https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emed17&AN=610051850//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:26549169&id=doi:10.1016%2Fj.pec.2015.10.026&issn=0738-3991&isbn=&volume=99&issue=4&spage=491&pages=491-500&date=2016&title=Patient+Education+and+Counseling&atitle=Choosing+treatment+and+screening+options+congruent+with+values%3A+Do+decision+aids+help%3F+Sub-analysis+of+a+systematic+review&aulast=Munro&pid=%3Cauthor%3EMunro+S.%3BStacey+D.%3BLewis+K.B.%3BBansback+N.%3C%2Fauthor%3E%3CAN%3E610051850%3C%2FAN%3E%3CDT%3EReview%3C%2FDT%3E",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Exclude",
        "Exclusion Reason Final Level 2": "Summary study, not guideline, no screening details, no details, no analysis",
        "Title": "Choosing treatment and screening options congruent with values: Do decision aids help? Sub-analysis of a systematic review",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "2022-07-26 00:00:00",
        "URL": "http://www.journals.elsevier.com/prostate-international///https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emed21&AN=2007903062//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:&id=doi:10.1016%2Fj.prnil.2020.09.001&issn=2287-8882&isbn=&volume=8&issue=3&spage=99&pages=99-106&date=2020&title=Prostate+International&atitle=Clinical+implications+of+genomic+evaluations+for+prostate+cancer+risk+stratification%2C+screening%2C+and+treatment%3A+a+narrative+review&aulast=Chung&pid=%3Cauthor%3EChung+J.-S.%3BMorgan+T.M.%3BHong+S.K.%3C%2Fauthor%3E%3CAN%3E2007903062%3C%2FAN%3E%3CDT%3EReview%3C%2FDT%3E",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Exclude",
        "Exclusion Reason Final Level 2": "Primary study or not systematic review",
        "Title": "Clinical implications of genomic evaluations for prostate cancer risk stratification, screening, and treatment: a narrative review",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "2022-07-08 00:00:00",
        "URL": "",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Exclude",
        "Exclusion Reason Final Level 2": "Primary study or not systematic review",
        "Title": "Clinical performance of serum [-2]proPSA derivatives, %p2PSA and PHI, in the detection and management of prostate cancer",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "2022-07-26 00:00:00",
        "URL": "http://www.icurology.org/Synapse/Data/PDFData/2020ICU/icu-62-1.pdf//https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emed22&AN=2005753280//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:33381926&id=doi:10.4111%2Ficu.20200395&issn=2466-0493&isbn=&volume=62&issue=1&spage=1&pages=1-13&date=2021&title=Investigative+and+Clinical+Urology&atitle=Clinical+utility+of+current+biomarkers+for+prostate+cancer+detection&aulast=Kim&pid=%3Cauthor%3EKim+J.H.%3BHong+S.K.%3C%2Fauthor%3E%3CAN%3E2005753280%3C%2FAN%3E%3CDT%3EReview%3C%2FDT%3E",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Exclude",
        "Exclusion Reason Final Level 2": "Primary study or not systematic review",
        "Title": "Clinical utility of current biomarkers for prostate cancer detection",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "2022-07-26 00:00:00",
        "URL": "https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emed17&AN=613236124//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:&id=doi:&issn=1524-4733&isbn=&volume=19&issue=7&spage=A607&pages=A607&date=2016&title=Value+in+Health&atitle=Comparing+costs+from+a+pragmatic+randomised+trial+to+published+modelling-based+estimates%3A+An+example+from+prostate-cancer+screening&aulast=Booth&pid=%3Cauthor%3EBooth+N.%3C%2Fauthor%3E%3CAN%3E613236124%3C%2FAN%3E%3CDT%3EConference+Abstract%3C%2FDT%3E",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Exclude",
        "Exclusion Reason Final Level 2": "Conference abstract",
        "Title": "Comparing costs from a pragmatic randomised trial to published modelling-based estimates: An example from prostate-cancer screening",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "2022-07-08 00:00:00",
        "URL": "",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Exclude",
        "Exclusion Reason Final Level 2": "Cost effectiveness",
        "Title": "Cost-effectiveness of prostate cancer screening: a systematic review of decision-analytical models",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "2022-07-08 00:00:00",
        "URL": "",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Exclude",
        "Exclusion Reason Final Level 2": "Primary study or not systematic review",
        "Title": "Counterpoint: Prostate-specific antigen velocity is not of value for early detection of cancer",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "2022-07-08 00:00:00",
        "URL": "",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Exclude",
        "Exclusion Reason Final Level 2": "Primary study or not systematic review",
        "Title": "Counterpoint: Randomized trials provide the strongest evidence for clinical guidelines: The US Preventive Services Task Force and Prostate Cancer Screening",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "2022-07-26 00:00:00",
        "URL": "https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emed17&AN=616057723//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:&id=doi:10.1111%2Fbju.13565&issn=1464-410X&isbn=&volume=118&issue=Supplement+1&spage=15&pages=15&date=2016&title=BJU+International&atitle=Current+PSA+screening+guidelines&aulast=Cabarkapa&pid=%3Cauthor%3ECabarkapa+S.%3BPerera+M.%3BLawrentschuk+N.%3C%2Fauthor%3E%3CAN%3E616057723%3C%2FAN%3E%3CDT%3EConference+Abstract%3C%2FDT%3E",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Exclude",
        "Exclusion Reason Final Level 2": "Conference abstract",
        "Title": "Current PSA screening guidelines",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "2022-07-08 00:00:00",
        "URL": "",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Exclude",
        "Exclusion Reason Final Level 2": "Others",
        "Title": "Diagnostic Accuracy of (68)Ga-PSMA PET/CT for Initial Detection in Patients With Suspected Prostate Cancer: A Systematic Review and Meta-Analysis",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "2022-07-08 00:00:00",
        "URL": "",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Exclude",
        "Exclusion Reason Final Level 2": "Others",
        "Title": "Digital Rectal Examination for Prostate Cancer Screening in Primary Care: A Systematic Review and Meta-Analysis",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "2022-07-08 00:00:00",
        "URL": "",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Exclude",
        "Exclusion Reason Final Level 2": "Not research study objectives - ie not prostate cancer-related or decision aid or guideline or programme related to prostate cancer",
        "Title": "Disutility associated with cancer screening programs: A systematic review",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "2022-07-26 00:00:00",
        "URL": "http://ije.oxfordjournals.org///https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emed16&AN=602966692//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:25596211&id=doi:10.1093%2Fije%2Fdyu140&issn=0300-5771&isbn=&volume=44&issue=1&spage=264&pages=264-277&date=2015&title=International+Journal+of+Epidemiology&atitle=Does+screening+for+disease+save+lives+in+asymptomatic+adults%3F+Systematic+review+of+meta-analyses+and+randomized+trials&aulast=Saquib&pid=%3Cauthor%3ESaquib+N.%3BSaquib+J.%3BIoannidis+J.P.A.%3C%2Fauthor%3E%3CAN%3E602966692%3C%2FAN%3E%3CDT%3EArticle%3C%2FDT%3E",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Exclude",
        "Exclusion Reason Final Level 2": "Summary study, not guideline, no screening details, no details, no analysis",
        "Title": "Does screening for disease save lives in asymptomatic adults? Systematic review of meta-analyses and randomized trials",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "2022-07-26 00:00:00",
        "URL": "http://www.futuremedicine.com/loi/fon//https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emed16&AN=602447860//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:25675126&id=doi:10.2217%2Ffon.14.273&issn=1479-6694&isbn=&volume=11&issue=3&spage=467&pages=467-477&date=2015&title=Future+Oncology&atitle=Economic+evaluation+of+prostate+cancer+screening%3A+A+systematic+review&aulast=Lao&pid=%3Cauthor%3ELao+C.%3BBrown+C.%3BRouse+P.%3BEdlin+R.%3BLawrenson+R.%3C%2Fauthor%3E%3CAN%3E602447860%3C%2FAN%3E%3CDT%3EReview%3C%2FDT%3E",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Exclude",
        "Exclusion Reason Final Level 2": "Cost effectiveness",
        "Title": "Economic evaluation of prostate cancer screening: A systematic review",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "2022-07-08 00:00:00",
        "URL": "",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Exclude",
        "Exclusion Reason Final Level 2": "Others",
        "Title": "Educational pamphlets for improving uptake of cancer screening: a systematic review",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "2022-07-26 00:00:00",
        "URL": "http://www.springer.com/biomed/human+genetics/journal/12687//https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emed20&AN=627634182//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:&id=doi:10.1007%2Fs12687-019-00419-6&issn=1868-310X&isbn=&volume=11&issue=1&spage=73&pages=73-83&date=2020&title=Journal+of+Community+Genetics&atitle=Effectiveness+of+interventions+to+identify+and+manage+patients+with+familial+cancer+risk+in+primary+care%3A+a+systematic+review&aulast=Lee&pid=%3Cauthor%3ELee+S.I.%3BPatel+M.%3BDutton+B.%3BWeng+S.%3BLuveta+J.%3BQureshi+N.%3C%2Fauthor%3E%3CAN%3E627634182%3C%2FAN%3E%3CDT%3EArticle%3C%2FDT%3E",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Exclude",
        "Exclusion Reason Final Level 2": "Summary study, not guideline, no screening details, no details, no analysis",
        "Title": "Effectiveness of interventions to identify and manage patients with familial cancer risk in primary care: a systematic review",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "2022-07-08 00:00:00",
        "URL": "",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Exclude",
        "Exclusion Reason Final Level 2": "Others",
        "Title": "Establishing the infrastructure to conduct comparative effectiveness research toward the elimination of disparities: a community-based participatory research framework",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "2022-07-26 00:00:00",
        "URL": "https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emed14&AN=369591103//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:23154423&id=doi:10.1515%2Fcclm-2012-0410&issn=1434-6621&isbn=&volume=51&issue=4&spage=729&pages=729-739&date=2013&title=Clinical+Chemistry+and+Laboratory+Medicine&atitle=Evaluation+of+%5B+-+2%5D+proPSA+and+prostate+health+index+%28phi%29+for+the+detection+of+prostate+cancer%3A+A+systematic+review+and+meta-analysis&aulast=Filella&pid=%3Cauthor%3EFilella+X.%3BGimenez+N.%3C%2Fauthor%3E%3CAN%3E369591103%3C%2FAN%3E%3CDT%3EReview%3C%2FDT%3E",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Exclude",
        "Exclusion Reason Final Level 2": "Others",
        "Title": "Evaluation of [ - 2] proPSA and prostate health index (phi) for the detection of prostate cancer: A systematic review and meta-analysis",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "2022-07-26 00:00:00",
        "URL": "http://www.sibioc.it/upload/bc/37/SS/916_86-188_Monday.pdf//https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emed14&AN=71435966//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:&id=doi:&issn=0393-0564&isbn=&volume=37&issue=SUPPL.+1&spage=S176&pages=S176&date=2013&title=Biochimica+Clinica&atitle=Evidence-based+early+biological+detection+of+prostate+cancer%3A+Which+test+to+use+and+why%3F&aulast=Lamy&pid=%3Cauthor%3ELamy+P.J.%3BFulla+Y.%3BGauchez+A.S.%3BGeorges+A.%3BHaugh+M.%3BLoric+S.%3BLuporsi+E.%3BMartin+P.M.%3BMolinie+V.%3BPerrin+P.%3BPiffret+J.%3BRebillard+X.%3BThuillier+F.%3C%2Fauthor%3E%3CAN%3E71435966%3C%2FAN%3E%3CDT%3EConference+Abstract%3C%2FDT%3E",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Exclude",
        "Exclusion Reason Final Level 2": "Conference abstract",
        "Title": "Evidence-based early biological detection of prostate cancer: Which test to use and why?",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "2022-07-26 00:00:00",
        "URL": "http://ajcp.oxfordjournals.org/search/volume%3A144%20issue%3Asuppl%2B2?facettoc-section-id0=Chemistry//https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emed16&AN=72167013//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:&id=doi:&issn=0002-9173&isbn=&volume=144&issue=SUPPL.+2&spage=A046&pages=A046&date=2015&title=American+Journal+of+Clinical+Pathology&atitle=Exosomal+biomarkers+for+early+diagnosis+of+prostate+cancer%3A+Systematic+review&aulast=Vasani&pid=%3Cauthor%3EVasani+N.%3BPatel+B.%3BRai+A.%3C%2Fauthor%3E%3CAN%3E72167013%3C%2FAN%3E%3CDT%3EConference+Abstract%3C%2FDT%3E",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Exclude",
        "Exclusion Reason Final Level 2": "Conference abstract",
        "Title": "Exosomal biomarkers for early diagnosis of prostate cancer: Systematic review",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "2022-07-26 00:00:00",
        "URL": "http://link.springer.de/link/service/journals/00120/index.htm//https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emexa&AN=2010795321//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:33721089&id=doi:10.1007%2Fs00120-021-01491-y&issn=0340-2592&isbn=&volume=60&issue=5&spage=567&pages=567-575&date=2021&title=Urologe&atitle=Familiares+Prostatakarzinom+und+genetische+Pradisposition&aulast=Meissner&pid=%3Cauthor%3EMeissner+V.H.%3BJahnen+M.%3BHerkommer+K.%3C%2Fauthor%3E%3CAN%3E2010795321%3C%2FAN%3E%3CDT%3EReview%3C%2FDT%3E",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Exclude",
        "Exclusion Reason Final Level 2": "Others",
        "Title": "Familial prostate cancer and genetic predisposition. [German]",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "2022-07-08 00:00:00",
        "URL": "",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Exclude",
        "Exclusion Reason Final Level 2": "Primary study or not systematic review",
        "Title": "Gene_Prostate-Specific-Antigen-Guided Personalized Screening for Prostate Cancer",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "2022-07-26 00:00:00",
        "URL": "https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emexa&AN=636153336//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:&id=doi:10.1186%2Fs40644-021-00422-6&issn=1470-7330&isbn=&volume=21&issue=SUPPL+1&spage=&pages=&date=2021&title=Cancer+Imaging&atitle=Genetic+insights+into+screening+for+prostate+cancer-13%3A50-14%3A10&aulast=Bancroft&pid=%3Cauthor%3EBancroft+E.K.%3BMcHugh+J.%3BEeles+R.A.%3C%2Fauthor%3E%3CAN%3E636153336%3C%2FAN%3E%3CDT%3EConference+Abstract%3C%2FDT%3E",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Exclude",
        "Exclusion Reason Final Level 2": "Conference abstract",
        "Title": "Genetic insights into screening for prostate cancer-13:50-14:10",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "2022-07-26 00:00:00",
        "URL": "http://annals.org/aim/fullarticle/2720863/families-like//https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emed20&AN=625958696//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:30641553&id=doi:10.7326%2FACPJC-2019-170-2-002&issn=0003-4819&isbn=&volume=170&issue=2&spage=JC2&pages=JC2&date=2019&title=Annals+of+Internal+Medicine&atitle=Guideline%3A+Experts+recommend+against+prostate+cancer+screening+with+prostate-specific+antigen+test&aulast=Fletcher&pid=%3Cauthor%3EFletcher+R.H.%3C%2Fauthor%3E%3CAN%3E625958696%3C%2FAN%3E%3CDT%3ENote%3C%2FDT%3E",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Exclude",
        "Exclusion Reason Final Level 2": "Primary study or not systematic review",
        "Title": "Guideline: Experts recommend against prostate cancer screening with prostate-specific antigen test",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "2022-07-26 00:00:00",
        "URL": "https://www.medrxiv.org///https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=empp&AN=2018155040//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:&id=doi:10.1101%2F2022.04.18.22273850&issn=&isbn=&volume=&issue=&spage=&pages=&date=2022&title=medRxiv&atitle=Incorporating+Genetic+Determinants+of+Prostate-Specific+Antigen+Levels+Improves+Prostate+Cancer+Screening&aulast=Kachuri&pid=%3Cauthor%3EKachuri+L.%3BHoffmann+T.J.%3BJiang+Y.%3BBerndt+S.I.%3BShelley+J.P.%3BSchaffer+K.%3BMachiela+M.J.%3BFreedman+N.D.%3BHuang+W.-Y.%3BLi+S.A.%3BEasterlin+R.%3BGoodman+P.J.%3BTill+C.%3BThompson+I.%3BLilja+H.%3BVan+Den+Eeden+S.K.%3BChanock+S.%3BHaiman+C.A.%3BConti+D.V.%3BKlein+R.J.%3BMosley+J.D.%3BGraff+R.E.%3BWitte+J.S.%3C%2Fauthor%3E%3CAN%3E2018155040%3C%2FAN%3E%3CDT%3EPreprint%3C%2FDT%3E",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Exclude",
        "Exclusion Reason Final Level 2": "Others",
        "Title": "Incorporating Genetic Determinants of Prostate-Specific Antigen Levels Improves Prostate Cancer Screening",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "2022-07-26 00:00:00",
        "URL": "http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1742-1241//https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emed19&AN=623356097//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:29920875&id=doi:10.1111%2Fijcp.13202&issn=1368-5031&isbn=&volume=72&issue=8&spage=e13202&pages=&date=2018&title=International+Journal+of+Clinical+Practice&atitle=Interventions+to+improve+the+uptake+of+screening+across+a+range+of+conditions+in+Ethnic+Minority+Groups%3A+a+systematic+review&aulast=Kelly&pid=%3Cauthor%3EKelly+C.%3BPericleous+M.%3BHendy+J.%3Bde+Lusignan+S.%3BAhmed+A.%3BVandrevala+T.%3BAla+A.%3C%2Fauthor%3E%3CAN%3E623356097%3C%2FAN%3E%3CDT%3EReview%3C%2FDT%3E",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Exclude",
        "Exclusion Reason Final Level 2": "Others",
        "Title": "Interventions to improve the uptake of screening across a range of conditions in Ethnic Minority Groups: a systematic review",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "2022-07-08 00:00:00",
        "URL": "",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Exclude",
        "Exclusion Reason Final Level 2": "Others",
        "Title": "Is prostate-specific antigen effective for population screening of prostate cancer? A systematic review",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "2022-07-08 00:00:00",
        "URL": "",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Exclude",
        "Exclusion Reason Final Level 2": "Attitude, belief, experience, behaviour, knowledge",
        "Title": "Knowledge of prostate cancer among African American men: A systematic review",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "2022-07-08 00:00:00",
        "URL": "",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Exclude",
        "Exclusion Reason Final Level 2": "Attitude, belief, experience, behaviour, knowledge",
        "Title": "Knowledge of prostate cancer presentation, etiology, and screening practices among women: a mixed-methods systematic review",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "2022-07-26 00:00:00",
        "URL": "http://www.journals.elsevier.com/the-lancet-oncology///https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emed15&AN=600257874//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:25281469&id=doi:10.1016%2FS1470-2045%252814%252970508-X&issn=1470-2045&isbn=&volume=15&issue=11&spage=e504&pages=e504-e516&date=2014&title=The+Lancet+Oncology&atitle=Knowledge%2C+attitudes%2C+and+behaviours+towards+cancer+screening+in+indigenous+populations%3A+A+systematic+review&aulast=Kolahdooz&pid=%3Cauthor%3EKolahdooz+F.%3BJang+S.L.%3BCorriveau+A.%3BGotay+C.%3BJohnston+N.%3BSharma+S.%3C%2Fauthor%3E%3CAN%3E600257874%3C%2FAN%3E%3CDT%3EReview%3C%2FDT%3E",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Exclude",
        "Exclusion Reason Final Level 2": "Attitude, belief, experience, behaviour, knowledge",
        "Title": "Knowledge, attitudes, and behaviours towards cancer screening in indigenous populations: A systematic review",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "2022-07-08 00:00:00",
        "URL": "",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Exclude",
        "Exclusion Reason Final Level 2": "Attitude, belief, experience, behaviour, knowledge",
        "Title": "Men's perspectives of prostate cancer screening: A systematic review of qualitative studies",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "2022-07-08 00:00:00",
        "URL": "",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Exclude",
        "Exclusion Reason Final Level 2": "Attitude, belief, experience, behaviour, knowledge",
        "Title": "Men's willingness to pay for prostate cancer screening: a systematic review",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "2022-07-26 00:00:00",
        "URL": "https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emexb&AN=637386688//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:35226140&id=doi:10.1007%2Fs00345-022-03947-y&issn=1433-8726&isbn=&volume=&issue=&spage=&pages=&date=2022&title=World+journal+of+urology&atitle=MRI+as+a+screening+tool+for+prostate+cancer%3A+current+evidence+and+future+challenges&aulast=Wurnschimmel&pid=%3Cauthor%3EWurnschimmel+C.%3BChandrasekar+T.%3BHahn+L.%3BEsen+T.%3BShariat+S.F.%3BTilki+D.%3C%2Fauthor%3E%3CAN%3E637386688%3C%2FAN%3E%3CDT%3EArticle%3C%2FDT%3E",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Exclude",
        "Exclusion Reason Final Level 2": "Primary study or not systematic review",
        "Title": "MRI as a screening tool for prostate cancer: current evidence and future challenges",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "2022-07-08 00:00:00",
        "URL": "",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Exclude",
        "Exclusion Reason Final Level 2": "Summary study, not guideline, no screening details, no details, no analysis",
        "Title": "Multi-cohort modeling strategies for scalable globally accessible prostate cancer risk tools",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "2022-07-08 00:00:00",
        "URL": "",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Exclude",
        "Exclusion Reason Final Level 2": "Summary study, not guideline, no screening details, no details, no analysis",
        "Title": "Multigene panels in prostate cancer risk assessment",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "2022-07-26 00:00:00",
        "URL": "http://www.journals.elsevier.com/urology-practice///https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emed19&AN=619542114//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:&id=doi:10.1016%2Fj.urpr.2016.12.001&issn=2352-0779&isbn=&volume=5&issue=1&spage=24&pages=24-30&date=2018&title=Urology+Practice&atitle=News+Media+Analysis+of+the+United+States+Preventive+Services+Task+Force+and+American+Urological+Association+Prostate+Cancer+Screening+Guidelines&aulast=Koo&pid=%3Cauthor%3EKoo+K.%3BShee+K.%3BYap+R.L.%3C%2Fauthor%3E%3CAN%3E619542114%3C%2FAN%3E%3CDT%3EArticle%3C%2FDT%3E",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Exclude",
        "Exclusion Reason Final Level 2": "Others",
        "Title": "News Media Analysis of the United States Preventive Services Task Force and American Urological Association Prostate Cancer Screening Guidelines",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "2022-07-26 00:00:00",
        "URL": "https://www.thieme-connect.com/products/ejournals/journal/10.1055/s-00035331//https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emed20&AN=630377908//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:&id=doi:10.1055%2Fs-0039-1693136&issn=0120-789X&isbn=&volume=28&issue=3&spage=209&pages=209-215&date=2019&title=Urologia+Colombiana&atitle=Tamizacion+poblacional+para+la+deteccion+temprana+del+cancer+de+prostata%3A+%3Fque+hemos+aprendido+en+los+ultimos+10+anos%3F&aulast=Castaneda-Millan&pid=%3Cauthor%3ECastaneda-Millan+D.A.%3BCapera-Lopez+C.A.%3BRamos-Ulloa+G.%3BVarela-Ramirez+R.%3BDonoso-Donoso+W.%3C%2Fauthor%3E%3CAN%3E630377908%3C%2FAN%3E%3CDT%3EArticle%3C%2FDT%3E",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Exclude",
        "Exclusion Reason Final Level 2": "Others",
        "Title": "Population screening for early detection of prostate cancer: What have we learned in the last decade?. [Spanish]",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "2022-07-08 00:00:00",
        "URL": "",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Exclude",
        "Exclusion Reason Final Level 2": "Others",
        "Title": "Properties of the 4-Kallikrein Panel Outside the Diagnostic Gray Zone: Meta-Analysis of Patients with Positive Digital Rectal Examination or Prostate Specific Antigen 10 ng/ml and Above",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "2022-07-26 00:00:00",
        "URL": "https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emed20&AN=628726082//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:&id=doi:10.1177%2F1010428319842942&issn=1423-0380&isbn=&volume=41&issue=7&spage=5&pages=5&date=2019&title=Tumor+Biology&atitle=Prostate+cancer+detection%3A+Biomarkers%2C+imaging%2C+and+clinical+data%2C+the+combination+is+a+key&aulast=Roobol&pid=%3Cauthor%3ERoobol+M.J.%3C%2Fauthor%3E%3CAN%3E628726082%3C%2FAN%3E%3CDT%3EConference+Abstract%3C%2FDT%3E",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Exclude",
        "Exclusion Reason Final Level 2": "Conference abstract",
        "Title": "Prostate cancer detection: Biomarkers, imaging, and clinical data, the combination is a key",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "2022-07-26 00:00:00",
        "URL": "https://www.journals.elsevier.com/european-urology-oncology//https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emexb&AN=2014240764//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:34446369&id=doi:10.1016%2Fj.euo.2021.07.006&issn=2588-9311&isbn=&volume=5&issue=1&spage=18&pages=18-29&date=2022&title=European+Urology+Oncology&atitle=Prostate+Cancer+Racial+Disparities%3A+A+Systematic+Review+by+the+Prostate+Cancer+Foundation+Panel&aulast=Mahal&pid=%3Cauthor%3EMahal+B.A.%3BGerke+T.%3BAwasthi+S.%3BSoule+H.R.%3BSimons+J.W.%3BMiyahira+A.%3BHalabi+S.%3BGeorge+D.%3BPlatz+E.A.%3BMucci+L.%3BYamoah+K.%3C%2Fauthor%3E%3CAN%3E2014240764%3C%2FAN%3E%3CDT%3EReview%3C%2FDT%3E",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Exclude",
        "Exclusion Reason Final Level 2": "Others",
        "Title": "Prostate Cancer Racial Disparities: A Systematic Review by the Prostate Cancer Foundation Panel",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "2022-07-08 00:00:00",
        "URL": "",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Exclude",
        "Exclusion Reason Final Level 2": "For public consumption, patient info/guide, trial information",
        "Title": "Prostate Cancer Risk Calculator Apps in a Taiwanese Population Cohort: Validation Study",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "2022-07-26 00:00:00",
        "URL": "http://www.nmanet.org/index.php/pub_past_issues/mainMenu//https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emed19&AN=2001245333//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:30409717&id=doi:10.1016%2Fj.jnma.2018.10.010&issn=0027-9684&isbn=&volume=112&issue=5&spage=448&pages=448-453&date=2020&title=Journal+of+the+National+Medical+Association&atitle=Prostate+Cancer+Screening+Guidelines+for+African+American+Veterans%3A+A+New+Perspective&aulast=Reddy&pid=%3Cauthor%3EReddy+A.%3BRoberts+R.%3BShenoy+D.%3BPackianathan+S.%3BGiri+S.%3BVijayakumar+S.%3C%2Fauthor%3E%3CAN%3E2001245333%3C%2FAN%3E%3CDT%3EEditorial%3C%2FDT%3E",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Exclude",
        "Exclusion Reason Final Level 2": "Others",
        "Title": "Prostate Cancer Screening Guidelines for African American Veterans: A New Perspective",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "2022-07-08 00:00:00",
        "URL": "",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Exclude",
        "Exclusion Reason Final Level 2": "Others",
        "Title": "Prostate cancer screening with prostate-specific antigen (PSA) test: a systematic review and meta-analysis",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "2022-07-08 00:00:00",
        "URL": "",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Exclude",
        "Exclusion Reason Final Level 2": "Others",
        "Title": "Prostate cancer screening: facts, statistics, and interpretation in response to the US Preventive Services Task Force Review",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "2022-07-08 00:00:00",
        "URL": "",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Exclude",
        "Exclusion Reason Final Level 2": "Others",
        "Title": "Prostate specific antigen testing policy worldwide varies greatly and seems not to be in accordance with guidelines: a systematic review",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "2022-07-26 00:00:00",
        "URL": "https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emed13&AN=368728878//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:&id=doi:10.1007%2Fs13631-012-0067-7&issn=1825-859X&isbn=&volume=8&issue=4&spage=231&pages=231-238&date=2012&title=Rivista+Italiana+della+Medicina+di+Laboratorio&atitle=Prostate-specific+antigen+%28PSA%29+isoform+p2PSA+in+prostate+cancer+screening%3A+Systematic+review+of+current+evidence+and+further+perspectives&aulast=Lippi&pid=%3Cauthor%3ELippi+G.%3BAloe+R.%3BMattiuzzi+C.%3C%2Fauthor%3E%3CAN%3E368728878%3C%2FAN%3E%3CDT%3EReview%3C%2FDT%3E",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Exclude",
        "Exclusion Reason Final Level 2": "Others",
        "Title": "Prostate-specific antigen (PSA) isoform p2PSA in prostate cancer screening: Systematic review of current evidence and further perspectives",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "2022-07-26 00:00:00",
        "URL": "http://www.hqontario.ca/Portals/0/Documents/eds/ohtas/economic-analysis-psa-screening-1505-en.pdf//https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emed16&AN=604390596//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:26366237&id=doi:&issn=1915-7398&isbn=&volume=15&issue=11&spage=&pages=&date=2015&title=Ontario+Health+Technology+Assessment+Series&atitle=Prostate-specific+antigen+%28PSA%29-based+population+screening+for+prostate+cancer%3A+An+economic+analysis&aulast=Tawfik&pid=%3Cauthor%3ETawfik+A.%3C%2Fauthor%3E%3CAN%3E604390596%3C%2FAN%3E%3CDT%3EArticle%3C%2FDT%3E",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Exclude",
        "Exclusion Reason Final Level 2": "Others",
        "Title": "Prostate-specific antigen (PSA)-based population screening for prostate cancer: An economic analysis",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "2022-07-08 00:00:00",
        "URL": "",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Exclude",
        "Exclusion Reason Final Level 2": "Conference abstract",
        "Title": "Prostate-specific antigen and prostate cancer mortality: a systematic review",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "2022-07-08 00:00:00",
        "URL": "",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Exclude",
        "Exclusion Reason Final Level 2": "Conference abstract",
        "Title": "Prostate-Specific Antigen-Based Screening for Prostate Cancer: Evidence Report and Systematic Review for the US Preventive Services Task Force",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "2022-07-26 00:00:00",
        "URL": "https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emed13&AN=71141359//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:&id=doi:10.1159%2F000171040&issn=0378-584X&isbn=&volume=35&issue=SUPPL.+6&spage=1&pages=1-2&date=2012&title=Onkologie&atitle=%22PSA+screening+-+Pros+and+cons%22&aulast=Weisbach&pid=%3Cauthor%3EWeisbach+L.%3C%2Fauthor%3E%3CAN%3E71141359%3C%2FAN%3E%3CDT%3EConference+Abstract%3C%2FDT%3E",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Exclude",
        "Exclusion Reason Final Level 2": "Conference abstract",
        "Title": "PSA screening - Pros and cons",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "2022-07-26 00:00:00",
        "URL": "http://link.springer.de/link/service/journals/00120/index.htm//https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emed20&AN=626822692//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:30874831&id=doi:10.1007%2Fs00120-019-0900-y&issn=0340-2592&isbn=&volume=58&issue=5&spage=486&pages=&date=2019&title=Urologe&atitle=PSA-Screening+und+molekulare+Marker&aulast=Lakes&pid=%3Cauthor%3ELakes+J.%3BArsov+C.%3C%2Fauthor%3E%3CAN%3E626822692%3C%2FAN%3E%3CDT%3EReview%3C%2FDT%3E",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Exclude",
        "Exclusion Reason Final Level 2": "Others",
        "Title": "PSA screening and molecular markers. [German]",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "2022-07-26 00:00:00",
        "URL": "https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emed19&AN=626874875//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:&id=doi:10.1089%2Fend.2018.29043.abstracts&issn=1557-900X&isbn=&volume=32&issue=Supplement+2&spage=A7&pages=A7-A8&date=2018&title=Journal+of+Endourology&atitle=Quality+of+knowledge+and+psychoscial+impact+associated+with+psa+testing+in+general+population+%3A+A+systematic+review+of+the+literature&aulast=Osman&pid=%3Cauthor%3EOsman+B.A.%3BAbdelmoteleb+H.%3BMosey+R.%3BJoshi+H.%3C%2Fauthor%3E%3CAN%3E626874875%3C%2FAN%3E%3CDT%3EConference+Abstract%3C%2FDT%3E",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Exclude",
        "Exclusion Reason Final Level 2": "Conference abstract",
        "Title": "Quality of knowledge and psychoscial impact associated with psa testing in general population : A systematic review of the literature",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "2022-07-26 00:00:00",
        "URL": "https://www.sibioc.it/bc/download/articolo/1449//https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emed19&AN=625539332//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:&id=doi:10.19186%2FBC_2018.053&issn=0393-0564&isbn=&volume=42&issue=4&spage=318&pages=318-320&date=2018&title=Biochimica+Clinica&atitle=Qualita+delle+raccomandazioni+o+raccomandazioni+di+qualita%3F+Il+caso+dell%27antigene+prostatico+specifico+nello+screening+del+carcinoma+della+prostata&aulast=Plebani&pid=%3Cauthor%3EPlebani+M.%3C%2Fauthor%3E%3CAN%3E625539332%3C%2FAN%3E%3CDT%3EReview%3C%2FDT%3E",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Exclude",
        "Exclusion Reason Final Level 2": "Others",
        "Title": "Quality of recommendations or recommandations of quality? The case of PSA-based screening for prostate cancer. [Italian]",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "2022-07-08 00:00:00",
        "URL": "",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Exclude",
        "Exclusion Reason Final Level 2": "Others",
        "Title": "Quantitative and Qualitative Analysis of Circulating Cell-Free DNA Can Be Used as an Adjuvant Tool for Prostate Cancer Screening: A Meta-Analysis",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "2022-07-26 00:00:00",
        "URL": "https://www.auajournals.org///https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emexa&AN=618847638//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:28552708&id=doi:10.1016%2Fj.juro.2017.05.074&issn=0022-5347&isbn=&volume=198&issue=6&spage=1230&pages=1230-1240&date=2017&title=Journal+of+Urology&atitle=Recent+changes+in+prostate+cancer+screening+practices+and+epidemiology&aulast=Lee&pid=%3Cauthor%3ELee+D.J.%3BMallin+K.%3BGraves+A.J.%3BChang+S.S.%3BPenson+D.F.%3BResnick+M.J.%3BBarocas+D.A.%3C%2Fauthor%3E%3CAN%3E618847638%3C%2FAN%3E%3CDT%3EReview%3C%2FDT%3E",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Exclude",
        "Exclusion Reason Final Level 2": "Others",
        "Title": "Recent changes in prostate cancer screening practices and epidemiology",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "2022-07-26 00:00:00",
        "URL": "https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emed21&AN=632060075//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:&id=doi:10.1097%2FJU.0000000000000958.08&issn=1527-3792&isbn=&volume=203&issue=Supplement+4&spage=e1117&pages=e1117-e1118&date=2020&title=Journal+of+Urology&atitle=Reconsidering+the+tradeoffs+of+prostate+cancer+screening&aulast=Shoag&pid=%3Cauthor%3EShoag+J.%3BNyame+Y.%3BGulati+R.%3BEtzioni+R.%3BHu+J.%3C%2Fauthor%3E%3CAN%3E632060075%3C%2FAN%3E%3CDT%3EConference+Abstract%3C%2FDT%3E",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Exclude",
        "Exclusion Reason Final Level 2": "Conference abstract",
        "Title": "Reconsidering the tradeoffs of prostate cancer screening",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "2022-07-26 00:00:00",
        "URL": "http://www.springer.com/medicine/oncology/journal/13193//https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emed18&AN=616110710//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:&id=doi:10.1007%2Fs13193-016-0584-3&issn=0975-7651&isbn=&volume=8&issue=2&spage=160&pages=160-168&date=2017&title=Indian+Journal+of+Surgical+Oncology&atitle=Screening+and+Detection+of+Prostate+Cancer-Review+of+Literature+and+Current+Perspective&aulast=Sivaraman&pid=%3Cauthor%3ESivaraman+A.%3BBhat+K.R.S.%3C%2Fauthor%3E%3CAN%3E616110710%3C%2FAN%3E%3CDT%3EReview%3C%2FDT%3E",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Exclude",
        "Exclusion Reason Final Level 2": "Primary study or not systematic review",
        "Title": "Screening and Detection of Prostate Cancer-Review of Literature and Current Perspective",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "2022-07-08 00:00:00",
        "URL": "",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Exclude",
        "Exclusion Reason Final Level 2": "Others",
        "Title": "Screening for prostate cancer",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "2022-07-08 00:00:00",
        "URL": "",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Exclude",
        "Exclusion Reason Final Level 2": "Attitude, belief, experience, behaviour, knowledge",
        "Title": "Screening for prostate cancer with prostate-specific antigen testing: American Society of Clinical Oncology Provisional Clinical Opinion",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "2022-07-08 00:00:00",
        "URL": "",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Exclude",
        "Exclusion Reason Final Level 2": "Others",
        "Title": "Screening for prostate cancer with the prostate-specific antigen test: a review of current evidence",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "2022-07-08 00:00:00",
        "URL": "",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Exclude",
        "Exclusion Reason Final Level 2": "Primary study or not systematic review",
        "Title": "Screening for prostate cancer: History, evidence, controversies and future perspectives toward individualized screening",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "2022-07-08 00:00:00",
        "URL": "",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Exclude",
        "Exclusion Reason Final Level 2": "Not research study objectives - ie not prostate cancer-related or decision aid or guideline or programme related to prostate cancer",
        "Title": "Screening for prostate cancer: reflecting on the quality of evidence from the ERSPC and PLCO studies",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "2022-07-26 00:00:00",
        "URL": "https://www.jmir.org/2021/7/e26759/PDF//https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emexa&AN=2013847690//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:34328423&id=doi:10.2196%2F26759&issn=1438-8871&isbn=&volume=23&issue=7&spage=e26759&pages=&date=2021&title=Journal+of+Medical+Internet+Research&atitle=Social+media+and+mhealth+technology+for+cancer+screening%3A+Systematic+review+and+meta-analysis&aulast=Ruco&pid=%3Cauthor%3ERuco+A.%3BDossa+F.%3BTinmouth+J.%3BLlovet+D.%3BJacobson+J.%3BKishibe+T.%3BBaxter+N.%3C%2Fauthor%3E%3CAN%3E2013847690%3C%2FAN%3E%3CDT%3EReview%3C%2FDT%3E",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Exclude",
        "Exclusion Reason Final Level 2": "Summary study, not guideline, no screening details, no details, no analysis",
        "Title": "Social media and mhealth technology for cancer screening: Systematic review and meta-analysis",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "2022-07-08 00:00:00",
        "URL": "",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Exclude",
        "Exclusion Reason Final Level 2": "Others",
        "Title": "Systematic review and meta-analysis of the associations between body mass index, prostate cancer, advanced prostate cancer, and prostate-specific antigen",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "2022-07-08 00:00:00",
        "URL": "",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Exclude",
        "Exclusion Reason Final Level 2": "Others",
        "Title": "Systematic Review of Commercially Available Mobile Phone Applications for Prostate Cancer Education",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "2022-07-26 00:00:00",
        "URL": "https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emed19&AN=2001249065//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:&id=doi:10.1016%2Fj.jval.2018.07.464&issn=1098-3015&isbn=&volume=21&issue=Supplement+2&spage=S61&pages=S61&date=2018&title=Value+in+Health&atitle=Systematic+Review+of+Prostate+Cancer+Screening+Guideline+in+Various+Country&aulast=Romyen&pid=%3Cauthor%3ERomyen+C.%3C%2Fauthor%3E%3CAN%3E2001249065%3C%2FAN%3E%3CDT%3EConference+Abstract%3C%2FDT%3E",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Exclude",
        "Exclusion Reason Final Level 2": "Conference abstract",
        "Title": "Systematic Review of Prostate Cancer Screening Guideline in Various Country",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "2022-07-26 00:00:00",
        "URL": "http://www.springerlink.com/content/120414///https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emed22&AN=601973397//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:25150033&id=doi:10.1007%2Fs11606-014-2996-5&issn=0884-8734&isbn=&volume=30&issue=2&spage=242&pages=242-248&date=2015&title=Journal+of+General+Internal+Medicine&atitle=The+Psychological+Harms+of+Screening%3A+the+Evidence+We+Have+Versus+the+Evidence+We+Need&aulast=DeFrank&pid=%3Cauthor%3EDeFrank+J.T.%3BBarclay+C.%3BSheridan+S.%3BBrewer+N.T.%3BGilliam+M.%3BMoon+A.M.%3BRearick+W.%3BZiemer+C.%3BHarris+R.%3C%2Fauthor%3E%3CAN%3E601973397%3C%2FAN%3E%3CDT%3EArticle%3C%2FDT%3E",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Exclude",
        "Exclusion Reason Final Level 2": "Others",
        "Title": "The Psychological Harms of Screening: the Evidence We Have Versus the Evidence We Need",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "2022-07-26 00:00:00",
        "URL": "https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emed16&AN=71860124//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:&id=doi:&issn=0022-5347&isbn=&volume=193&issue=4+SUPPL.+1&spage=e999&pages=e999&date=2015&title=Journal+of+Urology&atitle=The+use+of+decisional+aids+for+prostate+cancer+screening%3A+A+meta-analysis&aulast=Purifoy&pid=%3Cauthor%3EPurifoy+J.%3BSchurhamer+B.%3BKatz+M.%3BThomas+S.%3BPate+B.%3BDavis+R.%3C%2Fauthor%3E%3CAN%3E71860124%3C%2FAN%3E%3CDT%3EConference+Abstract%3C%2FDT%3E",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Exclude",
        "Exclusion Reason Final Level 2": "Conference abstract",
        "Title": "The use of decisional aids for prostate cancer screening: A meta-analysis",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "2022-07-08 00:00:00",
        "URL": "",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Exclude",
        "Exclusion Reason Final Level 2": "Summary study, not guideline, no screening details, no details, no analysis",
        "Title": "There are calls for a national screening programme for prostate cancer: what is the evidence to justify such a national screening programme?",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "2022-07-26 00:00:00",
        "URL": "",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Exclude",
        "Exclusion Reason Final Level 2": "Others",
        "Title": "Trends in prostate cancer screening before and after publication of us preventive services task force draft guidelines: An analysis of data from a large us laboratory service provider",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "2022-07-08 00:00:00",
        "URL": "",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Exclude",
        "Exclusion Reason Final Level 2": "Others",
        "Title": "Values and preferences of men for undergoing prostate-specific antigen screening for prostate cancer: a systematic review",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "2022-07-22 00:00:00",
        "URL": "https://search.ebscohost.com/login.aspx?direct=true&AuthType=shib&db=jlh&AN=103890403&site=ehost-live&scope=site&custid=s8849760",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Exclude",
        "Exclusion Reason Final Level 2": "Primary study or not systematic review",
        "Title": "Age appropriate screening for cancer: Evidence-based practice in the United States of America",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "2022-07-08 00:00:00",
        "URL": "",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Exclude",
        "Exclusion Reason Final Level 2": "Not research study objectives - ie not prostate cancer-related or decision aid or guideline or programme related to prostate cancer",
        "Title": "American Urological Association (AUA) guideline on prostate cancer detection: process and rationale",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "2022-07-26 00:00:00",
        "URL": "https://journals.viamedica.pl/nowotwory_journal_of_oncology/article/view/88049//https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emexb&AN=2018873625//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:&id=doi:10.5603%2FNJO.a2022.0022&issn=0029-540X&isbn=&volume=72&issue=3&spage=167&pages=167-173&date=2022&title=Nowotwory&atitle=Assessment+of+the+effectiveness+of+clinical+PSA+concentration+measurements+in+early+prostate+cancer+detection&aulast=Tatara&pid=%3Cauthor%3ETatara+T.%3BMiazga+W.%3BSwitalski+J.%3BWnuk+K.%3BJablonska+M.%3BMatera+A.%3BKarauda+D.%3BZagrobelna+A.%3BJopek+S.%3C%2Fauthor%3E%3CAN%3E2018873625%3C%2FAN%3E%3CDT%3EReview%3C%2FDT%3E",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Exclude",
        "Exclusion Reason Final Level 2": "Others",
        "Title": "Assessment of the effectiveness of clinical PSA concentration measurements in early prostate cancer detection",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "2022-07-08 00:00:00",
        "URL": "",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Exclude",
        "Exclusion Reason Final Level 2": "Primary study or not systematic review",
        "Title": "Do African-American men need separate prostate cancer screening guidelines?",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "2022-07-08 00:00:00",
        "URL": "",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Exclude",
        "Exclusion Reason Final Level 2": "Not research study objectives (ie. not prostate cancer-related or decision aid or guideline or programme related to prostate cancer)",
        "Title": "Estimating age and ethnic variation in the histological prevalence of prostate cancer to inform the impact of screening policies",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "2022-07-22 00:00:00",
        "URL": "https://search.ebscohost.com/login.aspx?direct=true&AuthType=shib&db=jlh&AN=153550799&site=ehost-live&scope=site&custid=s8849760",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Exclude",
        "Exclusion Reason Final Level 2": "Others",
        "Title": "Patient-Reported Factors Associated With Older Adults' Cancer Screening Decision-making: A Systematic Review",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "2022-07-26 00:00:00",
        "URL": "http://www.liebertonline.com/loi/pop//https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emed20&AN=626281352//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:29889616&id=doi:10.1089%2Fpop.2017.0206&issn=1942-7891&isbn=&volume=22&issue=1&spage=48&pages=48-62&date=2019&title=Population+Health+Management&atitle=Physician+Characteristics+and+Decisions+Regarding+Cancer+Screening%3A+A+Systematic+Review&aulast=Neugut&pid=%3Cauthor%3ENeugut+A.I.%3BMacLean+S.A.%3BDai+W.F.%3BJacobson+J.S.%3C%2Fauthor%3E%3CAN%3E626281352%3C%2FAN%3E%3CDT%3EArticle%3C%2FDT%3E",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Exclude",
        "Exclusion Reason Final Level 2": "Attitude, belief, experience, behaviour, knowledge",
        "Title": "Physician Characteristics and Decisions Regarding Cancer Screening: A Systematic Review",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "2022-07-22 00:00:00",
        "URL": "https://search.ebscohost.com/login.aspx?direct=true&AuthType=shib&db=jlh&AN=116202661&site=ehost-live&scope=site&custid=s8849760",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Exclude",
        "Exclusion Reason Final Level 2": "Not research study objectives (ie. not prostate cancer-related or decision aid or guideline or programme related to prostate cancer)",
        "Title": "Presentation of Benefits and Harms in US Cancer Screening and Prevention Guidelines: Systematic Review",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "2022-07-26 00:00:00",
        "URL": "http://bmjopen.bmj.com/content/early/by/section//https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emed21&AN=630825931//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:32029500&id=doi:10.1136%2Fbmjopen-2019-035411&issn=2044-6055&isbn=&volume=10&issue=2&spage=e035411&pages=&date=2020&title=BMJ+Open&atitle=Social+media+and+mobile+health+technology+for+cancer+screening%3A+A+systematic+review+and+meta-analysis+protocol&aulast=Ruco&pid=%3Cauthor%3ERuco+A.%3BDossa+F.%3BTinmouth+J.%3BLlovet+D.%3BKishibe+T.%3BBaxter+N.N.%3C%2Fauthor%3E%3CAN%3E630825931%3C%2FAN%3E%3CDT%3EReview%3C%2FDT%3E",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Exclude",
        "Exclusion Reason Final Level 2": "Primary study or not systematic review",
        "Title": "Social media and mobile health technology for cancer screening: A systematic review and meta-analysis protocol",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "2022-07-22 00:00:00",
        "URL": "https://search.ebscohost.com/login.aspx?direct=true&AuthType=shib&db=jlh&AN=128331323&site=ehost-live&scope=site&custid=s8849760",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Exclude",
        "Exclusion Reason Final Level 2": "Others",
        "Title": "The efficacy of prostate-specific antigen screening: Impact of key components in the ERSPC and PLCO trials",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "2022-07-26 00:00:00",
        "URL": "https://www.jmir.org/2020/11/e21582/PDF//https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emed21&AN=2010026365//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:33164907&id=doi:10.2196%2F21582&issn=1438-8871&isbn=&volume=22&issue=11&spage=e21582&pages=&date=2020&title=Journal+of+Medical+Internet+Research&atitle=Use+of+Social+Media+to+Promote+Cancer+Screening+and+Early+Diagnosis%3A+Scoping+Review&aulast=Plackett&pid=%3Cauthor%3EPlackett+R.%3BKaushal+A.%3BKassianos+A.P.%3BCross+A.%3BLewins+D.%3BSheringham+J.%3BWaller+J.%3Bvon+Wagner+C.%3C%2Fauthor%3E%3CAN%3E2010026365%3C%2FAN%3E%3CDT%3EReview%3C%2FDT%3E",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Exclude",
        "Exclusion Reason Final Level 2": "Others",
        "Title": "Use of Social Media to Promote Cancer Screening and Early Diagnosis: Scoping Review",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "2023-07-12 00:00:00",
        "URL": "",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Exclude",
        "Exclusion Reason Final Level 2": "Not research study objectives - ie not prostate cancer-related or decision aid or guideline or programme related to prostate cancer",
        "Title": "Including Information on Overdiagnosis in Shared Decision Making: A Review of Prostate Cancer Screening Decision Aids",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "2023-07-12 00:00:00",
        "URL": "",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Exclude",
        "Exclusion Reason Final Level 2": "Conference abstract",
        "Title": "Genetic testing in prostate cancer: a scoping literature review",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "[Chemoprevention for Prostate Cancer-The Potential of Angiotensin _ Receptor Blocker]",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "[Efficacy and safety of the 177Lu-PSMA-617 therapy in the treatment of metastatic castration-resistant prostate cancer: A meta-analysis]",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "[Localized Prostate cancer in candidates for renal transplantation and recipients of a kidney transplant: The French Guidelines from CTAFU]",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "[Management of low-risk prostate cancer]",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Intervention/ primary study/erratum/ conference abstract/ commentary/ clinic trial/ newsletter/ magazine/protocol/ literature review",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "[Screening for prostate cancer using prostate-specific antigen (PSA) : A commentary on a systematic review and meta-analysis]",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emed20&AN=627465913//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:&id=doi:10.1111%2Fbju.14724&issn=1464-410X&isbn=&volume=123&issue=Supplement+2&spage=45&pages=45&date=2019&title=BJU+International&atitle=68+Ga-PSMA+PET+in+advanced+prostate+cancer+updated+diagnostic+utility%2C+sensitivity+and+specificity+and+distribution+of+PSMAavid+lesions+systematic+review+and+meta-analysis&aulast=Perera&pid=%3Cauthor%3EPerera+M.%3BPapa+N.%3BWilliams+M.%3BRoberts+M.%3BUdovicic+C.%3BVela+I.%3BBolton+D.%3BLawrentschuk+N.%3BMurphy+D.%3C%2Fauthor%3E%3CAN%3E627465913%3C%2FAN%3E%3CDT%3EConference+Abstract%3C%2FDT%3E",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "68 Ga-PSMA PET in advanced prostate cancer updated diagnostic utility, sensitivity and specificity and distribution of PSMAavid lesions systematic review and meta-analysis",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emed14&AN=75001411//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:&id=doi:10.1007%2Fs13530-013-0171-8&issn=2005-9752&isbn=&volume=5&issue=Supplement&spage=S80&pages=S80&date=2013&title=Toxicology+and+Environmental+Health+Sciences&atitle=6th+International+Conference+on+Environmental+Health+Science&aulast=&pid=%3Cauthor%3Eanonymous%3C%2Fauthor%3E%3CAN%3E75001411%3C%2FAN%3E%3CDT%3EConference+Review%3C%2FDT%3E",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "6th International Conference on Environmental Health Science",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emed13&AN=51631150//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:21946906&id=doi:10.1097%2FNCC.0b013e31822fc76c&issn=0162-220X&isbn=&volume=35&issue=4&spage=E14&pages=E14-E26&date=2012&title=Cancer+Nursing&atitle=A+literature+review+of+suicide+in+cancer+patients&aulast=Anguiano&pid=%3Cauthor%3EAnguiano+L.%3BMayer+D.K.%3BPiven+M.L.%3BRosenstein+D.%3C%2Fauthor%3E%3CAN%3E51631150%3C%2FAN%3E%3CDT%3EReview%3C%2FDT%3E",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "A literature review of suicide in cancer patients",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "http://www.jeo-esska.com///https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emed22&AN=2010146932//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:&id=doi:10.1186%2Fs40634-020-00315-w&issn=2197-1153&isbn=&volume=8&issue=1&spage=3&pages=&date=2021&title=Journal+of+Experimental+Orthopaedics&atitle=A+narrative+review+of+the+last+decade%27s+literature+on+the+diagnostic+accuracy+of+septic+arthritis+of+the+native+joint&aulast=Turner&pid=%3Cauthor%3ETurner+E.H.G.%3BLang+M.D.H.%3BSpiker+A.M.%3C%2Fauthor%3E%3CAN%3E2010146932%3C%2FAN%3E%3CDT%3EReview%3C%2FDT%3E",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "A narrative review of the last decade's literature on the diagnostic accuracy of septic arthritis of the native joint",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "http://www.elsevier.com/inca/publications/store/6/2/2/9/0/1/index.htt//https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emed20&AN=2001277555//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:30691817&id=doi:10.1016%2Fj.jss.2018.09.017&issn=0022-4804&isbn=&volume=235&issue=&spage=350&pages=350-366&date=2019&title=Journal+of+Surgical+Research&atitle=A+Review+of+Decision+Aids+for+Patients+Considering+More+Than+One+Type+of+Invasive+Treatment&aulast=Leinweber&pid=%3Cauthor%3ELeinweber+K.A.%3BColumbo+J.A.%3BKang+R.%3BTrooboff+S.W.%3BGoodney+P.P.%3C%2Fauthor%3E%3CAN%3E2001277555%3C%2FAN%3E%3CDT%3EReview%3C%2FDT%3E",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "A Review of Decision Aids for Patients Considering More Than One Type of Invasive Treatment",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "A Systematic Review and Meta-analysis of Associations between Clinical Prostatitis and Prostate Cancer: New Estimates Accounting for Detection Bias",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "http://www.nature.com/pcan/index.html//https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emexb&AN=2007334702//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:33219368&id=doi:10.1038%2Fs41391-020-00298-w&issn=1365-7852&isbn=&volume=24&issue=3&spage=596&pages=596-611&date=2021&title=Prostate+Cancer+and+Prostatic+Diseases&atitle=A+systematic+review+and+meta-analysis+of+the+diagnostic+accuracy+of+biparametric+prostate+MRI+for+prostate+cancer+in+men+at+risk&aulast=Bass&pid=%3Cauthor%3EBass+E.J.%3BPantovic+A.%3BConnor+M.%3BGabe+R.%3BPadhani+A.R.%3BRockall+A.%3BSokhi+H.%3BTam+H.%3BWinkler+M.%3BAhmed+H.U.%3C%2Fauthor%3E%3CAN%3E2007334702%3C%2FAN%3E%3CDT%3EReview%3C%2FDT%3E",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "A systematic review and meta-analysis of the diagnostic accuracy of biparametric prostate MRI for prostate cancer in men at risk",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "http://www.europeanurology.com///https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emed15&AN=600423428//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:&id=doi:10.1016%2Fj.eururo.2014.08.059&issn=0302-2838&isbn=&volume=66&issue=6&spage=1054&pages=1054-1064&date=2014&title=European+Urology&atitle=A+systematic+review+and+meta-analysis+of+tobacco+use+and+prostate+cancer+mortality+and+incidence+in+prospective+cohort+studies&aulast=Islami&pid=%3Cauthor%3EIslami+F.%3BMoreira+D.M.%3BBoffetta+P.%3BFreedland+S.J.%3C%2Fauthor%3E%3CAN%3E600423428%3C%2FAN%3E%3CDT%3EReview%3C%2FDT%3E",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "A systematic review and meta-analysis of tobacco use and prostate cancer mortality and incidence in prospective cohort studies",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.dovepress.com/front_end/cr_data/cache/pdf/download_1611288387_600a4f43874d8/rru-268596-a-systematic-review-of-artificial-intelligence-in-prostate-c.pdf//https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emed22&AN=2005849838//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:&id=doi:10.2147%2FRRU.S268596&issn=2253-2447&isbn=&volume=13&issue=&spage=31&pages=31-39&date=2021&title=Research+and+Reports+in+Urology&atitle=A+systematic+review+of+artificial+intelligence+in+prostate+cancer&aulast=Van+Booven&pid=%3Cauthor%3EVan+Booven+D.J.%3BKuchakulla+M.%3BPai+R.%3BFrech+F.S.%3BRamasahayam+R.%3BReddy+P.%3BParmar+M.%3BRamasamy+R.%3BArora+H.%3C%2Fauthor%3E%3CAN%3E2005849838%3C%2FAN%3E%3CDT%3EReview%3C%2FDT%3E",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "A systematic review of artificial intelligence in prostate cancer",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "http://www.journalslibrary.nihr.ac.uk/__data/assets/pdf_file/0007/82744/FullReport-hta17420.pdf//https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emed14&AN=369978427//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:&id=doi:10.3310%2Fhta17420&issn=1366-5278&isbn=&volume=17&issue=42&spage=V&pages=V-274&date=2013&title=Health+Technology+Assessment&atitle=A+systematic+review+of+evidence+on+malignant+spinal+metastases%3A+Natural+history+and+technologies+for+identifying+patients+at+high+risk+of+vertebral+fracture+and+spinal+cord+compression&aulast=Sutcliffe&pid=%3Cauthor%3ESutcliffe+P.%3BConnock+M.%3BShyangdan+D.%3BCourt+R.%3BKandala+N.-B.%3BClarke+A.%3C%2Fauthor%3E%3CAN%3E369978427%3C%2FAN%3E%3CDT%3EArticle%3C%2FDT%3E",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "A systematic review of evidence on malignant spinal metastases: Natural history and technologies for identifying patients at high risk of vertebral fracture and spinal cord compression",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "http://www.annals.org/content/156/8/582.full.pdf+html//https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emed13&AN=364627335//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:22351515&id=doi:10.7326%2F0003-4819-156-8-201204170-00009&issn=0003-4819&isbn=&volume=156&issue=8&spage=582&pages=582-590&date=2012&title=Annals+of+Internal+Medicine&atitle=Active+surveillance+in+men+with+localized+prostate+cancer%3A+A+systematic+review&aulast=Dahabreh&pid=%3Cauthor%3EDahabreh+I.J.%3BChung+M.%3BBalk+E.M.%3BYu+W.W.%3BMathew+P.%3BLau+J.%3BIp+S.%3C%2Fauthor%3E%3CAN%3E364627335%3C%2FAN%3E%3CDT%3EReview%3C%2FDT%3E",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Active surveillance in men with localized prostate cancer: A systematic review",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "http://www.hindawi.com/journals/biomed///https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emed15&AN=372756794//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:24757679&id=doi:10.1155%2F2014%2F827265&issn=2314-6133&isbn=&volume=2014&issue=&spage=827265&pages=&date=2014&title=BioMed+Research+International&atitle=Advanced+imaging+for+the+early+diagnosis+of+local+recurrence+prostate+cancer+after+radical+prostatectomy&aulast=Panebianco&pid=%3Cauthor%3EPanebianco+V.%3BBarchetti+F.%3BMusio+D.%3BDe+Felice+F.%3BProietti+C.%3BIndino+E.L.%3BMegna+V.%3BSchillaci+O.%3BCatalano+C.%3BTombolini+V.%3C%2Fauthor%3E%3CAN%3E372756794%3C%2FAN%3E%3CDT%3EReview%3C%2FDT%3E",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Advanced imaging for the early diagnosis of local recurrence prostate cancer after radical prostatectomy",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "http://www.ro-journal.com///https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emed18&AN=614941012//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:28327203&id=doi:10.1186%2Fs13014-017-0786-z&issn=1748-717X&isbn=&volume=12&issue=1&spage=56&pages=&date=2017&title=Radiation+Oncology&atitle=An+appraisal+of+analytical+tools+used+in+predicting+clinical+outcomes+following+radiation+therapy+treatment+of+men+with+prostate+cancer%3A+A+systematic+review&aulast=Raymond&pid=%3Cauthor%3ERaymond+E.%3BO%27Callaghan+M.E.%3BCampbell+J.%3BVincent+A.D.%3BBeckmann+K.%3BRoder+D.%3BEvans+S.%3BMcNeil+J.%3BMillar+J.%3BZalcberg+J.%3BBorg+M.%3BMoretti+K.%3C%2Fauthor%3E%3CAN%3E614941012%3C%2FAN%3E%3CDT%3EArticle%3C%2FDT%3E",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "An appraisal of analytical tools used in predicting clinical outcomes following radiation therapy treatment of men with prostate cancer: A systematic review",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Are we ready to predict late effects? A systematic review of clinically useful prediction models",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "http://clincancerres.aacrjournals.org/content/21/4/756.full.pdf+html//https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emed16&AN=602249149//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:25520389&id=doi:10.1158%2F1078-0432.CCR-14-2235&issn=1078-0432&isbn=&volume=21&issue=4&spage=756&pages=756-762&date=2015&title=Clinical+Cancer+Research&atitle=Aspirin%2C+NSAIDs%2C+and+risk+of+prostate+cancer%3A+Results+from+the+REDUCE+study&aulast=Vidal&pid=%3Cauthor%3EVidal+A.C.%3BHoward+L.E.%3BMoreira+D.M.%3BCastro-Santamaria+R.%3BAndriole+G.L.%3BFreedland+S.J.%3C%2Fauthor%3E%3CAN%3E602249149%3C%2FAN%3E%3CDT%3EArticle%3C%2FDT%3E",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Aspirin, NSAIDs, and risk of prostate cancer: Results from the REDUCE study",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "http://tau.amegroups.com/article/view/55769/pdf//https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emed22&AN=2010582167//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:&id=doi:10.21037%2Ftau-20-843&issn=2223-4683&isbn=&volume=9&issue=6&spage=2519&pages=2519-2532&date=2020&title=Translational+Andrology+and+Urology&atitle=Association+of+5-alpha-reductase+inhibitor+and+prostate+cancer+incidence+and+mortality%3A+A+meta-analysis&aulast=Hu&pid=%3Cauthor%3EHu+X.%3BWang+Y.-H.%3BYang+Z.-Q.%3BShao+Y.-X.%3BYang+W.-X.%3BLi+X.%3C%2Fauthor%3E%3CAN%3E2010582167%3C%2FAN%3E%3CDT%3EArticle%3C%2FDT%3E",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Association of 5-alpha-reductase inhibitor and prostate cancer incidence and mortality: A meta-analysis",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emed18&AN=620057562//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:&id=doi:10.1515%2Fdx-2017-0034&issn=2194-802X&isbn=&volume=4&issue=4&spage=eA84&pages=eA84-eA85&date=2017&title=Diagnosis&atitle=Atrius+health+safety+nets%3A+Prostate+cancer&aulast=Uiterwyk&pid=%3Cauthor%3EUiterwyk+S.%3BKelly+M.%3C%2Fauthor%3E%3CAN%3E620057562%3C%2FAN%3E%3CDT%3EConference+Abstract%3C%2FDT%3E",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Atrius health safety nets: Prostate cancer",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "http://www.indianjurol.com//https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emed20&AN=625895959//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:&id=doi:10.4103%2Fiju.IJU_355_18&issn=0970-1591&isbn=&volume=35&issue=1&spage=6&pages=6-17&date=2019&title=Indian+Journal+of+Urology&atitle=Biochemical+recurrence+after+radical+prostatectomy%3A+Current+status+of+its+use+as+a+treatment+endpoint+and+early+management+strategies&aulast=McCormick&pid=%3Cauthor%3EMcCormick+B.%3BMahmoud+A.%3BWilliams+S.%3BDavis+J.%3C%2Fauthor%3E%3CAN%3E625895959%3C%2FAN%3E%3CDT%3EReview%3C%2FDT%3E",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Biochemical recurrence after radical prostatectomy: Current status of its use as a treatment endpoint and early management strategies",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emed18&AN=618192123//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:&id=doi:&issn=1879-0887&isbn=&volume=123&issue=Supplement+1&spage=S382&pages=S382&date=2017&title=Radiotherapy+and+Oncology&atitle=BRCA2+mutation+predicts+poor+survival+in+prostate+cancer%3A+A+compelling+evidence+from+8%2C988+patients&aulast=Cui&pid=%3Cauthor%3ECui+M.%3BGao+X.S.%3BGu+X.%3BPeng+C.%3BLi+X.%3BMa+M.%3C%2Fauthor%3E%3CAN%3E618192123%3C%2FAN%3E%3CDT%3EConference+Abstract%3C%2FDT%3E",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "BRCA2 mutation predicts poor survival in prostate cancer: A compelling evidence from 8,988 patients",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.auajournals.org///https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emed20&AN=632726561//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:&id=doi:10.1097%2FJU.0000000000000137&issn=0022-5347&isbn=&volume=202&issue=2&spage=223&pages=223-230&date=2019&title=Journal+of+Urology&atitle=Bringing+Prostate+Cancer+Germline+Genetics+into+Clinical+Practice&aulast=Das&pid=%3Cauthor%3EDas+S.%3BSalami+S.S.%3BSpratt+D.E.%3BKaffenberger+S.D.%3BJacobs+M.F.%3BMorgan+T.M.%3C%2Fauthor%3E%3CAN%3E632726561%3C%2FAN%3E%3CDT%3EReview%3C%2FDT%3E",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Bringing Prostate Cancer Germline Genetics into Clinical Practice",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "http://rd.springer.com/journal/40258//https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emed20&AN=627427738//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:31016686&id=doi:10.1007%2Fs40258-019-00475-6&issn=1175-5652&isbn=&volume=17&issue=4&spage=493&pages=493-511&date=2019&title=Applied+Health+Economics+and+Health+Policy&atitle=Budget+Impact+Analysis+of+Cancer+Screening%3A+A+Methodological+Review&aulast=Jahn&pid=%3Cauthor%3EJahn+B.%3BTodorovic+J.%3BBundo+M.%3BSroczynski+G.%3BConrads-Frank+A.%3BRochau+U.%3BEndel+G.%3BWilbacher+I.%3BMalbaski+N.%3BPopper+N.%3BChhatwal+J.%3BGreenberg+D.%3BMauskopf+J.%3BSiebert+U.%3C%2Fauthor%3E%3CAN%3E627427738%3C%2FAN%3E%3CDT%3EReview%3C%2FDT%3E",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Cost effective/ budget impact",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Budget Impact Analysis of Cancer Screening: A Methodological Review",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "https://cuaj.ca/index.php/journal/article/view/5865/3985//https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emexb&AN=626205939//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:&id=doi:10.5489%2Fcuaj.5788&issn=1911-6470&isbn=&volume=13&issue=2&spage=15&pages=15-23&date=2019&title=Canadian+Urological+Association+Journal&atitle=Canadian+Urological+Association+Best+Practice+Report%3A+Diagnosis+and+management+of+radiation-induced+hemorrhagic+cystitis&aulast=Goucher&pid=%3Cauthor%3EGoucher+G.%3BSaad+F.%3BLukka+H.%3BKapoor+A.%3C%2Fauthor%3E%3CAN%3E626205939%3C%2FAN%3E%3CDT%3EArticle%3C%2FDT%3E",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Canadian Urological Association Best Practice Report: Diagnosis and management of radiation-induced hemorrhagic cystitis",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.journalslibrary.nihr.ac.uk/hta/hta24660/#/abstract//https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emed22&AN=2005610576//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:33252328&id=doi:10.3310%2Fhta24660&issn=1366-5278&isbn=&volume=24&issue=66&spage=1&pages=1-366&date=2020&title=Health+Technology+Assessment&atitle=Cancer+diagnostic+tools+to+aid+decision-making+in+primary+care%3A+Mixed-methods+systematic+reviews+and+cost-effectiveness+analysis&aulast=Medina-Lara&pid=%3Cauthor%3EMedina-Lara+A.%3BGrigore+B.%3BLewis+R.%3BPeters+J.%3BPrice+S.%3BLanda+P.%3BRobinson+S.%3BNeal+R.%3BHamilton+W.%3BSpencer+A.E.%3C%2Fauthor%3E%3CAN%3E2005610576%3C%2FAN%3E%3CDT%3EArticle%3C%2FDT%3E",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Cancer diagnostic tools to aid decision-making in primary care: Mixed-methods systematic reviews and cost-effectiveness analysis",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "https://doi.org/10.7860/JCDR/2022/52714.16251//https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emexb&AN=2018101432//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:&id=doi:10.7860%2FJCDR%2F2022%2F52714.16251&issn=2249-782X&isbn=&volume=16&issue=4&spage=IE01&pages=IE01-IE07&date=2022&title=Journal+of+Clinical+and+Diagnostic+Research&atitle=Challenges+and+Issues+in+the+Treatment+of+Reproductive+Cancer+in+India%3A+A+Behavioural+Science+Perspective&aulast=Gadiraju&pid=%3Cauthor%3EGadiraju+P.%3BSingh+P.%3BVanlalhruaii+C.%3BDehury+R.K.%3C%2Fauthor%3E%3CAN%3E2018101432%3C%2FAN%3E%3CDT%3EReview%3C%2FDT%3E",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Challenges and Issues in the Treatment of Reproductive Cancer in India: A Behavioural Science Perspective",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Clinical characteristics, etiology, management and outcome of hematospermia: a systematic review",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "http://bmjopen.bmj.com/content/early/by/section//https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emexa&AN=634945661//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:33952556&id=doi:10.1136%2Fbmjopen-2020-047664&issn=2044-6055&isbn=&volume=11&issue=5&spage=e047664&pages=&date=2021&title=BMJ+Open&atitle=Clinical+outcomes+associated+with+prostate+cancer+conspicuity+on+biparametric+and+multiparametric+MRI%3A+A+protocol+for+a+systematic+review+and+meta-analysis+of+biochemical+recurrence+following+radical+prostatectomy&aulast=Morka&pid=%3Cauthor%3EMorka+N.%3BSimpson+B.S.%3BBall+R.%3BFreeman+A.%3BKirkham+A.%3BKelly+D.%3BWhitaker+H.C.%3BEmberton+M.%3BNorris+J.M.%3C%2Fauthor%3E%3CAN%3E634945661%3C%2FAN%3E%3CDT%3EArticle%3C%2FDT%3E",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Clinical outcomes associated with prostate cancer conspicuity on biparametric and multiparametric MRI: A protocol for a systematic review and meta-analysis of biochemical recurrence following radical prostatectomy",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Clinical performance of the 4Kscore Test to predict high-grade prostate cancer at biopsy: A meta-analysis of us and European clinical validation study results",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emed20&AN=2004939772//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:&id=doi:10.1016%2FS1569-9056%252819%252934651-2&issn=1569-9056&isbn=&volume=18&issue=11&spage=e3497&pages=e3497&date=2019&title=European+Urology%2C+Supplements&atitle=Clinical+utility+of+PSMA+PET+in+biochemically+recurrent+prostate+cancer%3A+A+systematic+review+and+meta-analysis&aulast=Perera&pid=%3Cauthor%3EPerera+M.%3BPapa+N.%3BRoberts+M.%3BUdovicic+C.%3BVela+I.%3BBolton+D.%3BHofman+M.%3BLawrentschuk+N.%3BMurphy+D.%3C%2Fauthor%3E%3CAN%3E2004939772%3C%2FAN%3E%3CDT%3EConference+Abstract%3C%2FDT%3E",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Clinical utility of PSMA PET in biochemically recurrent prostate cancer: A systematic review and meta-analysis",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.mdpi.com/2072-6694/13/17/4481/pdf//https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emexb&AN=2013645799//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:&id=doi:10.3390%2Fcancers13174481&issn=2072-6694&isbn=&volume=13&issue=17&spage=4481&pages=&date=2021&title=Cancers&atitle=Colorectal+cancer+screening+outcomes+of+2412+prostate+cancer+patients+considered+for+carbon+ion+radiotherapy&aulast=Kobayashi&pid=%3Cauthor%3EKobayashi+N.%3BOike+T.%3BKubo+N.%3BMiyasaka+Y.%3BMizukami+T.%3BSato+H.%3BAdachi+A.%3BKatoh+H.%3BKawamura+H.%3BOhno+T.%3C%2Fauthor%3E%3CAN%3E2013645799%3C%2FAN%3E%3CDT%3EArticle%3C%2FDT%3E",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Colorectal cancer screening outcomes of 2412 prostate cancer patients considered for carbon ion radiotherapy",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "http://journals.lww.com/co-urology/pages/default.aspx//https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emed18&AN=615575352//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:28426464&id=doi:10.1097%2FMOU.0000000000000405&issn=0963-0643&isbn=&volume=27&issue=4&spage=380&pages=380-394&date=2017&title=Current+Opinion+in+Urology&atitle=Comparative+effectiveness+in+urology%3A+A+state+of+the+art+review+utilizing+a+systematic+approach&aulast=Bandari&pid=%3Cauthor%3EBandari+J.%3BWessel+C.B.%3BJacobs+B.L.%3C%2Fauthor%3E%3CAN%3E615575352%3C%2FAN%3E%3CDT%3EReview%3C%2FDT%3E",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Comparative effectiveness in urology: A state of the art review utilizing a systematic approach",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "http://www.springer.com/medicine/radiology/journal/13244//https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emexb&AN=2015430854//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:&id=doi:10.1186%2Fs13244-022-01199-3&issn=1869-4101&isbn=&volume=13&issue=1&spage=59&pages=&date=2022&title=Insights+into+Imaging&atitle=Comparative+performance+of+fully-automated+and+semi-automated+artificial+intelligence+methods+for+the+detection+of+clinically+significant+prostate+cancer+on+MRI%3A+a+systematic+review&aulast=Sushentsev&pid=%3Cauthor%3ESushentsev+N.%3BMoreira+Da+Silva+N.%3BYeung+M.%3BBarrett+T.%3BSala+E.%3BRoberts+M.%3BRundo+L.%3C%2Fauthor%3E%3CAN%3E2015430854%3C%2FAN%3E%3CDT%3EReview%3C%2FDT%3E",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Comparative performance of fully-automated and semi-automated artificial intelligence methods for the detection of clinically significant prostate cancer on MRI: a systematic review",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Comparing the diagnostic performance of radiotracers in prostate cancer biochemical recurrence: a systematic review and meta-analysis",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "https://cebp.aacrjournals.org/content/29/6_Supplement_1A122//https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emed21&AN=633451635//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:&id=doi:10.1158%2F1538-7755.DISP18-A122&issn=1055-9965&isbn=&volume=29&issue=6+SUPPL+1&spage=&pages=&date=2020&title=Cancer+Epidemiology+Biomarkers+and+Prevention&atitle=Comparison+of+mutational+profiles+inprimary+prostate+cancers+between+men+with+African+and+European+ancestry&aulast=Kim&pid=%3Cauthor%3EKim+E.%3BKoga+Y.%3BCarrot-Zhang+J.%3BCampbell+J.D.%3BHuang+F.%3C%2Fauthor%3E%3CAN%3E633451635%3C%2FAN%3E%3CDT%3EConference+Abstract%3C%2FDT%3E",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Comparison of mutational profiles inprimary prostate cancers between men with African and European ancestry",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "http://www.amepc.org/tau/index//https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emed20&AN=630509781//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:&id=doi:10.21037%2Ftau.2019.12.03&issn=2223-4683&isbn=&volume=8&issue=6&spage=741&pages=741-753&date=2019&title=Translational+Andrology+and+Urology&atitle=Comparison+of+prostate+cancer+detection+rates+between+magnetic+resonance+imaging-targeted+biopsy+and+transrectal+ultrasound-guided+biopsy+according+to+Prostate+Imaging+Reporting+and+Data+System+in+patients+with+PSA+%3E%3D4+ng%2FmL%3A+A+systematic+review+and+meta-analysis&aulast=Zhu&pid=%3Cauthor%3EZhu+K.%3BQin+Z.%3BXue+J.%3BMiao+C.%3BTian+Y.%3BLiu+S.%3BZhu+S.%3BGu+Q.%3BHou+C.%3BXu+A.%3BYang+J.%3BWang+Z.%3C%2Fauthor%3E%3CAN%3E630509781%3C%2FAN%3E%3CDT%3EArticle%3C%2FDT%3E",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Comparison of prostate cancer detection rates between magnetic resonance imaging-targeted biopsy and transrectal ultrasound-guided biopsy according to Prostate Imaging Reporting and Data System in patients with PSA >=4 ng/mL: A systematic review and meta-analysis",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Consensus Statement on Circulating Biomarkers for Advanced Prostate Cancer",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "http://uro.sagepub.com/content/by/year//https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emed20&AN=625743192//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:&id=doi:10.1177%2F2051415818812316&issn=2051-4158&isbn=&volume=12&issue=3&spage=228&pages=228-238&date=2019&title=Journal+of+Clinical+Urology&atitle=Conservative+management+and+radical+treatment+in+localised+prostate+cancer%3A+A+systematic+review+with+meta-analysis+and+trial+sequential+analysis&aulast=Ng&pid=%3Cauthor%3ENg+K.T.%3BKwok+P.E.%3BTeoh+W.Y.%3C%2Fauthor%3E%3CAN%3E625743192%3C%2FAN%3E%3CDT%3EArticle%3C%2FDT%3E",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Conservative management and radical treatment in localised prostate cancer: A systematic review with meta-analysis and trial sequential analysis",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emed20&AN=2002633560//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:&id=doi:10.1016%2Fj.ijrobp.2019.06.1439&issn=0360-3016&isbn=&volume=105&issue=1+Supplement&spage=E469&pages=E469&date=2019&title=International+Journal+of+Radiation+Oncology+Biology+Physics&atitle=Country-Weighed+Estimate+of+Prostate+Cancer+Hypofractionated+Radiotherapy+Toxicity+Risk&aulast=Vinh-Hung&pid=%3Cauthor%3EVinh-Hung+V.%3BDehbi+H.M.%3BBougas+S.%3BVerellen+D.%3BLeduc+N.%3BVerschraegen+C.%3BDe+Ridder+M.%3BNguyen+N.P.%3C%2Fauthor%3E%3CAN%3E2002633560%3C%2FAN%3E%3CDT%3EConference+Abstract%3C%2FDT%3E",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Country-Weighed Estimate of Prostate Cancer Hypofractionated Radiotherapy Toxicity Risk",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Current Imaging Techniques for and Imaging Spectrum of Prostate Cancer Recurrence and Metastasis: A Pictorial Review",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Current Progress and Controversies in Prostate Cancer Management",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emed16&AN=71858988//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:&id=doi:&issn=0022-5347&isbn=&volume=193&issue=4+SUPPL.+1&spage=e516&pages=e516-e517&date=2015&title=Journal+of+Urology&atitle=Decision+aids+for+localized+prostate+cancer+treatment+choice%3A+Systematic+review+and+metaanalysis&aulast=Violette&pid=%3Cauthor%3EViolette+P.D.%3BAgoritsas+T.%3BRiikonen+J.%3BSantti+H.%3BAlexander+P.%3BAgarwal+A.%3BBhatnagar+N.%3BDahm+P.%3BMontori+V.%3BGuyatt+G.H.%3BTikkinen+K.%3C%2Fauthor%3E%3CAN%3E71858988%3C%2FAN%3E%3CDT%3EConference+Abstract%3C%2FDT%3E",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Decision aids for localized prostate cancer treatment choice: Systematic review and metaanalysis",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "http://www.nature.com/mp/index.html//https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emed20&AN=2003642998//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:31745237&id=doi:10.1038%2Fs41380-019-0595-x&issn=1359-4184&isbn=&volume=25&issue=7&spage=1487&pages=1487-1499&date=2020&title=Molecular+Psychiatry&atitle=Depression+and+anxiety+in+relation+to+cancer+incidence+and+mortality%3A+a+systematic+review+and+meta-analysis+of+cohort+studies&aulast=Wang&pid=%3Cauthor%3EWang+Y.-H.%3BLi+J.-Q.%3BShi+J.-F.%3BQue+J.-Y.%3BLiu+J.-J.%3BLappin+J.M.%3BLeung+J.%3BRavindran+A.V.%3BChen+W.-Q.%3BQiao+Y.-L.%3BShi+J.%3BLu+L.%3BBao+Y.-P.%3C%2Fauthor%3E%3CAN%3E2003642998%3C%2FAN%3E%3CDT%3EArticle%3C%2FDT%3E",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Depression and anxiety in relation to cancer incidence and mortality: a systematic review and meta-analysis of cohort studies",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "http://www.nature.com/pcan/index.html//https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emexa&AN=2006793475//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:32978524&id=doi:10.1038%2Fs41391-020-00286-0&issn=1365-7852&isbn=&volume=24&issue=2&spage=281&pages=281-289&date=2021&title=Prostate+Cancer+and+Prostatic+Diseases&atitle=Depression%2C+anxiety%2C+and+suicidality+in+patients+with+prostate+cancer%3A+a+systematic+review+and+meta-analysis+of+observational+studies&aulast=Brunckhorst&pid=%3Cauthor%3EBrunckhorst+O.%3BHashemi+S.%3BMartin+A.%3BGeorge+G.%3BVan+Hemelrijck+M.%3BDasgupta+P.%3BStewart+R.%3BAhmed+K.%3C%2Fauthor%3E%3CAN%3E2006793475%3C%2FAN%3E%3CDT%3EReview%3C%2FDT%3E",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Depression, anxiety, and suicidality in patients with prostate cancer: a systematic review and meta-analysis of observational studies",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emed20&AN=2001680732//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:&id=doi:10.1016%2FS1569-9056%252819%252931308-9&issn=1569-9056&isbn=&volume=18&issue=1&spage=e1808&pages=e1808&date=2019&title=European+Urology%2C+Supplements&atitle=Descriptive+analysis+of+BRCA-associated+cancer+family+history+among+Japanese+prostate+cancer+patients&aulast=Ishiyama&pid=%3Cauthor%3EIshiyama+Y.%3BShimbo+M.%3BDeshpande+G.%3BIizuka+J.%3BTanabe+K.%3BHattori+K.%3C%2Fauthor%3E%3CAN%3E2001680732%3C%2FAN%3E%3CDT%3EConference+Abstract%3C%2FDT%3E",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Descriptive analysis of BRCA-associated cancer family history among Japanese prostate cancer patients",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "http://intl-tau.sagepub.com///https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emed20&AN=625899530//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:&id=doi:10.1177%2F1756287218815793&issn=1756-2872&isbn=&volume=11&issue=&spage=&pages=&date=2019&title=Therapeutic+Advances+in+Urology&atitle=Detection+rates+of+recurrent+prostate+cancer%3A+68Gallium+%28Ga%29-labelled+prostate-specific+membrane+antigen+versus+choline+PET%2FCT+scans.+A+systematic+review&aulast=Moghul&pid=%3Cauthor%3EMoghul+M.%3BSomani+B.%3BLane+T.%3BVasdev+N.%3BChaplin+B.%3BPeedell+C.%3BKandaSwamy+G.V.%3BRai+B.P.%3C%2Fauthor%3E%3CAN%3E625899530%3C%2FAN%3E%3CDT%3EReview%3C%2FDT%3E",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Detection rates of recurrent prostate cancer: <sup>68</sup>Gallium (Ga)-labelled prostate-specific membrane antigen versus choline PET/CT scans. A systematic review",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emed17&AN=613235214//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:&id=doi:&issn=1524-4733&isbn=&volume=19&issue=7&spage=A740&pages=A740&date=2016&title=Value+in+Health&atitle=Development+of+a+global+model+for+the+economic+evaluation+of+personalized+medicine+for+the+treatment+of+prostate+cancer&aulast=Piche-Richard&pid=%3Cauthor%3EPiche-Richard+V.%3BMathurin+K.%3BSavoie+M.%3BLachaine+J.%3C%2Fauthor%3E%3CAN%3E613235214%3C%2FAN%3E%3CDT%3EConference+Abstract%3C%2FDT%3E",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Development of a global model for the economic evaluation of personalized medicine for the treatment of prostate cancer",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emed13&AN=51997866//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:22552844&id=doi:10.1007%2Fs10552-012-9972-3&issn=0957-5243&isbn=&volume=23&issue=6&spage=967&pages=967-981&date=2012&title=Cancer+Causes+and+Control&atitle=Diabetes+and+cancer+I%3A+Risk%2C+survival%2C+and+implications+for+screening&aulast=Onitilo&pid=%3Cauthor%3EOnitilo+A.A.%3BEngel+J.M.%3BGlurich+I.%3BStankowski+R.V.%3BWilliams+G.M.%3BDoi+S.A.%3C%2Fauthor%3E%3CAN%3E51997866%3C%2FAN%3E%3CDT%3EReview%3C%2FDT%3E",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Diabetes and cancer I: Risk, survival, and implications for screening",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Diagnostic accuracy of prostate-specific antigen below 4 ng/mL as a cutoff for diagnosing prostate cancer in a hospital setting: A systematic review and meta-analysis",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emexb&AN=2012236347//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:&id=doi:10.1016%2FS0302-2838%252821%252900685-0&issn=0302-2838&isbn=&volume=79&issue=Supplement+1&spage=S428&pages=S428-S429&date=2021&title=European+Urology&atitle=Diagnostic+and+prognostic+factors+in+patients+with+prostate+cancer&aulast=Beyer&pid=%3Cauthor%3EBeyer+K.%3BMoris+L.%3BLardas+M.%3BHaire+A.%3BBarletta+F.%3BScuderi+S.%3BMolnar+M.%3BHerrera+R.%3BRauf+A.%3BCampi+R.%3BGreco+I.%3BShiranov+K.%3BDabestani+S.%3BVan+Den+Broeck+T.%3BGacci+M.%3BGandaglia+G.%3BOmar+M.%3BRoobol+M.%3BZong+J.%3BMaclennan+S.%3BCollette+L.%3BBriganti+A.%3BBjartell+A.%3BVan+Hemelrijck+M.%3C%2Fauthor%3E%3CAN%3E2012236347%3C%2FAN%3E%3CDT%3EConference+Abstract%3C%2FDT%3E",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Diagnostic and prognostic factors in patients with prostate cancer",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Diagnostic, prognostic and predictive value of cell-free miRNAs in prostate cancer: a systematic review",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "DNA damage repair gene mutation testing and genetic counseling in men with/without prostate cancer: a systematic review",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emed18&AN=619025736//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:&id=doi:10.1016%2Fj.jval.2017.08.1012&issn=1524-4733&isbn=&volume=20&issue=9&spage=A577&pages=A577&date=2017&title=Value+in+Health&atitle=Do+budget+impact+analyses+for+screening+of+cancers+follow+international+guidelines%3F+A+systematic+review&aulast=Jahn&pid=%3Cauthor%3EJahn+B.%3BTodorovic+J.%3BBundo+M.%3BSroczynski+G.%3BConrads-Frank+A.%3BRochau+U.%3BChhatwal+J.%3BMauskopf+J.%3BSiebert+U.%3C%2Fauthor%3E%3CAN%3E619025736%3C%2FAN%3E%3CDT%3EConference+Abstract%3C%2FDT%3E",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Cost effective/ budget impact",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Do budget impact analyses for screening of cancers follow international guidelines? A systematic review",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "EAU guidelines on prostate cancer. Part II: Treatment of advanced, relapsing, and castration-resistant prostate cancer",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part II: Treatment of Relapsing, Metastatic, and Castration-Resistant Prostate Cancer",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "https://healtheconomicsreview.biomedcentral.com///https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emexa&AN=2012340582//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:&id=doi:10.1186%2Fs13561-021-00318-y&issn=2191-1991&isbn=&volume=11&issue=1&spage=19&pages=&date=2021&title=Health+Economics+Review&atitle=Economic+evaluation+of+HIV+testing+options+for+low-prevalence+high-income+countries%3A+a+systematic+review&aulast=Medu&pid=%3Cauthor%3EMedu+O.%3BLawal+A.%3BCoyle+D.%3BPottie+K.%3C%2Fauthor%3E%3CAN%3E2012340582%3C%2FAN%3E%3CDT%3EArticle%3C%2FDT%3E",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Economic evaluation of HIV testing options for low-prevalence high-income countries: a systematic review",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "https://ascopubs.org/doi/abs/10.1200/JCO.2021.39.6-suppl.224//https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emed22&AN=634497011//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:&id=doi:10.1200%2FJCO.2021.39.6_suppl.224&issn=1527-7755&isbn=&volume=39&issue=6+SUPPL&spage=224&pages=&date=2021&title=Journal+of+Clinical+Oncology&atitle=Effectiveness+of+early+diagnosis+for+prostate+cancer+based+on+PSA+and+multiparametric+MRI%3A+A+simulation+study&aulast=Timsit&pid=%3Cauthor%3ETimsit+M.-O.%3BBaciarello+G.%3BHennequin+C.%3BKleinclauss+F.%3BBazil+M.L.%3BBonnard+P.%3BPettre+S.%3BMartin+B.%3BLeleu+H.%3C%2Fauthor%3E%3CAN%3E634497011%3C%2FAN%3E%3CDT%3EConference+Abstract%3C%2FDT%3E",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Effectiveness of early diagnosis for prostate cancer based on PSA and multiparametric MRI: A simulation study",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Efficacy and Safety of (225)Ac-PSMA-617-Targeted Alpha Therapy in Metastatic Castration-Resistant Prostate Cancer: A Systematic Review and Meta-Analysis",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "http://www.europeanurology.com///https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emed21&AN=2006160849//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:32532512&id=doi:10.1016%2Fj.eururo.2020.05.004&issn=0302-2838&isbn=&volume=78&issue=2&spage=148&pages=148-154&date=2020&title=European+Urology&atitle=Efficacy+and+Safety+of+177Lu-labeled+Prostate-specific+Membrane+Antigen+Radionuclide+Treatment+in+Patients+with+Diffuse+Bone+Marrow+Involvement%3A+A+Multicenter+Retrospective+Study&aulast=Gafita&pid=%3Cauthor%3EGafita+A.%3BFendler+W.P.%3BHui+W.%3BSandhu+S.%3BWeber+M.%3BEsfandiari+R.%3BCalais+J.%3BRauscher+I.%3BRathke+H.%3BTauber+R.%3BDelpassand+E.S.%3BWeber+W.A.%3BHerrmann+K.%3BCzernin+J.%3BEiber+M.%3BHofman+M.S.%3C%2Fauthor%3E%3CAN%3E2006160849%3C%2FAN%3E%3CDT%3EArticle%3C%2FDT%3E",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Efficacy and Safety of <sup>177</sup>Lu-labeled Prostate-specific Membrane Antigen Radionuclide Treatment in Patients with Diffuse Bone Marrow Involvement: A Multicenter Retrospective Study",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "https://tau.amegroups.com/article/view/70630/html//https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emexa&AN=2013312602//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:&id=doi:10.21037%2Ftau-20-1363&issn=2223-4683&isbn=&volume=10&issue=6&spage=2750&pages=2750-2761&date=2021&title=Translational+Andrology+and+Urology&atitle=Endoscopic+surveillance+for+bladder+cancer%3A+A+systematic+review+of+contemporary+worldwide+practices&aulast=Russell&pid=%3Cauthor%3ERussell+B.%3BKotecha+P.%3BThurairaja+R.%3BNair+R.%3BMalde+S.%3BKumar+P.%3BKhan+M.S.%3C%2Fauthor%3E%3CAN%3E2013312602%3C%2FAN%3E%3CDT%3EReview%3C%2FDT%3E",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Endoscopic surveillance for bladder cancer: A systematic review of contemporary worldwide practices",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.journals.elsevier.com/european-urology-oncology//https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emexb&AN=2015297086//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:34716119&id=doi:10.1016%2Fj.euo.2021.09.006&issn=2588-9311&isbn=&volume=4&issue=6&spage=877&pages=877-892&date=2021&title=European+Urology+Oncology&atitle=Epidemiology+and+Prevention+of+Prostate+Cancer&aulast=Gandaglia&pid=%3Cauthor%3EGandaglia+G.%3BLeni+R.%3BBray+F.%3BFleshner+N.%3BFreedland+S.J.%3BKibel+A.%3BStattin+P.%3BVan+Poppel+H.%3BLa+Vecchia+C.%3C%2Fauthor%3E%3CAN%3E2015297086%3C%2FAN%3E%3CDT%3EReview%3C%2FDT%3E",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Epidemiology and Prevention of Prostate Cancer",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Epidemiology of cancer in Saudi Arabia thru 2010-2019: a systematic review with constrained meta-analysis",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Intervention/ primary study/erratum/ conference abstract/ commentary/ clinic trial/ newsletter/ magazine/protocol/ literature review",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "ERSPC, PLCO studies and critique of cochrane review 2013",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "http://www.elsevier.com//https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emed16&AN=610251343//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:26596722&id=doi:10.1016%2Fj.canep.2015.10.021&issn=1877-7821&isbn=&volume=39&issue=&spage=S139&pages=S139-S152&date=2015&title=Cancer+Epidemiology&atitle=European+Code+against+Cancer%2C+4th+Edition%3A+Cancer+screening&aulast=Armaroli&pid=%3Cauthor%3EArmaroli+P.%3BVillain+P.%3BSuonio+E.%3BAlmonte+M.%3BAnttila+A.%3BAtkin+W.S.%3BDean+P.B.%3Bde+Koning+H.J.%3BDillner+L.%3BHerrero+R.%3BKuipers+E.J.%3BLansdorp-Vogelaar+I.%3BMinozzi+S.%3BPaci+E.%3BRegula+J.%3BTornberg+S.%3BSegnan+N.%3C%2Fauthor%3E%3CAN%3E610251343%3C%2FAN%3E%3CDT%3EArticle%3C%2FDT%3E",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "European Code against Cancer, 4th Edition: Cancer screening",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "https://academic.oup.com/bjs//https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emexb&AN=2006741686//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:34043773&id=doi:10.1002%2Fbjs.11902&issn=0007-1323&isbn=&volume=108&issue=5&spage=484&pages=484-498&date=2021&title=British+Journal+of+Surgery&atitle=European+guidelines+from+the+EHTG+and+ESCP+for+Lynch+syndrome%3A+An+updated+third+edition+of+the+Mallorca+guidelines+based+on+gene+and+gender&aulast=Seppala&pid=%3Cauthor%3ESeppala+T.T.%3BLatchford+A.%3BNegoi+I.%3BSampaio+Soares+A.%3BJimenez-Rodriguez+R.%3BEvans+D.G.%3BRyan+N.%3BCrosbie+E.J.%3BDominguez-Valentin+M.%3BBurn+J.%3BKloor+M.%3BKnebel+Doeberitz+M.V.%3BDuijnhoven+F.J.B.V.%3BQuirke+P.%3BSampson+J.R.%3BMoller+P.%3BMoslein+G.%3C%2Fauthor%3E%3CAN%3E2006741686%3C%2FAN%3E%3CDT%3EReview%3C%2FDT%3E",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "European guidelines from the EHTG and ESCP for Lynch syndrome: An updated third edition of the Mallorca guidelines based on gene and gender",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Intervention/ primary study/erratum/ conference abstract/ commentary/ clinic trial/ newsletter/ magazine/protocol/ literature review",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Evaluation of New Tests and Interventions for Prostate Cancer Management: A Systematic Review",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emed17&AN=613434851//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:&id=doi:&issn=1743-7563&isbn=&volume=12&issue=Supplement+6&spage=23&pages=23-24&date=2016&title=Asia-Pacific+Journal+of+Clinical+Oncology&atitle=Examining+where+research+efforts+on+cancer-related+decision+aids+have+been+made&aulast=Herrmann&pid=%3Cauthor%3EHerrmann+A.%3BMansfield+E.%3BHall+A.%3BSanson-Fisher+R.%3BZdenkowski+N.%3C%2Fauthor%3E%3CAN%3E613434851%3C%2FAN%3E%3CDT%3EConference+Abstract%3C%2FDT%3E",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Intervention/ primary study/erratum/ conference abstract/ commentary/ clinic trial/ newsletter/ magazine/protocol/ literature review",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Examining where research efforts on cancer-related decision aids have been made",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emed21&AN=633776669//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:&id=doi:10.1111%2Fjgs.16431&issn=1532-5415&isbn=&volume=68&issue=SUPPL+1&spage=S98&pages=S98&date=2020&title=Journal+of+the+American+Geriatrics+Society&atitle=Facial+palsy+as+the+presenting+feature+of+metastatic+prostate+cancer%3A+A+case+report+and+review+of+literature&aulast=Joshi&pid=%3Cauthor%3EJoshi+K.%3BPriyambada+P.%3C%2Fauthor%3E%3CAN%3E633776669%3C%2FAN%3E%3CDT%3EConference+Abstract%3C%2FDT%3E",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Facial palsy as the presenting feature of metastatic prostate cancer: A case report and review of literature",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emexa&AN=636074557//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:&id=doi:10.1111%2Fajco.13652&issn=1743-7563&isbn=&volume=17&issue=SUPPL+5&spage=32&pages=32-33&date=2021&title=Asia-Pacific+Journal+of+Clinical+Oncology&atitle=Factors+influencing+older+adults%27+cancer+screening+decision-making%3A+A+systematic+review&aulast=Smith&pid=%3Cauthor%3ESmith+J.%3BDodd+R.%3BGainey+K.%3BNaganathan+V.%3BCvejic+E.%3BJansen+J.%3BMcCaffery+K.%3C%2Fauthor%3E%3CAN%3E636074557%3C%2FAN%3E%3CDT%3EConference+Abstract%3C%2FDT%3E",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Factors influencing older adults' cancer screening decision-making: A systematic review",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Fear of cancer recurrence and PSA anxiety in patients with prostate cancer: a systematic review",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "http://www.jri.ir/documents/supplement/75.pdf//https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emed19&AN=627393260//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:&id=doi:&issn=2251-676X&isbn=&volume=19&issue=2+Supplement+2&spage=91&pages=91&date=2018&title=Journal+of+Reproduction+and+Infertility&atitle=Fertility+preservation+in+patients+with+prostate+cancer&aulast=Hajaliakbari&pid=%3Cauthor%3EHajaliakbari+Z.%3C%2Fauthor%3E%3CAN%3E627393260%3C%2FAN%3E%3CDT%3EConference+Abstract%3C%2FDT%3E",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Fertility preservation in patients with prostate cancer",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "http://www.biomedcentral.com/bmccancer///https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emed20&AN=629151260//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:31477094&id=doi:10.1186%2Fs12885-019-6055-9&issn=1471-2407&isbn=&volume=19&issue=1&spage=871&pages=&date=2019&title=BMC+Cancer&atitle=First-degree+family+history+of+breast+cancer+is+associated+with+prostate+cancer+risk%3A+A+systematic+review+and+meta-analysis&aulast=Ren&pid=%3Cauthor%3ERen+Z.-J.%3BCao+D.-H.%3BZhang+Q.%3BRen+P.-W.%3BLiu+L.-R.%3BWei+Q.%3BWei+W.-R.%3BDong+Q.%3C%2Fauthor%3E%3CAN%3E629151260%3C%2FAN%3E%3CDT%3EArticle%3C%2FDT%3E",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "First-degree family history of breast cancer is associated with prostate cancer risk: A systematic review and meta-analysis",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "https://journals.lww.com/md-journal/pages/default.aspx//https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emexa&AN=635379731//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:33530178&id=doi:10.1097%2FMD.0000000000023816&issn=0025-7974&isbn=&volume=100&issue=4&spage=e23816&pages=&date=2021&title=Medicine+%28United+States%29&atitle=First-degree+family+history+of+prostate+cancer+is+associated+the+risk+of+breast+cancer+and+ovarian+cancer&aulast=Zheng&pid=%3Cauthor%3EZheng+Q.%3BYing+Q.%3BRen+Z.%3BZhang+Q.%3BLu+D.%3BWang+H.%3BWei+W.%3C%2Fauthor%3E%3CAN%3E635379731%3C%2FAN%3E%3CDT%3EArticle%3C%2FDT%3E",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "First-degree family history of prostate cancer is associated the risk of breast cancer and ovarian cancer",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "http://www.europeanurology.com///https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emexb&AN=2015465409//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:34740501&id=doi:10.1016%2Fj.eururo.2021.10.005&issn=0302-2838&isbn=&volume=81&issue=1&spage=34&pages=34-36&date=2022&title=European+Urology&atitle=Focal+Therapy+for+Prostate+Cancer%3A+Getting+Ready+for+Prime+Time&aulast=Abreu&pid=%3Cauthor%3EAbreu+A.L.%3BKaneko+M.%3BCacciamani+G.E.%3BLebastchi+A.H.%3C%2Fauthor%3E%3CAN%3E2015465409%3C%2FAN%3E%3CDT%3EEditorial%3C%2FDT%3E",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Intervention/ primary study/erratum/ conference abstract/ commentary/ clinic trial/ newsletter/ magazine/protocol/ literature review",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Focal Therapy for Prostate Cancer: Getting Ready for Prime Time",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "http://www.europeanurology.com///https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emed20&AN=2001572939//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:30773328&id=doi:10.1016%2Fj.eururo.2019.01.049&issn=0302-2838&isbn=&volume=77&issue=4&spage=403&pages=403-417&date=2020&title=European+Urology&atitle=Gallium-68+Prostate-specific+Membrane+Antigen+Positron+Emission+Tomography+in+Advanced+Prostate+Cancer-Updated+Diagnostic+Utility%2C+Sensitivity%2C+Specificity%2C+and+Distribution+of+Prostate-specific+Membrane+Antigen-avid+Lesions%3A+A+Systematic+Review+and+Meta-analysis&aulast=Perera&pid=%3Cauthor%3EPerera+M.%3BPapa+N.%3BRoberts+M.%3BWilliams+M.%3BUdovicich+C.%3BVela+I.%3BChristidis+D.%3BBolton+D.%3BHofman+M.S.%3BLawrentschuk+N.%3BMurphy+D.G.%3C%2Fauthor%3E%3CAN%3E2001572939%3C%2FAN%3E%3CDT%3EReview%3C%2FDT%3E",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Gallium-68 Prostate-specific Membrane Antigen Positron Emission Tomography in Advanced Prostate Cancer-Updated Diagnostic Utility, Sensitivity, Specificity, and Distribution of Prostate-specific Membrane Antigen-avid Lesions: A Systematic Review and Meta-analysis",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "http://oncology.jamanetwork.com/journal.aspx//https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emed22&AN=629465648//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:31560378&id=doi:10.1001%2Fjamaoncol.2019.2996&issn=2374-2437&isbn=&volume=5&issue=12&spage=1749&pages=1749-1768&date=2019&title=JAMA+Oncology&atitle=Global%2C+regional%2C+and+national+cancer+incidence%2C+mortality%2C+years+of+life+lost%2C+years+lived+with+disability%2C+and+disability-Adjusted+life-years+for+29+cancer+groups%2C+1990+to+2017%3A+A+systematic+analysis+for+the+global+burden+of+disease+study&aulast=Fitzmaurice&pid=%3Cauthor%3EFitzmaurice+C.%3BAbate+D.%3BAbbasi+N.%3BAbbastabar+H.%3BAbd-Allah+F.%3BAbdel-Rahman+O.%3BAbdelalim+A.%3BAbdoli+A.%3BAbdollahpour+I.%3BAbdulle+A.S.M.%3BAbebe+N.D.%3BAbraha+H.N.%3BAbu-Raddad+L.J.%3BAbualhasan+A.%3BAdedeji+I.A.%3BAdvani+S.M.%3BAfarideh+M.%3BAfshari+M.%3BAghaali+M.%3BAgius+D.%3BAgrawal+S.%3BAhmadi+A.%3BAhmadian+E.%3BAhmadpour+E.%3BAhmed+M.B.%3BAkbari+M.E.%3BAkinyemiju+T.%3BAl-Aly+Z.%3BAlabdulkader+A.M.%3BAlahdab+F.%3BAlam+T.%3BAlamene+G.M.%3BAlemnew+B.T.T.%3BAlene+K.A.%3BAlinia+C.%3BAlipour+V.%3BAljunid+S.M.%3BBakeshei+F.A.%3BAlmadi+M.A.H.%3BAlmasi-Hashiani+A.%3BAlsharif+U.%3BAlsowaidi+S.%3BAlvis-Guzman+N.%3BAmini+E.%3BAmini+S.%3BAmoako+Y.A.%3BAnbari+Z.%3BAnber+N.H.%3BAndrei+C.L.%3BAnjomshoa+M.%3BAnsari+F.%3BAnsariadi+A.%3BAppiah+S.C.Y.%3BArab-Zozani+M.%3BArabloo+J.%3BArefi+Z.%3BAremu+O.%3BAreri+H.A.%3BArtaman+A.%3BAsayesh+H.%3BAsfaw+E.T.%3BAshagre+A.F.%3BAssadi+R.%3BAtaeinia+B.%3BAtalay+H.T.%3BAtaro+Z.%3BAtique+S.%3BAusloos+M.%3BAvila-Burgos+L.%3BAvokpaho+E.F.G.A.%3BAwasthi+A.%3BAwoke+N.%3BAyala+Quintanilla+B.P.%3BAyanore+M.A.%3BAyele+H.T.%3BBabaee+E.%3BBacha+U.%3BBadawi+A.%3BBagherzadeh+M.%3BBagli+E.%3BBalakrishnan+S.%3BBalouchi+A.%3BBarnighausen+T.W.%3BBattista+R.J.%3BBehzadifar+M.%3BBekele+B.B.%3BBelay+Y.B.%3BBelayneh+Y.M.%3BBerfield+K.K.S.%3BBerhane+A.%3BBernabe+E.%3BBeuran+M.%3BBhakta+N.%3BBhattacharyya+K.%3BBiadgo+B.%3BBijani+A.%3BBin+Sayeed+M.S.%3BBirungi+C.%3BBisignano+C.%3BBitew+H.%3BBjorge+T.%3BBleyer+A.%3BBogale+K.A.%3BBojia+H.A.%3BBorzi+A.M.%3BBosetti+C.%3BBou-Orm+I.R.%3BBrenner+H.%3BBrewer+J.D.%3BBriko+A.N.%3BBriko+N.I.%3BBustamante-Teixeira+M.T.%3BButt+Z.A.%3BCarreras+G.%3BCarrero+J.J.%3BCarvalho+F.%3BCastro+C.%3BCastro+F.%3BCatala-Lopez+F.%3BCerin+E.%3BChaiah+Y.%3BChanie+W.F.%3BChattu+V.K.%3BChaturvedi+P.%3BChauhan+N.S.%3BChehrazi+M.%3BChiang+P.P.-C.%3BChichiabellu+T.Y.%3BChido-Amajuoyi+O.G.%3BChimed-Ochir+O.%3BChoi+J.-Y.J.%3BChristopher+D.J.%3BChu+D.-T.%3BConstantin+M.-M.%3BCosta+V.M.%3BCrocetti+E.%3BCrowe+C.S.%3BCurado+M.P.%3BDahlawi+S.M.A.%3BDamiani+G.%3BDarwish+A.H.%3BDaryani+A.%3BDas+Neves+J.%3BDemeke+F.M.%3BDemis+A.B.%3BDemissie+B.W.%3BDemoz+G.T.%3BDenova-Gutierrez+E.%3BDerakhshani+A.%3BDeribe+K.S.%3BDesai+R.%3BDesalegn+B.B.%3BDesta+M.%3BDey+S.%3BDharmaratne+S.D.%3BDhimal+M.%3BDiaz+D.%3BDinberu+M.T.T.%3BDjalalinia+S.%3BDoku+D.T.%3BDrake+T.M.%3BDubey+M.%3BDubljanin+E.%3BDuken+E.E.%3BEbrahimi+H.%3BEffiong+A.%3BEftekhari+A.%3BEl+Sayed+I.%3BZaki+M.E.S.%3BEl-Jaafary+S.I.%3BEl-Khatib+Z.%3BElemineh+D.A.%3BElkout+H.%3BEllenbogen+R.G.%3BElsharkawy+A.%3BEmamian+M.H.%3BEndalew+D.A.%3BEndries+A.Y.%3BEshrati+B.%3BFadhil+I.%3BFallah+V.%3BFaramarzi+M.%3BFarhangi+M.A.%3BFarioli+A.%3BFarzadfar+F.%3BFentahun+N.%3BFernandes+E.%3BFeyissa+G.T.%3BFilip+I.%3BFischer+F.%3BFisher+J.L.%3BForce+L.M.%3BForoutan+M.%3BFreitas+M.%3BFukumoto+T.%3BFutran+N.D.%3BGallus+S.%3BGankpe+F.G.%3BGayesa+R.T.%3BGebrehiwot+T.T.%3BGebremeskel+G.G.%3BGedefaw+G.A.%3BGelaw+B.K.%3BGeta+B.%3BGetachew+S.%3BGezae+K.E.%3BGhafourifard+M.%3BGhajar+A.%3BGhashghaee+A.%3BGholamian+A.%3BGill+P.S.%3BGinindza+T.T.G.%3BGirmay+A.%3BGizaw+M.%3BGomez+R.S.%3BGopalani+S.V.%3BGorini+G.%3BGoulart+B.N.G.%3BGrada+A.%3BRibeiro+Guerra+M.%3BGuimaraes+A.L.S.%3BGupta+P.C.%3BGupta+R.%3BHadkhale+K.%3BHaj-Mirzaian+A.%3BHamadeh+R.R.%3BHamidi+S.%3BHanfore+L.K.%3BHaro+J.M.%3BHasankhani+M.%3BHasanzadeh+A.%3BHassen+H.Y.%3BHay+R.J.%3BHay+S.I.%3BHenok+A.%3BHenry+N.J.%3BHerteliu+C.%3BHidru+H.D.%3BHoang+C.L.%3BHole+M.K.%3BHoogar+P.%3BHorita+N.%3BHosgood+H.D.%3BHosseiniM.%3BHosseinzadeh+M.%3BHostiuc+M.%3BHostiuc+S.%3BHouseh+M.%3BHussen+M.M.%3BIleanu+B.%3BIlic+M.D.%3BInnos+K.%3BIrvani+S.S.N.%3BIseh+K.R.%3BIslam+S.M.S.%3BIslami+F.%3BJafari+Balalami+N.%3BJafarinia+M.%3BJahangiry+L.%3BJahani+M.A.%3BJahanmehr+N.%3BJakovljevic+M.%3BJames+S.L.%3BJavanbakht+M.%3BJayaraman+S.%3BJee+S.H.%3BJenabi+E.%3BJha+R.P.%3BJonas+J.B.%3BJonnagaddala+J.%3BJoo+T.%3BJungari+S.B.%3BJurisson+M.%3BKabir+A.%3BKamangar+F.%3BKarch+A.%3BKarimi+N.%3BKarimian+A.%3BKasaeian+A.%3BKasahun+G.G.%3BKassa+B.%3BKassa+T.D.%3BKassaw+M.W.%3BKaul+A.%3BKeiyoro+P.N.%3BKelbore+A.G.%3BKerbo+A.A.%3BKhader+Y.S.%3BKhalilarjmandi+M.%3BKhan+E.A.%3BKhan+G.%3BKhang+Y.-H.%3BKhatab+K.%3BKhater+A.%3BKhayamzadeh+M.%3BKhazaee-Pool+M.%3BKhazaei+S.%3BKhoja+A.T.%3BKhosravi+M.H.%3BKhubchandani+J.%3BKianipour+N.%3BKim+D.%3BKim+Y.J.%3BKisa+A.%3BKisa+S.%3BKissimova-Skarbek+K.%3BKomaki+H.%3BKoyanagi+A.%3BKrohn+K.J.%3BBicer+B.K.%3BKugbey+N.%3BKumar+V.%3BKuupiel+D.%3BLa+Vecchia+C.%3BLad+D.P.%3BLake+E.A.%3BLakew+A.M.%3BLal+D.K.%3BLami+F.H.%3BLan+Q.%3BLasrado+S.%3BLauriola+P.%3BLazarus+J.V.%3BLeigh+J.%3BLeshargie+C.T.%3BLiao+Y.%3BLimenih+M.A.%3BListl+S.%3BLopez+A.D.%3BLopukhov+P.D.%3BLunevicius+R.%3BMadadin+M.%3BMagdeldin+S.%3BEl+Razek+H.M.A.%3BMajeed+A.%3BMaleki+A.%3BMalekzadeh+R.%3BManafi+A.%3BManafi+N.%3BManamo+W.A.%3BMansourian+M.%3BMansournia+M.A.%3BMantovani+L.G.%3BMaroufizadeh+S.%3BMartini+S.M.S.%3BMashamba-Thompson+T.P.%3BMassenburg+B.B.%3BMaswabi+M.T.%3BMathur+M.R.%3BMcAlinden+C.%3BMcKee+M.%3BMeheretu+H.A.A.%3BMehrotra+R.%3BMehta+V.%3BMeier+T.%3BMelaku+Y.A.%3BMeles+G.G.%3BMeles+H.G.%3BMelese+A.%3BMelku+M.%3BMemiah+P.T.N.%3BMendoza+W.%3BMenezes+R.G.%3BMerat+S.%3BMeretoja+T.J.%3BMestrovic+T.%3BMiazgowski+B.%3BMiazgowski+T.%3BMihretie+K.M.M.%3BMiller+T.R.%3BMills+E.J.%3BMir+S.M.%3BMirzaei+H.%3BMirzaei+H.R.%3BMishra+R.%3BMoazen+B.%3BMohammad+D.K.%3BMohammad+K.A.%3BMohammad+Y.%3BDarwesh+A.M.%3BMohammadbeigi+A.%3BMohammadi+H.%3BMohammadi+M.%3BMohammadian+M.%3BMohammadian-Hafshejani+A.%3BMohammadoo-Khorasani+M.%3BMohammadpourhodki+R.%3BMohammed+A.S.%3BMohammed+J.A.%3BMohammed+S.%3BMohebi+F.%3BMokdad+A.H.%3BMonasta+L.%3BMoodley+Y.%3BMoosazadeh+M.%3BMoossavi+M.%3BMoradi+G.%3BMoradi-Joo+M.%3BMoradi-Lakeh+M.%3BMoradpour+F.%3BMorawska+L.%3BMorgado-Da-costa+J.%3BMorisaki+N.%3BMorrison+S.D.%3BMosapour+A.%3BMousavi+S.M.%3BMuche+A.A.%3BMuhammed+O.S.S.%3BMusa+J.%3BNabhan+A.R.%3BNaderi+M.%3BNagarajan+A.J.%3BNagel+G.%3BNahvijou+A.%3BNaik+G.%3BNajafi+F.%3BNaldi+L.%3BNam+H.S.%3BNasiri+N.%3BNazari+J.%3BNegoi+I.%3BNeupane+S.%3BNewcomb+P.A.%3BNggada+H.A.%3BNgunjiri+J.W.%3BNguyen+C.T.%3BNikniaz+L.%3BNingrum+D.N.A.%3BNirayo+Y.L.%3BNixon+M.R.%3BNnaji+C.A.%3BNojomi+M.%3BNosratnejad+S.%3BShiadeh+M.N.%3BObsa+M.S.%3BOfori-Asenso+R.%3BOgbo+F.A.%3BOh+I.-H.%3BOlagunju+A.T.%3BOlagunju+T.O.%3BOluwasanu+M.M.%3BOmonisi+A.E.%3BOnwujekwe+O.E.%3BOommen+A.M.%3BOren+E.%3BOrtega-Altamirano+D.D.V.%3BOta+E.%3BOtstavnov+S.S.%3BOwolabi+M.O.%3BP+A+M.%3BPadubidri+J.R.%3BPakhale+S.%3BPakpour+A.H.%3BPana+A.%3BPark+E.-K.%3BParsian+H.%3BPashaei+T.%3BPatel+S.%3BPatil+S.T.%3BPennini+A.%3BPereira+D.M.%3BPiccinelli+C.%3BPillay+J.D.%3BPirestani+M.%3BPishgar+F.%3BPostma+M.J.%3BPourjafar+H.%3BPourmalek+F.%3BPourshams+A.%3BPrakash+S.%3BPrasad+N.%3BQorbani+M.%3BRabiee+M.%3BRabiee+N.%3BRadfar+A.%3BRafiei+A.%3BRahim+F.%3BRahimi+M.%3BRahman+M.A.%3BRajati+F.%3BRana+S.M.%3BRaoofi+S.%3BRath+G.K.%3BRawaf+D.L.%3BRawaf+S.%3BReiner+R.C.%3BRenzaho+A.M.N.%3BRezaei+N.%3BRezapour+A.%3BRibeiro+A.I.%3BRibeiro+D.%3BRonfani+L.%3BRoro+E.M.%3BRoshandel+G.%3BRostami+A.%3BSaad+R.S.%3BSabbagh+P.%3BSabour+S.%3BSaddik+B.%3BSafiri+S.%3BSahebkar+A.%3BSalahshoor+M.R.%3BSalehi+F.%3BSalem+H.%3BSalem+M.R.%3BSalimzadeh+H.%3BSalomon+J.A.%3BSamy+A.M.%3BSanabria+J.%3BSantric+Milicevic+M.M.%3BSartorius+B.%3BSarveazad+A.%3BSathian+B.%3BSatpathy+M.%3BSavic+M.%3BSawhney+M.%3BSayyah+M.%3BSchneider+I.J.C.%3BSchottker+B.%3BSekerija+M.%3BSepanlou+S.G.%3BSepehrimanesh+M.%3BSeyedmousavi+S.%3BShaahmadi+F.%3BShabaninejad+H.%3BShahbaz+M.%3BShaikh+M.A.%3BShamshirian+A.%3BShamsizadeh+M.%3BSharafi+H.%3BSharafi+Z.%3BSharif+M.%3BSharifi+A.%3BSharifi+H.%3BSharma+R%3BSheikh+A.%3BShirkoohi+R.%3BShukla+S.R.%3BSi+S.%3BSiabani+S.%3BSilva+D.A.S.%3BSilveira+D.G.A.%3BSingh+A.%3BSingh+J.A.%3BSisay+S.%3BSitas+F.%3BSobngwi+E.%3BSoofi+M.%3BSoriano+J.B.%3BStathopoulou+V.%3BSufiyan+M.B.%3BTabares-Seisdedos+R.%3BTabuchi+T.%3BTakahashi+K.%3BTamtaji+O.R.%3BTarawneh+M.R.%3BTassew+S.G.%3BTaymoori+P.%3BTehrani-Banihashemi+A.%3BTemsah+M.-H.%3BTemsah+O.%3BTesfay+B.E.%3BTesfay+F.H.%3BTeshale+M.Y.%3BTessema+G.A.%3BThapa+S.%3BTlaye+K.G.%3BTopor-Madry+R.%3BTovani-Palone+M.R.%3BTraini+E.%3BTran+B.X.%3BTran+K.B.%3BTsadik+A.G.%3BUllah+I.%3BUthman+O.A.%3BVacante+M.%3BVaezi+M.%3BVarona+Perez+P.%3BVeisani+Y.%3BVidale+S.%3BViolante+F.S.%3BVlassov+V.%3BVollset+S.E.%3BVos+T.%3BVosoughi+K.%3BVu+G.T.%3BVujcic+I.S.%3BWabinga+H.%3BWachamo+T.M.%3BWagnew+F.S.%3BWaheed+Y.%3BWeldegebreal+F.%3BWeldesamuel+G.T.%3BWijeratne+T.%3BWondafrash+D.Z.%3BWonde+T.E.%3BWondmieneh+A.B.%3BWorkie+H.M.%3BYadav+R.%3BYadegar+A.%3BYadollahpour+A.%3BYaseri+M.%3BYazdi-Feyzabadi+V.%3BYeshaneh+A.%3BYimam+M.A.%3BYimer+E.M.%3BYisma+E.%3BYonemoto+N.%3BYounis+M.Z.%3BYousefi+B.%3BYousefifard+M.%3BYu+C.%3BZabeh+E.%3BZadnik+V.%3BMoghadam+T.Z.%3BZaidi+Z.%3BZamani+M.%3BZandian+H.%3BZangeneh+A.%3BZaki+L.%3BZendehdel+K.%3BZenebe+Z.M.%3BZewale+T.A.%3BZiapour+A.%3BZodpey+S.%3BMurray+C.J.L.%3C%2Fauthor%3E%3CAN%3E629465648%3C%2FAN%3E%3CDT%3EArticle%3C%2FDT%3E",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-Adjusted life-years for 29 cancer groups, 1990 to 2017: A systematic analysis for the global burden of disease study",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "http://www.medscimonit.com///https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emed16&AN=605098521//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:&id=doi:10.12659%2FMSM.893579&issn=1234-1010&isbn=&volume=21&issue=&spage=1895&pages=1895-1903&date=2015&title=Medical+Science+Monitor&atitle=Gonorrhea+and+prostate+cancer+incidence%3A+An+updated+meta-analysis+of+21+epidemiologic+studies&aulast=Lian&pid=%3Cauthor%3ELian+W.-Q.%3BLuo+F.%3BSong+X.-L.%3BLu+Y.-J.%3BZhao+S.-C.%3C%2Fauthor%3E%3CAN%3E605098521%3C%2FAN%3E%3CDT%3EArticle%3C%2FDT%3E",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Gonorrhea and prostate cancer incidence: An updated meta-analysis of 21 epidemiologic studies",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1464-410X//https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emed19&AN=622122538//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:29633514&id=doi:10.1111%2Fbju.14237&issn=1464-4096&isbn=&volume=122&issue=4&spage=535&pages=535-548&date=2018&title=BJU+International&atitle=Guideline+of+guidelines%3A+primary+monotherapies+for+localised+or+locally+advanced+prostate+cancer&aulast=Lancee&pid=%3Cauthor%3ELancee+M.%3BTikkinen+K.A.O.%3Bde+Reijke+T.M.%3BKataja+V.V.%3BAben+K.K.H.%3BVernooij+R.W.M.%3C%2Fauthor%3E%3CAN%3E622122538%3C%2FAN%3E%3CDT%3EArticle%3C%2FDT%3E",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Guideline of guidelines: primary monotherapies for localised or locally advanced prostate cancer",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)2398-7324//https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emexa&AN=2013918240//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:&id=doi:10.1002%2Fpro6.1129&issn=2398-7324&isbn=&volume=5&issue=3&spage=160&pages=160-182&date=2021&title=Precision+Radiation+Oncology&atitle=Guidelines+for+radiotherapy+of+prostate+cancer+%282020+edition%29&aulast=Li&pid=%3Cauthor%3ELi+G.%3BLi+Y.%3BWang+J.%3BGao+X.%3BZhong+Q.%3BHe+L.%3BLi+C.%3BLiu+M.%3BLiu+Y.%3BMa+M.%3BWang+H.%3BWang+X.%3BZhu+H.%3C%2Fauthor%3E%3CAN%3E2013918240%3C%2FAN%3E%3CDT%3EArticle%3C%2FDT%3E",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Guidelines for radiotherapy of prostate cancer (2020 edition)",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "http://www.elsevier.com/locate/urology//https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emed20&AN=2004409983//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:31770548&id=doi:10.1016%2Fj.urology.2019.09.058&issn=0090-4295&isbn=&volume=136&issue=&spage=9&pages=9-18&date=2020&title=Urology&atitle=Health+Care+Disparities+in+Urologic+Oncology%3A+A+Systematic+Review&aulast=Das&pid=%3Cauthor%3EDas+H.%3BRodriguez+R.%3C%2Fauthor%3E%3CAN%3E2004409983%3C%2FAN%3E%3CDT%3EReview%3C%2FDT%3E",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Health Care Disparities in Urologic Oncology: A Systematic Review",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emed15&AN=75005894//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:&id=doi:&issn=1710-6222&isbn=&volume=21&issue=1&spage=e116&pages=e116&date=2014&title=Journal+of+Population+Therapeutics+and+Clinical+Pharmacology&atitle=%22Healthcare+Cost%2C+Quality%2C+and+Policy%3A+Driving+Stakeholder+Innovation+in+Process+and+Practice%22&aulast=&pid=%3Cauthor%3Eanonymous%3C%2Fauthor%3E%3CAN%3E75005894%3C%2FAN%3E%3CDT%3EConference+Review%3C%2FDT%3E",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Healthcare Cost, Quality, and Policy: Driving Stakeholder Innovation in Process and Practice",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "High mortality risk of prostate cancer patients in Asia and West Africa: A systematic review",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emed17&AN=72238983//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:&id=doi:&issn=0022-5347&isbn=&volume=195&issue=4+SUPPL.+1&spage=e96&pages=e96&date=2016&title=Journal+of+Urology&atitle=High+rates+of+metastatic+disease+in+prostate+cancer+among+BRCA2+mutation+carriers%3A+Implications+for+screening&aulast=Gleicher&pid=%3Cauthor%3EGleicher+S.%3BKauffman+E.%3BBratslavsky+G.%3BVourganti+S.%3C%2Fauthor%3E%3CAN%3E72238983%3C%2FAN%3E%3CDT%3EConference+Abstract%3C%2FDT%3E",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "High rates of metastatic disease in prostate cancer among BRCA2 mutation carriers: Implications for screening",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emexa&AN=635483218//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:&id=doi:10.1177%2F20514158211013240&issn=2051-4166&isbn=&volume=14&issue=1+SUPPL&spage=46&pages=46&date=2021&title=Journal+of+Clinical+Urology&atitle=History+of+endorectal+imaging+of+the+prostate&aulast=Tien&pid=%3Cauthor%3ETien+T.%3BWinters+D.%3BGreen+J.%3C%2Fauthor%3E%3CAN%3E635483218%3C%2FAN%3E%3CDT%3EConference+Abstract%3C%2FDT%3E",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "History of endorectal imaging of the prostate",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "http://www.karger.com/Journal/Home/224106//https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emed18&AN=614642964//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:28253510&id=doi:10.1159%2F000457130&issn=2296-5270&isbn=&volume=40&issue=3&spage=106&pages=106-112&date=2017&title=Oncology+Research+and+Treatment&atitle=HIV-Associated+Urogenital+Malignancies&aulast=Hentrich&pid=%3Cauthor%3EHentrich+M.%3BPfister+D.%3C%2Fauthor%3E%3CAN%3E614642964%3C%2FAN%3E%3CDT%3EReview%3C%2FDT%3E",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "HIV-Associated Urogenital Malignancies",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Homeobox B13 G84E Mutation and Prostate Cancer Risk",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "http://www.elsevier.com/locate/suronc//https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emed19&AN=619720309//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:29549907&id=doi:10.1016%2Fj.suronc.2017.11.010&issn=0960-7404&isbn=&volume=27&issue=1&spage=70&pages=70-75&date=2018&title=Surgical+Oncology&atitle=How+to+conduct+a+high-quality+systematic+review+on+diagnostic+research+topics&aulast=Yao&pid=%3Cauthor%3EYao+X.%3BVella+E.%3BBrouwers+M.%3C%2Fauthor%3E%3CAN%3E619720309%3C%2FAN%3E%3CDT%3EReview%3C%2FDT%3E",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "How to conduct a high-quality systematic review on diagnostic research topics",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Imaging of Prostate Cancer",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Intervention/ primary study/erratum/ conference abstract/ commentary/ clinic trial/ newsletter/ magazine/protocol/ literature review",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Impact of patient navigation on timely cancer care: the Patient Navigation Research Program",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emed20&AN=2002632055//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:&id=doi:10.1016%2Fj.ijrobp.2019.06.1826&issn=0360-3016&isbn=&volume=105&issue=1+Supplement&spage=E288&pages=E288&date=2019&title=International+Journal+of+Radiation+Oncology+Biology+Physics&atitle=Impact+of+Prediagnosis+Statins+on+Prostate+Cancer-Specific+Mortality+in+the+Veterans+Affairs+Healthcare+System&aulast=Kumar&pid=%3Cauthor%3EKumar+A.%3BRiviere+P.%3BSarkar+R.R.%3BBryant+A.K.%3BNalawade+V.%3BDeka+R.%3BMurphy+J.D.%3BRose+B.S.%3C%2Fauthor%3E%3CAN%3E2002632055%3C%2FAN%3E%3CDT%3EConference+Abstract%3C%2FDT%3E",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Impact of Prediagnosis Statins on Prostate Cancer-Specific Mortality in the Veterans Affairs Healthcare System",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Implications of High Rates of Metastatic Prostate Cancer in BRCA2 Mutation Carriers",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Improving the pre-screening of eligible patients in order to increase enrollment in cancer clinical trials",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emed13&AN=51693003//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:22195998&id=doi:10.1016%2Fj.purol.2011.09.011&issn=1166-7087&isbn=&volume=22&issue=1&spage=1&pages=1-6&date=2012&title=Progres+en+Urologie&atitle=Bilan+initial+et+suivi+de+l%27hyperplasie+benigne+de+prostate%3A+Revue+de+litterature+du+CTMH+de+l%27AFU&aulast=Descazeaud&pid=%3Cauthor%3EDescazeaud+A.%3BRobert+G.%3BDelongchamps+N.B.%3BCornu+J.-N.%3BSaussine+C.%3BHaillot+O.%3BDevonec+M.%3BFourmarier+M.%3BBallereau+C.%3BLukacs+B.%3BDumonceau+O.%3BAzzouzi+A.R.%3Bde+la+Taille+A.%3C%2Fauthor%3E%3CAN%3E51693003%3C%2FAN%3E%3CDT%3EShort+Survey%3C%2FDT%3E",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Initial assessment and follow-up of benign prostatic hyperplasia: Systematic review of the literature by the LUTS committee of the French Urological Association. [French]",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "http://bmjopen.bmj.com/content/early/by/section//https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emed18&AN=623795130//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:29175892&id=doi:10.1136%2Fbmjopen-2017-019823&issn=2044-6055&isbn=&volume=7&issue=11&spage=e019823&pages=&date=2017&title=BMJ+Open&atitle=Interrupted+versus+continuous+suturing+for+vesicourethral+anastomosis+during+radical+prostatectomy%3A+Protocol+for+a+systematic+review+and+meta-analysis&aulast=Kowalewski&pid=%3Cauthor%3EKowalewski+K.F.%3BTapking+C.%3BHetjens+S.%3BNickel+F.%3BMandel+P.%3BRitter+M.%3BKriegmair+M.C.%3C%2Fauthor%3E%3CAN%3E623795130%3C%2FAN%3E%3CDT%3EReview%3C%2FDT%3E",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Interrupted versus continuous suturing for vesicourethral anastomosis during radical prostatectomy: Protocol for a systematic review and meta-analysis",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Interventions to facilitate shared decision-making using decision aids with patients in Primary Health Care: A systematic review",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Is COVID-19 a risk factor for progression of benign prostatic hyperplasia and exacerbation of its related symptoms?: a systematic review",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emed21&AN=632924481//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:32900845&id=doi:10.1136%2Fmedethics-2020-106309&issn=1473-4257&isbn=&volume=&issue=&spage=medethics&pages=&date=2020&title=Journal+of+medical+ethics&atitle=Is+one+narrative+enough%3F+Analytical+tools+should+match+the+problems+they+address&aulast=Hodson&pid=%3Cauthor%3EHodson+N.%3BBewley+S.%3C%2Fauthor%3E%3CAN%3E632924481%3C%2FAN%3E%3CDT%3EArticle%3C%2FDT%3E",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Is one narrative enough? Analytical tools should match the problems they address",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "https://cancerres.aacrjournals.org/content/80/16_Supplement/2298//https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emed21&AN=633636528//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:&id=doi:10.1158%2F1538-7445.AM2020-2298&issn=1538-7445&isbn=&volume=80&issue=16+SUPPL&spage=&pages=&date=2020&title=Cancer+Research&atitle=Is+smoking+a+risk+factor+for+second+primary+lung+cancer&aulast=Aredo&pid=%3Cauthor%3EAredo+J.V.%3BLuo+S.J.%3BGardner+R.%3BHickey+T.P.%3BRiley+T.L.%3BWilkens+L.R.%3BMarchand+L.L.%3BAmos+C.I.%3BHung+R.J.%3BJohansson+M.%3BCheng+I.%3BWakelee+H.A.%3BHan+S.S.%3C%2Fauthor%3E%3CAN%3E633636528%3C%2FAN%3E%3CDT%3EConference+Abstract%3C%2FDT%3E",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Is smoking a risk factor for second primary lung cancer",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Is There a Role for Active Surveillance in Low-Risk Prostate Cancer?",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emed20&AN=2002154658//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:&id=doi:&issn=1098-3015&isbn=&volume=22&issue=Supplement+2&spage=A1&pages=A1-A2&date=2019&title=Value+in+Health&atitle=ISPOR+2019%3A+Rapid.+Disruptive.+Innovative%3A+A+New+Era+in+HEOR&aulast=&pid=%3Cauthor%3Eanonymous%3C%2Fauthor%3E%3CAN%3E2002154658%3C%2FAN%3E%3CDT%3EConference+Review%3C%2FDT%3E",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "ISPOR 2019: Rapid. Disruptive. Innovative: A New Era in HEOR",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "http://www.eurekaselect.com/158838/article//https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emed19&AN=2001592897//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:29303080&id=doi:10.2174%2F1871520618666180105105413&issn=1871-5206&isbn=&volume=18&issue=7&spage=925&pages=925-930&date=2018&title=Anti-Cancer+Agents+in+Medicinal+Chemistry&atitle=Latest+evidence+on+the+role+of+multiparametric+magnetic+resonance+imaging+in+active+surveillance+for+insignificant+prostate+cancer%3A+A+systematic+review&aulast=Cantiello&pid=%3Cauthor%3ECantiello+F.%3BManno+S.%3BRusso+G.I.%3BCimino+S.%3BPrivitera+S.%3BMorgia+G.%3BCicione+A.%3BDamiano+R.%3C%2Fauthor%3E%3CAN%3E2001592897%3C%2FAN%3E%3CDT%3EReview%3C%2FDT%3E",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Latest evidence on the role of multiparametric magnetic resonance imaging in active surveillance for insignificant prostate cancer: A systematic review",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Intervention/ primary study/erratum/ conference abstract/ commentary/ clinic trial/ newsletter/ magazine/protocol/ literature review",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Letter to the editor concerning 'Do prostate cancer risk models improve the predictive accuracy of PSA screening? A meta-analysis'",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "http://www.jcancer.org/v07p1842.pdf//https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emed17&AN=613577096//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:&id=doi:10.7150%2Fjca.15876&issn=1837-9664&isbn=&volume=7&issue=13&spage=1842&pages=1842-1855&date=2016&title=Journal+of+Cancer&atitle=Long+non-coding+RNAs+in+urologic+malignancies%3A+Functional+roles+and+clinical+translation&aulast=Chen&pid=%3Cauthor%3EChen+J.%3BMiao+Z.%3BXue+B.%3BShan+Y.%3BWeng+G.%3BShen+B.%3C%2Fauthor%3E%3CAN%3E613577096%3C%2FAN%3E%3CDT%3EReview%3C%2FDT%3E",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Long non-coding RNAs in urologic malignancies: Functional roles and clinical translation",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.systematicreviewsjournal.com///https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emexb&AN=2014633917//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:34980265&id=doi:10.1186%2Fs13643-021-01865-5&issn=2046-4053&isbn=&volume=11&issue=1&spage=2&pages=&date=2022&title=Systematic+Reviews&atitle=Mapping+the+prevalence+and+use+of+questionnaires+to+detect+the+neglected+sexual+side+effects+after+prostate+cancer+treatment%3A+a+scoping+review&aulast=Roscher&pid=%3Cauthor%3ERoscher+P.%3BSathiram+R.%3BMilios+J.E.%3Bvan+Wyk+J.M.%3C%2Fauthor%3E%3CAN%3E2014633917%3C%2FAN%3E%3CDT%3EArticle%3C%2FDT%3E",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Mapping the prevalence and use of questionnaires to detect the neglected sexual side effects after prostate cancer treatment: a scoping review",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "http://www.elsevier.com/wps/find/journaldescription.cws_home/723463/description#description//https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emed16&AN=605983892//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:26362356&id=doi:10.1016%2Fj.jgo.2015.08.006&issn=1879-4068&isbn=&volume=6&issue=6&spage=484&pages=484-496&date=2015&title=Journal+of+Geriatric+Oncology&atitle=Measurement+of+gait+speed+in+older+adults+to+identify+complications+associated+with+frailty%3A+A+systematic+review&aulast=Pamoukdjian&pid=%3Cauthor%3EPamoukdjian+F.%3BPaillaud+E.%3BZelek+L.%3BLaurent+M.%3BLevy+V.%3BLandre+T.%3BSebbane+G.%3C%2Fauthor%3E%3CAN%3E605983892%3C%2FAN%3E%3CDT%3EReview%3C%2FDT%3E",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Measurement of gait speed in older adults to identify complications associated with frailty: A systematic review",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "http://care.diabetesjournals.org/content/35/11/2402.full.pdf+html//https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emed13&AN=365944230//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:23093685&id=doi:10.2337%2Fdc12-0336&issn=0149-5992&isbn=&volume=35&issue=11&spage=2402&pages=2402-2411&date=2012&title=Diabetes+Care&atitle=Metabolic+syndrome+and+risk+of+cancer%3A+A+systematic+review+and+meta-analysis&aulast=Esposito&pid=%3Cauthor%3EEsposito+K.%3BChiodini+P.%3BColao+A.%3BLenzi+A.%3BGiugliano+D.%3C%2Fauthor%3E%3CAN%3E365944230%3C%2FAN%3E%3CDT%3EArticle%3C%2FDT%3E",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Metabolic syndrome and risk of cancer: A systematic review and meta-analysis",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emexa&AN=636426321//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:&id=doi:10.1111%2Fajco.13700&issn=1743-7563&isbn=&volume=17&issue=SUPPL+7&spage=59&pages=59&date=2021&title=Asia-Pacific+Journal+of+Clinical+Oncology&atitle=Methods+for+measuring+frailty+in+clinical+trials+involving+patients+with+advanced+prostate+cancer+on+novel+androgen+targeted+therapy&aulast=Ng&pid=%3Cauthor%3ENg+B.%3BRhee+H.%3C%2Fauthor%3E%3CAN%3E636426321%3C%2FAN%3E%3CDT%3EConference+Abstract%3C%2FDT%3E",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Methods for measuring frailty in clinical trials involving patients with advanced prostate cancer on novel androgen targeted therapy",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emed17&AN=622439485//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:&id=doi:&issn=1878-1500&isbn=&volume=15&issue=12&spage=e1513&pages=e1513-e1514&date=2016&title=European+Urology%2C+Supplements&atitle=Micro-ultrasound+of+the+prostate%2C+PRI-MUSTM+protocol+guidance+along+with+clinical+variables%3A+Combined+approach+for+reducing+unnecessary+biopsies&aulast=Wodlinger&pid=%3Cauthor%3EWodlinger+B.%3BGhai+S.%3BEure+G.%3BFradet+V.%3BHyndman+E.%3BMcgrath+T.%3BPavlovich+C.%3C%2Fauthor%3E%3CAN%3E622439485%3C%2FAN%3E%3CDT%3EConference+Abstract%3C%2FDT%3E",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Micro-ultrasound of the prostate, PRI-MUSTM protocol guidance along with clinical variables: Combined approach for reducing unnecessary biopsies",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "http://www.elsevier.com/locate/issn/10781439//https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emed17&AN=612735544//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:27641313&id=doi:10.1016%2Fj.urolonc.2016.05.030&issn=1078-1439&isbn=&volume=34&issue=10&spage=437&pages=437-451&date=2016&title=Urologic+Oncology%3A+Seminars+and+Original+Investigations&atitle=Microhematuria+assessment+an+IBCN+consensus-Based+upon+a+critical+review+of+current+guidelines&aulast=Schmitz-Drager&pid=%3Cauthor%3ESchmitz-Drager+B.J.%3BKuckuck+E.C.%3BZuiverloon+T.C.M.%3BZwarthoff+E.C.%3BSaltzman+A.%3BSrivastava+A.%3BHudson+M.A.%3BSeiler+R.%3BTodenhofer+T.%3BVlahou+A.%3BGrossman+H.B.%3BSchoenberg+M.P.%3BSanchez-Carbayo+M.%3BBrunn+L.-A.%3Bvan+Rhijn+B.W.G.%3BGoebell+P.J.%3BKamat+A.M.%3BRoupret+M.%3BShariat+S.F.%3BKiemeney+L.A.%3C%2Fauthor%3E%3CAN%3E612735544%3C%2FAN%3E%3CDT%3EReview%3C%2FDT%3E",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Microhematuria assessment an IBCN consensus-Based upon a critical review of current guidelines",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Minimally invasive strategies for the treatment of prostate cancer recurrence after radiation therapy: a systematic review",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emed18&AN=624693829//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:&id=doi:10.1097%2FNCC.0000000000000555&issn=1538-9804&isbn=&volume=40&issue=6+Supplement+1&spage=E4&pages=E4&date=2017&title=Cancer+Nursing&atitle=Models+of+patient+navigation+in+cancer+care%3A+A+review+of+literature&aulast=Ponto&pid=%3Cauthor%3EPonto+J.A.%3C%2Fauthor%3E%3CAN%3E624693829%3C%2FAN%3E%3CDT%3EConference+Abstract%3C%2FDT%3E",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Models of patient navigation in cancer care: A review of literature",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Models predicting survival to guide treatment decision-making in newly diagnosed primary non-metastatic prostate cancer: a systematic review",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emed19&AN=625368921//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:&id=doi:10.1136%2Fbmjebm-2018-111070.38&issn=2515-4478&isbn=&volume=23&issue=Supplement+2&spage=A17&pages=A17&date=2018&title=BMJ+Evidence-Based+Medicine&atitle=Mono-criterial+thresholds+are+a+likely+source+of+over-testing+and+over-treatment&aulast=Kaltoft&pid=%3Cauthor%3EKaltoft+M.K.%3BNielsen+J.B.%3BDowie+J.%3C%2Fauthor%3E%3CAN%3E625368921%3C%2FAN%3E%3CDT%3EConference+Abstract%3C%2FDT%3E",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Mono-criterial thresholds are a likely source of over-testing and over-treatment",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.journals.elsevier.com/cancer-treatment-and-research-communications///https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emed22&AN=2010451492//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:33360667&id=doi:10.1016%2Fj.ctarc.2020.100225&issn=2468-2942&isbn=&volume=26&issue=&spage=100225&pages=&date=2021&title=Cancer+Treatment+and+Research+Communications&atitle=%22More+men+die+with+prostate+cancer+than+because+of+it%22+-+an+old+adage+that+still+holds+true+in+the+21st+century&aulast=C&pid=%3Cauthor%3EC+J.%3BY+P.%3BSF+B.%3BRJ+B.%3C%2Fauthor%3E%3CAN%3E2010451492%3C%2FAN%3E%3CDT%3EArticle%3C%2FDT%3E",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "More men die with prostate cancer than because of it - an old adage that still holds true in the 21st century",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "https://ecancer.org/en/journal/article/1044-multidisciplinary-approach-to-covid-19-and-cancer-consensus-from-scientific-societies-in-argentina//https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emed21&AN=2006804511//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:&id=doi:10.3332%2FECANCER.2020.1044&issn=1754-6605&isbn=&volume=14&issue=&spage=1044&pages=&date=2020&title=ecancermedicalscience&atitle=Multidisciplinary+approach+to+COVID-19+and+cancer%3A+Consensus+from+scientific+societies+in+Argentina&aulast=Ismael&pid=%3Cauthor%3EIsmael+J.%3BLosco+F.%3BQuildrian+S.%3BSanchez+P.%3BPincemin+I.%3BLastiri+J.%3BBella+S.%3BChinellato+A.%3BDellamea+G.%3BAhualli+A.%3BRompato+S.%3BVelez+J.%3BEscobar+R.%3BZwenger+A.%3BRosales+C.%3BBagnes+C.%3BPuyol+J.%3BNiewiadomski+D.%3BSmecuol+E.%3BNachman+F.%3BGonzalez+E.%3BFerraris+G.%3BSuppicich+J.R.%3BPrice+P.%3BMedina+L.%3BO%27Connor+J.%3C%2Fauthor%3E%3CAN%3E2006804511%3C%2FAN%3E%3CDT%3EArticle%3C%2FDT%3E",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Multidisciplinary approach to COVID-19 and cancer: Consensus from scientific societies in Argentina",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.tandfonline.com/toc/tepm20/current//https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emed21&AN=2006941431//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:&id=doi:10.1080%2F23808993.2020.1804866&issn=2380-8993&isbn=&volume=5&issue=5&spage=383&pages=383-400&date=2020&title=Expert+Review+of+Precision+Medicine+and+Drug+Development&atitle=Noninvasive+biomarkers+to+guide+intervention%3A+toward+personalized+patient+management+in+prostate+cancer&aulast=Frantzi&pid=%3Cauthor%3EFrantzi+M.%3BGomez-Gomez+E.%3BMischak+H.%3C%2Fauthor%3E%3CAN%3E2006941431%3C%2FAN%3E%3CDT%3EReview%3C%2FDT%3E",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Intervention/ primary study/erratum/ conference abstract/ commentary/ clinic trial/ newsletter/ magazine/protocol/ literature review",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Noninvasive biomarkers to guide intervention: toward personalized patient management in prostate cancer",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "http://www.eurekaselect.com/CDN/download.php?param=Sk9VpUk5aBTFAMvQqkVOvL0NwNQyi8yNei82cLzA1wMTzBDLnnBkCZnxi8YXlBwbEGljAYXRkpb2n4vcxGRmqfHwp5NziFmYnzFmbMzAn5ZDfBkNtTgx7NDAfwZWiYwNgjhh1MmIy4MGcZlYfgTcVYTcVYe&key=VWlxkRWlkuZEhUtQAVNEpc2RuZZkmVJQcTMylRDMk1RjDc1NaDV2dLTQu3MzqItMsjM1iNjQjzMjuNERw2VEpeATcVYtTcVY//https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emed20&AN=2002203034//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:30215331&id=doi:10.2174%2F0929867325666180914115416&issn=0929-8673&isbn=&volume=26&issue=6&spage=1045&pages=1045-1058&date=2019&title=Current+Medicinal+Chemistry&atitle=Novel+diagnostic+biomarkers+of+prostate+cancer%3A+An+update&aulast=Anceschi&pid=%3Cauthor%3EAnceschi+U.%3BTuderti+G.%3BLugnani+F.%3BBiava+P.M.%3BMalossini+G.%3BLuciani+L.%3BCai+T.%3BMarsiliani+D.%3BFilianoti+A.%3BMattevi+D.%3BCostantini+M.%3BMisuraca+L.%3BSimone+G.%3C%2Fauthor%3E%3CAN%3E2002203034%3C%2FAN%3E%3CDT%3EArticle%3C%2FDT%3E",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Novel diagnostic biomarkers of prostate cancer: An update",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "http://www.annalsoftransplantation.com/download/index/idArt/890339//https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emed15&AN=373165683//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:24841765&id=doi:10.12659%2FAOT.890339&issn=1425-9524&isbn=&volume=19&issue=1&spage=241&pages=241-247&date=2014&title=Annals+of+Transplantation&atitle=Novel+guidelines+for+organ+donor+cancer+screening&aulast=Hassanain&pid=%3Cauthor%3EHassanain+M.%3C%2Fauthor%3E%3CAN%3E373165683%3C%2FAN%3E%3CDT%3EReview%3C%2FDT%3E",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Novel guidelines for organ donor cancer screening",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.mattioli1885journals.com/index.php/actabiomedica/article/download/11475/10082//https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emexa&AN=2013674372//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:34487074&id=doi:10.23750%2Fabm.v92i3.11475&issn=0392-4203&isbn=&volume=92&issue=4&spage=e2021191&pages=&date=2021&title=Acta+Biomedica&atitle=Oncologic+outcome+of+salvage+high-intensity+focused+ultrasound+%28Hifu%29+in+radiorecurrent+prostate+cancer.+a+systematic+review&aulast=Maestroni&pid=%3Cauthor%3EMaestroni+U.%3BTafuri+A.%3BDinale+F.%3BCampobasso+D.%3BAntonelli+A.%3BZiglioli+F.%3C%2Fauthor%3E%3CAN%3E2013674372%3C%2FAN%3E%3CDT%3EArticle%3C%2FDT%3E",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Oncologic outcome of salvage high-intensity focused ultrasound (Hifu) in radiorecurrent prostate cancer. a systematic review",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Oncological Response and Predictive Biomarkers for the Checkpoint Inhibitors in Castration-Resistant Metastatic Prostate Cancer: A Systematic Review and Meta-Analysis",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emed16&AN=72149073//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:&id=doi:10.1213%2F01.ane.0000470325.07465.0f&issn=0003-2999&isbn=&volume=120&issue=3+SUPPL.+1&spage=S230&pages=S230&date=2015&title=Anesthesia+and+Analgesia&atitle=Pain+management+after+radical+prostatectomy+surgery%3A+Systematic+review+of+randomized+controlled+trials&aulast=Joshi&pid=%3Cauthor%3EJoshi+G.P.%3BJaschinski+T.%3BBonnet+F.%3C%2Fauthor%3E%3CAN%3E72149073%3C%2FAN%3E%3CDT%3EConference+Abstract%3C%2FDT%3E",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Pain management after radical prostatectomy surgery: Systematic review of randomized controlled trials",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "http://bmjopen.bmj.com/content/early/by/section//https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emexa&AN=635413917//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:34215604&id=doi:10.1136%2Fbmjopen-2020-046329&issn=2044-6055&isbn=&volume=11&issue=7&spage=e046329&pages=&date=2021&title=BMJ+Open&atitle=Parkinson%27s+disease+and+cancer%3A+A+systematic+review+and+meta-analysis+of+over+17+million+participants&aulast=Zhang&pid=%3Cauthor%3EZhang+X.%3BGuarin+D.%3BMohammadzadehhonarvar+N.%3BChen+X.%3BGao+X.%3C%2Fauthor%3E%3CAN%3E635413917%3C%2FAN%3E%3CDT%3EReview%3C%2FDT%3E",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Parkinson's disease and cancer: A systematic review and meta-analysis of over 17 million participants",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "PARP inhibitors as a new therapeutic option in metastatic prostate cancer: a systematic review",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Passive-specific immunotherapy with monoclonal antibodies for prostate cancer: A systematic review",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "http://annonc.oxfordjournals.org///https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emed16&AN=606045542//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:25888610&id=doi:10.1093%2Fannonc%2Fmdv181&issn=0923-7534&isbn=&volume=26&issue=9&spage=1846&pages=1846-1858&date=2015&title=Annals+of+Oncology&atitle=Patient-reported+outcomes+in+routine+cancer+clinical+practice%3A+A+scoping+review+of+use%2C+impact+on+health+outcomes%2C+and+implementation+factors&aulast=Howell&pid=%3Cauthor%3EHowell+D.%3BMolloy+S.%3BWilkinson+K.%3BGreen+E.%3BOrchard+K.%3BWang+K.%3BLiberty+J.%3C%2Fauthor%3E%3CAN%3E606045542%3C%2FAN%3E%3CDT%3EReview%3C%2FDT%3E",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Patient-reported outcomes in routine cancer clinical practice: A scoping review of use, impact on health outcomes, and implementation factors",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "http://www.europeanurology.com///https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emed15&AN=52532319//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:23582879&id=doi:10.1016%2Fj.eururo.2013.03.057&issn=0302-2838&isbn=&volume=65&issue=1&spage=7&pages=7-16&date=2014&title=European+Urology&atitle=Pelvic+lymph+node+dissection+during+robot-assisted+radical+prostatectomy%3A+Efficacy%2C+limitations%2C+and+complications+-+A+systematic+review+of+the+literature&aulast=Ploussard&pid=%3Cauthor%3EPloussard+G.%3BBriganti+A.%3BDe+La+Taille+A.%3BHaese+A.%3BHeidenreich+A.%3BMenon+M.%3BSulser+T.%3BTewari+A.K.%3BEastham+J.A.%3C%2Fauthor%3E%3CAN%3E52532319%3C%2FAN%3E%3CDT%3EReview%3C%2FDT%3E",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Pelvic lymph node dissection during robot-assisted radical prostatectomy: Efficacy, limitations, and complications - A systematic review of the literature",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emed20&AN=2004939551//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:&id=doi:10.1016%2FS1879-4068%252819%252931282-2&issn=1879-4068&isbn=&volume=10&issue=6+Supplement+1&spage=S98&pages=S98&date=2019&title=Journal+of+Geriatric+Oncology&atitle=PERCEPTION+OF+STRUCTURED+EXERCISE+PROGRAMS+AND+FACTORS+ASSOCIATED+WITH+PARTICIPATION+AND+ADHERENCE+AMONG+MEN+WITH+PROSTATE+CANCER%3A+A+SCOPING+REVIEW&aulast=Sattar&pid=%3Cauthor%3ESattar+S.%3BHaase+K.%3BBradley+C.%3BPapadopoulos+E.%3BKuster+S.%3BSanta+Mina+D.%3BJoshua+A.%3BSouied+O.%3BRediger+C.%3BAlibhai+S.%3C%2Fauthor%3E%3CAN%3E2004939551%3C%2FAN%3E%3CDT%3EConference+Abstract%3C%2FDT%3E",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Perception of Structured Exercise Programs and Factors Associated with Participation and Adherence among Men with Prostate Cancer: A Scoping Review",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Performance of 18F-DCFPyL PET/CT Imaging in Early Detection of Biochemically Recurrent Prostate Cancer: A Systematic Review and Meta-Analysis",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emed20&AN=2004939843//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:&id=doi:10.1016%2FS1569-9056%252819%252934642-1&issn=1569-9056&isbn=&volume=18&issue=11&spage=e3485&pages=e3485-e3486&date=2019&title=European+Urology%2C+Supplements&atitle=PIONEER%27s+systematic+review+of+outcomes+reported+in+effectiveness+trials+for+interventions+in+locally+advanced+prostate+cancer&aulast=Beyer&pid=%3Cauthor%3EBeyer+K.%3BMoris+L.%3BLardas+M.%3BMacLennan+S.%3BMonagas+S.%3BAntunes-Lopes+T.%3BVradi+E.%3BOmar+M.I.%3BMacLennan+S.J.%3BBriganti+A.%3BVan+Hemelrijck+M.%3C%2Fauthor%3E%3CAN%3E2004939843%3C%2FAN%3E%3CDT%3EConference+Abstract%3C%2FDT%3E",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "PIONEER's systematic review of outcomes reported in effectiveness trials for interventions in locally advanced prostate cancer",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emexa&AN=2015167862//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:&id=doi:10.1016%2Fj.jtho.2021.08.737&issn=1556-0864&isbn=&volume=16&issue=10+Supplement&spage=S827&pages=S827-S828&date=2021&title=Journal+of+Thoracic+Oncology&atitle=PL04.04+Psychological+Distress+and+Stigma+for+People+with+Lung+Cancer%3A+Time+to+Act&aulast=Chambers&pid=%3Cauthor%3EChambers+S.%3BDunn+J.%3BScott+B.%3BBall+D.%3C%2Fauthor%3E%3CAN%3E2015167862%3C%2FAN%3E%3CDT%3EConference+Abstract%3C%2FDT%3E",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "PL04.04 Psychological Distress and Stigma for People with Lung Cancer: Time to Act",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emed21&AN=2007669744//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:&id=doi:10.1016%2Fj.vhri.2020.07.379&issn=2212-1099&isbn=&volume=22&issue=Supplement&spage=S72&pages=S72&date=2020&title=Value+in+Health+Regional+Issues&atitle=PMU21+Incorporating+Preference+Heterogeneity+in+Public+Healthcare+Policy+Decision-Making%3A+A+Scoping+Review+of+the+Literature&aulast=David&pid=%3Cauthor%3EDavid+G.%3BDixon+S.%3BBuykx+P.%3C%2Fauthor%3E%3CAN%3E2007669744%3C%2FAN%3E%3CDT%3EConference+Abstract%3C%2FDT%3E",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "PMU21 Incorporating Preference Heterogeneity in Public Healthcare Policy Decision-Making: A Scoping Review of the Literature",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emed20&AN=2001680560//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:&id=doi:10.1016%2FS1569-9056%252819%252930102-2&issn=1569-9056&isbn=&volume=18&issue=1&spage=e132&pages=e132&date=2019&title=European+Urology%2C+Supplements&atitle=Pooled+analysis+of+%3E1000+patients+enrolled+in+two+independent+prospective+validation+studies+show+consistent+performance+of+a+urine+exosome+gene+expression+assay+to+rule-out+benign+and+low-grade+prostate+cancer+at+initial+biopsy&aulast=Noerholm&pid=%3Cauthor%3ENoerholm+M.%3BMcKiernan+J.%3BDonovan+M.J.%3BPartin+A.%3BCarter+B.%3BBrown+G.%3BMargolis+E.%3BTorkler+P.%3BSkog+J.%3BShore+N.%3BAndriole+G.%3BThompson+I.%3BCarroll+P.%3C%2Fauthor%3E%3CAN%3E2001680560%3C%2FAN%3E%3CDT%3EConference+Abstract%3C%2FDT%3E",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Pooled analysis of >1000 patients enrolled in two independent prospective validation studies show consistent performance of a urine exosome gene expression assay to rule-out benign and low-grade prostate cancer at initial biopsy",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Predicting high-grade prostate cancer at initial biopsy: clinical performance of the ExoDx (EPI) Prostate Intelliscore test in three independent prospective studies",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Predicting Life Expectancy in Men Diagnosed with Prostate Cancer",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emed13&AN=70720042//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:&id=doi:10.1016%2Fj.juro.2012.02.405&issn=0022-5347&isbn=&volume=187&issue=4+SUPPL.+1&spage=e140&pages=e140&date=2012&title=Journal+of+Urology&atitle=Preoperative+statin+therapy+%28ST%29+is+not+associated+with+prolonged+biochemical+free+survival+%28BCFS%29+after+radical+prostatectomy+%28RP%29%3A+A+meta-analysis+of+five+retrospective+studies&aulast=Mass&pid=%3Cauthor%3EMass+A.%3BAgalliu+I.%3BLaze+J.%3BLepor+H.%3C%2Fauthor%3E%3CAN%3E70720042%3C%2FAN%3E%3CDT%3EConference+Abstract%3C%2FDT%3E",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Preoperative statin therapy (ST) is not associated with prolonged biochemical free survival (BCFS) after radical prostatectomy (RP): A meta-analysis of five retrospective studies",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "http://www.elsevier.com/locate/issn/10781439//https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emed17&AN=607363203//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:&id=doi:10.1016%2Fj.urolonc.2015.09.003&issn=1078-1439&isbn=&volume=34&issue=2&spage=e1&pages=e1-58&date=2016&title=Urologic+Oncology%3A+Seminars+and+Original+Investigations&atitle=Prevalence+and+management+of+prostate+cancer+among+East+Asian+men%3A+Current+trends+and+future+perspectives&aulast=Monn&pid=%3Cauthor%3EMonn+M.F.%3BTatem+A.J.%3BCheng+L.%3C%2Fauthor%3E%3CAN%3E607363203%3C%2FAN%3E%3CDT%3EArticle%3C%2FDT%3E",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Prevalence and management of prostate cancer among East Asian men: Current trends and future perspectives",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Primary care providers' cancer genetic testing-related knowledge, attitudes, and communication behaviors: A systematic review and research agenda",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Proclarix, A New Biomarker for the Diagnosis of Clinically Significant Prostate Cancer: A Systematic Review",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.cancernetwork.com/view/profilin-1-protein-and-its-implications-for-cancers//https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emexb&AN=2013847843//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:34264570&id=doi:10.46883%2FONC.2021.3507.0402&issn=0890-9091&isbn=&volume=35&issue=7&spage=402&pages=402-409&date=2021&title=ONCOLOGY+%28United+States%29&atitle=Profilin+1+protein+and+its+implications+for+cancers&aulast=Wang&pid=%3Cauthor%3EWang+Y.%3BWan+R.%3BHu+C.%3BLu+Y.%3C%2Fauthor%3E%3CAN%3E2013847843%3C%2FAN%3E%3CDT%3EReview%3C%2FDT%3E",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Profilin 1 protein and its implications for cancers",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Prognostic models for predicting overall survival in metastatic castration-resistant prostate cancer: a systematic review",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "http://www.europeanurology.com///https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emed20&AN=2001191892//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:30342843&id=doi:10.1016%2Fj.eururo.2018.10.011&issn=0302-2838&isbn=&volume=75&issue=6&spage=967&pages=967-987&date=2019&title=European+Urology&atitle=Prognostic+Value+of+Biochemical+Recurrence+Following+Treatment+with+Curative+Intent+for+Prostate+Cancer%3A+A+Systematic+Review&aulast=Van+den+Broeck&pid=%3Cauthor%3EVan+den+Broeck+T.%3Bvan+den+Bergh+R.C.N.%3BArfi+N.%3BGross+T.%3BMoris+L.%3BBriers+E.%3BCumberbatch+M.%3BDe+Santis+M.%3BTilki+D.%3BFanti+S.%3BFossati+N.%3BGillessen+S.%3BGrummet+J.P.%3BHenry+A.M.%3BLardas+M.%3BLiew+M.%3BRouviere+O.%3BPecanka+J.%3BMason+M.D.%3BSchoots+I.G.%3Bvan+Der+Kwast+T.H.%3Bvan+Der+Poel+H.G.%3BWiegel+T.%3BWillemse+P.-P.M.%3BYuan+Y.%3BLam+T.B.%3BCornford+P.%3BMottet+N.%3C%2Fauthor%3E%3CAN%3E2001191892%3C%2FAN%3E%3CDT%3EReview%3C%2FDT%3E",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Prognostic Value of Biochemical Recurrence Following Treatment with Curative Intent for Prostate Cancer: A Systematic Review",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emexa&AN=636276583//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:&id=doi:10.1097%2FJU.0000000000002036.04&issn=1527-3792&isbn=&volume=206&issue=SUPPL+3&spage=e565&pages=e565-e566&date=2021&title=Journal+of+Urology&atitle=Progression+on+active+surveillance+for+prostate+cancer+in+black+men%3A+A+systematic+review+and+meta-analysis&aulast=Vigneswaran&pid=%3Cauthor%3EVigneswaran+H.%3BMittelstaedt+L.%3BCrippa+A.%3BEklund+M.%3BVidal+A.%3BFreedland+S.%3BAbern+M.%3C%2Fauthor%3E%3CAN%3E636276583%3C%2FAN%3E%3CDT%3EConference+Abstract%3C%2FDT%3E",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Progression on active surveillance for prostate cancer in black men: A systematic review and meta-analysis",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Prostate Cancer and Asbestos: A Systematic Review and Meta-Analysis",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "http://www.cancerjournal.net//https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emed15&AN=600759102//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:25450286&id=doi:10.4103%2F0973-1482.145881&issn=0973-1482&isbn=&volume=10&issue=&spage=C218&pages=C218-C221&date=2014&title=Journal+of+Cancer+Research+and+Therapeutics&atitle=Prostate+cancer+antigen+3+as+a+biomarker+in+the+urine+for+prostate+cancer+diagnosis%3A+A+meta-analysis&aulast=Xue&pid=%3Cauthor%3EXue+W.-J.%3BYing+X.-L.%3BJiang+J.-H.%3BXu+Y.-H.%3C%2Fauthor%3E%3CAN%3E600759102%3C%2FAN%3E%3CDT%3EArticle%3C%2FDT%3E",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Prostate cancer antigen 3 as a biomarker in the urine for prostate cancer diagnosis: A meta-analysis",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Prostate cancer antigen 3 test for prostate biopsy decision: a systematic review and meta analysis",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "http://www.journals.elsevier.com/prostate-international///https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emed17&AN=613649938//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:&id=doi:10.1016%2Fj.prnil.2016.07.002&issn=2287-8882&isbn=&volume=4&issue=4&spage=130&pages=130-135&date=2016&title=Prostate+International&atitle=Prostate+cancer+biomarkers%3A+Are+we+hitting+the+mark%3F&aulast=McGrath&pid=%3Cauthor%3EMcGrath+S.%3BChristidis+D.%3BPerera+M.%3BHong+S.K.%3BManning+T.%3BVela+I.%3BLawrentschuk+N.%3C%2Fauthor%3E%3CAN%3E613649938%3C%2FAN%3E%3CDT%3EReview%3C%2FDT%3E",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Prostate cancer biomarkers: Are we hitting the mark?",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Prostate Cancer Characteristics in the US Preventive Services Task Force Grade D Era: A Single-Center Study and Meta-Analysis",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "http://www.nature.com/pcan/index.html//https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emexb&AN=2014681269//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:34997229&id=doi:10.1038%2Fs41391-021-00480-8&issn=1365-7852&isbn=&volume=25&issue=1&spage=39&pages=39-46&date=2022&title=Prostate+Cancer+and+Prostatic+Diseases&atitle=Prostate+cancer+detection%3A+a+systematic+review+of+urinary+biosensors&aulast=Chan&pid=%3Cauthor%3EChan+K.M.%3BGleadle+J.M.%3BO%27Callaghan+M.%3BVasilev+K.%3BMacGregor+M.%3C%2Fauthor%3E%3CAN%3E2014681269%3C%2FAN%3E%3CDT%3EReview%3C%2FDT%3E",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Prostate cancer detection: a systematic review of urinary biosensors",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Prostate cancer family history and eligibility for active surveillance: a systematic review of the literature",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "http://meeting.ascopubs.org/cgi/content/abstract/34/15_suppl/1525?sid=b1574933-7d62-4615-b468-8e3bed5cdb3e//https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emed17&AN=611753954//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:&id=doi:&issn=1527-7755&isbn=&volume=34&issue=Supplement+15&spage=&pages=&date=2016&title=Journal+of+Clinical+Oncology&atitle=Prostate+cancer+genome-wide+association+study+from+89%2C000+men+using+the+OncoArray+chip+to+identify+novel+prostate+cancer+susceptibility+loci&aulast=Eeles&pid=%3Cauthor%3EEeles+R.%3C%2Fauthor%3E%3CAN%3E611753954%3C%2FAN%3E%3CDT%3EConference+Abstract%3C%2FDT%3E",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Prostate cancer genome-wide association study from 89,000 men using the OncoArray chip to identify novel prostate cancer susceptibility loci",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "http://cancerres.aacrjournals.org/content/76/14_Supplement/2565//https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emed17&AN=613609544//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:&id=doi:10.1158%2F1538-7445.AM2016-2565&issn=1538-7445&isbn=&volume=76&issue=14+Supplement&spage=2565&pages=&date=2016&title=Cancer+Research&atitle=Prostate+cancer+GWAS+from+more+than+89%2C000+men+identifies+more+than+30+novel+prostate+cancer+susceptibility+loci&aulast=Schumacher&pid=%3Cauthor%3ESchumacher+F.R.%3BAl+Olama+A.A.%3BBerndt+S.I.%3BWiklund+F.%3BConti+D.V.%3BAhmed+M.%3BBenlloch+S.%3BEaston+D.F.%3BKraft+P.%3BChanock+S.J.%3BHenderson+B.E.%3BKote-Jarai+Z.%3BHaiman+C.A.%3BEeles+R.A.%3C%2Fauthor%3E%3CAN%3E613609544%3C%2FAN%3E%3CDT%3EConference+Abstract%3C%2FDT%3E",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Prostate cancer GWAS from more than 89,000 men identifies more than 30 novel prostate cancer susceptibility loci",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Prostate cancer in transgender women: what does a urologist need to know?",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emed13&AN=365278495//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:22616627&id=doi:&issn=1445-6354&isbn=&volume=12&issue=2&spage=2039&pages=2039&date=2012&title=Rural+and+remote+health&atitle=Prostate+cancer+incidence+and+mortality+in+rural+men--a+systematic+review+of+the+literature&aulast=Obertova&pid=%3Cauthor%3EObertova+Z.%3BBrown+C.%3BHolmes+M.%3BLawrenson+R.%3C%2Fauthor%3E%3CAN%3E365278495%3C%2FAN%3E%3CDT%3EReview%3C%2FDT%3E",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Prostate cancer incidence and mortality in rural men--a systematic review of the literature",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.mdpi.com/2072-6694/13/13/3373/pdf//https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emexb&AN=2007670135//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:&id=doi:10.3390%2Fcancers13133373&issn=2072-6694&isbn=&volume=13&issue=13&spage=3373&pages=&date=2021&title=Cancers&atitle=Prostate+cancer+liquid+biopsy+biomarkers%27+clinical+utility+in+diagnosis+and+prognosis&aulast=Matuszczak&pid=%3Cauthor%3EMatuszczak+M.%3BSchalken+J.A.%3BSalagierski+M.%3C%2Fauthor%3E%3CAN%3E2007670135%3C%2FAN%3E%3CDT%3EReview%3C%2FDT%3E",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Prostate cancer liquid biopsy biomarkers' clinical utility in diagnosis and prognosis",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emed17&AN=613695821//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:&id=doi:10.1016%2Fj.ejso.2016.07.092&issn=1532-2157&isbn=&volume=42&issue=11&spage=S240&pages=S240&date=2016&title=European+Journal+of+Surgical+Oncology&atitle=Prostate+cancer+meta-analysis+from+more+than+143%2C000+men+identifies+57+novel+prostate+cancer+susceptibility+loci&aulast=Eeles&pid=%3Cauthor%3EEeles+R.%3BSchumacher+F.R.%3BAl+Olama+A.A.%3BBerndt+S.I.%3BWilklund+F.%3BConti+D.V.%3BAhmed+M.%3BBenlloch+S.%3BEaston+D.F.%3BKraft+P.%3BChanock+S.J.%3BHenderson+B.E.%3BKote-Jarai+Z.%3BHaiman+C.A.%3C%2Fauthor%3E%3CAN%3E613695821%3C%2FAN%3E%3CDT%3EConference+Abstract%3C%2FDT%3E",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Prostate cancer meta-analysis from more than 143,000 men identifies 57 novel prostate cancer susceptibility loci",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "http://meetinglibrary.asco.org/record/140787/abstract//https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emed18&AN=618007035//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:&id=doi:&issn=1527-7755&isbn=&volume=35&issue=6+Supplement+1&spage=&pages=&date=2017&title=Journal+of+Clinical+Oncology&atitle=Prostate+cancer+meta-analysis+from+more+than+145%2C000+men+to+identify+65+novel+prostate+cancer+susceptibility+loci&aulast=Eeles&pid=%3Cauthor%3EEeles+R.%3BAl+Olama+A.A.%3BBerndt+S.%3BWiklund+F.%3BConti+D.V.%3BAhmed+M.%3BBenlloch+S.%3BEaston+D.%3BKraft+P.%3BChanock+S.J.%3BKote-Jarai+Z.%3BHaiman+C.%3BSchumacher+F.R.%3C%2Fauthor%3E%3CAN%3E618007035%3C%2FAN%3E%3CDT%3EConference+Abstract%3C%2FDT%3E",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Prostate cancer meta-analysis from more than 145,000 men to identify 65 novel prostate cancer susceptibility loci",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "http://theoncologist.alphamedpress.org//https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emexa&AN=2010860413//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:33683758&id=doi:10.1002%2Fonco.13749&issn=1083-7159&isbn=&volume=26&issue=7&spage=537&pages=537-548&date=2021&title=Oncologist&atitle=Prostate+Cancer%3A+Community+Education+and+Disparities+in+Diagnosis+and+Treatment&aulast=Carthon&pid=%3Cauthor%3ECarthon+B.%3BSibold+H.C.%3BBlee+S.%3BD.+Pentz+R.%3C%2Fauthor%3E%3CAN%3E2010860413%3C%2FAN%3E%3CDT%3EArticle%3C%2FDT%3E",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Prostate Cancer: Community Education and Disparities in Diagnosis and Treatment",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.oncologyreviews.org/site/article/view/449/435//https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emed22&AN=2010731526//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:&id=doi:10.4081%2Foncol.2020.449&issn=1970-5557&isbn=&volume=14&issue=1&spage=64&pages=64-71&date=2020&title=Oncology+Reviews&atitle=Prostate-specific+antigen+velocity+in+diagnosis+and+prognosis+of+prostate+cancer+-+A+systematic+review&aulast=Javaeed&pid=%3Cauthor%3EJavaeed+A.%3BGhauri+S.K.%3BIbrahim+A.%3BDoheim+M.F.%3C%2Fauthor%3E%3CAN%3E2010731526%3C%2FAN%3E%3CDT%3EReview%3C%2FDT%3E",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Prostate-specific antigen velocity in diagnosis and prognosis of prostate cancer - A systematic review",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "http://www.cancernetwork.com/printpdf/178390//https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emed14&AN=370170773//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:24367855&id=doi:&issn=0890-9091&isbn=&volume=27&issue=10&spage=981&pages=&date=2013&title=ONCOLOGY+%28United+States%29&atitle=PSA+screening%3A+Good+evidence+shows+little+benefit%2C+significant+harms&aulast=LeFevre&pid=%3Cauthor%3ELeFevre+M.%3BMoyer+V.%3C%2Fauthor%3E%3CAN%3E370170773%3C%2FAN%3E%3CDT%3ENote%3C%2FDT%3E",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Intervention/ primary study/erratum/ conference abstract/ commentary/ clinic trial/ newsletter/ magazine/protocol/ literature review",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "PSA screening: Good evidence shows little benefit, significant harms",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.krankenhauspharmazie.de/archiv/verzeichnis/2019/05.html//https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emed20&AN=2002950555//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:&id=doi:&issn=0173-7597&isbn=&volume=40&issue=5&spage=263&pages=263&date=2019&title=Krankenhauspharmazie&atitle=Metaanalyse+sieht+keinen+Benefit&aulast=Jungmayr&pid=%3Cauthor%3EJungmayr+P.%3C%2Fauthor%3E%3CAN%3E2002950555%3C%2FAN%3E%3CDT%3ENote%3C%2FDT%3E",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Non-english",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "PSA screening: Meta-analysis sees no benefit. [German]",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Psychological distress associated with cancer screening: A systematic review",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emed13&AN=366176043//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:22958553&id=doi:10.1071%2FSH11169&issn=1448-5028&isbn=&volume=9&issue=6&spage=620&pages=620-627&date=2012&title=Sexual+Health&atitle=Psychosocial+aspects+of+anal+cancer+screening%3A+A+review+and+recommendations&aulast=Landstra&pid=%3Cauthor%3ELandstra+J.M.B.%3BCiarrochi+J.%3BDeane+F.P.%3C%2Fauthor%3E%3CAN%3E366176043%3C%2FAN%3E%3CDT%3EArticle%3C%2FDT%3E",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Psychosocial aspects of anal cancer screening: A review and recommendations",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Qualitative systematic review of barber-administered health education, promotion, screening and outreach programs in African-American communities",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1442-2042//https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emed21&AN=2004375816//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:32141110&id=doi:10.1111%2Fiju.14202&issn=0919-8172&isbn=&volume=27&issue=4&spage=296&pages=296-306&date=2020&title=International+Journal+of+Urology&atitle=Quality+of+life+in+active+surveillance+for+early+prostate+cancer&aulast=Kato&pid=%3Cauthor%3EKato+T.%3BSugimoto+M.%3C%2Fauthor%3E%3CAN%3E2004375816%3C%2FAN%3E%3CDT%3EReview%3C%2FDT%3E",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Quality of life in active surveillance for early prostate cancer",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "http://cebp.aacrjournals.org/content/26/2_Supplement/B17//https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emed18&AN=615343658//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:&id=doi:10.1158%2F1538-7755.DISP16-B17&issn=1055-9965&isbn=&volume=26&issue=2+Supplement+1&spage=b17&pages=&date=2017&title=Cancer+Epidemiology+Biomarkers+and+Prevention&atitle=Race+and+mortality+in+prostate+cancer%3A+A+meta-analysis&aulast=Nair&pid=%3Cauthor%3ENair+R.G.%3BGeethakumari+P.R.%3BWilliams+A.A.A.%3BLepore+S.J.%3C%2Fauthor%3E%3CAN%3E615343658%3C%2FAN%3E%3CDT%3EConference+Abstract%3C%2FDT%3E",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Race and mortality in prostate cancer: A meta-analysis",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.cochranelibrary.com/cdsr/table-of-contents//https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emed21&AN=632284348//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:32495338&id=doi:10.1002%2F14651858.CD006590.pub3&issn=1469-493X&isbn=&volume=2020&issue=6&spage=CD006590&pages=&date=2020&title=Cochrane+Database+of+Systematic+Reviews&atitle=Radical+prostatectomy+versus+deferred+treatment+for+localised+prostate+cancer&aulast=Vernooij&pid=%3Cauthor%3EVernooij+R.W.M.%3BLancee+M.%3BCleves+A.%3BDahm+P.%3BBangma+C.H.%3BAben+K.K.H.%3C%2Fauthor%3E%3CAN%3E632284348%3C%2FAN%3E%3CDT%3EReview%3C%2FDT%3E",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Radical prostatectomy versus deferred treatment for localised prostate cancer",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emed13&AN=71310863//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:&id=doi:10.1007%2Fs00520-012-1479-7&issn=0941-4355&isbn=&volume=20&issue=SUPPL.+1&spage=S160&pages=S160&date=2012&title=Supportive+Care+in+Cancer&atitle=Radical+prostatectomy+versus+watchful+waiting+for+prostate+cancer%3A+A+systematic+review&aulast=Hegarty&pid=%3Cauthor%3EHegarty+J.%3C%2Fauthor%3E%3CAN%3E71310863%3C%2FAN%3E%3CDT%3EConference+Abstract%3C%2FDT%3E",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Radical prostatectomy versus watchful waiting for prostate cancer: A systematic review",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "http://www.journals.elsevier.com/ebiomedicine///https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emed19&AN=2000848462//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:29861410&id=doi:10.1016%2Fj.ebiom.2018.05.010&issn=2352-3964&isbn=&volume=32&issue=&spage=234&pages=234-244&date=2018&title=EBioMedicine&atitle=RankProd+Combined+with+Genetic+Algorithm+Optimized+Artificial+Neural+Network+Establishes+a+Diagnostic+and+Prognostic+Prediction+Model+that+Revealed+C1QTNF3+as+a+Biomarker+for+Prostate+Cancer&aulast=Hou&pid=%3Cauthor%3EHou+Q.%3BBing+Z.-T.%3BHu+C.%3BLi+M.-Y.%3BYang+K.-H.%3BMo+Z.%3BXie+X.-W.%3BLiao+J.-L.%3BLu+Y.%3BHorie+S.%3BLou+M.-W.%3C%2Fauthor%3E%3CAN%3E2000848462%3C%2FAN%3E%3CDT%3EArticle%3C%2FDT%3E",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "RankProd Combined with Genetic Algorithm Optimized Artificial Neural Network Establishes a Diagnostic and Prognostic Prediction Model that Revealed C1QTNF3 as a Biomarker for Prostate Cancer",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "http://www.europeanurology.com///https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emed16&AN=606253119//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:25666849&id=doi:10.1016%2Fj.eururo.2015.01.023&issn=0302-2838&isbn=&volume=68&issue=1&spage=e13&pages=e13&date=2015&title=European+Urology&atitle=Re%3A+Farhad+Islami%2C+Daniel+M.+Moreira%2C+Paolo+Boffetta%2C+Stephen+J.+Freedland.+A+Systematic+review+and+meta-analysis+of+tobacco+use+and+prostate+cancer+mortality+and+incidence+in+prospective+cohort+studies.+Eur+Urol+2014%3B66%3A1054-64&aulast=Schlatmann&pid=%3Cauthor%3ESchlatmann+F.W.M.%3BBlanker+M.H.%3C%2Fauthor%3E%3CAN%3E606253119%3C%2FAN%3E%3CDT%3ELetter%3C%2FDT%3E",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Re: Farhad Islami, Daniel M. Moreira, Paolo Boffetta, Stephen J. Freedland. A Systematic review and meta-analysis of tobacco use and prostate cancer mortality and incidence in prospective cohort studies. Eur Urol 2014;66:1054-64",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Intervention/ primary study/erratum/ conference abstract/ commentary/ clinic trial/ newsletter/ magazine/protocol/ literature review",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Re: Prostate specific antigen testing policy worldwide varies greatly and seems not to be in accordance with guidelines: a systematic review",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emed15&AN=372634824//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:&id=doi:10.1016%2Fj.eururo.2013.12.041&issn=0302-2838&isbn=&volume=65&issue=5&spage=1013&pages=1013-1014&date=2014&title=European+Urology&atitle=Re%3A+Treatment+of+prostate+cancer+with+intermittent+versus+continuous+androgen+deprivation%3A+A+systematic+review+of+randomized+trials&aulast=Tombal&pid=%3Cauthor%3ETombal+B.%3C%2Fauthor%3E%3CAN%3E372634824%3C%2FAN%3E%3CDT%3ENote%3C%2FDT%3E",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Re: Treatment of prostate cancer with intermittent versus continuous androgen deprivation: A systematic review of randomized trials",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.minervamedica.it/en/getpdf/ZEhKc2psUjgzZExaQ2RsbjVidllXTFpKSDgyQkY0K0tyKzRmN0FOdUs0NTNUdzRUQnBXRjRZTDVNamhjOGUyaA%253D%253D/R54Y2020N01A0060.pdf//https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emed21&AN=2007053327//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:&id=doi:10.23736%2FS1825-859X.20.00047-X&issn=1825-859X&isbn=&volume=16&issue=1&spage=60&pages=60-72&date=2020&title=Rivista+Italiana+della+Medicina+di+Laboratorio&atitle=Raccomandazioni+per+la+gestione+di+variabili+preanalitiche+legate+al+paziente+nella+determinazione+del+Psa+in+fase+di+screening+e+follow-up+di+cancro+prostatico&aulast=Polilli&pid=%3Cauthor%3EPolilli+E.%3BCappelletti+P.%3BBarocci+S.%3BCaruso+B.%3BDel+Ben+F.%3BDi+Vincenzo+V.%3BDorizzi+R.%3BImpicciatore+G.%3BLaneve+M.%3BMarin+M.G.%3BMartinotti+S.%3BMoretti+M.%3BPasini+L.%3BProcopio+A.D.%3BStenner+E.%3BTesta+R.%3BToffalori+E.%3BToniato+E.%3BVero+A.%3BGolato+M.%3C%2Fauthor%3E%3CAN%3E2007053327%3C%2FAN%3E%3CDT%3EArticle%3C%2FDT%3E",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Recommendations for the management of patients' preanalytical variables in Psa assessment for prostate cancer screening and follow-up. [Italian]",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Reduction in expression of the benign AR transcriptome is a hallmark of localised prostate cancer progression",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Reply to the letter to the editor 'Do prostate cancer risk models improve the predictive accuracy of PSA screening? A meta-analysis' by Louie et al",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "http://jnci.oxfordjournals.org///https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emed15&AN=372858540//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:24685927&id=doi:10.1093%2Fjnci%2Fdju021&issn=0027-8874&isbn=&volume=106&issue=4&spage=dju021&pages=&date=2014&title=Journal+of+the+National+Cancer+Institute&atitle=Response&aulast=Brasky&pid=%3Cauthor%3EBrasky+T.M.%3BThompson+I.M.%3BKing+I.B.%3BKristal+A.R.%3C%2Fauthor%3E%3CAN%3E372858540%3C%2FAN%3E%3CDT%3ELetter%3C%2FDT%3E",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Cannot access",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Response",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "http://www.frontiersin.org/Oncology/about//https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emed22&AN=633562045//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:&id=doi:10.3389%2Ffonc.2020.586192&issn=2234-943X&isbn=&volume=10&issue=&spage=586192&pages=&date=2020&title=Frontiers+in+Oncology&atitle=Revealing+Prognostic+Value+of+Skeletal-Related+Parameters+in+Metastatic+Castration-Resistant+Prostate+Cancer+on+Overall+Survival%3A+A+Systematic+Review+and+Meta-Analysis+of+Randomized+Controlled+Trial&aulast=Tong&pid=%3Cauthor%3ETong+T.%3BLei+H.%3BGuan+Y.%3BYang+X.%3BLiao+G.%3BLi+Y.%3BJiang+D.%3BPang+J.%3C%2Fauthor%3E%3CAN%3E633562045%3C%2FAN%3E%3CDT%3EReview%3C%2FDT%3E",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Revealing Prognostic Value of Skeletal-Related Parameters in Metastatic Castration-Resistant Prostate Cancer on Overall Survival: A Systematic Review and Meta-Analysis of Randomized Controlled Trial",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "http://www.annals.org/content/156/8/JC4-02.full.pdf+html//https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emed13&AN=364627345//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:&id=doi:10.7326%2F0003-4819-156-8-201204170-02002&issn=0003-4819&isbn=&volume=156&issue=8&spage=JC4&pages=JC4-2&date=2012&title=Annals+of+Internal+Medicine&atitle=Review%3A+PSA-based+screening+does+not+reduce+prostate+cancer+mortality+or+all-cause+mortality&aulast=Chou&pid=%3Cauthor%3EChou+R.%3BCroswell+J.M.%3BDana+T.%3C%2Fauthor%3E%3CAN%3E364627345%3C%2FAN%3E%3CDT%3ENote%3C%2FDT%3E",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Intervention/ primary study/erratum/ conference abstract/ commentary/ clinic trial/ newsletter/ magazine/protocol/ literature review",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Review: PSA-based screening does not reduce prostate cancer mortality or all-cause mortality",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "http://cancerres.aacrjournals.org/content/77/13_Supplement/2278//https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emed18&AN=618664811//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:&id=doi:10.1158%2F1538-7445.AM2017-2278&issn=1538-7445&isbn=&volume=77&issue=13+Supplement+1&spage=2278&pages=&date=2017&title=Cancer+Research&atitle=Risk+factors+by+molecular+subtypes+of+breast+cancer%3A+A+pooled+analysis+of+nine+cohorts&aulast=Gaudet&pid=%3Cauthor%3EGaudet+M.M.%3BGierach+G.%3BCarter+B.%3BLuo+J.%3BMilne+R.%3BWeiderpass+E.%3BGiles+G.%3BChen+W.%3BTamimi+R.%3BEliassen+H.%3BFeskanich+D.%3BWolk+A.%3BAdami+H.-O.%3BMargolis+K.%3BGapstur+S.%3BGarcia-Closas+M.%3BBrinton+L.%3C%2Fauthor%3E%3CAN%3E618664811%3C%2FAN%3E%3CDT%3EConference+Abstract%3C%2FDT%3E",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Risk factors by molecular subtypes of breast cancer: A pooled analysis of nine cohorts",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Risk of prostate cancer in men with spinal cord injury: A systematic review and meta-analysis",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emed20&AN=2002632808//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:&id=doi:10.1016%2Fj.ijrobp.2019.06.1829&issn=0360-3016&isbn=&volume=105&issue=1+Supplement&spage=E289&pages=E289&date=2019&title=International+Journal+of+Radiation+Oncology+Biology+Physics&atitle=Stereotactic+Body+Radiation+Therapy+Vs+Hypofractionated+Intensity+Modulated+Radiation+Therapy+for+Localized+Prostate+Cancer+%28SHRAPNEL%29%3A+An+International+Meta-Analysis+of+24+Prospective+Trials&aulast=Lehrer&pid=%3Cauthor%3ELehrer+E.J.%3BKishan+A.U.%3BYu+J.B.%3BTrifiletti+D.M.%3BShowalter+T.N.%3BEllis+R.J.%3BZaorsky+N.G.%3C%2Fauthor%3E%3CAN%3E2002632808%3C%2FAN%3E%3CDT%3EConference+Abstract%3C%2FDT%3E",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Stereotactic Body Radiation Therapy Vs Hypofractionated Intensity Modulated Radiation Therapy for Localized Prostate Cancer (SHRAPNEL): An International Meta-Analysis of 24 Prospective Trials",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "http://www.springer.com/medicine/oncology/journal/13193//https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emed19&AN=622468680//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:&id=doi:10.1007%2Fs13193-016-0594-1&issn=0975-7651&isbn=&volume=9&issue=2&spage=225&pages=225-231&date=2018&title=Indian+Journal+of+Surgical+Oncology&atitle=Surgical+Management+of+Organ-Confined+Prostate+Cancer+with+Review+of+Literature+and+Evolving+Evidence&aulast=Goolam&pid=%3Cauthor%3EGoolam+A.S.%3Bla+Rosa+A.H.-D.%3BManoharan+M.%3C%2Fauthor%3E%3CAN%3E622468680%3C%2FAN%3E%3CDT%3EReview%3C%2FDT%3E",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Surgical Management of Organ-Confined Prostate Cancer with Review of Literature and Evolving Evidence",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1464-410X//https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emed17&AN=611289374//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:27087414&id=doi:10.1111%2Fbju.13499&issn=1464-4096&isbn=&volume=118&issue=2&spage=193&pages=193-204&date=2016&title=BJU+International&atitle=Symptomatic+and+quality-of-life+outcomes+after+treatment+for+clinically+localised+prostate+cancer%3A+a+systematic+review&aulast=Whiting&pid=%3Cauthor%3EWhiting+P.F.%3BMoore+T.H.M.%3BJameson+C.M.%3BDavies+P.%3BRowlands+M.-A.%3BBurke+M.%3BBeynon+R.%3BSavovic+J.%3BDonovan+J.L.%3C%2Fauthor%3E%3CAN%3E611289374%3C%2FAN%3E%3CDT%3EReview%3C%2FDT%3E",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Symptomatic and quality-of-life outcomes after treatment for clinically localised prostate cancer: a systematic review",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Systematic review and meta-analysis of the diagnostic accuracy of prostate-specific antigen (PSA) for the detection of prostate cancer in symptomatic patients",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emed14&AN=52664261//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:23815285&id=doi:10.1111%2Fjcpt.12080&issn=0269-4727&isbn=&volume=38&issue=5&spage=405&pages=405-415&date=2013&title=Journal+of+Clinical+Pharmacy+and+Therapeutics&atitle=Systematic+review+evaluating+cardiovascular+events+of+the+5-alpha+reductase+inhibitor+-+Dutasteride&aulast=Loke&pid=%3Cauthor%3ELoke+Y.K.%3BHo+R.%3BSmith+M.%3BWong+O.%3BSandhu+M.%3BSage+W.%3BSingh+S.%3C%2Fauthor%3E%3CAN%3E52664261%3C%2FAN%3E%3CDT%3EReview%3C%2FDT%3E",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Systematic review evaluating cardiovascular events of the 5-alpha reductase inhibitor - Dutasteride",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Systematic review of clinical features of suspected prostate cancer in primary care",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "http://www.elsevier.com/wps/find/journaldescription.cws_home/724501/description#description//https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emexb&AN=2014701350//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:35031092&id=doi:10.1016%2Fj.jval.2021.07.002&issn=1098-3015&isbn=&volume=25&issue=1&spage=133&pages=133-146&date=2022&title=Value+in+Health&atitle=Systematic+Review+of+Cost-Effectiveness+Models+in+Prostate+Cancer%3A+Exploring+New+Developments+in+Testing+and+Diagnosis&aulast=Keeney&pid=%3Cauthor%3EKeeney+E.%3BThom+H.%3BTurner+E.%3BMartin+R.M.%3BMorley+J.%3BSanghera+S.%3C%2Fauthor%3E%3CAN%3E2014701350%3C%2FAN%3E%3CDT%3EReview%3C%2FDT%3E",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Cost effective/ budget impact",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Systematic Review of Cost-Effectiveness Models in Prostate Cancer: Exploring New Developments in Testing and Diagnosis",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Systematic Review of Focal Prostate Brachytherapy and the Future Implementation of Image-Guided Prostate HDR Brachytherapy Using MR-Ultrasound Fusion",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emed17&AN=618006272//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:&id=doi:10.1185%2F03007995.2016.1152850&issn=1473-4877&isbn=&volume=32&issue=Supplement+1&spage=S18&pages=S18&date=2016&title=Current+Medical+Research+and+Opinion&atitle=Systematic+versus+narrative+reviews%3A+How+do+they+compare%2C+and+what+does+that+tell+us+about+their+role+in+scientific+exchange%3F&aulast=Rees&pid=%3Cauthor%3ERees+T.%3BTakyar+S.%3BSherwood+D.%3BLindley+S.%3BSeghal+M.%3C%2Fauthor%3E%3CAN%3E618006272%3C%2FAN%3E%3CDT%3EConference+Abstract%3C%2FDT%3E",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Systematic versus narrative reviews: How do they compare, and what does that tell us about their role in scientific exchange?",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Targeted Prostate Biopsy and MR-Guided Therapy for Prostate Cancer",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "http://www.springer.com/engineering/biomedical+eng/journal/13534//https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emexa&AN=2013555399//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:&id=doi:10.1007%2Fs13534-021-00204-w&issn=2093-9868&isbn=&volume=11&issue=4&spage=309&pages=309-334&date=2021&title=Biomedical+Engineering+Letters&atitle=Technological+advances+in+electrochemical+biosensors+for+the+detection+of+disease+biomarkers&aulast=Kim&pid=%3Cauthor%3EKim+J.H.%3BSuh+Y.J.%3BPark+D.%3BYim+H.%3BKim+H.%3BKim+H.J.%3BYoon+D.S.%3BHwang+K.S.%3C%2Fauthor%3E%3CAN%3E2013555399%3C%2FAN%3E%3CDT%3EReview%3C%2FDT%3E",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Technological advances in electrochemical biosensors for the detection of disease biomarkers",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1097-0142//https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emed19&AN=621631935//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:29370456&id=doi:10.1002%2Fcncr.31247&issn=0008-543X&isbn=&volume=124&issue=8&spage=1808&pages=1808-1818&date=2018&title=Cancer&atitle=Temporal+trends+in+the+risk+of+second+primary+cancers+among+survivors+of+adult-onset+cancers%2C+1980+through+2013%3A+An+Australian+population-based+study&aulast=Ye&pid=%3Cauthor%3EYe+Y.%3BOtahal+P.%3BWills+K.E.%3BNeil+A.L.%3BVenn+A.J.%3C%2Fauthor%3E%3CAN%3E621631935%3C%2FAN%3E%3CDT%3EArticle%3C%2FDT%3E",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Temporal trends in the risk of second primary cancers among survivors of adult-onset cancers, 1980 through 2013: An Australian population-based study",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "http://www.journals.elsevier.com/the-journal-of-sexual-medicine//https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emed14&AN=52209907//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:22971200&id=doi:10.1111%2Fj.1743-6109.2012.02783.x&issn=1743-6095&isbn=&volume=10&issue=1&spage=245&pages=245-284&date=2013&title=Journal+of+Sexual+Medicine&atitle=Testosterone+Deficiency+in+Men%3A+Systematic+Review+and+Standard+Operating+Procedures+for+Diagnosis+and+Treatment&aulast=Buvat&pid=%3Cauthor%3EBuvat+J.%3BMaggi+M.%3BGuay+A.%3BTorres+L.O.%3C%2Fauthor%3E%3CAN%3E52209907%3C%2FAN%3E%3CDT%3EArticle%3C%2FDT%3E",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Testosterone Deficiency in Men: Systematic Review and Standard Operating Procedures for Diagnosis and Treatment",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.medrxiv.org///https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=empp&AN=2017166237//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:&id=doi:10.1101%2F2022.02.03.22270377&issn=&isbn=&volume=&issue=&spage=&pages=&date=2022&title=medRxiv&atitle=The+accuracy+of+machine+learning+models+using+ultrasound+images+in+prostate+cancer+diagnosis%3A+A+systematic+review&aulast=Sihotang&pid=%3Cauthor%3ESihotang+R.C.%3BAgustino+C.%3BHuang+F.%3BParikesit+D.%3BRahman+F.%3BHamid+A.R.A.%3C%2Fauthor%3E%3CAN%3E2017166237%3C%2FAN%3E%3CDT%3EPreprint%3C%2FDT%3E",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "The accuracy of machine learning models using ultrasound images in prostate cancer diagnosis: A systematic review",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "The association between RASSF1A promoter methylation and prostate cancer: evidence from 19 published studies",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "http://link.springer.com/journal/40336//https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emed21&AN=2005534041//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:&id=doi:10.1007%2Fs40336-020-00378-w&issn=2281-5872&isbn=&volume=8&issue=5&spage=313&pages=313-347&date=2020&title=Clinical+and+Translational+Imaging&atitle=The+current+role+of+PET%2FCT+in+urological+malignancies&aulast=Lima&pid=%3Cauthor%3ELima+M.%3BCamacho+M.%3BCarvalheira+J.B.C.%3BBiggi+A.%3Bde+Lima+M.L.%3BCiampi+J.%3BSalis+F.%3BSilveira+M.B.%3BFerreira+U.%3BEtchebehere+E.%3C%2Fauthor%3E%3CAN%3E2005534041%3C%2FAN%3E%3CDT%3EReview%3C%2FDT%3E",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "The current role of PET/CT in urological malignancies",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "The Diagnostic Role of (18)F-Choline, (18)F-Fluciclovine and (18)F-PSMA PET/CT in the Detection of Prostate Cancer With Biochemical Recurrence: A Meta-Analysis",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "The diagnostic test accuracy of rectal examination for prostate cancer diagnosis in symptomatic patients: a systematic review",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "The Effect of Higher Level Computerized Clinical Decision Support Systems on Oncology Care: A Systematic Review",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "http://www.eurekaselect.com/178720/article//https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emed21&AN=2004466792//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:31994469&id=doi:10.2174%2F1871520620666200128112558&issn=1871-5206&isbn=&volume=20&issue=6&spage=636&pages=636-642&date=2020&title=Anti-Cancer+Agents+in+Medicinal+Chemistry&atitle=The+effect+of+prostate+cancer+radiotherapy+on+testosterone+level%3A+A+systematic+review+and+meta-analysis&aulast=Mortezaee&pid=%3Cauthor%3EMortezaee+K.%3BMotallebzadeh+E.%3BMilajerdi+A.%3BFarhood+B.%3BNajafi+M.%3BSahebkar+A.%3C%2Fauthor%3E%3CAN%3E2004466792%3C%2FAN%3E%3CDT%3EReview%3C%2FDT%3E",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "The effect of prostate cancer radiotherapy on testosterone level: A systematic review and meta-analysis",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "http://www.springerlink.com/content/1527-2737///https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emed19&AN=622351108//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:29808235&id=doi:10.1007%2Fs11934-018-0815-y&issn=1527-2737&isbn=&volume=19&issue=8&spage=57&pages=&date=2018&title=Current+Urology+Reports&atitle=The+Effect+of+Shift+Work+on+Urogenital+Disease%3A+a+Systematic+Review&aulast=Deng&pid=%3Cauthor%3EDeng+N.%3BHaney+N.M.%3BKohn+T.P.%3BPastuszak+A.W.%3BLipshultz+L.I.%3C%2Fauthor%3E%3CAN%3E622351108%3C%2FAN%3E%3CDT%3EReview%3C%2FDT%3E",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "The Effect of Shift Work on Urogenital Disease: a Systematic Review",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "The effect of testosterone replacement therapy on prostate-specific antigen (PSA) levels in men being treated for hypogonadism: a systematic review and meta-analysis",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1097-0142//https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emed20&AN=627533974//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:31034604&id=doi:10.1002%2Fcncr.32147&issn=0008-543X&isbn=&volume=125&issue=16&spage=2747&pages=2747-2761&date=2019&title=Cancer&atitle=The+efficacy+and+cost-effectiveness+of+patient+navigation+programs+across+the+cancer+continuum%3A+A+systematic+review&aulast=Bernardo&pid=%3Cauthor%3EBernardo+B.M.%3BZhang+X.%3BBeverly+Hery+C.M.%3BMeadows+R.J.%3BPaskett+E.D.%3C%2Fauthor%3E%3CAN%3E627533974%3C%2FAN%3E%3CDT%3EReview%3C%2FDT%3E",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "The efficacy and cost-effectiveness of patient navigation programs across the cancer continuum: A systematic review",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.minervamedica.it/en/journals/minerva-urology-nephrology/article.php?cod=R19Y2021N04A0431//https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emexa&AN=2014494797//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:33949185&id=doi:10.23736%2FS2724-6051.21.04330-5&issn=2724-6051&isbn=&volume=73&issue=4&spage=442&pages=442-451&date=2021&title=Minerva+Urology+and+Nephrology&atitle=The+emerging+landscape+of+tumor+marker+panels+for+the+identification+of+aggressive+prostate+cancer%3A+The+perspective+through+bibliometric+analysis+of+an+Italian+translational+working+group+in+uro-oncology&aulast=Ferro&pid=%3Cauthor%3EFerro+M.%3BLucarelli+G.%3Bde+Cobelli+O.%3BDel+Giudice+F.%3BMusi+G.%3BMistretta+F.A.%3BLuzzago+S.%3BBusetto+G.M.%3BBuonerba+C.%3BSciarra+A.%3BConti+S.%3BPorreca+A.%3BBattaglia+M.%3BDitonno+P.%3BManfredi+M.%3BFiori+C.%3BPorpiglia+F.%3BTerracciano+D.%3C%2Fauthor%3E%3CAN%3E2014494797%3C%2FAN%3E%3CDT%3EReview%3C%2FDT%3E",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "The emerging landscape of tumor marker panels for the identification of aggressive prostate cancer: The perspective through bibliometric analysis of an Italian translational working group in uro-oncology",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "The epigenetic promise for prostate cancer diagnosis",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "The future direction of imaging in prostate cancer: MRI with or without contrast injection",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "The Kallikrein Panel for prostate cancer screening: its economic impact",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "The PCA3 test for guiding repeat biopsy of prostate cancer and its cut-off score: a systematic review and meta-analysis",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.mdpi.com/1422-0067/23/3/1258/pdf//https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emexb&AN=2015387465//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:35163181&id=doi:10.3390%2Fijms23031258&issn=1661-6596&isbn=&volume=23&issue=3&spage=1258&pages=&date=2022&title=International+Journal+of+Molecular+Sciences&atitle=The+Potential+Role+of+Spermine+and+Its+Acetylated+Derivative+in+Human+Malignancies&aulast=Tse&pid=%3Cauthor%3ETse+R.T.-H.%3BWong+C.Y.-P.%3BChiu+P.K.-F.%3BNg+C.-F.%3C%2Fauthor%3E%3CAN%3E2015387465%3C%2FAN%3E%3CDT%3EReview%3C%2FDT%3E",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "The Potential Role of Spermine and Its Acetylated Derivative in Human Malignancies",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "The promising role of new molecular biomarkers in prostate cancer: from coding and non-coding genes to artificial intelligence approaches",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "http://www.elsevier.com/locate/jdermsci//https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emed15&AN=53069836//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:24680127&id=doi:10.1016%2Fj.jdermsci.2014.02.007&issn=0923-1811&isbn=&volume=75&issue=1&spage=3&pages=3-9&date=2014&title=Journal+of+Dermatological+Science&atitle=The+risk+of+developing+a+second+primary+cancer+in+melanoma+patients%3A+A+comprehensive+review+of+the+literature+and+meta-analysis&aulast=Caini&pid=%3Cauthor%3ECaini+S.%3BBoniol+M.%3BBotteri+E.%3BTosti+G.%3BBazolli+B.%3BRussell-Edu+W.%3BGiusti+F.%3BTestori+A.%3BGandini+S.%3C%2Fauthor%3E%3CAN%3E53069836%3C%2FAN%3E%3CDT%3EReview%3C%2FDT%3E",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "The risk of developing a second primary cancer in melanoma patients: A comprehensive review of the literature and meta-analysis",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "http://www.journals.elsevier.com/european-urology-focus//https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emed16&AN=608974753//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:&id=doi:10.1016%2Fj.euf.2015.08.001&issn=2405-4569&isbn=&volume=1&issue=2&spage=99&pages=99-108&date=2015&title=European+Urology+Focus&atitle=The+Role+of+Biomarkers+and+Genetics+in+the+Diagnosis+of+Prostate+Cancer&aulast=Abdollah&pid=%3Cauthor%3EAbdollah+F.%3BDalela+D.%3BHaffner+M.C.%3BCulig+Z.%3BSchalken+J.%3C%2Fauthor%3E%3CAN%3E608974753%3C%2FAN%3E%3CDT%3EReview%3C%2FDT%3E",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "The Role of Biomarkers and Genetics in the Diagnosis of Prostate Cancer",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.mdpi.com/2072-6643/14/2/348/pdf//https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emexb&AN=2015316471//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:35057525&id=doi:10.3390%2Fnu14020348&issn=2072-6643&isbn=&volume=14&issue=2&spage=348&pages=&date=2022&title=Nutrients&atitle=The+Role+of+Diet+in+Prognosis+among+Cancer+Survivors%3A+A+Systematic+Review+and+Meta-Analysis+of+Dietary+Patterns+and+Diet+Interventions&aulast=Castro-Espin&pid=%3Cauthor%3ECastro-Espin+C.%3BAgudo+A.%3C%2Fauthor%3E%3CAN%3E2015316471%3C%2FAN%3E%3CDT%3EArticle%3C%2FDT%3E",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "The Role of Diet in Prognosis among Cancer Survivors: A Systematic Review and Meta-Analysis of Dietary Patterns and Diet Interventions",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "http://www.elsevier.com/journals/annals-of-medicine-and-surgery/2049-0801//https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emed21&AN=2007259107//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:&id=doi:10.1016%2Fj.amsu.2020.07.015&issn=2049-0801&isbn=&volume=57&issue=&spage=171&pages=171-178&date=2020&title=Annals+of+Medicine+and+Surgery&atitle=The+role+of+multiparametric+magnetic+resonance+imaging+and+magnetic+resonance-guided+biopsy+in+active+surveillance+for+low-risk+prostate+cancer%3A+A+systematic+review&aulast=Alshehri&pid=%3Cauthor%3EAlshehri+S.Z.%3BAlshahrani+O.S.%3BAlmsaoud+N.A.%3BAl-Ghamdi+M.A.%3BAlqahtani+A.M.%3BAlmurayyi+M.M.%3BAutwdi+A.S.%3BAl-Ghamdi+S.A.%3BZogan+M.M.%3BAlamri+A.M.%3C%2Fauthor%3E%3CAN%3E2007259107%3C%2FAN%3E%3CDT%3EReview%3C%2FDT%3E",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "The role of multiparametric magnetic resonance imaging and magnetic resonance-guided biopsy in active surveillance for low-risk prostate cancer: A systematic review",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "The role of Prostate Imaging Reporting and Data System score in Gleason 3_+_3 active surveillance candidates enrollment: a diagnostic meta-analysis",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emed14&AN=71342641//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:&id=doi:10.1158%2F1538-7445.AM2013-2865&issn=0008-5472&isbn=&volume=73&issue=8+SUPPL.+1&spage=2865&pages=&date=2013&title=Cancer+Research&atitle=The+significance+of+Vitamin+D+deficiency+and+low+grade+pathogens+in+etiology+of+prostate+cancer&aulast=Oliver&pid=%3Cauthor%3EOliver+T.R.T.D.%3C%2Fauthor%3E%3CAN%3E71342641%3C%2FAN%3E%3CDT%3EConference+Abstract%3C%2FDT%3E",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "The significance of Vitamin D deficiency and low grade pathogens in etiology of prostate cancer",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emed13&AN=70721493//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:&id=doi:10.1016%2Fj.juro.2012.02.1944&issn=0022-5347&isbn=&volume=187&issue=4+SUPPL.+1&spage=e588&pages=e588&date=2012&title=Journal+of+Urology&atitle=The+true+benefit+of+PSA-screening%3A+Modeling+the+impact+of+trial+setting+and+protocol+on+mortality&aulast=Heijnsdijk&pid=%3Cauthor%3EHeijnsdijk+E.%3BWever+E.%3BDe+Koning+H.%3C%2Fauthor%3E%3CAN%3E70721493%3C%2FAN%3E%3CDT%3EConference+Abstract%3C%2FDT%3E",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "The true benefit of PSA-screening: Modeling the impact of trial setting and protocol on mortality",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.frontiersin.org/journals/genetics#//https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emexa&AN=635151159//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:&id=doi:10.3389%2Ffgene.2021.684100&issn=1664-8021&isbn=&volume=12&issue=&spage=684100&pages=&date=2021&title=Frontiers+in+Genetics&atitle=The+Unsupervised+Feature+Selection+Algorithms+Based+on+Standard+Deviation+and+Cosine+Similarity+for+Genomic+Data+Analysis&aulast=Xie&pid=%3Cauthor%3EXie+J.%3BWang+M.%3BXu+S.%3BHuang+Z.%3BGrant+P.W.%3C%2Fauthor%3E%3CAN%3E635151159%3C%2FAN%3E%3CDT%3EArticle%3C%2FDT%3E",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "The Unsupervised Feature Selection Algorithms Based on Standard Deviation and Cosine Similarity for Genomic Data Analysis",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Timing of curative treatment for prostate cancer: a systematic review",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "http://www.nature.com/pcan/index.html//https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emed18&AN=616670156//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:28585573&id=doi:10.1038%2Fpcan.2017.28&issn=1365-7852&isbn=&volume=20&issue=4&spage=378&pages=378-388&date=2017&title=Prostate+Cancer+and+Prostatic+Diseases&atitle=Tools+for+predicting+patient-reported+outcomes+in+prostate+cancer+patients+undergoing+radical+prostatectomy%3A+A+systematic+review+of+prognostic+accuracy+and+validity&aulast=O%27Callaghan&pid=%3Cauthor%3EO%27Callaghan+M.E.%3BRaymond+E.%3BCampbell+J.%3BVincent+A.D.%3BBeckmann+K.%3BRoder+D.%3BEvans+S.%3BMcNeil+J.%3BMillar+J.%3BZalcberg+J.%3BBorg+M.%3BMoretti+K.%3C%2Fauthor%3E%3CAN%3E616670156%3C%2FAN%3E%3CDT%3EReview%3C%2FDT%3E",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Tools for predicting patient-reported outcomes in prostate cancer patients undergoing radical prostatectomy: A systematic review of prognostic accuracy and validity",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Top 20 Research Studies of 2015 for Primary Care Physicians",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.journals.elsevier.com/european-urology-oncology//https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emexb&AN=2018264749//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:35599144&id=doi:10.1016%2Fj.euo.2022.04.007&issn=2588-9311&isbn=&volume=&issue=&spage=&pages=&date=2022&title=European+Urology+Oncology&atitle=Treatments+for+Metastatic+Hormone-sensitive+Prostate+Cancer%3A+Systematic+Review%2C+Network+Meta-analysis%2C+and+Benefit-harm+assessment&aulast=Menges&pid=%3Cauthor%3EMenges+D.%3BYebyo+H.G.%3BSivec-Muniz+S.%3BHaile+S.R.%3BBarbier+M.C.%3BTomonaga+Y.%3BSchwenkglenks+M.%3BPuhan+M.A.%3C%2Fauthor%3E%3CAN%3E2018264749%3C%2FAN%3E%3CDT%3EReview%3C%2FDT%3E",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Treatments for Metastatic Hormone-sensitive Prostate Cancer: Systematic Review, Network Meta-analysis, and Benefit-harm assessment",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.karger.com/Journal/Home/261421//https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emed18&AN=618232953//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:&id=doi:10.1159%2F000472146&issn=2296-6870&isbn=&volume=2&issue=2&spage=472146&pages=&date=2017&title=Biomedicine+Hub&atitle=Trends+in+gene+expression+profiling+for+prostate+cancer+risk+assessment%3A+A+systematic+review&aulast=Chen&pid=%3Cauthor%3EChen+Z.%3BGerke+T.%3BBird+V.%3BProsperi+M.%3C%2Fauthor%3E%3CAN%3E618232953%3C%2FAN%3E%3CDT%3EReview%3C%2FDT%3E",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Trends in gene expression profiling for prostate cancer risk assessment: A systematic review",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emed14&AN=52239038//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:23032360&id=doi:10.1038%2Fpcan.2012.40&issn=1365-7852&isbn=&volume=16&issue=2&spage=151&pages=151-158&date=2013&title=Prostate+Cancer+and+Prostatic+Diseases&atitle=Type+2+diabetes+and+risk+of+prostate+cancer%3A+A+meta-analysis+of+observational+studies&aulast=Bansal&pid=%3Cauthor%3EBansal+D.%3BBhansali+A.%3BKapil+G.%3BUndela+K.%3BTiwari+P.%3C%2Fauthor%3E%3CAN%3E52239038%3C%2FAN%3E%3CDT%3EArticle%3C%2FDT%3E",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Type 2 diabetes and risk of prostate cancer: A meta-analysis of observational studies",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Ultrasensitive prostate specific antigen and its role after radical prostatectomy: a systematic review",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Untangling the association between prostate-specific antigen and diabetes: a systematic review and meta-analysis",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Urinary EN-2 to predict prostate cancer: Systematic review and meta-analysis",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1464-410X//https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emed20&AN=626816365//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:30740876&id=doi:10.1111%2Fbju.14705&issn=1464-4096&isbn=&volume=124&issue=5&spage=730&pages=730-737&date=2019&title=BJU+International&atitle=Use+of+multiparametric+magnetic+resonance+imaging+in+prostate+cancer+active+surveillance&aulast=Glass&pid=%3Cauthor%3EGlass+A.S.%3BDall%27Era+M.A.%3C%2Fauthor%3E%3CAN%3E626816365%3C%2FAN%3E%3CDT%3EReview%3C%2FDT%3E",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Use of multiparametric magnetic resonance imaging in prostate cancer active surveillance",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emed17&AN=622439400//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:&id=doi:&issn=1878-1500&isbn=&volume=15&issue=12&spage=e1499&pages=e1499-e1500&date=2016&title=European+Urology%2C+Supplements&atitle=Using+patient+screening+data+and+machine+learning+algorithms+to+improve+PRI-MUSTM+accuracy+with+micro-ultrasound-based+prostate+biopsies&aulast=Wodlinger&pid=%3Cauthor%3EWodlinger+B.%3BGhai+S.%3BEure+G.%3BFradet+V.%3BHyndman+E.%3BMcgrath+T.%3BPavlovich+C.%3C%2Fauthor%3E%3CAN%3E622439400%3C%2FAN%3E%3CDT%3EConference+Abstract%3C%2FDT%3E",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Using patient screening data and machine learning algorithms to improve PRI-MUSTM accuracy with micro-ultrasound-based prostate biopsies",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Value of Intact Prostate Specific Antigen and Human Kallikrein 2 in the 4 Kallikrein Predictive Model: An Individual Patient Data Meta-Analysis",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.journals.elsevier.com/european-urology-open-science//https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emexb&AN=2018218951//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:&id=doi:10.1016%2Fj.euros.2022.04.012&issn=2666-1691&isbn=&volume=41&issue=&spage=35&pages=35-44&date=2022&title=European+Urology+Open+Science&atitle=Vasectomy+and+Risk+of+Prostate+Cancer%3A+A+Systematic+Review+and+Meta-analysis&aulast=Baboudjian&pid=%3Cauthor%3EBaboudjian+M.%3BRajwa+P.%3BBarret+E.%3BBeauval+J.-B.%3BBrureau+L.%3BCrehange+G.%3BDariane+C.%3BFiard+G.%3BFromont+G.%3BGauthe+M.%3BMathieu+R.%3BRenard-Penna+R.%3BRoubaud+G.%3BRuffion+A.%3BSargos+P.%3BRoupret+M.%3BPloussard+G.%3C%2Fauthor%3E%3CAN%3E2018218951%3C%2FAN%3E%3CDT%3EReview%3C%2FDT%3E",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Vasectomy and Risk of Prostate Cancer: A Systematic Review and Meta-analysis",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emed14&AN=71352639//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:&id=doi:&issn=0090-4295&isbn=&volume=82&issue=3+SUPPL.+1&spage=S263&pages=S263-S264&date=2013&title=Urology&atitle=Vitamin+d+deficiency+and+low-grade+pathogens+in+aetiology+of+prostate+cancer&aulast=Oliver&pid=%3Cauthor%3EOliver+T.%3C%2Fauthor%3E%3CAN%3E71352639%3C%2FAN%3E%3CDT%3EConference+Abstract%3C%2FDT%3E",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Vitamin d deficiency and low-grade pathogens in aetiology of prostate cancer",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "http://www.journals.elsevier.com/the-journal-of-sexual-medicine//https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emed21&AN=2005140059//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:32146130&id=doi:10.1016%2Fj.jsxm.2020.02.005&issn=1743-6095&isbn=&volume=17&issue=5&spage=849&pages=849-860&date=2020&title=Journal+of+Sexual+Medicine&atitle=What+Is+a+%22Validated+Questionnaire%22%3F+A+Critical+Review+of+Erectile+Function+Assessment&aulast=Yafi&pid=%3Cauthor%3EYafi+F.A.%3BHuynh+L.M.%3BAhlering+T.%3BRosen+R.%3C%2Fauthor%3E%3CAN%3E2005140059%3C%2FAN%3E%3CDT%3EReview%3C%2FDT%3E",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "What Is a \"\"Validated Questionnaire\"\"? A Critical Review of Erectile Function Assessment",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "What Is the Effectiveness of Patient Decision Aids for Cancer-Related Decisions? A Systematic Review Subanalysis",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emed18&AN=618211592//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:&id=doi:10.1016%2FS1569-9056%252817%252930011-8&issn=1878-1500&isbn=&volume=16&issue=2&spage=34&pages=34-38&date=2017&title=European+Urology%2C+Supplements&atitle=Will+magnetic+resonance+imaging-guided+biopsy+replace+systematic+biopsy%3F&aulast=Barentsz&pid=%3Cauthor%3EBarentsz+J.%3BFutterer+J.J.%3BPadhani+A.R.%3C%2Fauthor%3E%3CAN%3E618211592%3C%2FAN%3E%3CDT%3EConference+Abstract%3C%2FDT%3E",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Will magnetic resonance imaging-guided biopsy replace systematic biopsy?",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emed20&AN=629468782//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:&id=doi:10.1097%2F01.JU.0000555414.21651.13&issn=1527-3792&isbn=&volume=201&issue=4+Supplement+1&spage=e251&pages=e251&date=2019&title=Journal+of+Urology&atitle=Willet+F.+Whitmore+Jr%3A+Four+questions+and+the+natural+history+of+prostate+cancer&aulast=Salter&pid=%3Cauthor%3ESalter+E.%3BFisher+H.%3C%2Fauthor%3E%3CAN%3E629468782%3C%2FAN%3E%3CDT%3EConference+Abstract%3C%2FDT%3E",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Willet F. Whitmore Jr: Four questions and the natural history of prostate cancer",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emed13&AN=52034861//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:22644997&id=doi:10.1007%2Fs00432-012-1246-7&issn=0171-5216&isbn=&volume=138&issue=10&spage=1689&pages=1689-1695&date=2012&title=Journal+of+Cancer+Research+and+Clinical+Oncology&atitle=XPD+Asp312Asn+polymorphism+is+a+risk+factor+for+prostate+cancer&aulast=Liao&pid=%3Cauthor%3ELiao+S.-G.%3BLiu+L.%3BWang+Y.%3BZhang+Y.-Y.%3BWang+Y.-J.%3C%2Fauthor%3E%3CAN%3E52034861%3C%2FAN%3E%3CDT%3EArticle%3C%2FDT%3E",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "XPD Asp312Asn polymorphism is a risk factor for prostate cancer",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Non-english",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "[French ccAFU guidelines - update 2020-2022: prostate cancer]",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Non-english",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "[Quality assessment of global prostate cancer screening guidelines]",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Non-english",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "[Role of tissue markers on diagnosis, prognosis and monitoring of prostate cancer]",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "https://search.ebscohost.com/login.aspx?direct=true&AuthType=shib&db=jlh&AN=127435888&site=ehost-live&scope=site&custid=s8849760",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Cannot access",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "2017 - Pooled RCTs: Reanalysis accounting for screening intensity suggests that screening reduces prostate cancer mortality",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "https://search.ebscohost.com/login.aspx?direct=true&AuthType=shib&db=jlh&AN=153368913&site=ehost-live&scope=site&custid=s8849760",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "A Systematic Review of Discrete Choice Experiments in Oncology Treatments",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "https://cebp.aacrjournals.org/content/29/12_Supplement/PO-063//https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emed21&AN=634339120//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:&id=doi:10.1158%2F1538-7755.DISP20-PO-063&issn=1055-9965&isbn=&volume=29&issue=12+SUPPL&spage=o&pages=&date=2020&title=Cancer+Epidemiology+Biomarkers+and+Prevention&atitle=A+systematic+review+of+tandem+cognitive+behavioral+therapy+and+healthy+lifestyle+interventions+on+health-related+outcomes&aulast=Addison&pid=%3Cauthor%3EAddison+S.%3BShirima+D.%3BDunovan+S.%3BLustberg+M.%3BArthur+E.K.%3BNolan+T.S.%3C%2Fauthor%3E%3CAN%3E634339120%3C%2FAN%3E%3CDT%3EConference+Abstract%3C%2FDT%3E",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Intervention/ primary study/erratum/ conference abstract/ commentary/ clinic trial/ newsletter/ magazine/protocol/ literature review",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "A systematic review of tandem cognitive behavioral therapy and healthy lifestyle interventions on health-related outcomes",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "A systematic review of the prevalence of DNA damage response gene mutations in prostate cancer",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "https://tandfonline.com/loi/taju20//https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emexa&AN=2013384408//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:&id=doi:10.1080%2F2090598X.2021.1959260&issn=2090-598X&isbn=&volume=19&issue=3&spage=370&pages=370-375&date=2021&title=Arab+Journal+of+Urology&atitle=A+systematic+review+on+the+latest+developments+in+testosterone+therapy%3A+Innovations%2C+advances%2C+and+paradigm+shifts&aulast=Al-Zoubi&pid=%3Cauthor%3EAl-Zoubi+R.M.%3BYassin+A.A.%3BAlwani+M.%3BAl-Qudimat+A.%3BAboumarzouk+O.M.%3BZarour+A.%3BAl+Ansari+A.%3C%2Fauthor%3E%3CAN%3E2013384408%3C%2FAN%3E%3CDT%3EReview%3C%2FDT%3E",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "A systematic review on the latest developments in testosterone therapy: Innovations, advances, and paradigm shifts",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1099-1611//https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emed20&AN=628704957//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:31291692&id=doi:10.1002%2Fpon.5172&issn=1057-9249&isbn=&volume=28&issue=9&spage=1803&pages=1803-1818&date=2019&title=Psycho-Oncology&atitle=A+systematic+review+on+the+use+of+the+emotion+thermometer+in+individuals+diagnosed+with+cancer&aulast=Harju&pid=%3Cauthor%3EHarju+E.%3BMichel+G.%3BRoser+K.%3C%2Fauthor%3E%3CAN%3E628704957%3C%2FAN%3E%3CDT%3EReview%3C%2FDT%3E",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "A systematic review on the use of the emotion thermometer in individuals diagnosed with cancer",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Active Surveillance for Low-risk Prostate Cancer: Are All Criteria Similar?",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Association between male infertility and prostate cancer: a systematic review and meta-analysis",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "https://jamanetwork.com/journals/jamanetworkopen//https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emed22&AN=634645385//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:33779745&id=doi:10.1001%2Fjamanetworkopen.2021.3520&issn=2574-3805&isbn=&volume=4&issue=3&spage=e213520&pages=&date=2021&title=JAMA+Network+Open&atitle=Association+of+Obesity+with+Survival+Outcomes+in+Patients+with+Cancer%3A+A+Systematic+Review+and+Meta-analysis&aulast=Petrelli&pid=%3Cauthor%3EPetrelli+F.%3BCortellini+A.%3BIndini+A.%3BTomasello+G.%3BGhidini+M.%3BNigro+O.%3BSalati+M.%3BDottorini+L.%3BIaculli+A.%3BVarricchio+A.%3BRampulla+V.%3BBarni+S.%3BCabiddu+M.%3BBossi+A.%3BGhidini+A.%3BZaniboni+A.%3C%2Fauthor%3E%3CAN%3E634645385%3C%2FAN%3E%3CDT%3EReview%3C%2FDT%3E",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Association of Obesity with Survival Outcomes in Patients with Cancer: A Systematic Review and Meta-analysis",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "https://search.ebscohost.com/login.aspx?direct=true&AuthType=shib&db=jlh&AN=103804236&site=ehost-live&scope=site&custid=s8849760",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Beyond the Black Box: A Systematic Review of Breast, Prostate, Colorectal, and Cervical Screening Among Native and Immigrant African-Descent Caribbean Populations",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "https://iopscience.iop.org/article/10.1088/1748-605X/ac41fd//https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emexa&AN=2016501553//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:34891145&id=doi:10.1088%2F1748-605X%2Fac41fd&issn=1748-6041&isbn=&volume=17&issue=1&spage=012002&pages=&date=2022&title=Biomedical+Materials+%28Bristol%29&atitle=Biosensors+and+nanotechnology+for+cancer+diagnosis+%28lung+and+bronchus%2C+breast%2C+prostate%2C+and+colon%29%3A+A+systematic+review&aulast=Sharifianjazi&pid=%3Cauthor%3ESharifianjazi+F.%3BJafari+Rad+A.%3BBakhtiari+A.%3BNiazvand+F.%3BEsmaeilkhanian+A.%3BBazli+L.%3BAbniki+M.%3BIrani+M.%3BMoghanian+A.%3C%2Fauthor%3E%3CAN%3E2016501553%3C%2FAN%3E%3CDT%3EReview%3C%2FDT%3E",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Biosensors and nanotechnology for cancer diagnosis (lung and bronchus, breast, prostate, and colon): A systematic review",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1600-6143//https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emed18&AN=612913875//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:27575845&id=doi:10.1111%2Fajt.13978&issn=1600-6135&isbn=&volume=17&issue=1&spage=103&pages=103-114&date=2017&title=American+Journal+of+Transplantation&atitle=Cancer+Screening+Recommendations+for+Solid+Organ+Transplant+Recipients%3A+A+Systematic+Review+of+Clinical+Practice+Guidelines&aulast=Acuna&pid=%3Cauthor%3EAcuna+S.A.%3BHuang+J.W.%3BScott+A.L.%3BMicic+S.%3BDaly+C.%3BBrezden-Masley+C.%3BKim+S.J.%3BBaxter+N.N.%3C%2Fauthor%3E%3CAN%3E612913875%3C%2FAN%3E%3CDT%3EArticle%3C%2FDT%3E",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Cancer Screening Recommendations for Solid Organ Transplant Recipients: A Systematic Review of Clinical Practice Guidelines",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "http://www.hindawi.com/journals/jo///https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emed21&AN=2006924217//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:&id=doi:10.1155%2F2020%2F9873954&issn=1687-8450&isbn=&volume=2020&issue=&spage=9873954&pages=&date=2020&title=Journal+of+Oncology&atitle=Cancer+Surveillance+in+Healthy+Carriers+of+Germline+Pathogenic+Variants+in+BRCA1%2F2%3A+A+Review+of+Secondary+Prevention+Guidelines&aulast=Dullens&pid=%3Cauthor%3EDullens+B.%3BDe+Putter+R.%3BLambertini+M.%3BToss+A.%3BHan+S.%3BVan+Nieuwenhuysen+E.%3BVan+Gorp+T.%3BVanderstichele+A.%3BVan+Ongeval+C.%3BKeupers+M.%3BPrevos+R.%3BCelis+V.%3BDekervel+J.%3BEveraerts+W.%3BWildiers+H.%3BNevelsteen+I.%3BNeven+P.%3BTimmerman+D.%3BSmeets+A.%3BDenayer+E.%3BVan+Buggenhout+G.%3BLegius+E.%3BPunie+K.%3C%2Fauthor%3E%3CAN%3E2006924217%3C%2FAN%3E%3CDT%3EReview%3C%2FDT%3E",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Cancer Surveillance in Healthy Carriers of Germline Pathogenic Variants in BRCA1/2: A Review of Secondary Prevention Guidelines",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emed18&AN=623740848//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:&id=doi:10.1097%2FHCR.0000000000000309&issn=1932-751X&isbn=&volume=37&issue=6&spage=454&pages=454&date=2017&title=Journal+of+Cardiopulmonary+Rehabilitation+and+Prevention&atitle=Cardiorespiratory+effects+and+modifications+to+cardiac+rehabilitation+for+non-cardiac+chronic+disease+populations%3A+A+scoping+review&aulast=Nguyen&pid=%3Cauthor%3ENguyen+C.H.%3BThomas+S.G.%3C%2Fauthor%3E%3CAN%3E623740848%3C%2FAN%3E%3CDT%3EConference+Abstract%3C%2FDT%3E",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Intervention/ primary study/erratum/ conference abstract/ commentary/ clinic trial/ newsletter/ magazine/protocol/ literature review",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Cardiorespiratory effects and modifications to cardiac rehabilitation for non-cardiac chronic disease populations: A scoping review",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.dovepress.com/getfile.php?fileID=75109//https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emed22&AN=2014300849//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:&id=doi:10.2147%2FOTT.S321658&issn=1178-6930&isbn=&volume=14&issue=&spage=5085&pages=5085-5093&date=2021&title=OncoTargets+and+Therapy&atitle=Clinical+application+of+tumor+vascular+disrupting+therapy%3A+A+systematic+review+and+meta-analysis&aulast=Tsang&pid=%3Cauthor%3ETsang+W.%3BGan+L.%3BZhang+Z.%3BLi+T.%3BLuo+Y.%3BZhong+L.%3BHuang+Y.%3C%2Fauthor%3E%3CAN%3E2014300849%3C%2FAN%3E%3CDT%3EReview%3C%2FDT%3E",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Clinical application of tumor vascular disrupting therapy: A systematic review and meta-analysis",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.mona.uwi.edu/fms/wimj/system/files/article_pdfs/8th_annual_research_day.pdf//https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emed17&AN=626451571//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:&id=doi:&issn=0043-3144&isbn=&volume=65&issue=Supplement+5&spage=46&pages=46&date=2016&title=West+Indian+Medical+Journal&atitle=Colorectal+cancer+in+the+Bahamian+population&aulast=Chandra&pid=%3Cauthor%3EChandra+A.%3BCooper+M.%3C%2Fauthor%3E%3CAN%3E626451571%3C%2FAN%3E%3CDT%3EConference+Abstract%3C%2FDT%3E",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Intervention/ primary study/erratum/ conference abstract/ commentary/ clinic trial/ newsletter/ magazine/protocol/ literature review",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Colorectal cancer in the Bahamian population",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emed21&AN=2008455948//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:&id=doi:10.1016%2FS2666-1683%252820%252936211-X&issn=2666-1683&isbn=&volume=21&issue=Supplement+3&spage=S154&pages=S154&date=2020&title=European+Urology+Open+Science&atitle=Comparing+the+characteristics+of+advanced+Prostate+Cancer+%28PC%29+patients+with+and+without+DNA+Damage+Repair+mutations+%28DDRm%29%3A+A+systematic+review&aulast=Castro&pid=%3Cauthor%3ECastro+E.%3BLang+S.H.%3BSwift+S.L.%3BLeadley+R.M.%3BChalker+A.%3BNoake+C.%3BFox+K.M.%3BQuek+R.G.W.%3C%2Fauthor%3E%3CAN%3E2008455948%3C%2FAN%3E%3CDT%3EConference+Abstract%3C%2FDT%3E",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Intervention/ primary study/erratum/ conference abstract/ commentary/ clinic trial/ newsletter/ magazine/protocol/ literature review",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Comparing the characteristics of advanced Prostate Cancer (PC) patients with and without DNA Damage Repair mutations (DDRm): A systematic review",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Comparison of meta-analyses among elastosonography (ES) and positron emission tomography/computed tomography (PET/CT) imaging techniques in the application of prostate cancer diagnosis",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emed20&AN=629469655//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:&id=doi:10.1097%2F01.JU.0000555639.75701.7b&issn=1527-3792&isbn=&volume=201&issue=4+Supplement+1&spage=e339&pages=e339&date=2019&title=Journal+of+Urology&atitle=Comparison+of+micro-ultrasound+and+multiparametric+MRI+imaging+for+prostate+cancer%3A+An+international+meta-analysis&aulast=Lughezzani&pid=%3Cauthor%3ELughezzani+G.%3BAstobieta+A.%3BStaerman+F.%3BEl-Shefai+A.%3BAbouassaly+R.%3BKlein+E.A.%3BGregg+E.%3C%2Fauthor%3E%3CAN%3E629469655%3C%2FAN%3E%3CDT%3EConference+Abstract%3C%2FDT%3E",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Intervention/ primary study/erratum/ conference abstract/ commentary/ clinic trial/ newsletter/ magazine/protocol/ literature review",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Comparison of micro-ultrasound and multiparametric MRI imaging for prostate cancer: An international meta-analysis",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "https://search.ebscohost.com/login.aspx?direct=true&AuthType=shib&db=jlh&AN=149363285&site=ehost-live&scope=site&custid=s8849760",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Comparison of Systemic Treatments for Metastatic Castration-Sensitive Prostate Cancer: A Systematic Review and Network Meta-analysis",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "https://search.ebscohost.com/login.aspx?direct=true&AuthType=shib&db=jlh&AN=150833382&site=ehost-live&scope=site&custid=s8849760",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Comprehensive Volatilome and Metabolome Signatures of Colorectal Cancer in Urine: A Systematic Review and Meta-Analysis",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "https://link.springer.de/link/service/journals/00520/index.htm//https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emed22&AN=2006734967//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:32951087&id=doi:10.1007%2Fs00520-020-05780-8&issn=0941-4355&isbn=&volume=29&issue=3&spage=1195&pages=1195-1203&date=2021&title=Supportive+Care+in+Cancer&atitle=Correlates+of+stigma+for+patients+with+cancer%3A+a+systematic+review+and+meta-analysis&aulast=Huang&pid=%3Cauthor%3EHuang+Z.%3BYu+T.%3BWu+S.%3BHu+A.%3C%2Fauthor%3E%3CAN%3E2006734967%3C%2FAN%3E%3CDT%3EReview%3C%2FDT%3E",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Correlates of stigma for patients with cancer: a systematic review and meta-analysis",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "https://search.ebscohost.com/login.aspx?direct=true&AuthType=shib&db=jlh&AN=113571912&site=ehost-live&scope=site&custid=s8849760",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Cost-effectiveness of serum CA125 compared to transvaginal ultrasound as a screening test for ovarian cancer: a systematic review protocol",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "https://search.ebscohost.com/login.aspx?direct=true&AuthType=shib&db=jlh&AN=104189910&site=ehost-live&scope=site&custid=s8849760",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Critical evaluation of oncology clinical practice guidelines",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emed19&AN=621478644//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:&id=doi:&issn=1878-1500&isbn=&volume=17&issue=2&spage=e381&pages=e381-e382&date=2018&title=European+Urology%2C+Supplements&atitle=Decision+aids+for+prostate+cancer+screening+choice%3A+A+systematic+review+and+meta-analysis&aulast=Riikonen&pid=%3Cauthor%3ERiikonen+J.%3BGuyatt+G.%3BKilpelainen+T.%3BCraigie+S.%3BAgarwal+A.%3BAgoritsas+T.%3BCouban+R.%3BDahm+P.%3BJarvinen+P.%3BMontori+V.%3BPower+N.%3BRichard+P.%3BRutanen+J.%3BSantti+H.%3BTailly+T.%3BViolette+P.%3BZhou+Q.%3BTikkinen+K.%3C%2Fauthor%3E%3CAN%3E621478644%3C%2FAN%3E%3CDT%3EConference+Abstract%3C%2FDT%3E",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Intervention/ primary study/erratum/ conference abstract/ commentary/ clinic trial/ newsletter/ magazine/protocol/ literature review",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Decision aids for prostate cancer screening choice: A systematic review and meta-analysis",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "https://ascopubs.org/doi/full/10.1200/GO.21.00056//https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emed22&AN=2014003228//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:34343029&id=doi:10.1200%2FGO.21.00056&issn=2687-8941&isbn=&volume=7&issue=&spage=1233&pages=1233-1250&date=2021&title=JCO+Global+Oncology&atitle=Depression%2C+anxiety%2C+and+other+mental+disorders+in+patients+with+cancer+in+low-+And+lower-middle-income+countries%3A+A+systematic+review+and+meta-analysis&aulast=Walker&pid=%3Cauthor%3EWalker+Z.J.%3BXue+S.%3BJones+M.P.%3BRavindran+A.V.%3C%2Fauthor%3E%3CAN%3E2014003228%3C%2FAN%3E%3CDT%3EReview%3C%2FDT%3E",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Depression, anxiety, and other mental disorders in patients with cancer in low- And lower-middle-income countries: A systematic review and meta-analysis",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.degruyter.com/downloadpdf/j/tjb.2017.42.issue-s2/tjb-2017-s217/tjb-2017-s217.pdf//https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emed18&AN=621486360//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:&id=doi:&issn=1303-829X&isbn=&volume=42&issue=Supplement+2&spage=46&pages=46&date=2017&title=Turkish+Journal+of+Biochemistry&atitle=Determination+of+common+miRNA+biomarkers+by+META+analysis+in+breast%2C+prostate+%26+lung+cancer+data+sets&aulast=Ors&pid=%3Cauthor%3EOrs+G.%3BIz+S.G.%3C%2Fauthor%3E%3CAN%3E621486360%3C%2FAN%3E%3CDT%3EConference+Abstract%3C%2FDT%3E",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Intervention/ primary study/erratum/ conference abstract/ commentary/ clinic trial/ newsletter/ magazine/protocol/ literature review",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Determination of common miRNA biomarkers by META analysis in breast, prostate & lung cancer data sets",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "https://search.ebscohost.com/login.aspx?direct=true&AuthType=shib&db=jlh&AN=157738482&site=ehost-live&scope=site&custid=s8849760",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Diagnostic Performance of Electronic Noses in Cancer Diagnoses Using Exhaled Breath: A Systematic Review and Meta-analysis",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "https://search.ebscohost.com/login.aspx?direct=true&AuthType=shib&db=jlh&AN=145187027&site=ehost-live&scope=site&custid=s8849760",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Diagnostic Performance of PET Imaging Using Different Radiopharmaceuticals in Prostate Cancer According to Published Meta-Analyses",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "https://search.ebscohost.com/login.aspx?direct=true&AuthType=shib&db=jlh&AN=130765437&site=ehost-live&scope=site&custid=s8849760",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Does pelvic radiation increase rectal cancer incidence? - A systematic review and meta-analysis",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "http://www.springerlink.com/content/121281///https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emed21&AN=2005014171//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:32744575&id=doi:10.1007%2Fs12603-020-1395-3&issn=1279-7707&isbn=&volume=24&issue=7&spage=772&pages=772-782&date=2020&title=Journal+of+Nutrition%2C+Health+and+Aging&atitle=Effectiveness+of+Therapeutic+Patient+Education+Interventions+for+Older+Adults+with+Cancer%3A+A+Systematic+Review&aulast=Champarnaud&pid=%3Cauthor%3EChamparnaud+M.%3BVillars+H.%3BGirard+P.%3BBrechemier+D.%3BBalardy+L.%3BNourhashemi+F.%3C%2Fauthor%3E%3CAN%3E2005014171%3C%2FAN%3E%3CDT%3EReview%3C%2FDT%3E",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Effectiveness of Therapeutic Patient Education Interventions for Older Adults with Cancer: A Systematic Review",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "http://www.hindawi.com/journals/ecam/contents.html//https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emexa&AN=2017687542//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:&id=doi:10.1155%2F2022%2F5800575&issn=1741-427X&isbn=&volume=2022&issue=&spage=5800575&pages=&date=2022&title=Evidence-based+Complementary+and+Alternative+Medicine&atitle=Efficacy+of+Chinese+Medicine+Injection+for+Cardiotoxic+Injury+of+Anthracycline+Chemotherapy+Drugs%3A+A+Network+Meta-Analysis+of+Randomized+Controlled+Trials&aulast=Li&pid=%3Cauthor%3ELi+M.%3BLi+H.%3BLiu+H.%3BLai+X.%3BXing+W.%3C%2Fauthor%3E%3CAN%3E2017687542%3C%2FAN%3E%3CDT%3EReview%3C%2FDT%3E",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Efficacy of Chinese Medicine Injection for Cardiotoxic Injury of Anthracycline Chemotherapy Drugs: A Network Meta-Analysis of Randomized Controlled Trials",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "https://search.ebscohost.com/login.aspx?direct=true&AuthType=shib&db=jlh&AN=104398076&site=ehost-live&scope=site&custid=s8849760",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Enhancing Informed Choice to Undergo Health Screening: A Systematic Review",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "http://www.cuaj.ca/index.php/journal/article/view/4185/3133//https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emexa&AN=616804076//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:&id=doi:10.5489%2Fcuaj.4185&issn=1911-6470&isbn=&volume=11&issue=5&spage=E222&pages=E222-E232&date=2017&title=Canadian+Urological+Association+Journal&atitle=Epidemiology+of+prostate+and+kidney+cancer+in+the+Aboriginal+population+of+Canada%3A+A+systematic+review&aulast=Wong&pid=%3Cauthor%3EWong+E.C.L.%3BKapoor+A.%3C%2Fauthor%3E%3CAN%3E616804076%3C%2FAN%3E%3CDT%3EReview%3C%2FDT%3E",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Epidemiology of prostate and kidney cancer in the Aboriginal population of Canada: A systematic review",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.elsevier.com/locate/canlet//https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emed15&AN=51812060//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:22198482&id=doi:10.1016%2Fj.canlet.2011.12.026&issn=0304-3835&isbn=&volume=342&issue=2&spage=264&pages=264-274&date=2014&title=Cancer+Letters&atitle=Epigenetic+biomarkers+in+urological+tumors%3A+A+systematic+review&aulast=Jeronimo&pid=%3Cauthor%3EJeronimo+C.%3BHenrique+R.%3C%2Fauthor%3E%3CAN%3E51812060%3C%2FAN%3E%3CDT%3EReview%3C%2FDT%3E",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Epigenetic biomarkers in urological tumors: A systematic review",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1099-1611//https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emed21&AN=2004881812//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:&id=doi:10.1002%2Fpon.5317&issn=1057-9249&isbn=&volume=29&issue=1&spage=237&pages=237&date=2020&title=Psycho-Oncology&atitle=Erratum+to%3A+A+behavioral+cancer+pain+intervention%3A+A+randomized+noninferiority+trial+comparing+in-person+with+videoconference+delivery+%28Psycho-Oncology%2C+%282019%29%2C+28%2C+8%2C+%281671-1678%29%2C+10.1002%2Fpon.5141%29&aulast=&pid=%3Cauthor%3Eanonymous%3C%2Fauthor%3E%3CAN%3E2004881812%3C%2FAN%3E%3CDT%3EErratum%3C%2FDT%3E",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Intervention/ primary study/erratum/ conference abstract/ commentary/ clinic trial/ newsletter/ magazine/protocol/ literature review",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Erratum to: A behavioral cancer pain intervention: A randomized noninferiority trial comparing in-person with videoconference delivery (Psycho-Oncology, (2019), 28, 8, (1671-1678), 10.1002/pon.5141)",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1099-1611//https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emed21&AN=2004881811//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:&id=doi:10.1002%2Fpon.5317&issn=1057-9249&isbn=&volume=29&issue=1&spage=237&pages=237&date=2020&title=Psycho-Oncology&atitle=Erratum+to%3A+A+user+centered+design+approach+to+development+of+an+online+self-management+program+for+cancer+survivors%3A+Springboard+Beyond+Cancer+%28Psycho-Oncology%2C+%282019%29%2C+28%2C+10%2C+%282060-2067%29%2C+10.1002%2Fpon.5193%29&aulast=&pid=%3Cauthor%3Eanonymous%3C%2Fauthor%3E%3CAN%3E2004881811%3C%2FAN%3E%3CDT%3EErratum%3C%2FDT%3E",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Intervention/ primary study/erratum/ conference abstract/ commentary/ clinic trial/ newsletter/ magazine/protocol/ literature review",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Erratum to: A user centered design approach to development of an online self-management program for cancer survivors: Springboard Beyond Cancer (Psycho-Oncology, (2019), 28, 10, (2060-2067), 10.1002/pon.5193)",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1099-1611//https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emed21&AN=2004804560//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:&id=doi:10.1002%2Fpon.5317&issn=1057-9249&isbn=&volume=29&issue=1&spage=237&pages=237&date=2020&title=Psycho-Oncology&atitle=Erratum+to%3A+Examining+the+feasibility%2C+acceptability%2C+and+potential+utility+of+mobile+distress+screening+in+adult+cancer+patients+%28Psycho-Oncology%2C+%282019%29%2C+28%2C+9%2C+%281887-1893%29%2C+10.1002%2Fpon.5168%29&aulast=&pid=%3Cauthor%3Eanonymous%3C%2Fauthor%3E%3CAN%3E2004804560%3C%2FAN%3E%3CDT%3EErratum%3C%2FDT%3E",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Intervention/ primary study/erratum/ conference abstract/ commentary/ clinic trial/ newsletter/ magazine/protocol/ literature review",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Erratum to: Examining the feasibility, acceptability, and potential utility of mobile distress screening in adult cancer patients (Psycho-Oncology, (2019), 28, 9, (1887-1893), 10.1002/pon.5168)",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1099-1611//https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emed21&AN=2004881814//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:&id=doi:10.1002%2Fpon.5317&issn=1057-9249&isbn=&volume=29&issue=1&spage=237&pages=237&date=2020&title=Psycho-Oncology&atitle=Erratum+to%3A+Iterative+adaptation+process+for+eHealth+Mindful+Movement+and+Breathing+to+improve+gynecologic+cancer+surgery+outcomes+%28Psycho-Oncology%2C+%282019%29%2C+28%2C+8%2C+%281774-1777%29%2C+10.1002%2Fpon.5146%29&aulast=&pid=%3Cauthor%3Eanonymous%3C%2Fauthor%3E%3CAN%3E2004881814%3C%2FAN%3E%3CDT%3EErratum%3C%2FDT%3E",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Intervention/ primary study/erratum/ conference abstract/ commentary/ clinic trial/ newsletter/ magazine/protocol/ literature review",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Erratum to: Iterative adaptation process for eHealth Mindful Movement and Breathing to improve gynecologic cancer surgery outcomes (Psycho-Oncology, (2019), 28, 8, (1774-1777), 10.1002/pon.5146)",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1099-1611//https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emed21&AN=2004881816//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:&id=doi:10.1002%2Fpon.5317&issn=1057-9249&isbn=&volume=29&issue=1&spage=237&pages=237&date=2020&title=Psycho-Oncology&atitle=Erratum+to%3A+Preferences+of+mHealth+app+features+for+weight+management+among+breast+cancer+survivors+from+underserved+populations+%28Psycho-Oncology%2C+%282019%29%2C+28%2C+10%2C+%282101-2104%29%2C+10.1002%2Fpon.5190%29&aulast=&pid=%3Cauthor%3Eanonymous%3C%2Fauthor%3E%3CAN%3E2004881816%3C%2FAN%3E%3CDT%3EErratum%3C%2FDT%3E",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Intervention/ primary study/erratum/ conference abstract/ commentary/ clinic trial/ newsletter/ magazine/protocol/ literature review",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Erratum to: Preferences of mHealth app features for weight management among breast cancer survivors from underserved populations (Psycho-Oncology, (2019), 28, 10, (2101-2104), 10.1002/pon.5190)",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1099-1611//https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emed21&AN=2004881813//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:&id=doi:10.1002%2Fpon.5317&issn=1057-9249&isbn=&volume=29&issue=1&spage=237&pages=237&date=2020&title=Psycho-Oncology&atitle=Erratum+to%3A+Systematic+review+of+technology-based+interventions+to+improve+anxiety%2C+depression%2C+and+health-related+quality+of+life+among+patients+with+prostate+cancer+%28Psycho-Oncology%2C+%282019%29%2C+28%2C+8%2C+%281601-1613%29%2C+10.1002%2Fpon.5158%29&aulast=&pid=%3Cauthor%3Eanonymous%3C%2Fauthor%3E%3CAN%3E2004881813%3C%2FAN%3E%3CDT%3EErratum%3C%2FDT%3E",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Intervention/ primary study/erratum/ conference abstract/ commentary/ clinic trial/ newsletter/ magazine/protocol/ literature review",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Erratum to: Systematic review of technology-based interventions to improve anxiety, depression, and health-related quality of life among patients with prostate cancer (Psycho-Oncology, (2019), 28, 8, (1601-1613), 10.1002/pon.5158)",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1099-1611//https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emed21&AN=2004881815//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:&id=doi:10.1002%2Fpon.5317&issn=1057-9249&isbn=&volume=29&issue=1&spage=237&pages=237&date=2020&title=Psycho-Oncology&atitle=Erratum+to%3A+Timing+and+tailoring+of+internet-based+cognitive-behavioral+treatment+for+insomnia+for+cancer+survivors%3A+A+qualitative+study+%28Psycho-Oncology%2C+%282019%29%2C+28%2C+9%2C+%281934-1937%29%2C+10.1002%2Fpon.5180%29&aulast=&pid=%3Cauthor%3Eanonymous%3C%2Fauthor%3E%3CAN%3E2004881815%3C%2FAN%3E%3CDT%3EErratum%3C%2FDT%3E",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Intervention/ primary study/erratum/ conference abstract/ commentary/ clinic trial/ newsletter/ magazine/protocol/ literature review",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Erratum to: Timing and tailoring of internet-based cognitive-behavioral treatment for insomnia for cancer survivors: A qualitative study (Psycho-Oncology, (2019), 28, 9, (1934-1937), 10.1002/pon.5180)",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emed20&AN=2003405845//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:&id=doi:10.1016%2Fj.jtho.2019.08.087&issn=1556-0864&isbn=&volume=14&issue=10+Supplement&spage=S24&pages=S24&date=2019&title=Journal+of+Thoracic+Oncology&atitle=ES05.01+Lung+Cancer+Survival%3A+Progress+and+Challenges&aulast=Nicolson&pid=%3Cauthor%3ENicolson+M.%3C%2Fauthor%3E%3CAN%3E2003405845%3C%2FAN%3E%3CDT%3EConference+Abstract%3C%2FDT%3E",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Intervention/ primary study/erratum/ conference abstract/ commentary/ clinic trial/ newsletter/ magazine/protocol/ literature review",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "ES05.01 Lung Cancer Survival: Progress and Challenges",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Ethnic inequalities in time to diagnosis of cancer: a systematic review",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.elsevier.com/inca/publications/store/5/0/6/0/4/0///https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emed21&AN=2008355493//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:33091832&id=doi:10.1016%2Fj.ijmedinf.2020.104293&issn=1386-5056&isbn=&volume=144&issue=&spage=104293&pages=&date=2020&title=International+Journal+of+Medical+Informatics&atitle=Exploring+the+use+of+Mobile+applications+by+cancer+patients+undergoing+chemotherapy%3A+A+scoping+review&aulast=Magalhaes&pid=%3Cauthor%3EMagalhaes+B.%3BFernandes+C.%3BMartinez-Galiano+J.M.%3BSantos+C.%3C%2Fauthor%3E%3CAN%3E2008355493%3C%2FAN%3E%3CDT%3EReview%3C%2FDT%3E",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Exploring the use of Mobile applications by cancer patients undergoing chemotherapy: A scoping review",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "https://link.springer.de/link/service/journals/00520/index.htm//https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emexb&AN=2015570998//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:35391575&id=doi:10.1007%2Fs00520-022-07032-3&issn=0941-4355&isbn=&volume=30&issue=8&spage=6483&pages=6483-6496&date=2022&title=Supportive+Care+in+Cancer&atitle=Factors+associated+with+benefit+finding+and+mental+health+of+patients+with+cancer%3A+a+systematic+review&aulast=Zhu&pid=%3Cauthor%3EZhu+P.%3BChen+C.%3BLiu+X.%3BGu+W.%3BShang+X.%3C%2Fauthor%3E%3CAN%3E2015570998%3C%2FAN%3E%3CDT%3EReview%3C%2FDT%3E",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Factors associated with benefit finding and mental health of patients with cancer: a systematic review",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "https://ascopubs.org/doi/abs/10.1200/JCO.2019.37.31_suppl.39//https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emed20&AN=630551579//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:&id=doi:10.1200%2FJCO.2019.37.31-suppl.39&issn=1527-7755&isbn=&volume=37&issue=31+Supplement+1&spage=&pages=&date=2019&title=Journal+of+Clinical+Oncology&atitle=Four-year+overview+of+enrollment+and+participation+in+research+studies+conducted+at+the+Prostate+Cancer+Supportive+Care+%28PCSC%29+Program&aulast=Wu&pid=%3Cauthor%3EWu+E.%3BArsovska+O.%3BSundar+M.%3BVivar+M.%3BPang+C.%3BSpillane+M.%3BHedden+L.%3BGoldenberg+L.%3BHigano+C.S.%3C%2Fauthor%3E%3CAN%3E630551579%3C%2FAN%3E%3CDT%3EConference+Abstract%3C%2FDT%3E",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Intervention/ primary study/erratum/ conference abstract/ commentary/ clinic trial/ newsletter/ magazine/protocol/ literature review",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Four-year overview of enrollment and participation in research studies conducted at the Prostate Cancer Supportive Care (PCSC) Program",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Genetic landscape of prostate cancer conspicuity on multiparametric MRI: a protocol for a systematic review and bioinformatic analysis",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Government regulation of private health insurance",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emed15&AN=52833016//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:24207115&id=doi:10.1016%2Fj.pec.2013.10.001&issn=0738-3991&isbn=&volume=94&issue=2&spage=149&pages=149-157&date=2014&title=Patient+Education+and+Counseling&atitle=Health+literacy+and+cancer+screening%3A+A+systematic+review&aulast=Oldach&pid=%3Cauthor%3EOldach+B.R.%3BKatz+M.L.%3C%2Fauthor%3E%3CAN%3E52833016%3C%2FAN%3E%3CDT%3EReview%3C%2FDT%3E",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Health literacy and cancer screening: A systematic review",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.journals.elsevier.com/clinical-and-translational-radiation-oncology///https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emed20&AN=2001787695//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:&id=doi:10.1016%2Fj.ctro.2019.04.002&issn=2405-6308&isbn=&volume=16&issue=&spage=55&pages=55-59&date=2019&title=Clinical+and+Translational+Radiation+Oncology&atitle=Healthcare+ex+Machina%3A+Are+conversational+agents+ready+for+prime+time+in+oncology%3F&aulast=Bibault&pid=%3Cauthor%3EBibault+J.-E.%3BChaix+B.%3BNectoux+P.%3BPienkowsky+A.%3BGuillemasse+A.%3BBrouard+B.%3C%2Fauthor%3E%3CAN%3E2001787695%3C%2FAN%3E%3CDT%3EReview%3C%2FDT%3E",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Healthcare ex Machina: Are conversational agents ready for prime time in oncology?",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emed21&AN=2005868127//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:&id=doi:&issn=1098-3015&isbn=&volume=23&issue=Supplement+1&spage=A1&pages=A1-A8&date=2020&title=Value+in+Health&atitle=HEOR%3A+Advancing+Evidence+to+Action&aulast=&pid=%3Cauthor%3Eanonymous%3C%2Fauthor%3E%3CAN%3E2005868127%3C%2FAN%3E%3CDT%3EConference+Review%3C%2FDT%3E",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Intervention/ primary study/erratum/ conference abstract/ commentary/ clinic trial/ newsletter/ magazine/protocol/ literature review",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "HEOR: Advancing Evidence to Action",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.minervamedica.it/en/getpdf/TQl9aGaauFZG5wRwIY6r5TgWEYq01jLG%252BAXeSoCFRuSVWkInmN82UFx%252FpyZnfqLoqEg2wEbkXtcvgkV9gK20Xg%253D%253D/R10Y2019N04A0301.pdf//https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emed20&AN=2002340596//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:31081309&id=doi:10.23736%2FS0026-4806.19.06091-9&issn=0026-4806&isbn=&volume=110&issue=4&spage=301&pages=301-319&date=2019&title=Minerva+Medica&atitle=Hereditary+ovarian+cancers%3A+State+of+the+art&aulast=Toss&pid=%3Cauthor%3EToss+A.%3BMolinaro+E.%3BSammarini+M.%3BDel+Savio+M.C.%3BCortesi+L.%3BFacchinetti+F.%3BGrandi+G.%3C%2Fauthor%3E%3CAN%3E2002340596%3C%2FAN%3E%3CDT%3EReview%3C%2FDT%3E",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Hereditary ovarian cancers: State of the art",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Histopathological features of prostate cancer conspicuity on multiparametric MRI: protocol for a systematic review and meta-analysis",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Human genome meeting 2016 : Houston, TX, USA. 28 February - 2 March 2016",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "http://bmjopen.bmj.com/content/early/by/section//https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emed22&AN=634185145//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:33574144&id=doi:10.1136%2Fbmjopen-2020-040751&issn=2044-6055&isbn=&volume=11&issue=2&spage=e040751&pages=&date=2021&title=BMJ+Open&atitle=Implementation+of+patient-reported+outcome+measures+and+patient-reported+experience+measures+in+melanoma+clinical+quality+registries%3A+A+systematic+review&aulast=Blood&pid=%3Cauthor%3EBlood+Z.%3BTran+A.%3BCaleo+L.%3BSaw+R.%3BDieng+M.%3BShackleton+M.%3BSoyer+H.P.%3BArnold+C.%3BMann+G.J.%3BMorton+R.L.%3C%2Fauthor%3E%3CAN%3E634185145%3C%2FAN%3E%3CDT%3EReview%3C%2FDT%3E",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Implementation of patient-reported outcome measures and patient-reported experience measures in melanoma clinical quality registries: A systematic review",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emexb&AN=636219702//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:34555932&id=doi:10.1097%2FJU.0000000000002251&issn=1527-3792&isbn=&volume=207&issue=1&spage=101097JU0000000000002251&pages=101097JU0000000000002251&date=2021&title=The+Journal+of+urology&atitle=Infection+Rate+after+Transperineal+Prostate+Biopsy+with+and+without+Prophylactic+Antibiotics%3A+Results+from+a+Systematic+Review+and+Meta-analysis+of+Comparative+Studies&aulast=Castellani&pid=%3Cauthor%3ECastellani+D.%3BPirola+G.M.%3BTerence+Law+Y.X.%3BGubbiotti+M.%3BGiulioni+C.%3BScarcella+S.%3BWroclawski+M.L.%3BChan+E.%3BKa-Fung+Chiu+P.%3BYuen-Chun+Teoh+J.%3BGauhar+V.%3BRubilotta+E.%3C%2Fauthor%3E%3CAN%3E636219702%3C%2FAN%3E%3CDT%3EArticle%3C%2FDT%3E",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Infection Rate after Transperineal Prostate Biopsy with and without Prophylactic Antibiotics: Results from a Systematic Review and Meta-analysis of Comparative Studies",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Inflammatory bowel disease and prostate cancer risk: A systematic review",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Intraoperative Frozen Section for Margin Evaluation During Radical Prostatectomy: A Systematic Review",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "http://aje.oxfordjournals.org///https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emed16&AN=606028689//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:26243738&id=doi:10.1093%2Faje%2Fkwv086&issn=0002-9262&isbn=&volume=182&issue=5&spage=390&pages=390-393&date=2015&title=American+Journal+of+Epidemiology&atitle=Invited+commentary%3A+Screening+and+the+elusive+etiology+of+prostate+cancer&aulast=Garcia-Closas&pid=%3Cauthor%3EGarcia-Closas+M.%3BDe+Gonzalez+A.B.%3C%2Fauthor%3E%3CAN%3E606028689%3C%2FAN%3E%3CDT%3EReview%3C%2FDT%3E",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Invited commentary: Screening and the elusive etiology of prostate cancer",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Is magnetic resonance imaging-targeted biopsy a useful addition to systematic confirmatory biopsy in men on active surveillance for low-risk prostate cancer? A systematic review and meta-analysis",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "http://www.nature.com/pcan/index.html//https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emexa&AN=2015215645//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:35246608&id=doi:10.1038%2Fs41391-022-00507-8&issn=1365-7852&isbn=&volume=25&issue=2&spage=180&pages=180-186&date=2022&title=Prostate+Cancer+and+Prostatic+Diseases&atitle=Liquid+biomarkers+for+early+detection+of+prostate+cancer+and+summary+of+available+data+for+their+use+in+African-American+men&aulast=Henning&pid=%3Cauthor%3EHenning+G.M.%3BAndriole+G.L.%3BKim+E.H.%3C%2Fauthor%3E%3CAN%3E2015215645%3C%2FAN%3E%3CDT%3EReview%3C%2FDT%3E",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Liquid biomarkers for early detection of prostate cancer and summary of available data for their use in African-American men",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1098-2280//https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emexa&AN=2015180982//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:35178782&id=doi:10.1002%2Fem.22472&issn=0893-6692&isbn=&volume=63&issue=4&spage=190&pages=190-203&date=2022&title=Environmental+and+Molecular+Mutagenesis&atitle=LncRNA+polymorphisms+and+urologic+cancer+risk&aulast=Abdi&pid=%3Cauthor%3EAbdi+E.%3BLatifi-Navid+S.%3C%2Fauthor%3E%3CAN%3E2015180982%3C%2FAN%3E%3CDT%3EReview%3C%2FDT%3E",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "LncRNA polymorphisms and urologic cancer risk",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "LOW RISK PROSTATE CANCER: ACTIVE TREATMENT OR ACTIVE SURVEILLANCE?",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "http://www.journals.elsevier.com/european-urology-focus//https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emed19&AN=2000935135//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:30005996&id=doi:10.1016%2Fj.euf.2018.07.003&issn=2405-4569&isbn=&volume=4&issue=2&spage=148&pages=148-152&date=2018&title=European+Urology+Focus&atitle=Low-risk+Prostate+Cancer+Prior+to+or+After+Kidney+Transplantation&aulast=Stockle&pid=%3Cauthor%3EStockle+M.%3BJunker+K.%3BFornara+P.%3C%2Fauthor%3E%3CAN%3E2000935135%3C%2FAN%3E%3CDT%3EReview%3C%2FDT%3E",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Low-risk Prostate Cancer Prior to or After Kidney Transplantation",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "http://cebp.aacrjournals.org/content/25/3_Supplement/IA03//https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emed17&AN=613273044//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:&id=doi:10.1158%2F1538-7755.DISP15-IA03&issn=1055-9965&isbn=&volume=25&issue=3+Supplement&spage=ia03&pages=&date=2016&title=Cancer+Epidemiology+Biomarkers+and+Prevention&atitle=Lung+cancer+risk+in+African+Americans%3A+Familial+aggregation+and+genetic+susceptibility&aulast=Schwartz&pid=%3Cauthor%3ESchwartz+A.G.%3C%2Fauthor%3E%3CAN%3E613273044%3C%2FAN%3E%3CDT%3EConference+Abstract%3C%2FDT%3E",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Lung cancer risk in African Americans: Familial aggregation and genetic susceptibility",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "http://jim.bmj.com/content/about-us//https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emed21&AN=630834372//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:31988219&id=doi:10.1136%2Fjim-2019-001233&issn=1081-5589&isbn=&volume=68&issue=2&spage=335&pages=335-356&date=2020&title=Journal+of+Investigative+Medicine&atitle=Male+hypogonadism%3A+A+review&aulast=Marcelli&pid=%3Cauthor%3EMarcelli+M.%3BMediwala+S.N.%3C%2Fauthor%3E%3CAN%3E630834372%3C%2FAN%3E%3CDT%3EReview%3C%2FDT%3E",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Male hypogonadism: A review",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "http://www.journals.elsevier.com/the-lancet-oncology///https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emed15&AN=373632941//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:25079103&id=doi:10.1016%2FS1470-2045%252814%252970018-X&issn=1470-2045&isbn=&volume=15&issue=9&spage=e404&pages=e404-e414&date=2014&title=The+Lancet+Oncology&atitle=Management+of+prostate+cancer+in+older+patients%3A+Updated+recommendations+of+a+working+group+of+the+International+Society+of+Geriatric+Oncology&aulast=Droz&pid=%3Cauthor%3EDroz+J.-P.%3BAapro+M.%3BBalducci+L.%3BBoyle+H.%3BVan+den+Broeck+T.%3BCathcart+P.%3BDickinson+L.%3BEfstathiou+E.%3BEmberton+M.%3BFitzpatrick+J.M.%3BHeidenreich+A.%3BHughes+S.%3BJoniau+S.%3BKattan+M.%3BMottet+N.%3BOudard+S.%3BPayne+H.%3BSaad+F.%3BSugihara+T.%3C%2Fauthor%3E%3CAN%3E373632941%3C%2FAN%3E%3CDT%3EReview%3C%2FDT%3E",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Management of prostate cancer in older patients: Updated recommendations of a working group of the International Society of Geriatric Oncology",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "https://journals.viamedica.pl/rpor/article/view/RPOR.a2021.0032/55638//https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emed22&AN=2012862540//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:&id=doi:10.5603%2FRPOR.a2021.0032&issn=1507-1367&isbn=&volume=26&issue=2&spage=303&pages=303-315&date=2021&title=Reports+of+Practical+Oncology+and+Radiotherapy&atitle=Novel+coronavirus+mitigation+measures+implemented+by+radiotherapy+centres+in+low+and+middle-income+countries%3A+A+systematic+review&aulast=Donkor&pid=%3Cauthor%3EDonkor+A.%3BAtuwo-Ampoh+V.D.%3BOpie+C.%3BYakanu+F.%3BLombe+D.%3BKhader+J.%3C%2Fauthor%3E%3CAN%3E2012862540%3C%2FAN%3E%3CDT%3EReview%3C%2FDT%3E",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Novel coronavirus mitigation measures implemented by radiotherapy centres in low and middle-income countries: A systematic review",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "http://meeting.ascopubs.org/cgi/content/abstract/33/15_suppl/e16126?sid=ce5d2676-c15b-4ce6-8ab2-831cc0ba7f44//https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emed16&AN=72013714//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:&id=doi:&issn=0732-183X&isbn=&volume=33&issue=15+SUPPL.+1&spage=&pages=&date=2015&title=Journal+of+Clinical+Oncology&atitle=Outcome+measures+in+trials+of+systemic+therapy+for+advanced+prostate+cancer%3A+A+systematic+review&aulast=Fabricius&pid=%3Cauthor%3EFabricius+M.J.%3BCottrell+A.%3BGujadhur+R.%3BSharaf+A.%3BPickard+R.%3BMcColl+E.%3C%2Fauthor%3E%3CAN%3E72013714%3C%2FAN%3E%3CDT%3EConference+Abstract%3C%2FDT%3E",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Intervention/ primary study/erratum/ conference abstract/ commentary/ clinic trial/ newsletter/ magazine/protocol/ literature review",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Outcome measures in trials of systemic therapy for advanced prostate cancer: A systematic review",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "https://search.ebscohost.com/login.aspx?direct=true&AuthType=shib&db=jlh&AN=123788692&site=ehost-live&scope=site&custid=s8849760",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Overuse of Health Care Services in the Management of Cancer: A Systematic Review",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "https://link.springer.de/link/service/journals/00520/index.htm//https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emed22&AN=2006040411//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:32875373&id=doi:10.1007%2Fs00520-020-05695-4&issn=0941-4355&isbn=&volume=29&issue=2&spage=573&pages=573-593&date=2021&title=Supportive+Care+in+Cancer&atitle=Patient+outcomes%2C+patient+experiences+and+process+indicators+associated+with+the+routine+use+of+patient-reported+outcome+measures+%28PROMs%29+in+cancer+care%3A+a+systematic+review&aulast=Graupner&pid=%3Cauthor%3EGraupner+C.%3BKimman+M.L.%3BMul+S.%3BSlok+A.H.M.%3BClaessens+D.%3BKleijnen+J.%3BDirksen+C.D.%3BBreukink+S.O.%3C%2Fauthor%3E%3CAN%3E2006040411%3C%2FAN%3E%3CDT%3EReview%3C%2FDT%3E",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Patient outcomes, patient experiences and process indicators associated with the routine use of patient-reported outcome measures (PROMs) in cancer care: a systematic review",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emed22&AN=636274638//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:&id=doi:10.1097%2FJU.0000000000002149.01&issn=1527-3792&isbn=&volume=206&issue=SUPPL+3&spage=e1175&pages=e1175&date=2021&title=Journal+of+Urology&atitle=Persistent+deficiencies+in+the+measurement+and+reporting+of+tobacco+use+in+contemporary+genitourinary+oncology+clinical+trials&aulast=Matulewicz&pid=%3Cauthor%3EMatulewicz+R.%3BZhao+C.%3BMyrie+A.%3BFeuer+Z.%3BRoberts+T.%3BBjurlin+M.%3C%2Fauthor%3E%3CAN%3E636274638%3C%2FAN%3E%3CDT%3EConference+Abstract%3C%2FDT%3E",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Persistent deficiencies in the measurement and reporting of tobacco use in contemporary genitourinary oncology clinical trials",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Predictive value of the official cancer alarm symptoms in general practice--a systematic review",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "http://www.bmj.com///https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emed19&AN=622630415//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:29914908&id=doi:10.1136%2Fbmj.k2387&issn=0959-8146&isbn=&volume=361&issue=&spage=k2387&pages=&date=2018&title=BMJ+%28Online%29&atitle=Prevalence+and+outcomes+of+incidental+imaging+findings%3A+Umbrella+review&aulast=O%27Sullivan&pid=%3Cauthor%3EO%27Sullivan+J.W.%3BMuntinga+T.%3BGrigg+S.%3BIoannidis+J.P.A.%3C%2Fauthor%3E%3CAN%3E622630415%3C%2FAN%3E%3CDT%3EArticle%3C%2FDT%3E",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Prevalence and outcomes of incidental imaging findings: Umbrella review",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Primary and secondary prevention of colorectal cancer",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "https://search.ebscohost.com/login.aspx?direct=true&AuthType=shib&db=jlh&AN=148703893&site=ehost-live&scope=site&custid=s8849760",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Prostate cancer screening does not affect overall mortality",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Prostate health index (PHI) as a reliable biomarker for prostate cancer: a systematic review and meta-analysis",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Prostate-specific membrane antigen positron emission tomography compared to multiparametric MRI for prostate cancer diagnosis: a protocol for a systematic review and meta-analysis",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "http://www.bmj.com/content/bmj/350/bmj.g7773.full.pdf//https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emed16&AN=601430388//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:25569206&id=doi:10.1136%2Fbmj.g7773&issn=0959-8146&isbn=&volume=350&issue=07&spage=g7773&pages=&date=2015&title=BMJ+%28Online%29&atitle=Quantifying+and+monitoring+overdiagnosis+in+cancer+screening%3A+A+systematic+review+of+methods&aulast=Carter&pid=%3Cauthor%3ECarter+J.L.%3BColetti+R.J.%3BHarris+R.P.%3C%2Fauthor%3E%3CAN%3E601430388%3C%2FAN%3E%3CDT%3EArticle%3C%2FDT%3E",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Quantifying and monitoring overdiagnosis in cancer screening: A systematic review of methods",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "https://search.ebscohost.com/login.aspx?direct=true&AuthType=shib&db=jlh&AN=141641959&site=ehost-live&scope=site&custid=s8849760",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Radiolabelled PSMA PET/CT in breast cancer. A systematic review",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "https://search.ebscohost.com/login.aspx?direct=true&AuthType=shib&db=jlh&AN=120629012&site=ehost-live&scope=site&custid=s8849760",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Relation of comorbidities and patient navigation with the time to diagnostic resolution after abnormal cancer screening",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "http://journals.cambridge.org//https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emexb&AN=2018953540//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:35730322&id=doi:10.1017%2Ferm.2022.20&issn=1462-3994&isbn=&volume=24&issue=&spage=e25&pages=&date=2022&title=Expert+Reviews+in+Molecular+Medicine&atitle=Relevance+of+Emerging+Metabolomics-Based+Biomarkers+of+Prostate+Cancer%3A+A+Systematic+Review&aulast=Bansal&pid=%3Cauthor%3EBansal+N.%3BKumar+M.%3BSankhwar+S.N.%3BGupta+A.%3C%2Fauthor%3E%3CAN%3E2018953540%3C%2FAN%3E%3CDT%3EArticle%3C%2FDT%3E",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Relevance of Emerging Metabolomics-Based Biomarkers of Prostate Cancer: A Systematic Review",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Repeat prostate biopsy strategies after initial negative biopsy: meta-regression comparing cancer detection of transperineal, transrectal saturation and MRI guided biopsy",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "http://gut.bmj.com/content/62/6/812.full.pdf+html//https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emed14&AN=52445326//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:23408351&id=doi:10.1136%2Fgutjnl-2012-304356&issn=0017-5749&isbn=&volume=62&issue=6&spage=812&pages=812-823&date=2013&title=Gut&atitle=Revised+guidelines+for+the+clinical+management+of+Lynch+syndrome+%28HNPCC%29%3A+Recommendations+by+a+group+of+European+experts&aulast=Vasen&pid=%3Cauthor%3EVasen+H.F.A.%3BBlanco+I.%3BAktan-Collan+K.%3BGopie+J.P.%3BAlonso+A.%3BAretz+S.%3BBernstein+I.%3BBertario+L.%3BBurn+J.%3BCapella+G.%3BColas+C.%3BEngel+C.%3BFrayling+I.M.%3BMaurizio+Genuardi+K.H.%3BHes+F.J.%3BHodgson+S.V.%3BKaragiannis+J.A.%3BLalloo+F.%3BLindblom+A.%3BMecklin+J.-P.%3BMoller+P.%3BMyrhoj+T.%3BNagengast+F.M.%3BParc+Y.%3BDe+Leon+M.P.%3BRenkonen-Sinisalo+L.%3BSampson+J.R.%3BStormorken+A.%3BSijmons+R.H.%3BTejpar+S.%3BThomas+H.J.W.%3BRahner+N.%3BWijnen+J.T.%3BJarvinen+H.J.%3BMoslein+G.%3C%2Fauthor%3E%3CAN%3E52445326%3C%2FAN%3E%3CDT%3EReview%3C%2FDT%3E",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Revised guidelines for the clinical management of Lynch syndrome (HNPCC): Recommendations by a group of European experts",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emed13&AN=51483891//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:21605201&id=doi:10.1111%2Fj.1365-2796.2011.02404.x&issn=0954-6820&isbn=&volume=271&issue=1&spage=51&pages=51-63&date=2012&title=Journal+of+Internal+Medicine&atitle=Risk+of+cancer+by+transferrin+saturation+levels+and+haemochromatosis+genotype%3A+Population-based+study+and+meta-analysis&aulast=Ellervik&pid=%3Cauthor%3EEllervik+C.%3BTybjaerg-Hansen+A.%3BNordestgaard+B.G.%3C%2Fauthor%3E%3CAN%3E51483891%3C%2FAN%3E%3CDT%3EArticle%3C%2FDT%3E",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Risk of cancer by transferrin saturation levels and haemochromatosis genotype: Population-based study and meta-analysis",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "https://search.ebscohost.com/login.aspx?direct=true&AuthType=shib&db=jlh&AN=114186121&site=ehost-live&scope=site&custid=s8849760",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Risk Prediction Models for Lung Cancer: A Systematic Review",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emed14&AN=71274877//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:&id=doi:10.1016%2FS1569-9056%252813%252962406-9&issn=1569-9056&isbn=&volume=12&issue=6&spage=161&pages=161&date=2013&title=European+Urology%2C+Supplements&atitle=Safety+of+using+testosterone+for+the+treatment+of+androgen+deficiency+syndrome+in+adult+patients+treated+for+prostate+cancer&aulast=Jimenez+Pacheco&pid=%3Cauthor%3EJimenez+Pacheco+A.%3BNogueras+Ocana+M.%3BVerdu+Martinez+M.%3BLopez+Luque+A.%3C%2Fauthor%3E%3CAN%3E71274877%3C%2FAN%3E%3CDT%3EConference+Abstract%3C%2FDT%3E",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Intervention/ primary study/erratum/ conference abstract/ commentary/ clinic trial/ newsletter/ magazine/protocol/ literature review",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Safety of using testosterone for the treatment of androgen deficiency syndrome in adult patients treated for prostate cancer",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "https://search.ebscohost.com/login.aspx?direct=true&AuthType=shib&db=jlh&AN=104085916&site=ehost-live&scope=site&custid=s8849760",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Screening for new primary cancers in cancer survivors compared to non-cancer controls: a systematic review and meta-analysis",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "https://search.ebscohost.com/login.aspx?direct=true&AuthType=shib&db=jlh&AN=108025590&site=ehost-live&scope=site&custid=s8849760",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Systematic review and economic modelling of the relative clinical benefit and cost-effectiveness of laparoscopic surgery and robotic surgery for removal of the prostate in men with localised prostate cancer",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Systematic screening and assessment of psychosocial well-being and care needs of people with cancer",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emed18&AN=614479383//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:&id=doi:10.1002%2Fpon.4353&issn=1099-1611&isbn=&volume=26&issue=Supplement+1&spage=44&pages=44-45&date=2017&title=Psycho-Oncology&atitle=The+American+cancer+society+survivorship+guidelines%3A+From+systematic+review+to+dissemination+tools&aulast=Padgett&pid=%3Cauthor%3EPadgett+L.%3C%2Fauthor%3E%3CAN%3E614479383%3C%2FAN%3E%3CDT%3EConference+Abstract%3C%2FDT%3E",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Intervention/ primary study/erratum/ conference abstract/ commentary/ clinic trial/ newsletter/ magazine/protocol/ literature review",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "The American cancer society survivorship guidelines: From systematic review to dissemination tools",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "http://www.elsevier.com/inca/publications/store/6/2/2/9/3/4/index.htt//https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emexa&AN=2016115658//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:34954244&id=doi:10.1016%2Fj.ypmed.2021.106927&issn=0091-7435&isbn=&volume=155&issue=&spage=106927&pages=&date=2022&title=Preventive+Medicine&atitle=The+association+between+adherence+to+cancer+screening+programs+and+health+literacy%3A+A+systematic+review+and+meta-analysis&aulast=Baccolini&pid=%3Cauthor%3EBaccolini+V.%3BIsonne+C.%3BSalerno+C.%3BGiffi+M.%3BMigliara+G.%3BMazzalai+E.%3BTuratto+F.%3BSinopoli+A.%3BRosso+A.%3BDe+Vito+C.%3BMarzuillo+C.%3BVillari+P.%3C%2Fauthor%3E%3CAN%3E2016115658%3C%2FAN%3E%3CDT%3EReview%3C%2FDT%3E",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "The association between adherence to cancer screening programs and health literacy: A systematic review and meta-analysis",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "https://search.ebscohost.com/login.aspx?direct=true&AuthType=shib&db=jlh&AN=137930419&site=ehost-live&scope=site&custid=s8849760",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "The Case for Patient Navigation in Lung Cancer Screening in Vulnerable Populations: A Systematic Review",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "The potential of microRNAs as human prostate cancer biomarkers: A meta-analysis of related studies",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "The Potential of MicroRNAs as Prostate Cancer Biomarkers",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emed14&AN=369970742//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:23804290&id=doi:10.1177%2F1077558713492202&issn=1077-5587&isbn=&volume=70&issue=5&spage=473&pages=473-496&date=2013&title=Medical+Care+Research+and+Review&atitle=The+state+of+overuse+measurement%3A+A+critical+review&aulast=Chan&pid=%3Cauthor%3EChan+K.S.%3BChang+E.%3BNassery+N.%3BChang+H.-Y.%3BSegal+J.B.%3C%2Fauthor%3E%3CAN%3E369970742%3C%2FAN%3E%3CDT%3EReview%3C%2FDT%3E",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "The state of overuse measurement: A critical review",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.mdpi.com/2218-1989/11/1/17/pdf//https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emed22&AN=2005695847//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:&id=doi:10.3390%2Fmetabo11010017&issn=2218-1989&isbn=&volume=11&issue=1&spage=1&pages=1-15&date=2021&title=Metabolites&atitle=Urinary+volatile+organic+compound+analysis+for+the+diagnosis+of+cancer%3A+A+systematic+literature+review+and+quality+assessment&aulast=Wen&pid=%3Cauthor%3EWen+Q.%3BBoshier+P.%3BMyridakis+A.%3BBelluomo+I.%3BHanna+G.B.%3C%2Fauthor%3E%3CAN%3E2005695847%3C%2FAN%3E%3CDT%3EReview%3C%2FDT%3E",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Urinary volatile organic compound analysis for the diagnosis of cancer: A systematic literature review and quality assessment",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Validation of proposed prostate cancer biomarkers with gene expression data: a long road to travel",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "http://jnci.oxfordjournals.org///https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emed18&AN=615731616//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:28376200&id=doi:10.1093%2Fjnci%2Fdjw230&issn=0027-8874&isbn=&volume=109&issue=3&spage=djw230&pages=&date=2017&title=Journal+of+the+National+Cancer+Institute&atitle=Vitamin+B6+and+cancer+risk%3A+A+field+synopsis+and+meta-analysis&aulast=Mocellin&pid=%3Cauthor%3EMocellin+S.%3BBriarava+M.%3BPilati+P.%3C%2Fauthor%3E%3CAN%3E615731616%3C%2FAN%3E%3CDT%3EReview%3C%2FDT%3E",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Vitamin B6 and cancer risk: A field synopsis and meta-analysis",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "VPAC1-targeted PET/CT scan: improved molecular imaging for the diagnosis of prostate cancer using a novel cell surface antigen",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "http://www.scielo.br/pdf/spmj/v135n4/1806-9460-spmj-135-04-00401.pdf//https://access.ovid.com/custom/redirector/index.html?dest=https://go.openathens.net/redirector/www.monash.edu?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emed18&AN=617917518//https://monash.hosted.exlibrisgroup.com/primo-explore/openurl?institution=MUA&vid=MONUI_SP&lang=en_US?vid=MONUI&openInSeperateWindow=N&lang=en_US&sid=OVID:embase&id=pmid:28813112&id=doi:10.1590%2F1516-3180.2017.0171110717&issn=1516-3180&isbn=&volume=135&issue=4&spage=401&pages=401-410&date=2017&title=Sao+Paulo+Medical+Journal&atitle=O+que+as+revisoes+sistematicas+de+cochrane+falam+sobre+a+eficacia+clinica+dos+testes+de+rastreamento+e+diagnostico+para+o+cancer%3F&aulast=Bueno&pid=%3Cauthor%3EBueno+A.T.P.%3BCapelasso+V.L.%3BPacheco+R.L.%3BLatorraca+C.O.C.%3BDe+Castria+T.B.%3BPachito+D.V.%3BRiera+R.%3C%2Fauthor%3E%3CAN%3E617917518%3C%2FAN%3E%3CDT%3EArticle%3C%2FDT%3E",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "What do cochrane systematic reviews say about the clinical effectiveness of screening and diagnostic tests for cancer?",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "https://search.ebscohost.com/login.aspx?direct=true&AuthType=shib&db=jlh&AN=156548632&site=ehost-live&scope=site&custid=s8849760",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Intervention/ primary study/erratum/ conference abstract/ commentary/ clinic trial/ newsletter/ magazine/protocol/ literature review",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "What interventions affect the psychosocial burden experienced by prostate cancer patients undergoing active surveillance? A scoping review",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "2022 Update on Prostate Cancer Epidemiology and Risk Factors-A Systematic Review",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Acceptability of risk stratification within population-based cancer screening from the perspective of healthcare professionals: A mixed methods systematic review and recommendations to support implementation",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Acceptability of risk stratification within population_based cancer screening from the perspective of the general public: A mixed_methods systematic review",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ Diagnosis/",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Accuracy of novel urinary biomarker tests in the diagnosis of prostate cancer: A systematic review and network meta-analysis",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ Diagnosis/",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Analysis of Clinical Trials and Review of Recent Advances in Therapy Decisions for Locally Advanced Prostate Cancer",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "The association between dairy products consumption and prostate cancer risk: a systematic review and meta-analysis",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "ASSOCIATION BETWEEN HEART FAILURE AND INCIDENCE OF CANCER: A SYSTEMATIC REVIEW AND META-ANALYSIS",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Association of cigarette smoking habits with the risk of prostate cancer: a systematic review and meta-analysis",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ Diagnosis/",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Association of Second-generation Antiandrogens With Cognitive and Functional Toxic Effects in Randomized Clinical Trials: A Systematic Review and Meta-analysis",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Association of Statin Use with the Risk of Incident Prostate Cancer: A Meta-Analysis and Systematic Review",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Cancer incidence and mortality in Australia from 2020 to 2044 and an exploratory analysis of the potential effect of treatment delays during the COVID-19 pandemic: a statistical modelling study",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Cancer risk and mortality among firefighters: a meta-analytic review",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Cancer screening educational interventions in rural and farmworker communities: a systematic literature review",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Cigarette smoking and prostate cancer: A systematic review and meta-analysis of prospective cohort studies",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "The clinical impact of continued smoking in patients with breast and other hormone-dependent cancer: A systematic literature review",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ Diagnosis/",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Clinicopathological Significance and Prognostic Values of Long Noncoding RNA BCYRN1 in Cancer Patients: A Meta-Analysis and Bioinformatics Analysis",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ Diagnosis/",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Dual tracer PET using 68-Ga PSMA and 18-F FDG for staging prostate cancer: A systematic review",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ Diagnosis/",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Early Detection of Prostate Cancer: AUA/SUO Guideline Part II: Considerations for a Prostate Biopsy",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "EarlyCDT Lung blood test for risk classification of solid pulmonary nodules: systematic review and economic evaluation",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Effect and feasibility of gamification interventions for improving physical activity and health-related outcomes in cancer survivors: an early systematic review and meta-analysis",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "The effect of exercise on cancer-related pain: A systematic review with meta-analysis",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ Diagnosis/",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Efficacy and Safety of 225Ac-PSMA-617-Targeted Alpha Therapy in Metastatic Castration-Resistant Prostate Cancer: A Systematic Review and Meta-Analysis",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "eHealth-Based Interventions for Older Patients with Prostate Cancer: A Quick Review of the Literature",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Endocrine-disrupting chemicals and endocrine neoplasia: A forty-year systematic review",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Epidemiological outcomes in immunocompromised vs. immunocompetent prostate cancer patients: A systematic review, meta-analysis and meta-regression",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Cost effective/ budget impact",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Estimating the cost of prostate cancer diagnosis, treatment, and follow-up in New Zealand: A modelling study",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Factors affecting the decision to investigate older adults with potential cancer symptoms: a systematic review",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Factors influencing cancer patients' experiences of care in the USA, United Kingdom, and Canada: A systematic review",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Factors Influencing Primary Care Practitioners' Cancer Screening Recommendations for Older Adults: a Systematic Review",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Intervention/ primary study/erratum/ conference abstract/ commentary/ clinic trial/ newsletter/ magazine/protocol/ literature review",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Genetically adjusted PSA levels for prostate cancer screening",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Genitourinary manifestations of Lynch syndrome in the urological practice",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Germline mutations in prostate cancer: a systematic review of the evidence for personalized medicine",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "GI factors, potential to predict prostate motion during radiotherapy; a scoping review",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ Diagnosis/",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Glutathione-S-Transferase p1 Gene Promoter Methylation in Cell-Free DNA as a Diagnostic and Prognostic Tool for Prostate Cancer: A Systematic Review and Meta-Analysis",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ Diagnosis/",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Impact of comedonecrosis on prostate cancer outcome: a systematic review",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Intervention/ primary study/erratum/ conference abstract/ commentary/ clinic trial/ newsletter/ magazine/protocol/ literature review",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Impact of COVID-19 pandemic on screening and diagnosis of patients with prostate cancer: A systematic review protocol",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ Diagnosis/",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "The Impact of Image Guided Radiation Therapy (IGRT) on Efficacy and Toxicity of Prostate Cancer: A Systematic Review and Meta-Analysis",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ Diagnosis/",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "The impact of lag time to cancer diagnosis and treatment on clinical outcomes prior to the COVID-19 pandemic: a scoping review of systematic reviews and meta-analyses",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "The Impact of Socioeconomic Status (SES), Insurance Type, and Treatment Facility on Survival in Metastatic Prostate Cancer (MPC): A Systematic Literature Review (SLR) of Social Determinants of Health (SDOH)",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Inflammatory bowel disease-associated malignancies and considerations for radiation impacting bowel: a scoping review",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Interactive or tailored digital interventions to increase uptake in cervical, breast, and colorectal cancer screening to reduce health inequity: A systematic review",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ Diagnosis/",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Machine learning prediction of prostate cancer from transrectal ultrasound video clips",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ Diagnosis/",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Management of bone loss due to endocrine therapy during cancer treatment",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Non-english",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "MANAGEMENT OF PATIENTS WITH MULTIPLE PRIMARY SANCER IN THE PRACTICE OF A MODERN ONCOLOGIST. CASE REPORT AND LITERATURE REVIEW",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ Diagnosis/",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Micro-Ultrasound: Current Role in Prostate Cancer Diagnosis and Future Possibilities",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ Diagnosis/",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "The Microultrasound-Guided Prostate Biopsy in Detection of Prostate Cancer: A Systematic Review and Meta-Analysis",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ Diagnosis/",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Mitochondrial Alterations in Prostate Cancer: Roles in Pathobiology and Racial Disparities",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Models of communication for polygenic scores and associated psychosocial and behavioral effects on recipients: A systematic review",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Multi-cancer early detection test sensitivity for cancers with and without current population-level screening options",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Overdiagnosis and overuse of diagnostic and screening tests in low-income and middle-income countries: A scoping review",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "The patient, diagnostic, and treatment intervals in adult patients with cancer from high- And lower-income countries: A systematic review and meta-analysis",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ Diagnosis/",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "The potential of cell-free and exosomal microRNAs as biomarkers in liquid biopsy in patients with prostate cancer",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ Diagnosis/",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "The Potential of MicroRNAs as Non-Invasive Prostate Cancer Biomarkers: A Systematic Literature Review Based on a Machine Learning Approach",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Prevalence of Germline BRCA1/2 Variants in Ashkenazi and Non-Ashkenazi Prostate Cancer Populations: A Systematic Review and Meta-Analysis",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Prevalence of hypertension and pre-hypertension in the Middle East region: a systematic review & meta-analysis",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Intervention/ primary study/erratum/ conference abstract/ commentary/ clinic trial/ newsletter/ magazine/protocol/ literature review",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Prostate cancer screening: Continued controversies and novel biomarker advancements",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Prostate cancer, e-Health and consumer information - global field state and frontiers",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Intervention/ primary study/erratum/ conference abstract/ commentary/ clinic trial/ newsletter/ magazine/protocol/ literature review",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Prostate-Specific Antigen Screening in Transgender Patients",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Quality of life in early-onset colorectal cancer patients: systematic review",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Quantification of overdiagnosis in randomised trials of cancer screening: an overview and re-analysis of systematic reviews",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ Diagnosis/",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Recent advances in exosomal RNAs analysis towards diagnostic and therapeutic applications",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Recruitment rates and strategies in exercise trials in cancer survivorship: a systematic review",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Relationship between non-syndromic oral clefts and cancer: A systematic review and meta-analysis",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Research Quality and Impact of Cardiac Rehabilitation in Cancer Survivors: A Systematic Review and Meta-Analysis",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Review of psychological interventions in patients with cancer",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Risk of second primary cancer among breast cancer patients: A systematic review and meta-analysis",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ Diagnosis/",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "The role of localised prostate cancer treatment in renal transplant patients: A systematic review",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "The Role of Long Noncoding RNAs on Male Infertility: A Systematic Review and In Silico Analysis",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "A scoping review of ageism towards older adults in cancer care",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ Diagnosis/",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "A scoping review protocol to elucidate outcomes following abiraterone versus enzalutamide for prostate cancer",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Intervention/ primary study/erratum/ conference abstract/ commentary/ clinic trial/ newsletter/ magazine/protocol/ literature review",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Screening for prostate cancer: protocol for updating multiple systematic reviews to inform a Canadian Task Force on Preventive Health Care guideline update",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ Diagnosis/",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Systematic Evaluation of Studies in the Fields of Diagnosis and Management of Prostate Cancer in Coronavirus Disease 2019 Era",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ Diagnosis/",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "A Systematic Review of Circulating Tumor Cells Clinical Application in Prostate Cancer Diagnosis",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ Diagnosis/",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Systematic review of methods used to improve the efficacy of magnetic resonance in early detection of clinically significant prostate cancer",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "A SYSTEMATIC REVIEW ON THE ASSOCIATION BETWEEN OVARIAN AND PROSTATE CANCER WITH BRCA1 AND BRCA2 GENE",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Therapeutic strategies for gastric cancer targeting immune cells: Future directions",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Tuberculosis and risk of cancer: A systematic review and meta-analysis",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Intervention/ primary study/erratum/ conference abstract/ commentary/ clinic trial/ newsletter/ magazine/protocol/ literature review",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Underlying Features of Prostate Cancer-Statistics, Risk Factors, and Emerging Methods for Its Diagnosis",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "PEC",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ Diagnosis/",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "What are the effects of multimodal prehabilitation interventions in men affected by prostate cancer? A systematic review",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "Supplemental Scoping Review",
        "Type": "",
        "Date Access": "2022-07-10 00:00:00",
        "URL": "Supplemental Scoping Review",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Include",
        "Exclusion Reason Final Level 2": "",
        "Title": "Counseling Patients About Prostate Cancer Screening",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "Supplemental Scoping Review",
        "Type": "",
        "Date Access": "2022-07-10 00:00:00",
        "URL": "Supplemental Scoping Review",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Include",
        "Exclusion Reason Final Level 2": "",
        "Title": "Prostate Cancer Screening with PSA: Ten Years' Experience of Population Based Early Prostate Cancer Detection Programme in Lithuania",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "Supplemental Scoping Review",
        "Type": "",
        "Date Access": "2022-07-10 00:00:00",
        "URL": "Supplemental Scoping Review",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Include",
        "Exclusion Reason Final Level 2": "",
        "Title": "Program for Prostate Cancer Screening Using a Mobile Unit: Results From Brazil",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "Supplemental Scoping Review",
        "Type": "",
        "Date Access": "2022-07-10 00:00:00",
        "URL": "Supplemental Scoping Review",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Include",
        "Exclusion Reason Final Level 2": "",
        "Title": "Tyrol Prostate Cancer Demonstration Project: early detection, treatment, outcome, incidence and mortality",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "Grey",
        "Date Access": "2022-07-15 00:00:00",
        "URL": "https://www.iqwig.de/download/s19-01_psa-screening_extract-of-final-report_v1-0.pdf",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Include",
        "Exclusion Reason Final Level 2": "",
        "Title": "Prostate cancer screening with the PSA test",
        "Theme": "Psa testing",
        "Research Paper Type": "Review Journal",
        "Country/ Organisation": "Institute for Quality and Efficiency in Healthcare"
    },
    {
        "Source": "TRIP",
        "Type": "Non-Grey",
        "Date Access": "2022-07-15 00:00:00",
        "URL": "https://www.cua.org/system/files/Guideline-Files/7851_v6_1.pdf",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Include",
        "Exclusion Reason Final Level 2": "",
        "Title": "Canadian Urological Association recommendations on prostate cancer screening and early diagnosis",
        "Theme": "Guidelines",
        "Research Paper Type": "Guidelines/Recommendations",
        "Country/ Organisation": "Canadian Urological Association"
    },
    {
        "Source": "TRIP",
        "Type": "Grey",
        "Date Access": "2022-07-15 00:00:00",
        "URL": "https://www.nice.org.uk/guidance/ng12/resources/suspected-cancer-recognition-and-referral-pdf-1837268071621",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Include",
        "Exclusion Reason Final Level 2": "",
        "Title": "Suspected cancer: recognition and referral",
        "Theme": "Guidelines",
        "Research Paper Type": "Guidelines",
        "Country/ Organisation": "National Institute for Health and Care Excellence"
    },
    {
        "Source": "TRIP",
        "Type": "Non-Grey",
        "Date Access": "2022-07-15 00:00:00",
        "URL": "https://www.auanet.org/guidelines/guidelines/prostate-cancer-early-detection-guideline",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Include",
        "Exclusion Reason Final Level 2": "",
        "Title": "Early Detection of Prostate Cancer",
        "Theme": "Guidelines",
        "Research Paper Type": "Guidelines",
        "Country/ Organisation": "American Urological Association"
    },
    {
        "Source": "TRIP",
        "Type": "Grey",
        "Date Access": "2022-07-15 00:00:00",
        "URL": "https://web.archive.org/web/20180712165217/https://www.guideline.gov/syntheses/synthesis/49682",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Include",
        "Exclusion Reason Final Level 2": "",
        "Title": "Screening for Prostate Cancer*",
        "Theme": "Guidelines",
        "Research Paper Type": "Recommendation",
        "Country/ Organisation": "American College of Physician"
    },
    {
        "Source": "TRIP",
        "Type": "Non-Grey",
        "Date Access": "2022-07-15 00:00:00",
        "URL": "https://www.annalsofoncology.org/article/S0923-7534(19)31645-X/fulltext",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Include",
        "Exclusion Reason Final Level 2": "",
        "Title": "Prevention and Screening in BRCA Mutation Carriers and Other Breast/Ovarian Hereditary Cancer Syndromes",
        "Theme": "Guidelines",
        "Research Paper Type": "Recommendation",
        "Country/ Organisation": "European Society for Medical Oncology"
    },
    {
        "Source": "TRIP",
        "Type": "Grey",
        "Date Access": "2022-07-15 00:00:00",
        "URL": "https://www.cancer.org.au/assets/pdf/clinical-practice-guidelines-for-psa-testing-and-early-management-of-test-detected-prostate-cancer",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Include",
        "Exclusion Reason Final Level 2": "",
        "Title": "Clinical practice guidelines PSA Testing and Early Management of Test-Detected Prostate Cancer",
        "Theme": "Guidelines",
        "Research Paper Type": "Recommendation",
        "Country/ Organisation": "American College of Physician"
    },
    {
        "Source": "TRIP",
        "Type": "Grey",
        "Date Access": "2022-07-15 00:00:00",
        "URL": "https://dkf1ato8y5dsg.cloudfront.net/uploads/47/451/1-psa-consensus-statement-and-pcrmp-guidelines.pdf",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Include",
        "Exclusion Reason Final Level 2": "",
        "Title": "Consensus statements on PSA testing in asymptomatic men in the UK",
        "Theme": "Guidelines",
        "Research Paper Type": "Recommendation",
        "Country/ Organisation": "Prostate Cancer UK"
    },
    {
        "Source": "TRIP",
        "Type": "Non-Grey",
        "Date Access": "2022-07-15 00:00:00",
        "URL": "https://www.auanet.org/guidelines/guidelines/shared-decision-making",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Include",
        "Exclusion Reason Final Level 2": "",
        "Title": "AUA White Paper on Implementation of Shared Decision Making into Urological Practice",
        "Theme": "Decision aids",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "Non-Grey",
        "Date Access": "2022-07-15 00:00:00",
        "URL": "NMA",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Include",
        "Exclusion Reason Final Level 2": "",
        "Title": "Shared Decision Making for Cancer Screening",
        "Theme": "Decision aids (sdm)",
        "Research Paper Type": "Systematic Review",
        "Country/ Organisation": "Department of Veteran Affairs Health Services Research & Development Service"
    },
    {
        "Source": "TRIP",
        "Type": "Grey",
        "Date Access": "2022-07-15 00:00:00",
        "URL": "https://canadiantaskforce.ca/guidelines/published-guidelines/prostate-cancer/",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Include",
        "Exclusion Reason Final Level 2": "",
        "Title": "Prostate Cancer",
        "Theme": "Guidelines",
        "Research Paper Type": "Summary of recommendations for clinicians and policy makers ",
        "Country/ Organisation": "Canadian Task Force on Preventive Health Care"
    },
    {
        "Source": "TRIP",
        "Type": "Non-Grey",
        "Date Access": "2022-07-15 00:00:00",
        "URL": "https://www.acpjournals.org/doi/10.7326/0003-4819-158-10-201305210-00633",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Include",
        "Exclusion Reason Final Level 2": "",
        "Title": "Guidance Statement: Screening for Prostate Cancer: A Guidance Statement from the American College of Physicians",
        "Theme": "Guidelines",
        "Research Paper Type": "Recommendation",
        "Country/ Organisation": "American College of Physicians"
    },
    {
        "Source": "TRIP",
        "Type": "Grey",
        "Date Access": "2022-07-15 00:00:00",
        "URL": "https://www.crd.york.ac.uk/prospero/display_record.php?ID=CRD42022292949",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Exclude",
        "Exclusion Reason Final Level 2": "News, lecturer note, thesis, draft, proposal, module, stimulation, presscast, fact sheet, opinion, editorial",
        "Title": "A systematic review of clinical practice guidelines on prostate cancer",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "Grey",
        "Date Access": "2022-07-15 00:00:00",
        "URL": "https://evidence.nihr.ac.uk/collection/improving-mens-health-outcomes/",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Exclude",
        "Exclusion Reason Final Level 2": "For public consumption, patient info/guide, trial information",
        "Title": "Improving menÃs health outcomes",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "Non-Grey",
        "Date Access": "2022-07-15 00:00:00",
        "URL": "https://www.esmo.org/guidelines/guidelines-by-topic/genitourinary-cancers/prostate-cancer",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Exclude",
        "Exclusion Reason Final Level 2": "Others",
        "Title": "Clinical Practice Guidelines Ã Prostate Cancer",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "Grey",
        "Date Access": "2022-07-15 00:00:00",
        "URL": "https://www.saxinstitute.org.au/wp-content/uploads/22.05_Evidence-Check_Support-along-the-cancer-pathway-for-Aboriginal-People-1.pdf",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Exclude",
        "Exclusion Reason Final Level 2": "Others",
        "Title": "Support along the cancer pathway for Aboriginal people",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "Grey",
        "Date Access": "2022-07-15 00:00:00",
        "URL": "https://aimproviders.com/genetictesting/wp-content/uploads/sites/15/2021/10/GT02-Hereditary-Cancer-Susceptibility-March-6-2022.pdf",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Exclude",
        "Exclusion Reason Final Level 2": "Others",
        "Title": "Genetic Testing for Hereditary Cancer Susceptibility",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "Grey",
        "Date Access": "2022-07-15 00:00:00",
        "URL": "https://www.nice.org.uk/guidance/ng131/resources/prostate-cancer-diagnosis-and-management-pdf-66141714312133",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Exclude",
        "Exclusion Reason Final Level 2": "Summary study, not guideline, no screening details, no details, no analysis",
        "Title": "Prostate cancer: diagnosis and management",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "Grey",
        "Date Access": "2022-07-15 00:00:00",
        "URL": "https://www.albertahealthservices.ca/assets/info/hp/cancer/if-hp-cancer-guide-gu012-local-prostate.pdf",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Exclude",
        "Exclusion Reason Final Level 2": "Management and/or treatment",
        "Title": "Local Prostate Cancer",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "Non-Grey",
        "Date Access": "2022-07-15 00:00:00",
        "URL": "https://www.researchsquare.com/article/rs-9323/v1",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Exclude",
        "Exclusion Reason Final Level 2": "News, lecturer note, thesis, draft, proposal, module, stimulation, presscast, fact sheet, opinion, editorial",
        "Title": "Methodology quality and grading recommendations in cancer screening guidelines: a systematic review",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "Grey",
        "Date Access": "2022-07-15 00:00:00",
        "URL": "https://www.cadth.ca/prostate-specific-antigen-testing-prostate-cancer-clinical-utility-and-guidelines",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Exclude",
        "Exclusion Reason Final Level 2": "News, lecturer note, thesis, draft, proposal, module, stimulation, presscast, fact sheet, opinion, editorial",
        "Title": "Prostate-Specific Antigen Testing for Prostate Cancer: Clinical Utility and Guidelines",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "Grey",
        "Date Access": "2022-07-15 00:00:00",
        "URL": "https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/brca-related-cancer-risk-assessment-genetic-counseling-and-genetic-testing",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Exclude",
        "Exclusion Reason Final Level 2": "Not research study objectives - ie not prostate cancer-related or decision aid or guideline or programme related to prostate cancer",
        "Title": "BRCA-Related Cancer: Risk Assessment, Genetic Counseling, and Genetic Testing",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "Grey",
        "Date Access": "2022-07-15 00:00:00",
        "URL": "https://www.jla.nihr.ac.uk/priority-setting-partnerships/detecting-cancer-early/top-10.htm",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Exclude",
        "Exclusion Reason Final Level 2": "For public consumption, patient info/guide, trial information",
        "Title": "Detecting Cancer Early",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "Grey",
        "Date Access": "2022-07-15 00:00:00",
        "URL": "https://www.hca.wa.gov/assets/program/gene-expression-final-findings-decision-20180518.pdf",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Exclude",
        "Exclusion Reason Final Level 2": "Summary study, not guideline, no screening details, no details, no analysis",
        "Title": "Gene expression profile testing of cancer tissue",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "Grey",
        "Date Access": "2022-07-15 00:00:00",
        "URL": "https://www.decisionbox.ulaval.ca/en/box-details/?tx_tmboites_tmboitesmain%5Bclear%5D=1&tx_tmboites_tmboitesmain%5Bboite%5D=60",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Exclude",
        "Exclusion Reason Final Level 2": "For public consumption, patient info/guide, trial information",
        "Title": "Prostate Cancer Screening",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "Non-Grey",
        "Date Access": "2022-07-15 00:00:00",
        "URL": "https://web.archive.org/web/20180609222337/https://www.guideline.gov/summaries/summary/51025/clinically-localized-prostate-cancer-auaastrosuo-guideline",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Exclude",
        "Exclusion Reason Final Level 2": "Management and/or treatment",
        "Title": "Clinically localized prostate cancer: AUA/ASTRO/SUO guideline.",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "Non-Grey",
        "Date Access": "2022-07-15 00:00:00",
        "URL": "https://acsearch.acr.org/docs/69397/Narrative/",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Exclude",
        "Exclusion Reason Final Level 2": "Management and/or treatment",
        "Title": "Locally Advanced, High-Risk Prostate Cancer",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "Non-Grey",
        "Date Access": "2022-07-15 00:00:00",
        "URL": "https://acsearch.acr.org/docs/69371/Narrative/",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Exclude",
        "Exclusion Reason Final Level 2": "Management and/or treatment",
        "Title": "Prostate Cancer?Pretreatment Detection, Surveillance, and Staging",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "Non-Grey",
        "Date Access": "2022-07-15 00:00:00",
        "URL": "https://www.journals.elsevier.com/annals-of-oncology",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Exclude",
        "Exclusion Reason Final Level 2": "Others",
        "Title": "Cancer of the Prostate",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "Grey",
        "Date Access": "2022-07-15 00:00:00",
        "URL": "https://www.nice.org.uk/guidance/dg17",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Exclude",
        "Exclusion Reason Final Level 2": "Others",
        "Title": "Diagnosing prostate cancer: PROGENSA PCA3 assay and Prostate Health Index",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "Non-Grey",
        "Date Access": "2022-07-15 00:00:00",
        "URL": "https://www.acmg.net/docs/gim2014147a.pdf",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Exclude",
        "Exclusion Reason Final Level 2": "Others",
        "Title": "A Practice Guideline from the American College of Medical Genetics and Genomics and the National Society of Genetic Counselors: Referral Indications for Cancer Predisposition Assessment",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "Non-Grey",
        "Date Access": "2022-07-15 00:00:00",
        "URL": "https://www.acpjournals.org/doi/10.7326/M14-2327?articleid=2293237",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Exclude",
        "Exclusion Reason Final Level 2": "Not research study objectives (ie. not prostate cancer-related or decision aid or guideline or programme related to prostate cancer)",
        "Title": "A Value Framework for Cancer Screening: Advice for High-Value Care From the American College of Physicians",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "Non-Grey",
        "Date Access": "2022-07-15 00:00:00",
        "URL": "https://www.acpjournals.org/doi/10.7326/M14-2326?resultClick=3&articleid=2294149",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Exclude",
        "Exclusion Reason Final Level 2": "Not research study objectives (ie. not prostate cancer-related or decision aid or guideline or programme related to prostate cancer)",
        "Title": "Screening for Cancer: Advice for High-Value Care From the American College of Physicians",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "Non-Grey",
        "Date Access": "2022-07-15 00:00:00",
        "URL": "https://www.racgp.org.au/afp/2013/may/the-male-reproductive-system",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Exclude",
        "Exclusion Reason Final Level 2": "Management and/or treatment",
        "Title": "The male reproductive system. An overview of common problems",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "Non-Grey",
        "Date Access": "2022-07-15 00:00:00",
        "URL": "https://www.journals.elsevier.com/annals-of-oncology",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Exclude",
        "Exclusion Reason Final Level 2": "Others",
        "Title": "Prostate cancer",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "Grey",
        "Date Access": "2022-07-15 00:00:00",
        "URL": "https://www.crd.york.ac.uk/crdweb/ShowRecord.asp?ID=32014000867&ID=32014000867",
        "Final Level 1 Consensus": "Include",
        "Exclusion Reason Final Level 1": "",
        "Final Level 2 Consensus": "Exclude",
        "Exclusion Reason Final Level 2": "News, lecturer note, thesis, draft, proposal, module, stimulation, presscast, fact sheet, opinion, editorial",
        "Title": "Prostate cancer screening: a review of the guidelines",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://d56bochluxqnz.cloudfront.net/documents/full-guideline/EAU-Guidelines-on-Primary-Urethral-Carcinoma-2022.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Primary Urethral Carcinoma",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.leitlinienprogramm-onkologie.de/fileadmin/user_upload/Oncological_quality_indicators_5.0_EN.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Guideline-based quality indicators in the guideline program on oncology (OL)",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.saxinstitute.org.au/wp-content/uploads/22.06_Evidence-Check_Measuring-clinician-experience-of-providing-care.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Measuring clinician experience of providing care",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://aimspecialtyhealth.com/wp-content/uploads/2021/09/RBM_oncologic-imaging.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Appropriate Use Criteria: Oncologic Imaging",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://ascopubs.org/doi/full/10.1200/JCO.22.00687",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Exercise, Diet, and Weight Management During Cancer Treatment",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.asge.org/docs/default-source/about-asge/piis00165107210187217f66644f-297a-4be7-99a8-595f69849005.pdf?sfvrsn=b80d665c_1",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "American Society for Gastrointestinal Endoscopy guideline on screening for pancreatic cancer in individuals with genetic susceptibility: methodology and review of evidence",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://d56bochluxqnz.cloudfront.net/documents/full-guideline/EAU-Guidelines-on-Penile-Cancer-2022.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Penile Cancer",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://aimspecialtyhealth.com/wp-content/uploads/2021/12/Cardiac-Imaging-03-13-22.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Appropriate Use Criteria: Imaging of the Heart",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "file:///Users/chutizzah/Downloads/213407_95fe179c-b59b-4891-819b-0b1d42e1117d.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Stop Smoking National Clinical Guideline",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://aimspecialtyhealth.com/wp-content/uploads/2021/12/Radiation-Therapy-excludes-Proton-03-13-22.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Appropriate Use Criteria: Brachytherapy, Intensity Modulated Radiation Therapy, Stereotactic Body Radiation Therapy, and Stereotactic Radiosurgery",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "file:///Users/chutizzah/Downloads/9789241509220-eng.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Systematic review of needs for medical devices for ageing populations",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.facs.org/media/k45gikqv/spine_injury_guidelines.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Spine Injury",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://d56bochluxqnz.cloudfront.net/documents/full-guideline/EAU-Guidelines-on-Chronic-Pelvic-Pain-2022_2022-03-29-084111_kpbq.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Chronic Pelvic Pain",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "file:///Users/chutizzah/Downloads/Localized%20Prostate%20Cancer%20Guideline%20050922.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Clinically Localized Prostate Cancer",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://aimspecialtyhealth.com/wp-content/uploads/2021/12/Therapeutic-Radiopharmaceuticals-03-13-22.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Appropriate Use Criteria: Therapeutic Radiopharmaceuticals",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://aimspecialtyhealth.com/wp-content/uploads/2021/12/Proton-Beam-Therapy-03-13-22.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Appropriate Use Criteria: Proton Beam Therapy",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://aimproviders.com/genetictesting/wp-content/uploads/sites/15/2021/10/GT04-Molecular-Testing-of-Solid-and-Hematologic-Tumors-March-6-2022.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Molecular Testing of Solid and Hematologic Tumors and Malignancies",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://aimspecialtyhealth.com/wp-content/uploads/2021/09/RBM_abdomen-pelvis-imaging.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Appropriate Use Criteria: Imaging of the Abdomen and Pelvis",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.ahajournals.org/doi/10.1161/ATV.0000000000000153",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Nonalcoholic Fatty Liver Disease and Cardiovascular Risk: A Scientific Statement From the American Heart Association",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "http://s3.amazonaws.com/rdcms-snmmi/files/production/public/FileDownloads/ProcedureStandards/Joint%20EANM_SNMMI%20Radiomics%20Guideline%20Final.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Joint EANM/SNMMI Guideline on Radiomics in Nuclear Medicine",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.nogg.org.uk/full-guideline/section-7-strategies-management-osteoporosis-and-fracture-risk",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Clinical guideline for the prevention and treatment of osteoporosis: Strategies for management of osteoporosis and fracture risk",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.nogg.org.uk/full-guideline/section-3-fracture-risk-assessment-and-case-finding",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Clinical guideline for the prevention and treatment of osteoporosis: Fracture risk assessment and case finding",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.annalsofoncology.org/article/S0923-7534(22)00691-3/fulltext",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "The role of patient-reported outcome measures in the continuum of cancer clinical care: ESMO Clinical Practice Guideline",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.albertahealthservices.ca/assets/info/hp/cancer/if-hp-cancer-guide-oncologic-emergencies.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Oncologic Emergencies",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.albertahealthservices.ca/assets/info/hp/cancer/if-hp-cancer-guide-gu009-noninvasive-bladder.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Non-muscle Invasive Bladder Cancer",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://kce.fgov.be/sites/default/files/2022-04/KCE_352C_HSPA_Chronic_Conditions_Report_0.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Health system performance assessment: care for people living with chronic conditions",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://acsearch.acr.org/docs/69358/Narrative/?_ga=2.64315695.1208439396.1649760002-2082026322.1646820991&_gl=1*1ecgsi0*_ga*MjA4MjAyNjMyMi4xNjQ2ODIwOTkx*_ga_K9XZBF7MXP*MTY0OTc2MDAwMS4xLjAuMTY0OTc2MDAwMS4w",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Osteoporosis and Bone Mineral Density",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.tandfonline.com/doi/full/10.1080/24745332.2022.2036073",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Extra-pulmonary tuberculosis",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://icer.org/wp-content/uploads/2021/08/ICER_Neutropenia_Evidence-Report_033122.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Novel Agents to Prevent Chemotherapy-Induced Neutropenia and Other Myelosuppressive Effects",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.saxinstitute.org.au/wp-content/uploads/22.03_Evidence-Check_Review-of-effectiveness-of-certain-health-lifestyle-interventions-2014-2019.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Review of effectiveness of certain health lifestyle interventions 2014-2019",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.cua.org/system/files/Guideline-Files/7906_BPH-LUTS%20Guideline_Epub_NB.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Canadian Urological Association guideline on male lower urinary tract symptoms/benign prostatic hyperplasia (MLUTS/BPH)",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://ijgc.bmj.com/content/31/12/1508",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "European Society of Gynaecological Oncology quality indicators for the surgical treatment of endometrial carcinoma",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.ctro.science/article/S2405-6308(21)00103-8/fulltext",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "GEC ESTRO ACROP consensus recommendations for contact brachytherapy for rectal cancer",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/models-care-adult-survivors-childhood-cancer-evidence-report.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Models of Care That Include Primary Care for Adult Survivors of Childhood Cancer: A Realist Review",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.jmdjournal.org/article/S1525-1578(21)00327-5/fulltext",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Electronic Health Records and Genomics: Perspectives from the Association for Molecular Pathology Electronic Health Record (EHR) Interoperability for Clinical Genomics Data Working Group",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://ascopubs.org/doi/full/10.1200/JCO.21.02767",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Somatic Genomic Testing in Patients with Metastatic or Advanced Cancer",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://ascopubs.org/doi/full/10.1200/JCO.21.01440",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: ASCO Guideline Update",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.cancercareontario.ca/en/file/64371/download?token=ZH-6iMB2",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Enhancing the Delivery of Oncology Systemic Treatment in the Home and Community in Ontario Recommendations Report",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://uroweb.org/guidelines/chronic-pelvic-pain",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Chronic Pelvic Pain",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://blogs.bmj.com/bjsm/2022/01/07/dna-damage-and-repair-capacity-related-to-diet-and-exercise-a-new-dimension-in-cancer-treatment/",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "DNA damage and repair capacity related to diet and exercise: a new dimension in cancer treatment?",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.cua.org/system/files/Guideline-Files/7660.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Canadian Urological Association best practice report: Bone health in prostate cancer",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.giejournal.org/article/S0016-5107(21)01437-1/fulltext",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Updates on age to start and stop colorectal cancer screening: recommendations from the U.S. Multi-Society Task Force on Colorectal Cancer",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.wses.org.uk/wp-content/uploads/2022/01/953-Anorectal-emergencies_-WSES-AAST-guidelines.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Anorectal emergencies: WSES-AAST guidelines",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.ace-hta.gov.sg/docs/default-source/default-document-library/artificial-intelligence-and-its-clinical-applications.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Artificial Intelligence and Its Clinical Applications",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.scottishmedicines.org.uk/media/6666/enzalutamide-xtandi-final-jan-2022-for-website.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Enzalutamide (Xtandi) - treatment of adults with metastatic hormone-sensitive prostate cancer (mHSPC) in combination with androgen deprivation therapy (ADT)",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.cancercareontario.ca/en/file/64186/download?token=wkbOfsUu",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Evidence from Primary Studies and Systematic Reviews and Recommendations from Clinical Practice Guidelines January to June 2021",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.eshre.eu/Eshre/NotFound.aspx",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Endometriosis",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://kce.fgov.be/sites/default/files/2022-04/KCE_351_Right_to_be_forgotten_Breast_Cancer_Report_2nd_print.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "The right to be forgotten in breast cancer: new propositions",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://kce.fgov.be/sites/default/files/2022-02/KCE_348_Patient_Needs_Report.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Identifying Patient needs: methodological approach and application",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.nice.org.uk/advice/mib280/resources/paige-prostate-for-prostate-cancer-pdf-2285965868093125",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Paige Prostate for prostate cancer",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.nice.org.uk/guidance/mtg61/resources/synergo-for-nonmuscleinvasive-bladder-cancer-pdf-64372171671493",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Synergo for non-muscle-invasive bladder cancer",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://uroweb.org/guidelines/urological-infections/chapter/the-guideline",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Urological Infections",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://ashpublications.org/bloodadvances/article/5/4/927/475194/American-Society-of-Hematology-2021-guidelines-for",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "American Society of Hematology 2021 guidelines for management of venous thromboembolism: prevention and treatment in patients with cancer",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.bmus.org/static/uploads/resources/2021_SoR_and_BMUS_guidelines_v1.0_.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Guidelines for Professional Ultrasound Practice",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://muhc.ca/sites/default/files/micro/m-TAU/MRI-Linac-report-final-13-Dec2021.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Magnetic resonance imaging-guided radiotherapy for cancer patients undergoing radiotherapy at the MUHC",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.cancercareontario.ca/en/file/63276/download?token=8Y9hOa-l",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "An Endorsement of the 2021 Guideline on the Initial Management of Noncastrate Advanced, Recurrent, or Metastatic Prostate Cancer: ASCO Guideline Update",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.cancercareontario.ca/en/file/63491/download?token=F7OoHvFg",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Prevention and Outpatient Management of Febrile Neutropenia in Adult Cancer Patients: Clinical Practice Guideline",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://onlinelibrary.wiley.com/doi/10.1111/codi.15503",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "The Association of Coloproctology of Great Britain and Ireland consensus guidelines in emergency colorectal surgery",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.nice.org.uk/guidance/ng203/resources/chronic-kidney-disease-assessment-and-management-pdf-66143713055173",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Chronic kidney disease: assessment and management",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.auanet.org/guidelines/guidelines/acute-ischemic-priapism",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Acute Ischemic Priapism",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.annalsofoncology.org/article/S0923-7534(21)04827-4/fulltext",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Bladder Cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://icer.org/wp-content/uploads/2021/04/ICER_HCM_Final_Evidence_Report_111621.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Mavacamten for Hypertrophic Cardiomyopathy: Effectiveness and Value",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "http://bioethicsdiscussion.blogspot.com/2021/11/preserving-patient-dignity-formerly.html",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Preserving Patient Dignity (Formerly Patient Modesty) Volume 120",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.jogc.com/article/S1701-2163(21)00603-4/fulltext",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Menopause: Vasomotor Symptoms, Prescription Therapeutic Agents, Complementary and Alternative Medicine, Nutrition, and Lifestyle",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.nice.org.uk/guidance/ta741/resources/apalutamide-with-androgen-deprivation-therapy-for-treating-hormonesensitive-metastatic-prostate-cancer-pdf-82611309932485",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Apalutamide with androgen deprivation therapy for treating hormone-sensitive metastatic prostate cancer",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.thegreenjournal.com/article/S0167-8140(10)00055-1/fulltext",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "The European Society of Therapeutic Radiology and OncologyÃEuropean Institute of Radiotherapy (ESTROÃEIR) report on 3D CT-based in-room image guidance systems: A practical and technical review and guide",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://ejnmmipharmchem.springeropen.com/articles/10.1186/s41181-021-00149-6",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "EANM guideline for harmonisation on molar activity or specific activity of radiopharmaceuticals: impact on safety and imaging quality",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.leitlinienprogramm-onkologie.de/fileadmin/user_upload/S3_Guideline_Breast_Cancer.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Evidence-based Guideline for the Early Detection, Diagnosis, Treatment and Follow-up of Breast Cancer",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.practicalradonc.org/article/S1879-8500(21)00233-2/fulltext",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "External Beam Radiation Therapy for Primary Liver Cancers",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "file:///Users/chutizzah/Downloads/197784_2e897cca-3b57-4753-b420-c397474dd171.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Sepsis Management for Adults (including maternity)",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://academic.oup.com/HTTPHandlers/Sigma/LoginHandler.ashx?error=login_required&state=b8cfacdc-9de8-466f-b3d3-86ac2c45e907redirecturl%3Dhttpszazjzjacademiczwoupzwcomzjhropenzjarticlezj2021zj4zjhoab025zj6406628",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Endometriosis classification, staging and reporting systems: a review on the road to a universally accepted endometriosis classification",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://acsearch.acr.org/docs/69365/Narrative/?_ga=2.123307595.1385830465.1636370147-690048462.1636370147",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Post-Treatment Follow-up and Active Surveillance of Clinically Localized Renal Cell Cancer",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://journal.chestnet.org/article/S0012-3692(21)01307-6/fulltext",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Screening for Lung Cancer: CHEST Guideline and Expert Panel Report",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.asrm.org/globalassets/asrm/asrm-content/news-and-publications/practice-guidelines/for-non-members/obesity_and_reproduction.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Obesity and reproduction: a committee opinion",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.canceraustralia.gov.au/sites/default/files/publications/impact-covid-19-cancer-related-medical-services-and-procedures-australia-2020-examination-mbs-claims/pdf/the-impact-of-covid-19-on-cancer-services-in-australia-in-2020.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "The impact of COVID-19 on cancer-related medical services and procedures in Australia in 2020: Examination of MBS claims data for 2020, nationally and by jurisdiction",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.annalsofoncology.org/article/S0923-7534(21)04493-8/fulltext",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "eUpdate Ã Renal Cell Carcinoma Treatment Recommendations",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.iqwig.de/download/a20-87_durvalumab_extract-of-dossier-assessment_v1-0.pdf?rev=209240",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Durvalumab (small cell lung cancer) - Benefit assessment according to Â¤35a Social Code Book V",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www2.gov.bc.ca/gov/content/health/practitioner-professional-resources/bc-guidelines/lung-cancer",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Suspected Lung Cancer in Primary Care",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://journals.sagepub.com/doi/full/10.1177/08465371211000739",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Investigation of Acute Pulmonary Embolism, Part 2: Technical Issues and Interpretation Pitfalls",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://journals.lww.com/ajg/Fulltext/2021/10000/ACG_Clinical_Guidelines__Management_of_Benign.13.aspx?context=FeaturedArticles&collectionId=2",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Management of Benign Anorectal Disorders",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://pubmed.ncbi.nlm.nih.gov/34536287/",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Life expectancy estimates based on comorbidities and frailty to inform preventive care",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://aimspecialtyhealth.com/wp-content/uploads/2020/05/AIM_Guidelines_Nuclear_Medicine_Imaging.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Appropriate Use Criteria: Nuclear Medicine Imaging",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.worldgastroenterology.org/UserFiles/file/guidelines/helicobacter-pylori-english-2021.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Helicobacter Pylori",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://aimspecialtyhealth.com/wp-content/uploads/2021/06/AIM_Guidelines_Febrile_Neutropenia_Risk.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Appropriate Use Criteria: Febrile Neutropenia Risk",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://aimproviders.com/genetictesting/wp-content/uploads/sites/15/2021/03/GT02-Hereditary-Cancer-Susceptibility-9-6-2021.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Genetic Testing for Hereditary Cancer Susceptibility",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://aimspecialtyhealth.com/wp-content/uploads/2021/01/AIM_Guidelines_Therapeutic-Radiopharmaceuticals.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Appropriate Use Criteria: Therapeutic Radiopharmaceuticals",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://aimproviders.com/wp-content/uploads/2019/11/AIM_Workbook.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "AIM Cancer Treatment Pathways",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://aimspecialtyhealth.com/wp-content/uploads/2021/03/AIM_Guidelines_AbdomenPelvis_Imaging.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Appropriate Use Criteria: Imaging of the Abdomen and Pelvis",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.auanet.org/guidelines/guidelines/adult-neurogenic-lower-urinary-tract-dysfunction",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "AUA/SUFU Guideline on Adult Neurogenic Lower Urinary Tract Dysfunction",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://aimproviders.com/genetictesting/wp-content/uploads/sites/15/2021/03/GT04-Molecular-Testing-of-Solid-and-Hematologic-Tumors-9-6-2021.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Molecular Testing of Solid and Hematologic Tumors and Malignancies",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://aimspecialtyhealth.com/wp-content/uploads/2021/01/AIM_Guidelines_Cardiac_Imaging.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Appropriate Use Criteria: Imaging of the Heart",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://aimspecialtyhealth.com/wp-content/uploads/2021/01/AIM_Guidelines_ProtonBeam.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Appropriate Use Criteria: Proton Beam Therapy",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.nice.org.uk/advice/mib273/resources/collipee-for-first-void-urine-collection-pdf-2285965812665797",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Colli-Pee for first void urine collection",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://academic.oup.com/HTTPHandlers/Sigma/LoginHandler.ashx?error=login_required&state=c898f28f-1453-4e7c-b571-0a7fa65da23dredirecturl%3Dhttpszazjzjacademiczwoupzwcomzjeurheartjzjadvancezyarticlezjdoizj10zw1093zjeurheartjzjehab368zj6358045",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://link.springer.com/article/10.1007/s00259-021-05334-y",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "The EANM practice guidelines for parathyroid imaging",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.cua.org/system/files/Guideline-Files/7572_ED%20guideline_Epub.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Canadian Urological Association guideline: Erectile dysfunction",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://aimspecialtyhealth.com/guidelines/PDFs/2019/Jan27/AIM_Guidelines_RadiationOncology.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Appropriate Use Criteria: Brachytherapy, Intensity Modulated Radiation Therapy, Stereotactic Body Radiation Therapy, and Stereotactic Radiosurgery",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://link.springer.com/article/10.1007/s00259-021-05245-y",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "E-PSMA: the EANM standardized reporting guidelines v1.0 for PSMA-PET",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.bmj.com/content/374/bmj.n2040",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Medical cannabis or cannabinoids for chronic pain",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://michmed-public.policystat.com/policy/10073504/latest/",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Ambulatory Adult Management of Chronic Kidney Disease Guideline",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.annalsofoncology.org/article/S0923-7534(21)02214-6/fulltext",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "EANOÃESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up of patients with brain metastasis from solid tumours",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.auanet.org/guidelines/guidelines/renal-mass-and-localized-renal-cancer-evaluation-management-and-follow-up",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Renal Mass and Localized Renal Cancer: Evaluation, Management, and Follow Up",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://michmed-public.policystat.com/policy/8093109/latest/",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Ambulatory Urinary Tract Infection (UTI) in Adults, Pregnant Women and Minors",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.bfmed.org/assets/DOCUMENTS/PROTOCOLS/Protocol%20%2333%20-%20English%20Translation.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "LGBTQ+ Patients",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "http://bioethicsdiscussion.blogspot.com/2021/07/preserving-patient-dignity-formerly.html",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Preserving Patient Dignity (Formerly Patient Modesty) Volume 119",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.aasld.org/sites/default/files/2021-07/Malnutrition%2C%20Frailty%20Sarcopenia%20in%20Patient%20w%20Cirrhosis%202021%20hep.32049.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Malnutrition, Frailty, and Sarcopenia in Patients With Cirrhosis",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.iqwig.de/download/a20-43_darolutamide_extract-of-dossier-assessment_v1-0.pdf?rev=190692",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Darolutamide (prostate cancer) - Benefit assessment according to Â¤35a Social Code Book V",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.iqwig.de/download/ht18-01_screening-for-testicular-cancer_extract-of-hta-report_v1-0.pdf?rev=197647",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Testicular cancer. Does routine screening for men aged 16 years and older lead to better treatment outcomes?",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.annalsofoncology.org/article/S0923-7534(21)02064-0/fulltext",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Anal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://ijgc.bmj.com/content/31/7/961",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "ESGO/ISUOG/IOTA/ESGE Consensus Statement on pre-operative diagnosis of ovarian tumors",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.nice.org.uk/guidance/ta712/resources/enzalutamide-for-treating-hormonesensitive-metastatic-prostate-cancer-pdf-82611130213573",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Enzalutamide for treating hormone-sensitive metastatic prostate cancer",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.nice.org.uk/advice/mib268/resources/trubloodprostate-for-triaging-and-diagnosing-people-with-prostate-cancer-symptoms-pdf-2285965760597701",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "trublood-prostate for triaging and diagnosing people with prostate cancer symptoms",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.mcmasterforum.org/docs/default-source/product-documents/rapid-responses/expanding-scopes-of-practice-in-cancer-care-to-provide-high-quality-person-centred-care-and-to-enhance-access-to-care.pdf?sfvrsn=32d27ea9_5",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Expanding Scopes of Practice in Cancer Care to Provide High-quality Person-centred Care and to Enhance Access to Care",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://jitc.bmj.com/content/9/6/e002435",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immune checkpoint inhibitor-related adverse events",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://jitc.bmj.com/content/9/7/e002552",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment or urothelial cancer",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "file:///Users/chutizzah/Downloads/9789240024168-eng.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Guidelines for the management of symptomatic sexually transmitted infections",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://effectivehealthcare.ahrq.gov/sites/default/files/pdf/cer-242-radiation-therapy-brain-metastases.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Radiation Therapy for Brain Metastases",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.mcmasterforum.org/docs/default-source/product-documents/rapid-responses/enhancing-shared-care-models-between-primary-care-teams-and-oncology-in-post-treatment-care.pdf?sfvrsn=35a19580_8",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Enhancing Shared-care Models Between Primary-care and Cancer-care Teams in Post-treatment Care",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "file:///Users/chutizzah/Downloads/H0039_Denosumab%20Scoping%20Report.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Denosumab (Prolia) for the treatment of osteoporosis",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "file:///Users/chutizzah/Downloads/Bone_Targeting_Agents_Scoping%20Report%20(1).pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Trimonthly vs. monthly use of bone-targeted agents in patients with bone metastases and multiple myeloma",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://abcd.care/sites/abcd.care/files/site_uploads/Resources/Position-Papers/Management-of-hyperglycaemia-in-adults%20-with-DKD.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "ABCD and Renal Association Clinical practice guidelines for management of hyperglycaemia in adults with diabetic kidney disease",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.acmg.net/PDFLibrary/41436_2021_1151_OnlinePDF.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Management of individuals with germline variants in PALB2: a clinical practice resource of the American College of Medical Genetics and Genomics (ACMG)",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.ahajournals.org/doi/10.1161/HCG.0000000000000082",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Impact of Hormonal Therapies for Treatment of Hormone-Dependent Cancers (Breast and Prostate) on the Cardiovascular System: Effects and Modifications: A Scientific Statement From the American Heart Association",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.tripdatabase.com/Searchresult?category=%281%20OR%2011%20OR%2016%20OR%2018%20OR%2010%20OR%209%20OR%204%20OR%2034%29&criteria=%28prostate%20cancer%20OR%20prostate%20carcinoma%20OR%20prostatic%20neoplasm%20OR%20prostate%20tumor%29%20AND%20%28screening%20OR%20early%20diagnosis%20OR%20early%20detection%29%20AND%20%28guideline%20OR%20best%20practice%20OR%20evidence%20OR%20recommendation%20OR%20management%20OR%20program%20OR%20initiative%20OR%20strategy%20OR%20tool%20OR%20screening%20tool%20OR%20monitoring%20tool%20OR%20instrument%20OR%20questionnaire%20OR%20risk%20assessment%20OR%20assessment%20tool%20OR%20screening%20questionnaire%20OR%20decisions%20aids%20OR%20examination%20OR%20digital%20rectal%20examination%20OR%20dre%20OR%20test%20OR%20psa%20OR%20prostate-specific%20antigen%20OR%20program%20evaluation%20OR%20kpi%20OR%20key%20performance%20indicator%20OR%20quality%20indicator%20OR%20evaluation%20OR%20monitoring%20OR%20program%20delivery%29&page=7&search_type=standard&sort=y",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Denosumab (Prolia) for the treatment of osteoporosis",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.nice.org.uk/advice/mib263/resources/magtrace-and-sentimag-for-locating-sentinel-lymph-nodes-pdf-2285965752199621",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Magtrace and Sentimag for locating sentinel lymph nodes",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://effectivehealthcare.ahrq.gov/sites/default/files/pdf/cer-244-safety-vaccines-update-final_rev.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Safety of Vaccines Used for Routine Immunization in the United States: An Update",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.cua.org/system/files/Guidelines/7367_NMIBC%20Guideline_Epub.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Canadian Urological Association guideline on the management of non-muscle invasive bladder cancer",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://acsearch.acr.org/docs/3158176/Narrative/?_ga=2.96239964.1324093738.1620663695-1022421025.1615804733",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Nontraumatic Chest Wall Pain",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://fascrs.org/ascrs/media/files/Surveillance-and-Survivorship-CPG.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Surveillance and Survivorship Care of Patients After Curative Treatment of Colon and Rectal Cancer",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.cua.org/system/files/Guidelines/7252_v6.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Canadian Urological Association guideline on testosterone deficiency in men: Evidence-based Q&A",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.cua.org/system/files/Guidelines/7355_Guideline_ADT_Epub.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Canadian Urological Association guideline on androgen deprivation therapy: Adverse events and management strategies",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.liebertpub.com/doi/full/10.1089/thy.2020.0944",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "2021 American Thyroid Association Guidelines for Management of Patients with Anaplastic Thyroid Cancer",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.mcmasterforum.org/docs/default-source/product-documents/rapid-responses/identifying-educational-approaches-and-resources-to-support-seamless-transitions-between-cancer-programs-and-primary-care.pdf?sfvrsn=3da59d5_2",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Identifying Educational Approaches and Resources to Support Seamless Transitions Between Cancer Programs and Primary Care",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://effectivehealthcare.ahrq.gov/sites/default/files/pdf/cer-238-cervical-ripening-final-report.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Cervical Ripening in the Outpatient Setting",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.cancercareontario.ca/en/file/59141/download?token=tplUodw_",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Virtual Care in Patients with Cancer: A Systematic Review",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.acog.org/clinical/clinical-guidance/committee-opinion/articles/2021/03/health-care-for-transgender-and-gender-diverse-individuals",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Health Care for Transgender and Gender Diverse Individuals",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://effectivehealthcare.ahrq.gov/sites/default/files/pdf/tb-39-pediatric-cancer-survivorship-final.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Disparities and Barriers to Pediatric Cancer Survivorship Care",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.cua.org/system/files/Guidelines/7245_v2.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Management of advanced kidney cancer",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/lung-cancer-screening",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Lung Cancer: Screening",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.cua.org/system/files/Guidelines/7252_GUIDELINE_Epub.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Testosterone deficiency in men",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.cancercareontario.ca/en/file/58336/download?token=SVce5G9o",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Multiparametric Magnetic Resonance Imaging in the Diagnosis of Clinically Significant Prostate Cancer",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.onlinecjc.ca/article/S0828-282X(20)30991-0/fulltext",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "The 2020 Canadian Cardiovascular Society/Canadian Heart Rhythm Society Comprehensive Guidelines for the Management of Atrial Fibrillation",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.healthcareimprovementscotland.org/idoc.ashx?docid=dbd9d717-43d0-43d0-9d63-16688640a55f&version=-1",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Review of recently published evidence on the relationship between the volume of robotic-assisted surgery (RAS) performed and the outcomes achieved",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.saxinstitute.org.au/wp-content/uploads/2021_Evidence-Check_Pharmacological-actions-and-associated-therapeutic-levels-of-phytocannabinoids-Addendum-2021.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Pharmacological actions and associated therapeutic levels of phytocannabinoids",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.cua.org/system/files/Guidelines/7074.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "2021 Canadian Urological Association (CUA)-Canadian Uro Oncology Group (CUOG) guideline: Management of castration-resistant prostate cancer (CRPC)",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://s3.amazonaws.com/rdcms-snmmi/files/production/public/Quality/EANM_SNMMI%20practice%20guideline%20for%2018F%20FDG%20PETCT%20external%20beam%20radiotherapy%20treatment%20planning%20in%20uterine%20cervical%20cancer.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "EANM Practice Guideline/SNMMI Procedure Standard for FDG-PET/CT External Beam Radiotherapy Treatment Planning in Uterine Cervical Cancer",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.hiqa.ie/sites/default/files/2021-01/eHealth-in-Ireland_FAQ_0.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "eHealth in Ireland Frequently Asked Questions",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.idsociety.org/globalassets/idsa/practice-guidelines/covid-19/diagnostics/idsa-covid-19-gl-dx-v2.0.0.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "The Infectious Diseases Society of America Guidelines on the Diagnosis of COVID-19: Molecular Diagnostic Testing",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.npojip.org/english/MedCheck/Med%20Check%20Tip-19-2020-12-24.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Poor evidence of direct anticoagulant (DOAC), DOAC and increased thrombosis without APS and COVID-19",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://icer.org/wp-content/uploads/2020/11/ICER_UPI_2020_Report_011221.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Unsupported Price Increase Report",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.sign.ac.uk/media/1812/sign-142-osteoporosis-v3.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Management of osteoporosis and the prevention of fragility fractures",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.thegreenjournal.com/article/S0167-8140(21)06162-4/fulltext",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "ESTRO-ACROP recommendations on the clinical implementation of hybrid MR-linac systems in radiation oncology",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.albertahealthservices.ca/assets/info/hp/cancer/if-hp-cancer-guide-bmt-manual.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Alberta Bone Marrow and Blood Cell Transplant Program: Standard Practice Manual",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.espen.org/files/ESPEN-Guidelines/ESPEN-practical-guideline-clinical-nutrition-in-cancer.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "ESPEN practical guideline: Clinical Nutrition in cancer",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.ejves.com/article/S1078-5884(20)30868-6/fulltext",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Management of Venous Thrombosis",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.albertahealthservices.ca/assets/info/hp/cancer/if-hp-cancer-guide-gi005-early-stage-rectal.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Rectal Cancer",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.publichealthontario.ca/-/media/documents/ncov/covid-wwksf/2021/02/wwksf-factors-affecting-period-communicability.pdf?sc_lang=en",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Factors Affecting COVID-19 Period of Communicability Ã What We Know So Far",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.publichealthontario.ca/-/media/documents/ncov/covid-wwksf/2020/12/routes-transmission-covid-19.pdf?sc_lang=en",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Additional Routes of COVID-19 Transmission Ã What We Know So Far",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.albertahealthservices.ca/assets/info/hp/cancer/if-hp-cancer-guide-supp001-tobacco-cessation.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Tobacco screening and treatment for adult cancer patients",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "file:///Users/chutizzah/Downloads/CNS%20GUIDELINES_Neuroablative%20Procedures%20for%20Patients%20with%20Cancer%20Pain%20(1).pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Guidelines on Neuroablative Procedures for Patients with Cancer Pain",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.cosa.org.au/media/332692/cosa-smoking-cessation-in-cancer-patients-140820-final.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Smoking Cessation in Cancer Patients",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.asrm.org/globalassets/asrm/asrm-content/news-and-publications/practice-guidelines/for-non-members/recs_for_reducing-risk-of-viral-transmission.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Recommendations for reducing the risk of viral transmission during fertility treatment with the use of autologous gametes: a committee opinion",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.cancercareontario.ca/en/file/54256/download?token=x2Vw_YMR",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Pandemic Planning Clinical Guideline for Patients with Cancer",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://kce.fgov.be/sites/default/files/2022-02/KCE_347_Evidence_gaps_Europe_Report_V2_0.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Evidence gaps for drugs and medical devices at market entry in Europe and potential solutions",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://kce.fgov.be/sites/default/files/2021-11/KCE_343_Innovative_oncology_drugs_in_Belgium_Report.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Do innovative medicines against cancer always have a real added value?",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://kce.fgov.be/sites/default/files/2021-11/KCE_338_Psychosomatic_Report_2.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Somatic health care in a psychiatric setting",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8382305/?report=classic",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Multi-gene Pharmacogenomic Testing That Includes Decision-Support Tools to Guide Medication Selection for Major Depression: A Health Technology Assessment",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8202600/?report=classic",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Prostatic Artery Embolization for Benign Prostatic Hyperplasia: A Health Technology Assessment",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8382304/?report=classic",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "DPYD Genotyping in Patients Who Have Planned Cancer Treatment With Fluoropyrimidines: A Health Technology Assessment",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://painmed.wpengine.com/wp-content/uploads/2020/12/LowBackPain.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Evidence-Based Clinical Guidelines For Multidisciplinary Spine Care",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8130814/?report=classic",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Proton Beam Therapy for Cancer in Children and Adults: A Health Technology Assessment",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://evidence.nihr.ac.uk/alert/better-care-after-cancer-surgery-increases-survival/",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Extra emphasis on care after cancer surgery could increase survival worldwide",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.iqwig.de/download/a21-100_daratumumab_extract-of-dossier-assessment_v1-0.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Daratumumab (systemic light chain amyloidosis) - Benefit assessment according to Â¤35a Social Code Book V",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.iqwig.de/download/a20-106_olaparib_extract-of-dossier-assessment_v1-0.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Olaparib (prostate cancer) - Benefit assessment according to Â¤35a Social Code Book V",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.gastrojournal.org/article/S0016-5085(21)03626-X/fulltext",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Updates on age to start and stop colorectal cancer screening",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.albertahealthservices.ca/assets/info/hp/cancer/if-hp-cancer-guide-supp023-early-palliative-care-advanced-cancer.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Integrating an Early Palliative Approach into Advanced Cancer Care",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.albertahealthservices.ca/assets/info/hp/cancer/if-hp-cancer-guide-gu014-ambc.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Locally Advanced/Metastatic Bladder Cancer",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.albertahealthservices.ca/assets/info/hp/cancer/if-hp-cancer-guide-gu013-mibc.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Muscle-Invasive Bladder Cancer",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.albertahealthservices.ca/assets/info/hp/cancer/if-hp-cancer-guide-br013-early-stage-follow-up.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Follow-Up Care for Early-Stage Breast Cancer",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.leitlinienprogramm-onkologie.de/fileadmin/user_upload/GGPO_Prevention_of_Skin_Cancer_2.1.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Evidence-based Guideline on Prevention of Skin Cancer",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.mja.com.au/journal/2021/215/10/cancer-australia-consensus-statement-covid-19-and-cancer-care-embedding-high",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Cancer Australia consensus statement on COVID?19 and cancer care: embedding high value changes in practice",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "file:///Users/chutizzah/Downloads/Male-Infertility-Guideline.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Diagnosis and Treatment of Infertility in Men: AUA/ASRM Guideline",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.annemergmed.com/article/S0196-0644(19)31380-0/fulltext",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Should Cancer Patients Receive Apixaban to Prevent Venous Thromboembolism? An Analysis of the AVERT Trial",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.asrm.org/globalassets/asrm/asrm-content/news-and-publications/practice-guidelines/for-non-members/diagnosis-and-treatment-of-infertility-in-men-aua-asrm.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Diagnosis and treatment of infertility in men: AUA/ASRM Guideline",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.asrm.org/globalassets/asrm/asrm-content/news-and-publications/practice-guidelines/for-non-members/diagnosis_and_treatment_of_infertility_in_men-aua-asrm_guideline_part_1.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Summary: Diagnosis and treatment of infertility in men: AUA/ASRM guideline part I",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.nice.org.uk/guidance/ta660/resources/darolutamide-with-androgen-deprivation-therapy-for-treating-hormonerelapsed-nonmetastatic-prostate-cancer-pdf-82609252402885",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Darolutamide with androgen deprivation therapy for treating hormone-relapsed non-metastatic prostate cancer",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.esmoopen.com/?ijkey=tCRlStXtazLs37r&keytype=ref",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Management of Orphan Symptoms: ESMO Clinical Practice Guidelines for diagnosis and treatment",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://link.springer.com/article/10.1007/s00259-020-05112-2",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "EANM / SNMMI Practice Guideline for [18F]FDG PET/CT External Beam Radiotherapy Treatment Planning in Uterine Cervical Cancer",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www2.gov.bc.ca/gov/content/health/practitioner-professional-resources/bc-guidelines/hematuria",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Workup of Microscopic Hematuria",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.canceraustralia.gov.au/sites/default/files/publications/report-lung-cancer-screening-enquiry/pdf/report_on_the_lung_cancer_screening_enquiry_0.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Report on the Lung Cancer Screening enquiry",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.scottishmedicines.org.uk/media/5563/darolutamide-nubeqa-final-october-2020-for-website.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Darolutamide (Nubeqa) - non-metastatic castration resistant prostate cancer (nmCRPC)",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://academic.oup.com/cid/article/73/11/e3572/5956736?login=false",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Primary Care Guidance for Persons With Human Immunodeficiency Virus: 2020 Update by the HIV Medicine Association of the Infectious Diseases Society of America",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www2.gov.bc.ca/gov/content/health/practitioner-professional-resources/bc-guidelines/magnetic-resonance-imaging-mri-prioritization",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Magnetic Resonance Imaging (MRI) Prioritization",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://effectivehealthcare.ahrq.gov/sites/default/files/pdf/opioids-older-adults-techbrief.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Prevention, Diagnosis, and Management of Opioids, Opioid Misuse, and Opioid Use Disorder in Older Adults",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.cghjournal.org/article/S1542-3565(20)30769-2/fulltext",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "AGA Clinical Practice Update on Young Adult Onset Colorectal Cancer Diagnosis and Management: Expert Review",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.iqwig.de/download/A20-36_Apalutamide_Extract-of-dossier-assessment_V1-0.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Apalutamide (prostate cancer) - Benefit assessment according to Â¤35a Social Code Book V",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.jogc.com/article/S1701-2163(19)30826-6/fulltext",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Initial Investigation and Management of Adnexal Masses",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.jogc.com/article/S1701-2163(20)30044-X/fulltext",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Initial Investigation and Management of Benign Ovarian Masses",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "http://eppi.ioe.ac.uk/CMS/Portals/0/PPH_Report_Sept_2020.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Precision public health Ã A critical review of the opportunities and obstacles",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://effectivehealthcare.ahrq.gov/sites/default/files/pdf/registries-evaluating-patient-outcomes-4th-edition.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Registries for Evaluating Patient Outcomes: A User's Guide: 4th Edition",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://effectivehealthcare.ahrq.gov/sites/default/files/pdf/prostate-cancer-therapies-report.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Therapies for Clinically Localized Prostate Cancer",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.cancercareontario.ca/en/file/56691/download?token=nZtHkYf7",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Risk Reduction Strategies for BRCA1/2 Hereditary Ovarian Cancer Syndromes",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "http://msts.org/view/download.php/education/mbd-cpg-amended",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "MSTS/ASTRO/ASCO Metastatic Carcinoma and Myeloma of the Femur",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.canceraustralia.gov.au/sites/default/files/publications/covid-19-recovery-implications-cancer-care/pdf/covid-19_recovery-implications_for_cancer_care.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "COVID-19 Recovery: Implications for cancer care",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.esmo.org/content/download/347819/6934778/1/ESMO-CPG-mNSCLC-15SEPT2020.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Metastatic Non-Small-Cell Lung Cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://acsearch.acr.org/docs/69364/Narrative/",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Post-Treatment Surveillance of Bladder Cancer",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.healthquality.va.gov/guidelines/CD/obesity/VADoDObesityCPGFinal5087242020.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Management of Adult Overweight and Obesity",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.healthquality.va.gov/guidelines/CD/OA/VADoDOACPG.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "The Non-Surgical Management of Hip & Knee Osteoarthritis",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.bashhguidelines.org/media/1242/eo-2019.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "United Kingdom BASHH national guideline for the management of epididymo-orchitis",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www2.gov.bc.ca/gov/content/health/practitioner-professional-resources/bc-guidelines/prostate-cancer-part-2",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Prostate Cancer Part 2: Follow-up in Primary Care",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.sign.ac.uk/media/1741/sign142.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Management of osteoporosis and the prevention of fragility fractures",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://157slyoyo4y17zpa538hczs1-wpengine.netdna-ssl.com/wp-content/uploads/2020/06/2020_Genetics_toolkit_FULL.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Society of Gynecologic Oncology Genetics Toolkit",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.annalsofoncology.org/action/showPdf?pii=S0923-7534%2820%2939995-6",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Clinical Practice Guidelines Ã Bone Health in Cancer Patients",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.canceraustralia.gov.au/sites/default/files/publications/optimal-care-pathway-aboriginal-and-torres-strait-islander-people-cancer-guide/pdf/optimal_care_pathway_for_aboriginal_and_torres_strait_islander_people_with_cancer_the_guide.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Guide to implementing the Optimal Care Pathway for Aboriginal and Torres Strait Islander people with cancer",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.auanet.org/guidelines/guidelines/microhematuria",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Microhematuria: AUA/SUFU Guideline",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.auanet.org/guidelines/guidelines/bladder-cancer-non-muscle-invasive-guideline",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Diagnosis and Treatment of Non-Muscle Invasive Bladder Cancer: AUA/SUO Joint Guideline",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.hiqa.ie/sites/default/files/2020-08/Summary-Care-Records-AS-IS-Review.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Summary care records an as-is analysis of the Irish landscape",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.auanet.org/guidelines/guidelines/disorders-of-ejaculation",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Disorders of Ejaculation: An AUA/SMSNA Guideline",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.auanet.org/guidelines/guidelines/advanced-prostate-cancer",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Advanced Prostate Cancer: AUA/ASTRO/SUO Guideline",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://2019.iph.ie/sites/default/files/The%20benefits%20of%20physical%20activity%20and%20the%20consequences%20of%20physical%20inactivity%20in%20older%20adults.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Evidence review on the benefits of physical activity for older people",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://saudijournals.com/media/articles/SIJAP_37_57-61.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Duplication of Ureter in the Cadaveric Dissection: A Systematic Review",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://oncourology.abvpress.ru/oncur/article/view/1269",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Risk factors and methods for prevention of lymphogenic complications in oncourological operations in pelvic area (systematic review)",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.cancercareontario.ca/en/file/55641/download?token=PoFUoS1Y",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Cancer and the Health Effects of Cannabis and Cannabinoids: An update of the systematic review by the National Academies of Sciences, Engineering, and Medicine (2017) Consensus Study Report",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.hiqa.ie/sites/default/files/2020-06/Pathways-for-the-resumption-of-hospital-care-after-COVID-19.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Evidence summary for the resumption of scheduled hospital care in the context of COVID-19",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://apps.who.int/iris/bitstream/handle/10665/332974/9789289055130-eng.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Mental health, men and culture: how do sociocultural constructions of masculinities relate to menÃs mental health help-seeking behaviour in the WHO European Region?",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "file:///Users/chutizzah/Downloads/Microhematuria%20Guideline.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Microhematuria: AUA/SUFU Guideline",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://acmedsci.ac.uk/file-download/77652269",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Artificial intelligence and health",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://content.iospress.com/articles/bladder-cancer/blc200281",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Patient-Derived Urothelial Cancer Xenograft Models: A Systematic Review and Future Perspectives",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.saxinstitute.org.au/wp-content/uploads/20.06_Community-Based-Health-Promotion-for-Older-Adults.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Community-based health promotion for older adults",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://acmedsci.ac.uk/file-download/23442253",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Transforming health through innovation: Integrating the NHS and academia - supporting case studies",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.thegreenjournal.com/article/S0167-8140(20)30184-5/pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Defining Oligometastatic Disease from a Radiation Oncology Perspective",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://jmhg.springeropen.com/articles/10.1186/s43042-020-00057-5",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Vitamin D receptor (VDR) gene FokI, BsmI, ApaI, and TaqI polymorphisms and osteoporosis risk: a meta-analysis",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.onlinecjc.ca/article/S0828-282X(19)31551-X/fulltext",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Canadian Cardiovascular Society/Canadian Cardiac Transplant Network Position Statement on Heart Transplantation: Patient Eligibility, Selection, and Post-Transplantation Care",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.annalsofoncology.org/",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Acute Myeloid Leukaemia in Adult Patients",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://effectivehealthcare.ahrq.gov/products/health-worker-certification/technical-brief",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Impact of Community Health Worker Certification on Workforce and Service Delivery for Asthma and Other Selected Chronic Diseases",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.iqwig.de/download/a19-90_larotrectinib_extract-of-dossier-assessment_v1-0.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Larotrectinib (solid tumours) - Benefit assessment according to Â¤35a Social Code Book V",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://ascopubs.org/doi/full/10.1200/JCO.19.03120",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Management of Male Breast Cancer",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.spine.org/Portals/0/assets/downloads/ResearchClinicalCare/Guidelines/LowBackPain.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Evidence-Based Clinical Guidelines for Multidisciplinary Spine Care: Diagnosis and Treatment of Low Back Pain",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "http://www.ukm.edu.my/jsm/pdf_files/SM-PDF-49-3-2020/ARTIKEL%2017.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "A Systematic Review on the Effectiveness of Enteral Immunonutrition (EIN) on Pre- and Post-Operative Outcomes in Gastric Cancer Patients",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.researchsquare.com/article/rs-19477/v1",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Whether pelvic radiotherapy increased the risk of secondary bladder cancer? A systematic review and meta-analysis",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://actascientific.com/ASMI/pdf/ASMI-03-0565.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "An Update on Aetiopathogenesis and Management of Japanese Encephalitis - A Systematic Review",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "http://www.foodandnutritionjournal.org/volume8number1/effect-of-annona-muricata-l-on-metabolic-parameters-in-diabetes-mellitus-a-systematic-review/",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Effect of Annona Muricata L. on Metabolic Parameters in Diabetes Mellitus: A Systematic Review",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://onlinelibrary.wiley.com/doi/10.1002/osi2.1054",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Tongue necrosis caused by systemic vascular diseases: A systematic review of the literature",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.jvir.org/article/S1051-0443(19)31013-9/fulltext",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Society of Interventional Radiology Quality Improvement Standards for Image-Guided Percutaneous Drainage and Aspiration of Abscesses and Fluid Collections",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://onlinelibrary.wiley.com/doi/10.1002/prm2.12005",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Whether extended pelvic lymph node dissection should be performed in prostate cancer: The present evidence from a systematic review and meta_analysis",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.sciencerepository.org/diagnosis-and-clinical-management-of-neuroendocrine-tumor-of-the-breast_ACO-2020-1-102",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Diagnosis and Clinical Management of Neuroendocrine Tumor of the Breast: Report of Six Cases and Systematic Review of Existing Literature",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.spine.org/Portals/0/assets/downloads/ResearchClinicalCare/Guidelines/LowBackPain.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Diagnosis and Treatment of Low Back Pain",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.icsi.org/wp-content/uploads/2020/01/PalliativeCare_6th-Ed_2020_v2.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Palliative Care for Adults",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.acpjournals.org/doi/10.7326/M19-0882?_ga=2.254013007.614967891.1581670498-245079834.1581670498",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Testosterone Treatment in Adult Men with Age-Related Low Testosterone",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.annalsofoncology.org/article/S0923-7534(19)36080-6/pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Management of Cardiac Disease in Cancer Patients Throughout Oncological Treatment: ESMO Consensus Recommendations",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "file:///Users/chutizzah/Downloads/[1479683X%20-%20European%20Journal%20of%20Endocrinology]%20European%20Society%20of%20Endocrinology%20Clinical%20Practice%20Guideline_%20Endocrine%20work-up%20in%20obesity.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "European Society of Endocrinology Clinical Practice Guideline: Endocrine work-up in obesity",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://ascopubs.org/doi/full/10.1200/JCO.19.02768",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Molecular Biomarkers in Localized Prostate Cancer",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.asge.org/docs/default-source/guidelines/asge-guideline-on-the-role-of-endoscopy-for-bleeding-from-chronic-radiation-proctopathy-2019-august-gie.pdf?sfvrsn=7112af52_3",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "ASGE guideline on the role of endoscopy for bleeding from chronic radiation proctopathy",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.thecommunityguide.org/findings/cancer-screening-interventions-engaging-community-health-workers-breast-cancer",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Cancer Screening: Interventions Engaging Community Health Workers Ã Breast Cancer",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.thecommunityguide.org/findings/cancer-screening-interventions-engaging-community-health-workers-cervical-cancer",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Cancer Screening: Interventions Engaging Community Health Workers Ã Cervical Cancer",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.thecommunityguide.org/findings/cancer-screening-interventions-engaging-community-health-workers-colorectal-cancer",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Cancer Screening: Interventions Engaging Community Health Workers Ã Colorectal Cancer",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.eunethta.eu/wp-content/uploads/2019/10/PTJA07-Final-assessment-report-v1.0.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Ustekinumab for the treatment of adult patients with moderately to severely active ulcerative colitis (UC) who have had an inadequate response with, lost response to, or were intolerant to either conventional therapy or a biologic, or have medical contrai",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://biomedgrid.com/fulltext/volume6/a-systematic-review-of-the-trace-element-concentrations-in-the-prostate-fluid-of-normal-gland.001093.php",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "A Systematic Review of the Trace Element Concentrations in the Prostate Fluid of Normal Gland",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "No link",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "WHO guidelines on physical activity and sedentary behaviour",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "http://www.msac.gov.au/internet/msac/publishing.nsf/Content/5128EFED7C5AC114CA25848200015CD5/$File/1602%20Final%20PSD_Nov%202020_redacted.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Testing for neurotrophic tyrosine receptor kinase (NTRK) gene fusion status, in patients with locally advanced or metastatic solid tumours, to determine eligibility for larotrectinib",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.iqwig.de/download/s19-02_lung-cancer-screening-with-low-dose-ct_extract-of-final-report_v1-0.pdf?rev=172804",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Lung cancer screening using low-dose computed tomography",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.albertahealthservices.ca/assets/info/ppih/if-ppih-covid-19-sag-starting-or-resuming-cancer-treatment-rapid-review.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Starting or resuming cancer treatment after COVID 19 infection: A Rapid Response Report",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.scottishmedicines.org.uk/media/4979/abiraterone-zytiga-final-december-2019-amended-181219-for-website.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Abiraterone acetate (Zytiga) - for the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.nice.org.uk/guidance/ng162",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "COVID-19 rapid guideline: delivery of radiotherapy",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.medrxiv.org/content/10.1101/2020.03.19.20039008v2.full.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Covid-19: Effectiveness and safety of antiviral or antibody treatments for coronavirus",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.esmo.org/Guidelines/Genitourinary-Cancers/Testicular-Seminoma-and-Non-Seminoma/eUpdate-Treatment-Recommendation2",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "eUpdate Ã Testicular Seminoma and Non-Seminoma Treatment Recommendations",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://academic.oup.com/ejcts/article/55/1/91/5124324?login=false",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Guidelines for enhanced recovery after lung surgery: recommendations of the Enhanced Recovery After Surgery (ERAS) Society and the European Society of Thoracic Surgeons (ESTS)",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://academic.oup.com/hropen/article/2019/4/hoz025/5625062?searchresult=1&login=false",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Recommendations for good practice in Ultrasound: Oocyte retrieval",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.esmo.org/Guidelines/Genitourinary-Cancers/Bladder-Cancer/eUpdate-Bladder-Cancer-Treatment-Recommendations2",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "eUpdate Ã Bladder Cancer Treatment Recommendations",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.canceraustralia.gov.au/sites/default/files/publications/shared-care-summary/pdf/shared_care_summary.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Shared follow-up care for early breast cancer: summary of evidence",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://ebn.bmj.com/content/23/1/2",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "What are sensitivity and specificity?",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.ctro.science/article/S2405-6308(20)30056-2/fulltext",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "ESTRO/ACROP IORT recommendations for intraoperative radiation therapy in locally recurrent rectal cancer",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.thegreenjournal.com/article/S0167-8140(20)30105-5/fulltext",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "GEC-ESTRO/ACROP recommendations for quality assurance of ultrasound imaging in brachytherapy",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.thegreenjournal.com/article/S0167-8140(20)30184-5/fulltext",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Defining oligometastatic disease from a radiation oncology perspective: An ESTRO-ASTRO consensus document",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://michmed-public.policystat.com/policy/7662393/latest/",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Ambulatory Adult and Pediatric Obesity Prevention and Management Guideline",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.geriatriconcology.net/article/S1879-4068(19)30481-3/fulltext",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Management Of Bladder Cancer In Older Patients: Position Paper Of A SIOG Task Force",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.geriatriconcology.net/article/S1879-4068(20)30366-0/fulltext",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Adapting Care For Older Cancer Patients During The COVID-19 Pandemic: Recommendations From The International Society Of Geriatric Oncology (SIOG)",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://link.springer.com/article/10.1007/s00520-020-05708-2",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "MASCC 2020 clinical practice recommendations for the management of immune-related adverse events: pulmonary toxicity",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.hse.ie/eng/services/list/5/cancer/profinfo/guidelines/diagnosis-staging-and-treatment-of-patients-with-rectal-cancer.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Diagnosis, staging and treatment of patients with rectal cancer",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.esaic.org/uploads/2021/01/perseus-part-ii-nerve-blocks-and-neuraxial-anaesthesia-november-2020.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "European Society of Anaesthesiology Guidelines on peri-operative use of ultrasound for regional anaesthesia (PERSEUS regional anesthesia)",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://michmed-public.policystat.com/policy/8668970/latest/",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Ambulatory Adult Venous Thromboembolism (VTE) Guideline",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "file:///Users/chutizzah/Downloads/132083_2bfaeeab-da00-42fd-9835-8a679281c74f.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Diagnosis, Staging and Treatment of Patients with Rectal Cancer",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "file:///Users/chutizzah/Downloads/132081_cffa9a8c-c845-4d92-b7ef-859001feb0d8.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Diagnosis, Staging and Treatment of Patients with Colon Cancer",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.jomos.org/articles/mbcb/full_html/2020/04/mbcb200044/mbcb200044.html",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Cancerous lesions in the vicinity of dental implants: a systematic review",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.gastrojournal.org/article/S0016-5085(19)41479-0/fulltext",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Recommendations for Follow-Up After Colonoscopy and Polypectomy: A Consensus Update by the US Multi-Society Task Force on Colorectal Cancer",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.esmo.org/Guidelines/Gastrointestinal-Cancers/Hepatocellular-Carcinoma/eUpdate-Treatment-Algorithms2",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "eUpdate: Hepatocellular Carcinoma Algorithms",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.esmo.org/guidelines/guidelines-by-topic/gastrointestinal-cancers/hepatocellular-carcinoma/eupdate-hepatocellular-carcinoma-treatment-recommendations",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "eUpdate: Hepatocellular Carcinoma Treatment Recommendations",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "file:///Users/chutizzah/Downloads/BPH-Surgical-Mgmt.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Benign Prostatic Hyperplasia: Surgical Management of Benign Prostatic Hyperplasia/Lower Urinary Tract Symptoms",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.anzca.edu.au/news/top-news/acute-pain-management-scientific-evidence-5th-edit",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Acute pain management: scientific evidence (5th Edition)",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "http://www.msac.gov.au/internet/msac/publishing.nsf/Content/9C7DCF1C2DD56CBECA25801000123C32/$File/Discussion%20paper%202020-01-13.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Discussion paper on pan-tumour biomarker testing to determine eligibility for targeted treatment",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://kce.fgov.be/sites/default/files/2021-11/KCE_332_Antibiotics_in_dental_office_Report_1.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Guideline on the prudent prescription of antibiotics in the dental office",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://kce.fgov.be/sites/default/files/2021-11/KCE_335_Surge_capacity_during_COVID-19_Belgium_Report.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Assessing the management of hospital surge capacity in the first wave of the COVID-19 pandemic in Belgium",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://ard.bmj.com/content/80/1/36",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "EULAR points to consider for the diagnosis and management of rheumatic immune-related adverse events due to cancer immunotherapy with checkpoint inhibitors",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.leitlinienprogramm-onkologie.de/fileadmin/user_upload/Downloads/Leitlinien/Palliativmedizin/Version_2/GGPO_Palliative_Care_ShortVersion_2.2.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Palliative care for patients with incurable cancer",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://e-journal.unair.ac.id/JNERS/article/view/16973",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "The Experiences of Cancer-Related Fatigue among Adult Cancer Patients: A Systematic Review",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.iqwig.de/download/a19-09_apalatumid_extract-of-dossier-assessment_v1-0.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Apalutamide (prostate cancer) - Benefit assessment according to Â¤35a Social Code Book V",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.leitlinienprogramm-onkologie.de/fileadmin/user_upload/Downloads/Leitlinien/Kolorektales_Karzinom/Version_2/GGPO_Guideline_Colorectal_Cancer_2.1.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Colorectal Cancer",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.journals.elsevier.com/annals-of-oncology",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "EAUÃESMO consensus statements on the management of advanced and variant bladder cancer",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://effectivehealthcare.ahrq.gov/sites/default/files/pdf/cer-222-report-health-equity-preventive-services.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Achieving Health Equity in Preventive Services",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.acog.org/clinical/clinical-guidance/committee-opinion/articles/2019/12/hereditary-cancer-syndromes-and-risk-assessment",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Hereditary Cancer Syndromes and Risk Assessment",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.clinmedjournals.org/articles/iauc/international-archives-of-urology-and-complications-iauc-5-065.php?jid=iauc",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Retzius Sparing (RS) Robotic Assisted Radical Prostatectomy (RARP) and Retzius Space Reconstruction Technique after RARP Improve Urinary Continence Compared to Conventional RARP (C-RARP): Systematic Review and Metanalysis",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.sciendo.com/article/10.2478/FON-2019-0027",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Effectiveness of integrated nursing interventions for fatigue in patients with advanced cancer: a systematic review of randomized controlled trials",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.accessdata.fda.gov/drugsatfda_docs/nda/2019/022075Orig1s000MedR.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Istradefylline (Nourianz) - Parkinson's disease",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.esmo.org/guidelines/guidelines-by-topic/gastrointestinal-cancers/gastric-cancer/eupdate-gastric-cancer-treatment-recommendations2",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "eUpdate: Gastric Cancer Treatment Recommendations",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.accessdata.fda.gov/drugsatfda_docs/nda/2019/211675Orig1s000MedR.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Upadacitinib (Rinvoq) - rheumatoid arthritis",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.bsg.org.uk/asset/F0F4BB8F-A020-46E9-B2B624F25BCD2668",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Management of patients with increased risk for familial pancreatic cancer",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://japsonline.com/abstract.php?article_id=3023&sts=2",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "The effectiveness of zoledronic acid and ibandronic acid as therapy for bone metastases in multiple myeloma: A systematic review",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "http://medcraveonline.com/UNOAJ/physical-activity-and-prostate-cancer-a-systematic-review.html",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Physical activity and prostate cancer: a systematic review",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.cadth.ca/dv/ieht/overview-clinical-applications-3-d-printing-and-bioprinting",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "An Overview of Clinical Applications of 3-D Printing and Bioprinting",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.cadth.ca/radical-prostatectomy-and-radiation-therapy-prostate-cancer-clinical-effectiveness-and-guidelines-0",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Radical Prostatectomy and Radiation Therapy for Prostate Cancer: Clinical Effectiveness and Guidelines",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.cadth.ca/cryotherapy-prostate-cancer-clinical-effectiveness-and-guidelines",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Cryotherapy for Prostate Cancer: Clinical Effectiveness and Guidelines",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.cancercareontario.ca/en/file/48736/download?token=_zZ4a1QZ",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Complex surgery and perioperative systemic therapy for genitourinary cancer of the retroperitoneum",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.cancercareontario.ca/en/file/56426/download?token=cplZhXem",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Regional Models of Care for Systemic Treatment: Standards for the Organization and Delivery of Systemic Treatment",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.cancercareontario.ca/en/file/49496/download?token=9-yhD6Sj",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Management of Cancer Medication-Related Infusion Reactions",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://apps.who.int/iris/bitstream/handle/10665/328634/9789289054423-eng.pdf?ua=1",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "What is the evidence on availability and integration of refugee and migrant health data in health information systems in the WHO European Region?",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.healthcareimprovementscotland.org/idoc.ashx?docid=184d687a-c55e-42f9-85b2-c668247a1540&version=-1",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "The association between cancer outcomes and time intervals to diagnosis and treatment",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.jaad.org/article/S0190-9622(18)33002-0/fulltext",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with awareness and attention to comorbidities",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://acsearch.acr.org/docs/69345/Narrative/",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Radiologic Management of Infected Fluid Collections",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://acsearch.acr.org/docs/69496/Narrative/",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Stage I Breast Cancer: Initial Workup and Surveillance for Local Recurrence and Distant Metastases in Asymptomatic Women.",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.hiqa.ie/sites/default/files/2019-06/Guide-to-the-Review-Programme_eHealth-Programmes.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Guide to a review programme of eHealth services in Ireland",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.esmo.org/guidelines/guidelines-by-topic/gastrointestinal-cancers/localised-colon-cancer/eupdate-early-colon-cancer-algorithm",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "New eUpdate featuring treatment algorithm for Early Colon Cancer",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.esmo.org/content/download/227453/3874538/file/ESMO-CPG-mNSCLC-18SEPT2019.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Metastatic Non-Small-Cell Lung Cancer",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.esmo.org/guidelines/guidelines-by-topic/gastrointestinal-cancers/localised-colon-cancer/eupdate-early-colon-cancer-treatment-recommendations",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Updated treatment recommendations for Early Colon Cancer",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.medrxiv.org/content/10.1101/19005421v1",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Systematic Review and Meta-Analysis of the Associations Between Body Mass Index, Prostate Cancer, Advanced Prostate Cancer and Prostate Specific Antigen",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://academic.oup.com/jcem/article/104/5/1595/5418884?login=false",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Pharmacological Management of Osteoporosis in Postmenopausal Women",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.auanet.org/guidelines/guidelines/incontinence-after-prostate-treatment",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Incontinence after Prostate Treatment: AUA/SUFU Guideline (2019)",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.mcmasterforum.org/docs/default-source/product-documents/rapid-responses/learning-from-the-experience-of-accountable-care-organizations-in-the-us.pdf?sfvrsn=2",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Learning from the Experience of Accountable Care Organizations in the U.S.",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.canceraustralia.gov.au/sites/default/files/publications/technical-report-position-statement-testing-ovarian-cancer-asymptomatic-women/pdf/cancer_care_-_gynaecological_cancers_-_ovarian_cancer_position_-_final_approved_for_website.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Position Statement Ã Testing for ovarian cancer in asymptomatic women: Technical Report",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.esmo.org/Guidelines/Genitourinary-Cancers/Bladder-Cancer/eUpdate-Bladder-Cancer-Treatment-Recommendations",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "eUpdate: Bladder Cancer Treatment Recommendations",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://academic.oup.com/eurheartj/article/41/1/111/5556353?login=false",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Management of Dyslipidaemias",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.peelregion.ca/health/library/pdf/Health-Effects-of-Recreational-Cannabis-Use.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Understanding the Health Effects of Recreational Cannabis Use: A Focused Practice Question",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.kjuo.or.kr/journal/view.php?doi=10.22465/kjuo.2019.17.2.75",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "The Systematic Review of the Efficacy and Safety of Immune Checkpoint Inhibitor in Urological Cancers",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "file:///Users/chutizzah/Downloads/Overactive-Bladder.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Diagnosis and Treatment of Non-Neurogenic Overactive Bladder (OAB) in Adults: an AUA/SUFU Guideline",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "file:///Users/chutizzah/Downloads/IPT-guideline.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Incontinence after Prostate Treatment",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.oregon.gov/oha/HPA/DSI-HERC/EvidenceBasedReports/ASC-ESC-final-report-6-17-2019.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Extended Stay Centers: Patient characteristics and appropriate procedures",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.wjgnet.com/2308-3840/full/v7/i6/269.htm",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Significance of multivisceral resections in oncologic surgery: A systematic review of the literature",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "http://eppi.ioe.ac.uk/CMS/Portals/0/CommunityPharmacyReportJune2019.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Public health service provision by community pharmacies: a systematic map of evidence",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.auanet.org/guidelines/guidelines/benign-prostatic-hyperplasia-(bph)-guideline",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Benign Prostatic Hyperplasia: Surgical Management of Benign Prostatic Hyperplasia/Lower Urinary Tract Symptoms",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.auanet.org/guidelines/guidelines/testicular-cancer-guideline",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Diagnosis and Treatment of Early Stage Testicular Cancer",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.auanet.org/guidelines/guidelines/overactive-bladder-(oab)-guideline",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Diagnosis and Treatment of Non-Neurogenic Overactive Bladder (OAB) in Adults",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.auanet.org/guidelines/guidelines/prostate-cancer-adjuvant-and-salvage-radiotherapy-guideline",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Adjuvant and Salvage Radiotherapy after Prostatectomy: ASTRO/AUA Guideline",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.asnr.org/wp-content/uploads/2019/06/MR-Guided-NonBreast.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "ACRÃASNR Practice Parameter for the Performance of Non-Breast Magnetic Resonance Imaging (MRI) Guided Procedures",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.acmg.net/PDFLibrary/Value-Framework-Genetic-Diagnosis.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Developing a Value Framework for Genetic Diagnosis: Part I A Systematic Review of Outcomes Hierarchies and Measurement Approaches",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.hiqa.ie/sites/default/files/2019-01/Clinical-Effectiveness-Guidelines.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Guidelines for Evaluating the Clinical Effectiveness of Health Technologies in Ireland",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.esmo.org/guidelines/guidelines-by-topic/gastrointestinal-cancers/gastric-cancer/eupdate-gastric-cancer-treatment-recommendations",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "eUpdate: Gastric Cancer Treatment Recommendations",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.nice.org.uk/guidance/ta580/resources/enzalutamide-for-hormonerelapsed-nonmetastatic-prostate-cancer-pdf-82607196552901",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Enzalutamide for hormone-relapsed non-metastatic prostate cancer",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.eunethta.eu/wp-content/uploads/2019/05/Robot-assisted-surgery-in-thoracic-and-visceral-indications_v1.4_final.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Robot-assisted surgery in thoracic and visceral indications",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.cancercareontario.ca/en/search?nav_field_type_of_contents=All&nav-search=Follow-Up+Model+of+Care+for+Cancer+Survivors",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Follow-Up Model of Care for Cancer Survivors: Recommendations for the Delivery of Follow-up Care for Cancer Survivors in Ontario",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://uroweb.org/guidelines/primary-urethral-carcinoma",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Primary Urethral Carcinoma",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://uroweb.org/eau-guidelines/discontinued-topics/urinary-incontinence",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Urinary Incontinence",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://uroweb.org/guidelines/muscle-invasive-and-metastatic-bladder-cancer",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Muscle-invasive and Metastatic Bladder Cancer",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://apps.who.int/iris/bitstream/handle/10665/279700/9789241550390-eng.pdf?ua=1",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "WHO Guidelines for the pharmacological and radiotherapeutic management of cancer pain in adults and adolescents",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.idsociety.org/globalassets/idsa/practice-guidelines/2019-asymptomatic-bacteriuria.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Asymptomatic Bacteriuria",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://uroweb.org/guidelines/renal-transplantation",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Renal Transplantation",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://uroweb.org/guidelines/neuro-urology",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Neuro-urology",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://uroweb.org/guidelines/upper-urinary-tract-urothelial-cell-carcinoma",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Upper Urinary Tract Urothelial Cell Carcinoma",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.saxinstitute.org.au/wp-content/uploads/19.04_Addressing-unwarranted-variation-in-healthcare.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Addressing unwarranted variation in healthcare",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.journals.elsevier.com/annals-of-oncology",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Renal Cell Carcinoma",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.iqwig.de/download/a17-64_abiraterone-acetate_extract-of-dossier-assessment_v1-0.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Abiraterone acetate (prostate cancer) - Benefit assessment according to Â¤35a Social Code Book V",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://uroweb.org/eau-guidelines/discontinued-topics/male-infertility",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Male Infertility",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://uroweb.org/guidelines/non-muscle-invasive-bladder-cancer",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Non-muscle-invasive Bladder Cancer",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://uroweb.org/guidelines/urolithiasis",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Bladder Stones",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://uroweb.org/guidelines/urolithiasis",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Urolithiasis",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://uroweb.org/guidelines/paediatric-urology",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Paediatric Urology",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.bmus.org/static/uploads/resources/Guidelines_for_Professional_Ultrasound_Practice_v3_OHoz76r.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Guidelines For Professional Ultrasound Practice",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://uroweb.org/guidelines/renal-cell-carcinoma",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Renal Cell Carcinoma",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://uroweb.org/eau-guidelines/discontinued-topics/male-hypogonadism",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Male Hypogonadism",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://uroweb.org/guidelines/urological-trauma",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Urological Trauma",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://uroweb.org/eau-guidelines/discontinued-topics/male-sexual-dysfunction",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Male Sexual Dysfunction",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://uroweb.org/guidelines/penile-cancer",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Penile Cancer",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://uroweb.org/guidelines/management-of-non-neurogenic-male-luts",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Management of Non-neurogenic Male LUTS",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://acsearch.acr.org/docs/69368/Narrative/",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Lower Urinary Tract Symptoms-Suspicion of Benign Prostatic Hyperplasia",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.genetics.edu.au/publications-and-resources/booklets-and-pamphlets/understanding-genetic-tests-for-men-who-have-a-family-history-of-breast-and-ovarian-cancer",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Understanding genetic tests for men who have a family history of breast and ovarian cancer",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.genetics.edu.au/publications-and-resources/booklets-and-pamphlets/understanding-genetic-tests-for-breast-and-ovarian-cancer-that-runs-in-the-family-information-and-decision-aid",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Understanding genetic tests for breast and ovarian cancer that runs in the family",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.clinicalcorrelations.org/2019/02/07/how-far-should-we-search-for-malignancy-in-the-seemingly-unprovoked-venous-thromboembolism/",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "How far should we search for malignancy in the seemingly ?unprovoked? venous thromboembolism?",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.cancercareontario.ca/en/file/41501/download?token=JLlHJGUk",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Biodegradable Rectal Spacers for Prostate Cancer Radiotherapy",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.practicalradonc.org/article/S1879-8500(18)30353-9/pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Standardizing Normal Tissue Contouring for Radiation Therapy Treatment Planning",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.nice.org.uk/advice/mib172/resources/axumin-for-functional-imaging-of-prostate-cancer-recurrence-pdf-2285963634203845",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Axumin for functional imaging of prostate cancer recurrence",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www2.gov.bc.ca/gov/content/health/practitioner-professional-resources/bc-guidelines/testosterone-testing",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Testosterone Testing - Protocol",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.ahajournals.org/doi/10.1161/CIR.0000000000000659",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Heart Disease and Stroke Statistics",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://content.iospress.com/articles/bladder-cancer/blc180196",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Systematic Review: Targeting HER2 in Bladder Cancer",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.rcr.ac.uk/system/files/publication/field_publication_files/bfcr198-provision-interventional-radiology-services-second-ed.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Provision of interventional radiology services, Second edition",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://link.springer.com/article/10.1007/s00259-019-04485-3",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "EANM procedure guidelines for radionuclide therapy with 177Lu-labelled PSMA-ligands (177Lu-PSMA-RLT)",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www2.gov.bc.ca/gov/content/health/practitioner-professional-resources/bc-guidelines/chronic-kidney-disease",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Chronic Kidney Disease - Identification, Evaluation and Management of Adult Patients",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.iqwig.de/download/v18-03_relationship-between-volume-and-quality-for-lung-carcinoma_extract-of-rapid-report_v1-0.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Relationship between volume of services and quality of treatment outcome for lung cancer - rapid report",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.thegreenjournal.com/article/S0167-8140(19)30075-1/fulltext",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "GEC-ESTRO ACROP recommendations on calibration and traceability of LE-LDR photon-emitting brachytherapy sources at the hospital level",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.nature.com/articles/s41436-019-0489-y",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "The Manchester International Consensus Group recommendations for the management of gynecological cancers in Lynch syndrome. Guideline",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://onlinelibrary.wiley.com/doi/full/10.1111/jth.14598?af=R",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Scientific and Standardization Committee Communication: Guidance document on the periprocedural management of patients on chronic oral anticoagulant therapy: Recommendations for standardized reporting of procedural/surgical bleed risk and patient?specific",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.albertahealthservices.ca/assets/info/hp/cancer/if-hp-cancer-guide-rt002-proton-beam-RT.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Guideline: Proton Beam Radiation Therapy",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.ejves.com/article/S1078-5884(18)30698-1/fulltext",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Management of Abdominal Aorto-iliac Artery Aneurysms",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://insightsimaging.springeropen.com/articles/10.1186/s13244-019-0764-0",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Validated imaging biomarkers as decision-making tools in clinical trials and routine practice: current status and recommendations from the EIBALL* subcommittee of the European Society of Radiology (ESR)",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.ejcancer.com/article/S0959-8049(19)30287-4/fulltext",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Updated Recommendations Of The International Society Of Geriatric Oncology On Prostate Cancer Management In Older Patients",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://fvvo.eu/assets/803/FVVinObGyn-11-4-Recommendations_for_surgical_treatment_endometriosis_Pt_2_deep_endometriosis.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Recommendations for the surgical treatment of endometriosis Part 2: deep endometriosis",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://linkinghub.elsevier.com/retrieve/pii/S0923753419310464",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with metastatic non-small cell lung cancer",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "http://medwinpublishers.com/OAJDS/OAJDS16000226.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Association between Dental Agenesis and Cancer-A Systematic Review of Literature",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://ebm.bmj.com/content/24/5/e6",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "General medicine: Individuals with high-risk adenomas are at elevated risk for colorectal cancer",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.aapd.org/globalassets/media/policies_guidelines/bp_cariesriskassessment.pdf?v=new",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Caries-risk Assessment and Management for Infants, Children, and Adolescents",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.jvir.org/article/S1051-0443(18)31259-4/pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Adult and Pediatric Antibiotic Prophylaxis during Vascular and IR Procedures: A Society of Interventional Radiology Practice Parameter Update Endorsed by the Cardiovascular and Interventional Radological Society of Europe and the Canadian Association for",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "http://www.apjonline.in/uploaded/p102.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "A systematic review on si-RNA: Advances and drug development in cancer therapy",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.scielo.br/j/rbgg/a/dC3mJS8WBpDL8X5dcBfGbVP/?lang=en",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Level of resilience in the elderly according to the Connor-Davidson scale: a systematic review",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://kce.fgov.be/sites/default/files/2021-11/KCE_305_Quality_indicators_Head_and_neck_Report_6.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Quality indicators for the management of head and neck squamous cell carcinoma",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://kce.fgov.be/sites/default/files/2021-12/KCE_313C_Performance_Belgian_health_system_Report.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Performance of the Belgian health system",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://kce.fgov.be/sites/default/files/2021-11/KCE_307_Proton_beam_therapy_adults_Report.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Proton beam therapy in adults",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://kce.fgov.be/sites/default/files/2021-12/KCE_327_Polyvalent_Immunoglobulines_Report.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Polyvalent immunoglobulins Ã Part 1: A rapid review",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6395059/?report=classic",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Noninvasive Prenatal Testing for Trisomies 21, 18, and 13, Sex Chromosome Aneuploidies, and Microdeletions: A Health Technology Assessment",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6395058/?report=classic",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Intermittent Catheters for Chronic Urinary Retention: A Health Technology Assessment",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.apa.org/about/policy/boys-men-practice-guidelines.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Professional Practice Guidelines for Psychological Practice with Boys and Men",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://onlinelibrary.wiley.com/doi/10.1111/jth.14478",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Anticoagulation of cancer patients with non?valvular atrial fibrillation receiving chemotherapy",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.thieme-connect.com/products/ejournals/pdf/10.1055/a-0825-6708.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "EFSUMB Recommendations for Gastrointestinal Ultrasound Part 3: Endorectal, Endoanal and Perineal Ultrasound",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.canceraustralia.gov.au/system/tdf/publications/risk-factors-breast-cancer-review-evidence-2018/pdf/risk_factors_for_breast_cancer_a_review_of_the_evidence_2018.pdf?file=1&type=node&id=6421",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Risk factors for breast cancer: A review of the evidence 2018",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://effectivehealthcare.ahrq.gov/sites/default/files/pdf/patient-navigation-model-lung-cancer-rapid.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Patient Navigation Models for Lung Cancer",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.saxinstitute.org.au/wp-content/uploads/CAR-T-Cell-Therapy-Evidence-Check_with-preface-from-NSW-Health.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "CAR T-cell therapy: a summary of evidence",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.nice.org.uk/guidance/ta546/resources/padeliporfin-for-untreated-localised-prostate-cancer-pdf-82606964765893",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Padeliporfin for untreated localised prostate cancer",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.sgo.org/wp-content/uploads/2018/01/CO-727-Cascade-Testing-002.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Committee Opinion: Cascade Testing: Testing Women for Known Hereditary Genetic Mutations Associated With Cancer",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.europeanproceedings.com/article/10.15405/epsbs.2018.11.9",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Resilience In Cancer Patients: A Systematic Review Of The Literature",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.cancercareontario.ca/en/file/39961/download?token=GrslJ2U9",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "PET Evidence from Primary Studies and Systematic Reviews and Recommendations from Clinical Practice Guidelines",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://acsearch.acr.org/docs/3102390/Narrative/",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Lung Cancer Screening",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.journals.elsevier.com/annals-of-oncology",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Diarrhoea in Adult Cancer Patients: ESMO Clinical Practice Guidelines",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.journals.elsevier.com/annals-of-oncology",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "4th ESO?ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 4)",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.annalsofoncology.org/article/S0923-7534(19)31698-9/pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Management of Cancer Pain in Adult Patients: ESMO Clinical Practice Guidelines",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://acsearch.acr.org/docs/70545/Narrative/",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Management of Vertebral Compression Fractures",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://ascopubs.org/doi/10.1200/jgo.18.55700",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "The Appetite-Regulating Hormones Leptin, Adiponectin and Ghrelin and the Development of Prostate Cancer: A Systematic Review",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.acog.org/clinical/clinical-guidance/committee-opinion/articles/2018/10/the-utility-of-and-indications-for-routine-pelvic-examination?utm_source=redirect&utm_medium=web&utm_campaign=otn",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "The Utility of and Indications for Routine Pelvic Examination",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.auanet.org/guidelines/prostate-cancer-castration-resistant-(2013-amended-2018)",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Castration-Resistant Prostate Cancer",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.auanet.org/guidelines/urodynamics-(2012-reviewed-for-currency-2018)",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Adult Urodynamics",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.aagbi.org/sites/default/files/JW_Guideline_2018.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Jehovah's Witnesses and patients who refuse blood",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://ascopubs.org/doi/full/10.1200/JCO.18.00374",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Antimicrobial Prophylaxis for Adult Patients with Cancer-Related Immunosuppression",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "file:///Users/chutizzah/Downloads/BTS%20Guideline%20for%20the%20initial%20outpatient%20management%20of%20pulmonary%20embolism%20(1).pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "BTS Guidelines for the outpatient management of pulmonary embolism",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "http://www.annexpublishers.co/full-text/JNH/5308/The-Contribution-of-Alcohol-Consumption-to-Overall-Cancer-Incidence-in-the-Western-World-A-Meta-Analysis.php",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "The Contribution of Alcohol Consumption to Overall Cancer Incidence in the Western World: A Meta-Analysis",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.canceraustralia.gov.au/system/tdf/publications/optimal-care-pathway-aboriginal-and-torres-strait-islander-people-cancer/pdf/optimal-care-pathway-for-aboriginal-and-torres-strait-islander-people-with-cancer.pdf?file=1&type=node&id=6156",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Optimal Care Pathway for Aboriginal and Torres Strait Islander people with cancer",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://muhc.ca/sites/default/files/micro/m-TAU/SpaceOAR.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Hydrogel Spacer to reduce rectal toxicity in prostate cancer radiotherapy: a health technology assessment",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://academic.oup.com/jcem/article/103/4/1233/4924418?login=false",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Evaluation and Treatment of Hirsutism in Premenopausal Women",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.acr.org/-/media/ACR/Files/Practice-Parameters/PNB.pdf?la=en",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "ACR/SIR/SPR Practice Parameter for the Performance of Image-Guided Percutaneous Needle Biopsy (PNB)",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.acr.org/-/media/ACR/Files/Practice-Parameters/PDFAC.pdf?la=en",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "ACR/SIR/SPR Practice Parameter for Specifications and Performance of Image-Guided Percutaneous Drainage/Aspiration of Abscesses and Fluid Collections (PDAFC)",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://uroweb.org/guidelines/paediatric-urology",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Paediatric Urology",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://academic.oup.com/eurheartj/article/39/34/3165/5078465?login=false",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Management of Cardiovascular Diseases during Pregnancy",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Public_assessment_report/human/004030/WC500255243.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Neratinib (Nerlynx) - Breast cancer, breast neoplasms",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://academic.oup.com/eurheartj/article/39/33/3021/5079119?login=false",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "ESC/ESH Management of Arterial Hypertension",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.pharmacoeconomics.ru/jour/article/view/254",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Comments to the article by O. Yu. Rebrova and co-authors ÃScreening at the first stage of periodical health checkup: a systematic review of long-term resultsÃ",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.acog.org/error/404",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Value-Based Payments in Obstetrics and Gynecology",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.thoracic.org/statements/resources/lcod/inc-chronic-illness-into-lung-cancer-screening.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Incorporating Coexisting Chronic Illness into Lung Cancer Screening: A Research Statement",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.tripdatabase.com/top/testosterone?sort=v12m",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Testosterone",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.tripdatabase.com/top/ultrasound?sort=v12m",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Ultrasound",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.tripdatabase.com/top/finasteride?sort=v12m",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Finasteride",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.tripdatabase.com/top/overdiagnosis?sort=v12m",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Overdiagnosis",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.tripdatabase.com/top/mammography?sort=v12m",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Mammography",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.tripdatabase.com/top/lung-cancer?sort=v12m",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Lung cancer",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.tripdatabase.com/top/aids?sort=v12m",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "AIDS",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.ema.europa.eu/en/documents/assessment-report/hefiya-epar-public-assessment-report_en.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Adalimumab (Hefiya) - Juvenile Rheumatoid Arthritis, Hidradenitis Suppurativa, Psoriasis, Ankylosing Spondylitis, Uveitis",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.ema.europa.eu/en/documents/assessment-report/halimatoz-epar-public-assessment-report_en.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Adalimumab (Halimatoz) - Juvenile Rheumatoid Arthritis, Psoriatic Arthritis, Rheumatoid Arthritis, Hidradenitis Suppurativa, Psoriasis, Ankylosing Spondylitis, Uveitis",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.icsi.org/wp-content/uploads/2019/08/March-2018-LBP-Interactive2.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Low Back Pain, Adult Acute and Subacute",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://academic.oup.com/cid/article/67/6/e1/5046039?login=false",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "A Guide to Utilization of the Microbiology Laboratory for Diagnosis of Infectious Diseases: 2018 Update by the Infectious Diseases Society of America and the American Society for Microbiology",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.lidsen.com/journals/icm/icm-03-02-011",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "The Efficacy of Mindfulness-Based Interventions on Depressive Symptoms and Quality of Life: A Systematic Review of Randomized Controlled Trials",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "No access",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Erectile Dysfunction",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://ascopubs.org/doi/full/10.1200/JCO.2018.78.8687",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Practical Assessment and Management of Vulnerabilities in Older Patients Receiving Chemotherapy",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "No access",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Surgical Management of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://ascopubs.org/doi/full/10.1200/JCO.2018.78.9636",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Metastatic Pancreatic Cancer",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "No access",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Evaluation and Management of Testosterone Deficiency",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://hrbopenresearch.org/articles/1-16/v1",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Promoting menÃs awareness, self-examination, and help-seeking for testicular disorders: a systematic review of interventions",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.healthcareimprovementscotland.org/idoc.ashx?docid=3cb8d8da-ecc4-4c4f-b3ac-6c2815eb80cf&version=-1",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "PET-CT in investigating and or assessing patients for diagnosis and or staging of myeloma",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.npojip.org/english/MedCheck/Med%20Check-TIP%2010-05-09.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Do general health checks prolong lifespan?",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.cancercareontario.ca/en/file/33636/download?token=hJie5D1i",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "PET Evidence from Primary Studies and Systematic Reviews and Recommendations from Clinical Practice Guidelines",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.cancercareontario.ca/en/file/33576/download?token=S9QSuqt0",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Recommendations for the Delivery of Psychosocial Oncology Services in Ontario",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD013020/full",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Bisphosphonates or RANK-ligand-inhibitors for men with prostate cancer and bone metastases: a Cochrane Review and network meta-analysis",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.ema.europa.eu/en/documents/assessment-report/segluromet-epar-public-assessment-report_en.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Ertugliflozin l-pyroglutamic acid / metformin hydrochloride (Segluromet) - Diabetes Mellitus, Type 2",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://ascopubs.org/doi/full/10.1200/JCO.2017.77.6385",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://ascopubs.org/doi/full/10.1200/JCO.2017.76.6402",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Role of Bone-Modifying Agents in Multiple Myeloma",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Ertugliflozin l-pyroglutamic acid (Steglatro) - Diabetes Mellitus, Type 2",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.ema.europa.eu/en/documents/assessment-report/steglujan-epar-public-assessment-report_en.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Ertugliflozin l-pyroglutamic acid / sitagliptin phosphate monohydrate (Steglujan) - Diabetes Mellitus, Type 2",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.nice.org.uk/guidance/ng96/resources/care-and-support-of-people-growing-older-with-learning-disabilities-pdf-1837758519493",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Care and support of people growing older with learning disabilities",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Metastasis of breast carcinoma to the paranasal sinus: report of two cases and systematic review of literature",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://effectivehealthcare.ahrq.gov/sites/default/files/pdf/prioritization-selection-of-harms.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Prioritization and Selection of Harms for Inclusion in Systematic Reviews",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.safefood.net/research-reports/estimated-costs-childhood-obesity",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "What are the estimated costs of childhood overweight and obesity on the island of Ireland?",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.bmus.org/static/uploads/resources/SCoR__BMUS_Guidelines_for_Professional_Ultrasound_Practice_Revised_Jan_2018.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Guidelines For Professional Ultrasound Practice",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.cadth.ca/dv/ieht/overview-clinical-applications-artificial-intelligence",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "An Overview of Clinical Applications of Artificial Intelligence",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.rcr.ac.uk/system/files/publication/field_publication_files/bfco182_good_pract_paed_rt_second_ed.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Good practice guide for paediatric radiotherapy, second edition",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Guidelines for Gender Affirming Healthcare for Gender Diverse and Transgender Children, Young People and Adults in Aotearoa New Zealan",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://easl.eu/wp-content/uploads/2018/10/EASL-CPG-Management-of-hepatocellular-carcinoma-.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Management of hepatocellular carcinoma",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/ovarian-cancer-screening",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Ovarian Cancer: Screening",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/obesity-in-adults-interventions",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Weight Loss to Prevent Obesity-Related Morbidity and Mortality in Adults: Behavioral Interventions",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://fascrs.org/ascrs/media/files/downloads/Clinical%20Practice%20Guidelines/rad_proctitis_cpg_2018.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Treatment of Chronic Radiation Proctitis",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://fascrs.org/ascrs/media/files/downloads/Clinical%20Practice%20Guidelines/cpg_management_of_hemorrhoids.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Management of Hemorrhoids",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://ukkidney.org/sites/renal.org/files/Living-Donor.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Guidelines for Living Donor Kidney Transplantation",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.thegreenjournal.com/article/S0167-8140(18)30197-X/fulltext",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "ESTRO-ACROP guideline: Interstitial multi-catheter breast brachytherapy as Accelerated Partial Breast Irradiation alone or as boost Ã GEC-ESTRO Breast Cancer Working Group practical recommendations",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.thegreenjournal.com/article/S0167-8140(17)32733-0/fulltext",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "ESTRO ACROP: Technology for precision small animal radiotherapy research: Optimal use and challenges",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.espen.org/files/ESPEN-Guidelines/Pediatrics/ESPGHAN_ESPEN_ESPR_CSPEN-guidelines-on-pediatric-parenteral-nutrition-Vitamins.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "ESPGHAN/ESPEN/ESPR/(CSPEN) guidelines on pediatric: Vitamins",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.sign.ac.uk/media/1088/sign151.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Management of stable angina",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.sign.ac.uk/media/1073/sign135_oct2018.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Management of epithelial ovarian cancer",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.leitlinienprogramm-onkologie.de/fileadmin/user_upload/Downloads/Leitlinien/Endometriumkarzinom/GGPO_Endometrial_Carcinoma_short_Version_1.0.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Guideline on the Diagnosis, Treatment, and Follow-up of Patients with Endometrial Cancer",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://eje.bioscientifica.com/configurable/contentpage/journals$002feje$002f179$002f3$002fEJE-18-0279.xml",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Rare defects in Adrenal Steroidogenesis",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://academic.oup.com/jcem/article/103/11/4043/5107759?login=false",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Congenital Adrenal Hyperplasia Due to Steroid 21-Hydroxylase Deficiency",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://eje.bioscientifica.com/view/journals/eje/179/4/EJE-18-0608.xml",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "European Society of Endocrinology Clinical Practice Guidelines on the management of adrenocortical carcinoma in adults",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://bpac.org.nz/guidelines/4/docs/Sepsis.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Sepsis: recognition, diagnosis and early management",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://icer.org/wp-content/uploads/2020/10/ICER_Elagolix_Final_Evidence_Report_080318.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Elagolix for Treating Endometriosis",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://icer.org/wp-content/uploads/2020/10/ICER_Prostate_Cancer_Final_Evidence_Report_100418.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Antiandrogen Therapies for Nonmetastatic Castration-Resistant Prostate Cancer: Effectiveness and Value",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://associationofbreastsurgery.org.uk/media/64821/jpras-breast-imaging-for-aesthetic-surgery-2018.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Breast imaging for aesthetic surgery: British Society of Breast Radiology (BSBR), Association of Breast Surgery Great Britain & Ireland (ABS), British Association of Plastic Reconstructive and Aesthetic Surgeons (BAPRAS)",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://aci.health.nsw.gov.au/__data/assets/pdf_file/0007/306088/water-for-dialysis2018.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Water for dialysis: A guide for in-centre, satellite and home haemodialysis in NSW",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://bestpractice.bmj.com/topics/en-gb/315",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Assessment of non-visible haematuria",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://bestpractice.bmj.com/topics/en-gb/255",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Testicular cancer",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://bestpractice.bmj.com/topics/en-gb/223",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Androgenic alopecia",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://bestpractice.bmj.com/topics/en-gb/457",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Assessment of lower gastrointestinal bleeding",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://bestpractice.bmj.com/topics/en-gb/548",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Assessment of unintentional weight loss",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.saxinstitute.org.au/wp-content/uploads/Tools-to-aid-clinical-identification-of-end-of-life.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Tools to aid the clinical identification of end of life",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.ohtn.on.ca/rapid-response-barriers-to-accessing-health-care-among-transgender-individuals/",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Barriers to accessing health care among transgender individuals",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "Ocrelizumab (Ocrevus) - multiple sclerosis",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Ocrelizumab (Ocrevus) - multiple sclerosis",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.cancercareontario.ca/en/file/29696/download?token=EuepG53n",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "PET Evidence from Primary Studies and Systematic Reviews and Recommendations from Clinical Practice Guidelines",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.moh.gov.my/moh/resources/penerbitan/CPG/MSH%20Hypertension%20CPG%202018%20V3.8%20FA.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Management of Hypertension (5th Edition)",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.auanet.org/guidelines/guidelines/erectile-dysfunction-(ed)-guideline",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Erectile Dysfunction",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.jscisociety.com/article.asp?issn=0974-5009;year=2018;volume=45;issue=2;spage=84;epage=89;aulast=Pentyala",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Bladder preservation protocols in the management of muscle-invasive bladder cancer: A systematic review",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "The Effects of Simultaneous Versus Staged Bilateral Femoral Intramedullary Nailing for Metastatic Disease on Survival Time and Perioperative Complications: A Systematic Review",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://onlinelibrary.wiley.com/doi/10.1002/CL2.203",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "PROTOCOL: Protocol for a systematic review: Interventions addressing men, masculinities and gender equality in sexual and reproductive health: An evidence and gap map and systematic review of reviews",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.asrm.org/globalassets/asrm/asrm-content/news-and-publications/practice-guidelines/for-non-members/diagnostic_evaluation_of_sexual_dysfunction_in_the_male_partner.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Diagnostic evaluation of sexual dysfunction in the male partner in the setting of infertility: a committee opinion",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.menopause.org/docs/default-source/default-document-library/2018-translational-science-symposium-publication.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Utian Translational Science Symposium report: New Ttherapies for Leiomyomas: When Surgery May Not Be the Best Option",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.eunethta.eu/wp-content/uploads/2018/04/OTCA09_HIFU-for-prostate-cancer_v1.4.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "High-intensity focused ultrasound (HIFU) ablation for the treatment of prostate cancer",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://ebm.bmj.com/content/23/1/1",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Overdiagnosis: what it is and what it isn?t",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://kce.fgov.be/sites/default/files/2021-12/KCE_304_Optimisation_lump_sums_incontinence_Report.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Optimisation of RIZIV Ã INAMI lump sums for incontinence",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://kce.fgov.be/sites/default/files/2021-12/KCE_303_Patient_reported_outcomes_Report_2.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Use of patient-reported outcome and experience measures in patient care and policy",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "http://www.bssm.org.uk/wp-content/uploads/2018/09/ijcp13054-1.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Erectile Dysfunction and Testosterone Deficiency as Cardiovascular Risk Factors?",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "http://www.bssm.org.uk/wp-content/uploads/2018/09/BSSM-ED-guidelines-2018-1.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "British Society for Sexual Medicine Guidelines on the Management of Erectile Dysfunction in Men",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "http://www.bssm.org.uk/wp-content/uploads/2018/09/guidelines-on-adult-testosterone-deficiency-with-statements-for-uk-practice.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "British Society for Sexual Medicine Guidelines on Adult Testosterone Deficiency, With Statements for UK Practice",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "http://www.bssm.org.uk/wp-content/uploads/2018/02/BSSM-Practical-Guide-High-Res-single-pp-view-final.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "A Practical Guide Ã On The Assessment and Management of Testosterone Deficiency in Adult Men",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.facs.org/media/oxdjw5zj/imaging_guidelines.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Imaging Guidelines",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "The EFSUMB Guidelines and Recommendations for the Clinical Practice of Elastography in Non-Hepatic Applications: Update 2018",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.ema.europa.eu/en/documents/assessment-report/tookad-epar-public-assessment-report_en.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Padeliporfin (Tookad) - prostate cancer / Prostatic Neoplasms",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.bsg.org.uk/wp-content/uploads/2019/12/Guidelines-on-the-management-of-abnormal-liver-blood-tests.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Guidelines on the management of abnormal liver blood tests",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://effectivehealthcare.ahrq.gov/sites/default/files/pdf/cer-195-uterine-fibroids-final-revision.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Management of Uterine Fibroids",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.ema.europa.eu/en/documents/assessment-report/tremfya-epar-public-assessment-report_en.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Guselkumab (Tremfya) - Psoriasis",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://insa.nic.in/writereaddata/UpLoadedFiles/PINSA/2017_Art66.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Clinical Pharmacology in India-A Systematic Review of Research in the Past 5 Years",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.ema.europa.eu/en/documents/assessment-report/bavencio-epar-public-assessment-report_en.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Avelumab (Bavencio) - Neuroendocrine Tumors",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.esmo.org/Guidelines/Genitourinary-Cancers/Cancer-of-the-Prostate/eUpdate-Treatment-Recommendation",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "eUpdate ? Cancer of the Prostate Treatment Recommendations",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.ema.europa.eu/en/documents/assessment-report/skilarence-epar-public-assessment-report_en.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Dimethyl fumarate (Skilarence) - plaque psoriasis",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.ema.europa.eu/en/documents/assessment-report/mavenclad-epar-public-assessment-report_en.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Cladribine (Mavenclad) - multiple sclerosis",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.esmo.org/Guidelines/Sarcoma-and-GIST/Soft-Tissue-and-Visceral-Sarcomas/eUpdate-Treatment-Recommendations",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "eUpdate ? Soft Tissue Sarcoma Treatment Recommendations",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.esmo.org/guidelines/guidelines-by-topic/gynaecological-cancers/endometrial-cancer/esmo-esgo-estro-consensus-conference-on-endometrial-cancer/eupdate-endometrial-cancer-algorithms",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "eUpdate: Endometrial Cancer Algorithms",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.esmo.org/guidelines/guidelines-by-topic/gastrointestinal-cancers/pancreatic-cancer/eupdate-cancer-of-the-pancreas-treatment-recommendations2",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "eUpdate ? Cancer of the Pancreas Treatment Recommendations",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.esmo.org/guidelines/guidelines-by-topic/haematological-malignancies/chronic-lymphocytic-leukaemia/eupdate-chronic-lymphocytic-leukaemia-treatment-recommendations",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "eUpdate ? Chronic Lymphocytic Leukaemia Treatment Recommendations",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.esmo.org/Guidelines/Genitourinary-Cancers/Testicular-Seminoma-and-Non-Seminoma/eUpdate-Treatment-Recommendation",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "eUpdate ? Testicular Seminoma and Non-Seminoma Treatment Recommendations",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://prodigy.clarity.co.uk/",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Antiocoagulation - oral",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.ema.europa.eu/en/documents/assessment-report/besponsa-epar-public-assessment-report_en.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Inotuzumab ozogamicin (Besponsa) - B-cell precursor acute lymphoblastic leukaemia (ALL)",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://effectivehealthcare.ahrq.gov/sites/default/files/pdf/asd-interventions_research-2017.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Interventions Targeting Sensory Challenges in Children with Autism Spectrum Disorder - An Update",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.ema.europa.eu/en/documents/assessment-report/trimbow-epar-public-assessment-report_en.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Trimbow (beclometasone / formoterol / glycopyrronium bromide) - chronic obstructive pulmonary disease (COPD)",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.nice.org.uk/advice/es15",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Early breast cancer (preventing recurrence and improving survival): adjuvant bisphosphonates",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.mcmasterforum.org/docs/default-source/product-documents/rapid-responses/identifying-the-effects-of-using-telecommunications-technology-to-provide-clinical-care-at-a-distance.pdf?sfvrsn=8",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Identifying the Effects of Using Telecommunications Technology to Provide Clinical Care at a Distance",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.sciencepubco.com/index.php/IJH/article/view/7745",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "The what, why and how of health literacy: a systematic review of literature",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://doi.org/10.30841/2307-5090.2(61).2017.116940",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Salvage radical prostatectomy after distance radiation therapy: a systematic review of modern approaches",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Public_assessment_report/human/003861/WC500226452.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Parathyroid hormone (Natpar) - hypoparathyroidism",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.healthcareimprovementscotland.org/idoc.ashx?docid=22c1bc09-7e8a-4e36-871a-05f43f8e2fac&version=-1",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Non-FDG tracers for use in PET-CT for suspected recurrent prostate cancer",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://effectivehealthcare.ahrq.gov/sites/default/files/pdf/cognitive-decline_research-2017.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Interventions to Prevent Age-Related Cognitive Decline, Mild Cognitive Impairment, and Clinical Alzheimer's-Type Dementia",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://brieflands.com/articles/amhsr-59684.html",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Hyperbaric Oxygen Therapy and Quality of Life: A Systematic Review",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.nice.org.uk/advice/es7/resources/skin-involvement-in-systemic-sclerosis-rituximab-32179717573",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Skin involvement in systemic sclerosis: rituximab",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.ema.europa.eu/en/documents/assessment-report/olumiant-epar-public-assessment-report_en.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Baricitinib (Olumiant) - rheumatoid arthritis",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.iqwig.de/download/v14-03_dmp-osteoporosis_extract-of-final-report.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Systematic guideline search and appraisal, as well as extraction of relevant recommendations, for a DMP \"\"osteoporosis\"\"",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.journals.elsevier.com/annals-of-oncology",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Metastatic Non-Small-Cell Lung Cancer",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.cadth.ca/guidelines-economic-evaluation-health-technologies-canada-4th-edition",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Guidelines for the Economic Evaluation of Health Technologies: Canada ÂÃÃ 4th Edition",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://onlinelibrary.wiley.com/doi/full/10.4073/csr.2017.11",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Mindfulness?based stress reduction (MBSR) for improving health, quality of life and social functioning in adults: a systematic review and meta?analysis",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/gynecological-conditions-screening-with-the-pelvic-examination",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Gynecological Conditions: Periodic Screening With the Pelvic Examination",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://ukhsa.koha-ptfs.co.uk/cgi-bin/koha/opac-retrieve-file.pl?id=99b8c94d3ba0d9e3a162a67d3af4c105",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "What does the evidence say about employee sleep??",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://ukhsa.koha-ptfs.co.uk/cgi-bin/koha/opac-retrieve-file.pl?id=ab2fa9951083e13599a51093816d4bb9",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Do teachable moments change the lifestyle behaviours of patients after they received their investigation results having been referred to secondary care with suspected cancer?",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://fascrs.org/ascrs/media/files/downloads/Clinical%20Practice%20Guidelines/clinical_practice_guidelines_for_the_treatment_of-3.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Treatment of Rectal Prolapse",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://ukkidney.org/sites/renal.org/files/FINAL-Post-Operative-Care-Guideline-1.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Post-Operative Care in the Kidney Transplant Recipient",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.thegreenjournal.com/article/S0167-8140(16)34463-2/fulltext",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "GEC-ESTRO/ACROP recommendations for performing bladder-sparing treatment with brachytherapy for muscle-invasive bladder carcinoma",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://onlinelibrary.wiley.com/doi/full/10.1111/jth.13791",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Occult cancer screening in patients with venous thromboembolism: guidance from the SSC of the ISTH",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.albertahealthservices.ca/assets/info/hp/cancer/if-hp-cancer-guide-supp008-fatigue.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Cancer-Related Fatigue",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.albertahealthservices.ca/assets/info/hp/cancer/if-hp-cancer-guide-supp008-fatigue-summary.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Cancer-Related Fatigue",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.espen.org/files/ESPEN-Guidelines/PIIS0261561417302285.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "ESPEN expert group recommendations for action against cancer-related malnutrition",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.espen.org/files/ESPEN-Guidelines/ESPEN_guidelines_on_nutrition_in_cancer_patients.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "ESPEN guidelines on nutrition in cancer patients",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.hse.ie/eng/services/list/5/cancer/profinfo/guidelines/lung-cancer/nccp-lung-guideline-full.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Diagnosis, staging and treatment of patients with Lung Cancer",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://english.zorginstituutnederland.nl/publications/reports/2017/12/07/zinnige-zorg-room-for-improvement-report---appropriate-use-of-expensive-medicines-in-cases-of-metastatic-renal-cell-carcinoma",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Zinnige Zorg room for improvement report - Appropriate use of expensive medicines in cases of metastatic renal cell carcinoma",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://icer.org/wp-content/uploads/2020/10/MWCEPAC_OVARIAN_FINAL_EVIDENCE_REPORT_10112017-1.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Poly ADP-Ribose Polymerase (PARP) Inhibitors for Ovarian Cancer: Effectiveness and Value",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://web.archive.org/web/20180609154531/https://www.guideline.gov/summaries/summary/51172/diagnosis-and-treatment-of-osteoporosis",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Diagnosis and treatment of osteoporosis.",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://web.archive.org/web/20180609222350/https://www.guideline.gov/summaries/summary/51085/renal-mass-and-localized-renal-cancer-aua-guideline",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Renal mass and localized renal cancer: AUA guideline.",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "http://circ.ahajournals.org/lookup/doi/10.1161/CIR.0000000000000523",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Methodological Standards for Meta-Analyses and Qualitative Systematic Reviews of Cardiac Prevention and Treatment Studies: A Scientific Statement From the American Heart Association",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.ahajournals.org/doi/10.1161/HYP.0000000000000065",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.thoracic.org/statements/resources/lcod/molec-biomarkers-lung-cancer.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Evaluating biomarkers for the early detection of lung cancer: An Official ATS Policy Statement",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.ahajournals.org/doi/pdf/10.1161/CIR.0000000000000535",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Diagnosis and Management of Noncardiac Complications in Adults With Congenital Heart Disease: A Scientific Statement From the American Heart Association",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.foodstandards.gov.scot/downloads/FSS_Big_Number_Report_August_15_FINAL_Oct_2017.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "A review of the evidence base for modelling the costs of overweight, obesity and diet-related illness for Scotland, and critical appraisal of the cost-effectiveness evidence base for population wide interventions to reduce overweight, obesity and diet-rel",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.phrc.online/papers/PHRC_014_Final_Report.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Prescribing patterns of dependence forming medicines",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.jacc.org/journal/null//7/871.full.p",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Periprocedural Management of Anticoagulation in Patients With Nonvalvular Atrial Fibrillation",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.canceraustralia.gov.au/system/tdf/guidelines/management_of_menopausal_symptoms_in_women_with_a_history_of_breast_cancer.pdf?file=1&type=node&id=4711",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Management of menopausal symptoms in women with a history of breast cancer",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.ema.europa.eu/en/documents/assessment-report/venclyxto-epar-public-assessment-report_en.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Venetoclax (Venclyxto) - Chronic, B-Cell Lymphocytic Leukemia",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://car.ca/wp-content/uploads/CT-Screening-for-Lung-Cancer-2017.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "CT Screening for Lung Cancer",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://wa.kaiserpermanente.org/static/pdf/public/guidelines/colon.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Colorectal Cancer Screening",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://web.archive.org/web/20180712165223/https://www.guideline.gov/syntheses/synthesis/50782",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Screening for Gynecologic Conditions with Pelvic Examination",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://web.archive.org/web/20180610230335/https://www.guideline.gov/summaries/summary/51034/secondline-hormonal-therapy-for-men-with-chemotherapyna-ve-castrationresistant-prostate-cancer-american-society-of-clinical-oncology-provisional-clinical-opinion",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Second-line hormonal therapy for men with chemotherapy-na&iuml",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://web.archive.org/web/20180610000454/https://www.guideline.gov/summaries/summary/51027/brachytherapy-for-patients-with-prostate-cancer-american-society-of-clinical-oncologycancer-care-ontario-joint-guideline-update",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Brachytherapy for patients with prostate cancer: American Society of Clinical Oncology/Cancer Care Ontario joint guideline update.",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.auanet.org/guidelines/guidelines/stress-urinary-incontinence-(sui)-guideline",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Surgical Treatment of Female Stress Urinary Incontinence (SUI): AUA/SUFU Guideline",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.auanet.org/guidelines/renal-mass-and-localized-renal-cancer-new-(2017)",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Renal Mass and Localized Renal Cancer",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://acsearch.acr.org/docs/69369/Narrative/",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Post-treatment Follow-up of Prostate Cancer",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.jacc.org/doi/10.1016/j.jacc.2017.02.001",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Appropriate Use Criteria for Coronary Revascularization in Patients With Stable Ischemic Heart Disease",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.moh.gov.my/moh/resources/Penerbitan/CPG/CARDIOVASCULAR/3.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Primary & Secondary Prevention of CVD",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.aium.org/resources/guidelines/abdominal.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "AIUM Practice Parameter for the Performance of an Ultrasound Examination of the Abdomen and/or Retroperitoneum",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.sgo.org/wp-content/uploads/2012/09/PB-182.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Practice Bulletin: Hereditary Breast and Ovarian Cancer Syndrome",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.sgo.org/wp-content/uploads/2012/09/CO-716.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Committee Opinion: The Role of the Obstetrician Gynecologist in the Early Detection of Epithelial Ovarian Cancer in Women at Average Risk",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://ascopubs.org/doi/full/10.1200/JCO.2016.72.0466",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Brachytherapy for Patients With Prostate Cancer",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.astro.org/uploadedFiles/_MAIN_SITE/Patient_Care/Clinical_Practice_Statements/Content_Pieces/MuscleInvasiveBladderCancer.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Treatment of Non-Metastatic Muscle-Invasive Bladder Cancer Guideline",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.auanet.org/guidelines/guidelines/bladder-cancer-non-metastatic-muscle-invasive-guideline",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Treatment of Non-Metastatic Muscle-Invasive Bladder Cancer",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://acsearch.acr.org/docs/69370/Narrative/",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Pretreatment Staging of Muscle-Invasive Bladder Cancer",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.astro.org/uploadedFiles/_MAIN_SITE/Patient_Care/Clinical_Practice_Statements/Content_Pieces/ClinicallyLocalizedProstateCancer.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Clinically Localized Prostate Cancer Guideline",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.acog.org/clinical/clinical-guidance/committee-opinion/articles/2017/09/the-role-of-the-obstetriciangynecologist-in-the-early-detection-of-epithelial-ovarian-cancer-in-women-at-average-risk?utm_source=redirect&utm_medium=web&utm_campaign=otn",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "The Role of the Obstetrician-Gynecologist in the Early Detection of Epithelial Ovarian Cancer in Women at Average Risk",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.acog.org/clinical/clinical-guidance/committee-opinion/articles/2017/06/asymptomatic-microscopic-hematuria-in-women?utm_source=redirect&utm_medium=web&utm_campaign=otn",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Asymptomatic Microscopic Hematuria in Women",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.auanet.org/guidelines/guidelines/vesicoureteral-reflux-guideline",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Mangement and Screening of Primary Vesicoureteral Reflux in Children",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.auanet.org/guidelines/guidelines/urotrauma-guideline",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Urotrauma",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://ascopubs.org/doi/full/10.1200/JCO.2017.75.8995",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Interventions to Address Sexual Problems in People With Cancer",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.endocrine.org/clinical-practice-guidelines/gender-dysphoria-gender-incongruence",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Endocrine Treatment of Gender-Dysphoric/Gender-Incongruent Persons",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.sciencepublishinggroup.com/journal/paperinfo?journalid=651&doi=10.11648/j.ejpm.20170505.11",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Common Determinant and Prevention Strategies of Cancer in the Pacific Countries: A Systematic Review",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://rnao.ca/sites/rnao-ca/files/bpg/FINAL_TOBACCO_INTERVENTION_WEB.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Integrating Tobacco Interventions into Daily Practice",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://academic.oup.com/jcem/article/102/11/3869/4157558?login=false",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Endocrine Treatment of Gender-Dysphoric/Gender-Incongruent Persons: An Endocrine Society Clinical Practice Guideline",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5451271/?report=classic",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Prolaris Cell Cycle Progression Test for Localized Prostate Cancer: A Health Technology Assessment",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5451209/?report=classic",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Prostate Cancer Patient Perspectives on the Use of Information in Treatment Decision-Making: A Systematic Review and Qualitative Meta-synthesis",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://kce.fgov.be/sites/default/files/2021-12/KCE_296_Appropriate_care_at_end_of_life_Report.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Appropriate care at the end of life",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://kce.fgov.be/sites/default/files/2021-11/KCE_280_Routine_preoperative_testing_Report_1.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Routine preoperative testing in adults undergoing elective non-cardiothoracic surgery",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://kce.fgov.be/sites/default/files/2021-11/KCE_282_Day_surgery_Report_0_0.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Proposals for a further expansion of day surgery in Belgium",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://kce.fgov.be/sites/default/files/2021-11/Download%20the%20report%20in%20English%20%28550%20p.%29.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Required hospital capacity in 2025 and criteria for rationalisation of complex cancer surgery, radiotherapy and maternity services",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5515322/?report=classic",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Robotic Surgical System for Radical Prostatectomy: A Health Technology Assessment",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "http://www.bssm.org.uk/wp-content/uploads/2017/12/guidelines-on-adult-testosterone-deficiency-with-statements-for-uk-practice.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Guidelines on Adult Testosterone Deficiency, with Statements for UK Practice",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "http://palliativecare.walescancerresearchcentre.com/uploads/Rapid_Review/Pelvic_Radiotherapy_RR_V1.0_16112017.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "What outpatient models have proven efficacy for assessment and management of pelvic radiotherapy late effects?",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.thieme-connect.com/products/ejournals/pdf/10.1055/a-0586-1107.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "The EFSUMB Guidelines and Recommendations for the Clinical Practice of Contrast-Enhanced Ultrasound (CEUS) in Non-Hepatic Applications: Update 2017",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.ema.europa.eu/en/documents/assessment-report/lartruvo-epar-public-assessment-report_en.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Olaratumab (Lartruvo) - Sarcoma",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://journals.sagepub.com/doi/10.1177/1758998316679387",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Psychological consequences of traumatic upper limb peripheral nerve injury: A systematic review",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.onlinecjc.ca/article/S0828-282X(16)30829-7/pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "2016 Focused update of the Canadian Cardiovascular Society guidelines for the management of atrial fibrillation",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.ema.europa.eu/en/documents/assessment-report/onivyde-epar-public-assessment-report_en.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Onivyde - metastatic adenocarcinoma of the pancreas",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.intechopen.com/chapters/50740",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Grain Legume Consumption Inhibits Colorectal Tumorigenesis: A Meta-Analysis of Human and Animal Studies",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.ema.europa.eu/en/documents/assessment-report/cabometyx-epar-public-assessment-report_en.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Cabometyx (cabozantinib) - advanced renal cell carcinoma",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://academic.oup.com/eurheartj/article/37/27/2129/1748921",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Acute and Chronic Heart Failure",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://academic.oup.com/eurheartj/article/37/39/2999/2414995",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Dyslipidaemias",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "http://eppi.ioe.ac.uk/CMS/Portals/0/PDF%20reviews%20and%20summaries/Employer-led%20workplace%20health%202016%20Brunton.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Developing evidence informed, employer-led workplace health",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.eanm.org/publications/guidelines/EANM_Bone_Scintigraphy_GL_2016.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "The EANM practice guidelines for Bone Scintigraphy",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www2.gov.bc.ca/gov/content/health/practitioner-professional-resources/bc-guidelines/special-endocrine-testing",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Special Endocrine Testing",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "http://www.npojip.org/english/MedCheck/Med%20Check-TIP%2005-08-08.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Pioglitazone (brand name: Actos) and bladder cancer: A new type \"\"time-related bias\"\"",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.ema.europa.eu/en/documents/assessment-report/qtern-epar-public-assessment-report_en.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Qtern (saxagliptin / dapagliflozin propanediol monohydrate) - Diabetes Mellitus, Type 2",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.oregon.gov/oha/HPA/DSI-HERC/EvidenceBasedReports/Indications%20for%20Proton%20Beam%20Therapy.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Proton Beam Therapy",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.nice.org.uk/guidance/ng51/resources/sepsis-recognition-diagnosis-and-early-management-1837508256709",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Sepsis: recognition, diagnosis and early management",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.ema.europa.eu/en/documents/assessment-report/endolucinbeta-epar-public-assessment-report_en.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "EndolucinBeta - lutetium (177 Lu) chloride - radiolabelling",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.ema.europa.eu/en/documents/assessment-report/ongentys-epar-public-assessment-report_en.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Ongentys (opicapone) - Parkinson?s disease",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.cadth.ca/sites/default/files/pdf/ES0301_Drugs_with_cDx.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Pharmaceuticals Requiring Companion Diagnostics",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.ema.europa.eu/en/documents/assessment-report/flixabi-epar-public-assessment-report_en.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Flixabi (infliximab) - rheumatoid arthritis, Crohn?s disease, ulcerative colitis, ankylosing spondylitis, psoriatic arthritis or psoriasis",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.cancercareontario.ca/",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Magnetic Resonance Imaging for Pre-treatment Local Staging of Prostate Cancer",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.nice.org.uk/guidance/ta387/resources/abiraterone-for-treating-metastatic-hormonerelapsed-prostate-cancer-before-chemotherapy-is-indicated-82602854745541",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Abiraterone for treating metastatic hormone-relapsed prostate cancer before chemotherapy is indicated",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.saxinstitute.org.au/wp-content/uploads/Healthcare-performance-reporting-bodies.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Healthcare performance reporting bodies",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.ema.europa.eu/en/documents/assessment-report/briviact-epar-public-assessment-report_en.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Briviact - brivaracetam",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.cfp.ca/content/cfp/62/3/211.full.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Recommendations on routine screening pelvic examination",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.ema.europa.eu/en/documents/assessment-report/tagrisso-epar-public-assessment-report_en.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Tagrisso - osimertinib",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.nice.org.uk/guidance/ta377/resources/enzalutamide-for-treating-metastatic-hormonerelapsed-prostate-cancer-before-chemotherapy-is-indicated-82602794279365",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Enzalutamide for treating metastatic hormone-relapsed prostate cancer before chemotherapy is indicated",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.nice.org.uk/advice/esuom50/resources/hormonesensitive-metastatic-prostate-cancer-docetaxel-54116459176256197",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Hormone-sensitive metastatic prostate cancer: docetaxel",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.cadth.ca/pharmaceuticals-requiring-companion-diagnostics",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Pharmaceuticals Requiring Companion Diagnostics",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.cadth.ca/guidance-document-costing-health-care-resources-canadian-setting",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Guidance Document for the Costing of Health Care Resources in the Canadian Setting",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://easl.eu/wp-content/uploads/2018/10/NAFLD-English-report.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "The management of non-alcoholic fatty liver disease",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/breast-cancer-screening",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Breast Cancer: Screening",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.acpgbi.org.uk/_userfiles/import/2017/02/Prevention-diagnosis-and-management-of-colorectal-anastomotic-leakage-ASGBI-ACPGBI-2016.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Prevention, diagnosis and management of colorectal anastomotic leakage",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.albertahealthservices.ca/assets/info/hp/cancer/if-hp-cancer-guide-rt005-palliative-rt-bleeding.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Palliative Radiotherapy: Bleeding and Gastrointestinal Obstruction",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.albertahealthservices.ca/assets/info/hp/cancer/if-hp-cancer-guide-rt003-palliative-rt-bone.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Palliative Radiotherapy: Bone Metastases and Spinal Cord Compression",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.publichealthontario.ca/-/media/documents/e/2016/environmental-burden-cancer-on.pdf?sc_lang=en",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Environmental Burden of Cancer in Ontario",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.jaad.org/article/S0190-9622(15)02614-6/fulltext",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Acne clinical guideline",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.mja.com.au/journal/2016/205/5/endocrine-society-australia-position-statement-male-hypogonadism-part-2",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Endocrine Society of Australia position statement on male hypogonadism (part 2): treatment and therapeutic considerations",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.mja.com.au/journal/2016/205/4/endocrine-society-australia-position-statement-male-hypogonadism-part-1",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Endocrine Society of Australia position statement on male hypogonadism (part 1): assessment and indications for testosterone therapy",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.wjgnet.com/2308-3840/full/v4/i3/69.htm",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Efficacy, safety, and dose comparison of degarelix for the treatment of prostate cancer: A systematic review and meta-analysis",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://icer.org/wp-content/uploads/2020/10/MWCEPAC_NSCLC_Final_Evidence_Report_Meeting_Summary_110116.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Treatment Options for Advanced Non-Small Cell Lung Cancer: Effectiveness, Value and Value Based Price Benchmarks",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://car.ca/wp-content/uploads/Breast-Imaging-and-Intervention-2016.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Breast Imaging and Intervention",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.coaghealthcouncil.gov.au/Portals/0/HealthPACT/Surefire%20Infusion%20System_Technology%20Brief_August%202016.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "SureFireÂ¨ Precision Chemoembolization Infusion System",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.coaghealthcouncil.gov.au/Portals/0/HealthPACT/Blood%20and%20stool%20biomarker%20testing%20for%20colorectal%20cancer%20screening_Technology%20Brief%20Update_August%202016.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Blood and stool biomarker for colorectal cancer screening",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://journals.lww.com/ccmjournal/Fulltext/2017/03000/Surviving_Sepsis_Campaign___International.15.aspx",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.fhi.no/en/publ/2016/effekt-av-fysisk-trening-for-personer-med-kreft/",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "The effectiveness of physical exercise for people with cancer",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://wa.kaiserpermanente.org/static/pdf/public/guidelines/alcohol-adult.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Alcohol: Adult Unhealthy Drinking",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.ecdc.europa.eu/sites/default/files/media/en/publications/Publications/PPS-HAI-antimicrobial-use-EU-acute-care-hospitals-V5-3.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Point prevalence survey of healthcare-associated infections and antimicrobial use in European acute care hospitals ? protocol version 5.3",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "http://www.archivesofpathology.org/doi/abs/10.5858/arpa.2015-0450-SA",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Bone Marrow Synoptic Reporting for Hematologic Neoplasms",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://meridian.allenpress.com/aplm/article/140/1/29/193793/Interpretive-Diagnostic-Error-Reduction-in",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Interpretive Diagnostic Error Reduction in Surgical Pathology and Cytology",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://gi.org/wp-content/uploads/2016/03/ACGGuideline-Acute-Lower-GI-Bleeding-03012016.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Management of Patients With Acute Lower Gastrointestinal Bleeding",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.ahajournals.org/doi/10.1161/CIR.0000000000000381",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Preventing and Experiencing Ischemic Heart Disease as a Woman: State of the Science",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.ahajournals.org/doi/10.1161/HCG.0000000000000030",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Nutrigenomics, the Microbiome, and Gene-Environment Interactions: New Directions in Cardiovascular Disease Research, Prevention, and Treatment",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.ahajournals.org/doi/10.1161/CIR.0000000000000426",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Drugs That May Cause or Exacerbate Heart Failure",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.auanet.org/guidelines/guidelines/urethral-stricture-guideline",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Male Urethral Stricture",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.auanet.org/guidelines/guidelines/prostate-mri-and-mri-targeted-biopsy",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Prostate MRI and MRI-Targeted Biopsy in Patients with Prior Negative Biopsy",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.auanet.org/guidelines/guidelines/prostate-needle-biopsy-complications",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "The Prevention and Treatment of the More Common Complications Related to Prostate Biopsy Update",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.auanet.org/guidelines/guidelines/chronic-urinary-retention",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Non-Neurogenic Chronic Urinary Retention: Consensus Definition, Management Strategies, and Future Opportunities",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.auanet.org/guidelines/guidelines/bladder-cancer-non-muscle-invasive-guideline",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Diagnosis and Treatment of Non-Muscle Invasive Bladder Cancer",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.auanet.org/guidelines/asymptomatic-microhematuria-(2012-reviewed-and-validity-confirmed-2016)",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Diagnosis, Evaluation and Follow-up of Asymptomatic Microhematuria (AMH) in Adults",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://ascopubs.org/doi/full/10.1200/JCO.2015.65.9797",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Guidelines on muscle-invasive and metastatic bladder cancer (European Association of Urology Guideline)",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://acsearch.acr.org/docs/69399/Narrative/",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Permanent Source Brachytherapy for Prostate Cancer",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.auanet.org/guidelines/guidelines/kidney-stones-surgical-management-guideline",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Surgical Management of Stones: AUA/Endourology Society Guideline",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://acsearch.acr.org/docs/69396/Narrative/",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "External Beam Radiation Therapy Treatment Planning for Clinically Localized Prostate Cancer",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://nurses.uroweb.org/wp-content/uploads/EAUN16_Guideline_complete_LR.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Male external catheters in adults",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://actt.albertadoctors.org/CPGs/Lists/CPGDocumentList/Primary-Care-Management-of-Headache-in-Adults.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Headache",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://actt.albertadoctors.org/CPGs/Lists/CPGDocumentList/ED-CPG.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Erectile Dysfunction",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.karger.com/Article/Pdf/452150",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "GH Deficiency, Idiopathic Short Stature, and IGF-I Deficiency treatment guidelines",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4901201/?report=classic",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Vertebral Augmentation Involving Vertebroplasty or Kyphoplasty for Cancer-Related Vertebral Compression Fractures: An Economic Analysis",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4902848/?report=classic",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Vertebral Augmentation Involving Vertebroplasty or Kyphoplasty for Cancer-Related Vertebral Compression Fractures: A Systematic Review",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5156844/?report=classic",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Magnetic Resonance Imaging as an Adjunct to Mammography for Breast Cancer Screening in Women at Less Than High Risk for Breast Cancer: A Health Technology Assessment",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4947971/?report=classic",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Ultrasound as an Adjunct to Mammography for Breast Cancer Screening: A Health Technology Assessment",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.cancertreatmentreviews.com/article/S0305-7372%2815%2900228-5/fulltext",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Taxanes In The Treatment Of Breast Cancer: Have We Better Defined Their Role In Older Patients? A Position Paper From A SIOG Task Force",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://clinmedjournals.org/articles/iauc/international-archives-of-urology-and-complications-iauc-1-009.php?jid=iauc",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Prostate Cancer Survivorship: A Systematic Review",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://effectivehealthcare.ahrq.gov/sites/default/files/pdf/major-depressive-disorder_research.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Nonpharmacological Versus Pharmacological Treatments for Adult Patients With Major Depressive Disorder",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.cmaj.ca/content/cmaj/early/2015/10/26/cmaj.150033.full.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Diagnosis and management of testosterone deficiency syndrome in men: clinical practice guideline",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.crd.york.ac.uk/crdweb/ShowRecord.asp?ID=32015001165&ID=32015001165",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "[Cabazitaxel, abiraterone and enzalutamide in metastatic castration-resistant prostate cancer not responding to docetaxel]",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://pubmed.ncbi.nlm.nih.gov/29349121/",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Adherence to clinical preventive services guidelines: Population-based online randomized trial",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.peertechz.com/Clinical-Research-Ophthalmology/JCRO-2-123.php",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Patient Adherence to Follow-Up in Clinical Research: A Systematic Review of Measurements, Associated Factors and Intervention Strategies",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://prostatecanceruk.org/media/4auju3qs/pcuk-chronic-prostatitis-guideline-full-sept-2015.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Chronic prostatitis and chronic pelvic pain syndrome",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.saxinstitute.org.au/wp-content/uploads/Self-management-of-psychological-distress-for-people-with-cancer.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Self-management of psychological distress for people with cancer",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.canceraustralia.gov.au/sites/default/files/publications/lung-cancer-our-mob-handbook-aboriginal-and-torres-strait-islander-health-workers/pdf/lcom_-_atsi_health_worker_handbook.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Lung Cancer in our Mob: a handbook for Aboriginal and Torres Strait Islander Health Workers",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.baus.org.uk/_userfiles/pages/files/Publications/Robotic%20Surgery%20Curriculum.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Robotic Surgery Curriculum",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.journals.elsevier.com/annals-of-oncology",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Cancer of the Pancreas",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "http://www.has-sante.fr/upload/docs/application/pdf/2015-09/xofigo_en_ct13429_val.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Radium-223 (Ra-223) dichloride (Xofigo) - castration-resistant prostate cancer, symptomatic bone metastases and no known visceral metastases",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.cancercareontario.ca/",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Multiparametric Magnetic Resonance Imaging in the Diagnosis of Clinically Significant Prostate Cancer",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.cancercareontario.ca/",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Follow-up Care and Psychosocial Needs of Survivors of Prostate Cancer",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.baus.org.uk/_userfiles/pages/files/Publications/Transrectal%20Ultrasound%20%20Prostatic%20Biopsy%20FINAL.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Transrectal Ultrasound & Prostatic Biopsy",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "http://apps.who.int/iris/bitstream/handle/10665/177992/9789241508995_eng.pdf?sequence=1",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Tool to set and monitor targets for HIV prevention, diagnosis, treatment and care for key populations",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.cadth.ca/sites/default/files/pcodr/pcodr_enzalutamide_xtandi_1stln_mcrpc_fn_rec.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Xtandi First Line mCRPC",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "http://openventio.org/Volume1-Issue2/Green-Tea-Catechins-as-Neuroprotective-Agents-Systematic-Review-of-the-Literature-in-Animal-Pre-Clinical-Trials-AFTNSOJ-1-108.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Green Tea Catechins as Neuroprotective Agents: Systematic Review of the Literature in Animal Pre-Clinical Trials",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.cadth.ca/sites/default/files/pdf/htis/apr-2015/RB0842%20Biophonsphonates%20in%20osteopenia%20and%20low%20risk%20fracture%20Final.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Bisphosphonate Use in Patients with Osteopenia and Low Risk of Fractures",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.cadth.ca/sites/default/files/pdf/ATS0022_Pruning%20Emtree_Methods_Project_e.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Pruning Emtree: Does Focusing Embase Subject Headings Impact Search Strategy Precision and Sensitivity?",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.cadth.ca/sites/default/files/pdf/htis/apr-2015/RB0832%20-%20Palliative%20Radiation%20in%20Bone%20Metastases%20Final.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Palliative Radiation for an Uncomplicated and Painful Bone Metastasis",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.cadth.ca/sites/default/files/pdf/htis/apr-2015/RB0822%20Screening%20for%20Recurrent%20Cancer%20Final.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Screening for Recurrent Cancer",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.cadth.ca/sites/default/files/pdf/htis/apr-2015/RB0828%20-%20Bone%20Scan%20and%20CT%20Scan%20in%20Low%20Risk%20Prostate%20Cancer%20Final.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Bone Scan and Computed Tomography Scan in Male Patients with Low-Risk Prostate Cancer",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.cadth.ca/sites/default/files/pdf/htis/apr-2015/RB0834%20Treatment%20versus%20active%20surveillance%20in%20low%20risk%20prostate%20cancer%20Final.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Treatment versus Active Surveillance in Men with Low Risk Prostate Cancer",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.evidentlycochrane.net/unprovoked-venous-thromboembolism-should-we-be-looking-for-cancer/",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Unprovoked venous thromboembolism: should we be looking for cancer?",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.cadth.ca/media/pdf/htis/feb-2015/RB0785%20Newborn%20Circumcision%20Final.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Newborn Male Circumcision for the Prevention of Sexually Transmitted Infections, Urinary Tract Infections, and Cancer",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.journals.elsevier.com/annals-of-oncology",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Bladder Cancer: ESMO Clinical Practice Guidelines",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "http://eppi.ioe.ac.uk/cms/LinkClick.aspx?fileticket=YGfbx68KJp4%3d&tabid=3468",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Depression, anxiety, pain and quality of life in people living with chronic hepatitis C: a systematic review and meta-analysis",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://effectivehealthcare.ahrq.gov/sites/default/files/pdf/fibromyalgia_research.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Treatments for Fibromyalgia in Adult Subgroups",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.sign.ac.uk/media/1646/sign142-2020-update.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Management of osteoporosis and the prevention of fragility fractures",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://onlinelibrary.wiley.com/doi/full/10.4073/csr.2015.5",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Behavioral, Psychological, Educational, and Vocational Interventions to Facilitate Employment Outcomes for Cancer Survivors: A Systematic Review",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://fascrs.org/ascrs/media/files/downloads/Clinical%20Practice%20Guidelines/practice_guideline_for_the_surveillance_of-1.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Surveillance of Patients After Curative Treatment of Colon and Rectal Cancer",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.agencymeddirectors.wa.gov/Files/2015AMDGOpioidGuideline.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Interagency Guideline for Prescribing Opioids for Pain Agency Medical Directors' Group (AMDG)",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.endocrinepractice.org/article/S1530-891X(20)43462-7/fulltext",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "AACE/ACE Clinical Practice Guidelines for Developing a Diabetes Mellitus Comprehensive Care Plan",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://onlinelibrary.wiley.com/doi/full/10.1111/jth.12838",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Management of cancer-associate disseminate intravascular coagulation: guidance from the SSC of the ISTH",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.publichealthontario.ca/-/media/documents/p/2015/priority-populations-technical.pdf?sc_lang=en",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Understanding and Identifying Priority Populations for Public Health in Ontario: Technical Report",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.ejso.com/article/S0748-7983(15)00903-8/fulltext",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "The Assessment And Management Of Older Cancer Patients: A SIOG Surgical Task Force Survey On SurgeonsÃ Attitudes",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.moh.gov.my/moh/resources/penerbitan/CPG/CPG%20Management%20of%20Cervical%20Cancer%20(Second%20Edition).pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Management of Cervical Cancer",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "http://www.health.gov.ie/wp-content/uploads/2015/12/GTD-Guideline-Full_FINAL-APPROVED-FOR-WEB.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Diagnosis, Staging and Treatment of Patients with Gestational Trophoblastic Disease",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://patient.info/news-and-features/psa-testing-options",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not by country health authorities or medical organisation",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "PSA Testing",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.gov.ie/en/collection/c9fa9a-national-clinical-guidelines/?referrer=http://www.health.gov.ie/wp-content/uploads/2016/01/Pharma-Mgmt-Cancer-Pain.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Pharmacological Management of Cancer Pain in Adults",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.longdom.org/open-access/5alpha-reductase-inhibitors-for-treatment-of-benign-prostatic-hyperplasiaa-systematic-review-and-metaanalysis-1920-4159-1000204.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "5-Alpha Reductase Inhibitors for Treatment of Benign Prostatic Hyperplasia: A Systematic Review and Meta-Analysis",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.wjgnet.com/2308-3840/full/v3/i1/72.htm",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Association between SHBG (TAAAA)n and AR (CAG)n polymorphisms and PCOS risk: A meta-analysis",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://associationofbreastsurgery.org.uk/media/64260/final-family-history-nice-by-us.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Overview of the Implications and Implementation of NICE Guidelines on Familial Breast Cancer",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.who.int/medical_devices/systematic_Review_needs.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Systematic review of needs for medical devices for ageing populations",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.saxinstitute.org.au/wp-content/uploads/Patient-safety-in-primary-healthcare.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Patient safety in primary healthcare: a review of the literature",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.iqwig.de/download/s13-04_extract_ultrasound-screening-for-abdominal-aortic-aneurysms.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Ultrasound screening for abdominal aortic aneurysms",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.ema.europa.eu/en/documents/assessment-report/kyprolis-epar-public-assessment-report_en.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Kyprolis - carfilzomib",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.ema.europa.eu/en/documents/assessment-report/akynzeo-epar-public-assessment-report_en.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Akynzeo (netupitant / palonosetron)",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.ema.europa.eu/en/documents/assessment-report/bindren-epar-public-assessment-report_en.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "BindRen (colestilan)",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.ema.europa.eu/en/documents/assessment-report/cotellic-epar-public-assessment-report_en.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Cotellic - cobimetinib",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.ema.europa.eu/en/documents/assessment-report/blincyto-epar-public-assessment-report_en.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Blincyto (blinatumomab)",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.ema.europa.eu/en/documents/assessment-report/farydak-epar-public-assessment-report_en.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Farydak - panobinostat",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.ema.europa.eu/en/documents/assessment-report/odomzo-epar-public-assessment-report_en.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Odomzo - sonidegib",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://wiki.cancer.org.au/australia/Guidelines:PSA_Testing/Watchful_waiting",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Clinical practice guidelines PSA Testing and Early Management of Test-Detected Prostate Cancer - Watchful waiting",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://wiki.cancer.org.au/australia/Guidelines:PSA_Testing/Prostate_biopsy_and_multiparametric_MRI",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Clinical practice guidelines PSA Testing and Early Management of Test-Detected Prostate Cancer - Prostate biopsy and multiparametric MRI",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://wiki.cancer.org.au/australia/Guidelines:PSA_Testing/Active_surveillance",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Clinical practice guidelines PSA Testing and Early Management of Test-Detected Prostate Cancer - Active surveillance",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.accessdata.fda.gov/drugsatfda_docs/nda/2015/203313Orig1s000_203314Orig1s000MedR.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Insulin degludec/Insulin aspart (Ryzodeg 70/30)",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.nice.org.uk/guidance/ng2/resources/bladder-cancer-diagnosis-and-management-of-bladder-cancer-51036766405",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Bladder cancer: diagnosis and management",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://ebm.bmj.com/content/20/1/31",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Systematic review: Evidence is lacking to support pelvic examinations as a screening tool for non-cervical cancers or other conditions",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.nice.org.uk/guidance/ng14/resources/melanoma-assessment-and-management-1837271430853",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Melanoma: assessment and management",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.ema.europa.eu/en/documents/assessment-report/xadago-epar-public-assessment-report_en.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Xadago - safinamide",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.ema.europa.eu/en/documents/assessment-report/jinarc-epar-public-assessment-report_en.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Jinarc - tolvaptan",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.ema.europa.eu/en/documents/assessment-report/lynparza-epar-public-assessment-report_en.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Lynparza - olaparib",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.ema.europa.eu/en/documents/assessment-report/lumark-epar-public-assessment-report_en.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Lumark - lutetium, isotope of mass 177",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.ema.europa.eu/en/documents/assessment-report/keytruda-epar-public-assessment-report_en.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Keytruda - pembrolizumab",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.ema.europa.eu/en/documents/assessment-report/otezla-epar-public-assessment-report_en.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Otezla - apremilast",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.ema.europa.eu/en/documents/assessment-report/repatha-epar-public-assessment-report_en.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Repatha - evolocumab",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.ema.europa.eu/en/documents/assessment-report/senshio-epar-public-assessment-report_en.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Senshio - ospemifene",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.ema.europa.eu/en/documents/assessment-report/sivextro-epar-public-assessment-report_en.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Sivextro - tedizolid phosphate",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://uroweb.org/wp-content/uploads/EAU-Guidelines-Non-Neurogenic-Male-LUTS-Guidelines-2015-v2.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Treatment of Non-neurogenic Male LUTS",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://uroweb.org/wp-content/uploads/EAU-Guidelines-Non-muscle-invasive-Bladder-Cancer-2015-v1.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Non-muscle-invasive Bladder Cancer",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://uroweb.org/wp-content/uploads/EAU-Guidelines-Male-Sexual-Dysfunction-2015-v2.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Male Sexual Dysfunction",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://uroweb.org/wp-content/uploads/EAU-Guidelines-Penile-Cancer-2015-v2.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Penile Cancer",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://uroweb.org/wp-content/uploads/EAU-Guidelines-Muscle-invasive-and-Metastatic-Bladder-Cancer-2015-v1.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Muscle-invasive and Metastatic Bladder Cancer",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://uroweb.org/wp-content/uploads/EAU-Guidelines-Paediatric-Urology-2015.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Paediatric Urology",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://uroweb.org/wp-content/uploads/EAU-Guidelines-Male-Infertility-20151.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Male Infertility",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://uroweb.org/wp-content/uploads/EAU-Guidelines-Neuro-Urology-2015-v2.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Neuro-urology",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://uroweb.org/wp-content/uploads/EAU-Guidelines-Male-Hypogonadism-2015.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Male Hypogonadism",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://uroweb.org/wp-content/uploads/EAU-Guidelines-Penile-Curvature-2015.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Penile Curvature",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.canceraustralia.gov.au/system/tdf/position-statements/lifestyle_risk_factors_and_the_primary_prevention_of_cancer.pdf?file=1&type=node&id=4210",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Lifestyle risk factors and the primary prevention of cancer",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://onlinelibrary.wiley.com/doi/full/10.1111/bjh.13853",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Diagnosis and Management of Aplastic Anaemia",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.anzca.edu.au/getattachment/4c3b03b7-52bf-4c10-9115-83d827c0fc38/Acute-Pain-Management-Scientific-Evidence.aspx",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Acute Pain Management: Scientific Evidence",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "http://www.msac.gov.au/internet/msac/publishing.nsf/Content/5F3B6BD9007ED966CA25801000123BC2/$File/1319FinalPSD-IGRT-Accessible.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "The use of Image Guided Radiation Therapy (IGRT) in the treatment of cancer",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "http://www.msac.gov.au/internet/msac/publishing.nsf/Content/0267C90C3BD27AC5CA25801000123BBA/$File/1313-FinalPSD-BMD-DXA-accessible.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Bone mineral density analyses using Dual Energy X-Ray Absorptiometry (DXA) in breast cancer patients receiving aromatase inhibitor treatment",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://academic.oup.com/ndt/article/30/suppl_2/ii1/2272478?login=false",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Clinical Practice Guideline on management of patients with diabetes and chronic kidney disease stage 3b or higher (eGFR <45 mL/min)",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://nurses.uroweb.org/wp-content/uploads/EAUN15-Guideline-Intravesical-instillation.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Intravesical instillation with mitomycin C or bacillus Calmette-GuÂrin in non-muscle invasive bladder cancer",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.sgo.org/wp-content/uploads/2012/11/SGO-Position-Statement-Genetics.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Society of Gynecologic Oncology statement on risk assessment for inherited gynecologic cancer predispositions",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.menopause.org/docs/default-source/professional/2015-nonhormonal-therapy-position-statement.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Nonhormonal management of menopause-associated vasomotor symptoms: 2015 position statement of The North American Menopause Society",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://acsearch.acr.org/docs/69343/Narrative/",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Radiologic Management of Thoracic Nodules and Masses",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://acsearch.acr.org/docs/69451/Narrative/",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Routine Chest Radiography",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://ascopubs.org/doi/full/10.1200/JCO.2015.62.3488",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Recommendations for the Use of WBC Growth Factors Update",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://ascopubs.org/doi/full/10.1200/JCO.2014.59.2360",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Definitive and Adjuvant Radiotherapy in Locally Advanced Non?Small-Cell Lung Cancer Guideline Endorsement",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://ascopubs.org/doi/full/10.1200/JCO.2015.64.3809",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "ACS/ASCO Breast Cancer Survivorship Care Guideline",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://ascopubs.org/doi/full/10.1200/JCO.2014.60.2557",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Prostate Cancer Survivorship Care Guideline Endorsement",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://gi.org/2015/02/12/acg-clinical-guideline-genetic-testing-and-management-of-hereditary-gastrointestinal-cancer-syndromes/",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Genetic Testing and Management of Hereditary Gastrointestinal Cancer Syndromes",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.auanet.org/guidelines/castration-resistant-prostate-cancer-(2013-amended-2015)",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Castration-Resistant Prostate Cancer",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.auanet.org/guidelines/guidelines/vasectomy-guideline",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Vasectomy",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.auanet.org/guidelines/guidelines/peyronies-disease-guideline",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Peyronie's Disease",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.auanet.org/guidelines/guidelines/prostate-biopsy-and-specimen-handling",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Optimal Techniques of Prostate Biopsy and Specimen Handling",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://actt.albertadoctors.org/CPGs/Lists/CPGDocumentList/urinary-tract-infection-guideline.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Urinary Tract Infection - Long Term Care Facilities",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://actt.albertadoctors.org/CPGs/Lists/CPGDocumentList/Adult-Insomnia-CPG.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Adult Insomnia",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.liebertpub.com/doi/pdfplus/10.1089/thy.2014.0335",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Revised ATA guidelines for the management of medullary thyroid carcinoma",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.liebertpub.com/doi/pdfplus/10.1089/thy.2015.0020",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.cancercareontario.ca/",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Active Surveillance for the Management of Localized Prostate Cancer",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4558769/?report=classic",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Magnetic ResonanceÃGuided High-Intensity Focused Ultrasound (MRgHIFU) Treatment of Symptomatic Uterine Fibroids: An Evidence-Based Analysis",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4558770/?report=classic",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Magnetic Resonance-Guided High-Intensity Focused Ultrasound (MRgHIFU) for Treatment of Symptomatic Uterine Fibroids: An Economic Analysis",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://kce.fgov.be/sites/default/files/2021-11/KCE_256_Head-and-neck_cancer_Report_1.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Oropharyngeal, hypopharyngeal and laryngeal cancer: diagnosis, treatment and follow-up",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://kce.fgov.be/sites/default/files/2021-11/KCE_240_Targeted%20therapy_Scientific%20Report.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Next generation sequencing gene panels for targeted therapy in oncology and haemato-oncology",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://kce.fgov.be/sites/default/files/2021-11/KCE_247_Bladder_cancer_Report_1.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Bladder cancer: an assessment of international practice guidelines",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://kce.fgov.be/sites/default/files/2021-11/KCE_239_team%20meetings_oncology_Report_2_1.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Ten years of multidisciplinary teams meetings in oncology: current situation and perspectives",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://kce.fgov.be/sites/default/files/2021-11/KCE_253_Renal_cancer_Report%20%282%29.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Renal cancer in adults: diagnosis, treatment and follow-up",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://kce.fgov.be/sites/default/files/2021-11/KCE_235_Hadron%20Therapy_Report_1.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Hadron therapy in children Ã an update of the scientific evidence for 15 paediatric cancers",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://kce.fgov.be/sites/default/files/2021-12/KCE_245_geriatric_care_in_hospitals_Report_1.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Comprehensive geriatric care in hospitals: the role of inpatient geriatric consultation teams",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://kce.fgov.be/sites/default/files/2021-11/KCE_246_Public_funded_clinical_trials_Report_1.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Publicly funded Practice-oriented Clinical Trials",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.cadth.ca/media/pdf/htis/dec-2014/RB0777%20Vitamin%20D%20Toxicity%20Final.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Vitamin D Toxicity Associated with Different Vitamin D Dosing Regimens",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.crd.york.ac.uk/crdweb/ShowRecord.asp?ID=32014001208&ID=32014001208",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "PALB2-associated hereditary breast cancer",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "http://www.baets.org.uk/wp-content/uploads/2014-British-Thyroid-Association-guidelines-on-the-management-of-thyroid-cancer.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Management of Thyroid Cancer",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://onlinelibrary.wiley.com/doi/pdf/10.1111/cen.12515",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Management of Thyroid Cancer",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.canceraustralia.gov.au/sites/default/files/guidelines/cns_metastases_in_women_with_secondary_breast_cancer.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Recommendations for the management of central nervous system (CNS) metastases in women with secondary breast cancer",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.canceraustralia.gov.au/guidelines/guideline_21.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Recommendations for the identification and management of fear of cancer recurrence in adult cancer survivors",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.evidentlycochrane.net/testosterone/",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "MenÃs Health Weak?",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.crd.york.ac.uk/crdweb/ShowRecord.asp?ID=32014000483&ID=32014000483",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "PTEN gene expression testing in Non-Small Cell Lung Cancer (NSCLC)",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.esmo.org/guidelines/guidelines-by-topic/supportive-and-palliative-care/bone-health-in-cancer-patients",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Bone Health in Cancer Patients",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.clinicalcorrelations.org/2014/04/25/direct-to-consumer-genetic-testing-impact-on-patients-and-preventive-medicine/",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Direct-to-Consumer Genetic Testing: Impact on Patients and Preventive Medicine",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.crd.york.ac.uk/crdweb/ShowRecord.asp?ID=12013066997&ID=12013066997",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Communication and dissemination strategies to facilitate the use of health-related evidence",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.crd.york.ac.uk/crdweb/ShowRecord.asp?ID=32014000385&ID=32014000385",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Prolaris test for prediction of prostate cancer progression",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.sahealth.sa.gov.au/wps/wcm/connect/5578f78041609ea994d2fd9fb790f180/Gynaecological+Cancer+Pathway+FINAL.pdf?MOD=AJPERES&CACHEID=5578f78041609ea994d2fd9fb790f180",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "South Australian gynaecological cancer pathway",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.flyingdoctor.org.au/assets/magazine/file/Part_1_-_Clinical_Manual.pdf/",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Royal Flying Doctor Service Western Operations Clinical manual part 1.Clinical guidelines",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.hsrd.research.va.gov/publications/esp/acupuncture.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Evidence Map of Acupuncture",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/vitamin-supplementation-to-prevent-cancer-and-cvd-counseling",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Vitamin Supplementation to Prevent Cancer and CVD: Preventive Medication",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.wjgnet.com/2308-3840/full/v2/i3/107.htm",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Comparison of functional outcomes after retropubic, laparoscopic and robot-assisted radical prostatectomy: A meta-analysis",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.folkhalsomyndigheten.se/contentassets/f9e4fa10950b434b8058578584299d85/adverse-ecological-effects-of-antibiotic.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Adverse ecological effects on the individual as a consequence of previous antibiotic exposure",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://eje.bioscientifica.com/view/journals/eje/170/3/G1.xml",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "European Society of Endocrinology Clinical guideline for the management of hyponatraemia",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.jvascsurg.org/article/S0741-5214%2814%2900851-9/fulltext",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Management of Venous Leg Ulcers: Clinical Practice Guidelines of the Society for Vascular Surgery and the American Venous Forum",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://aci.health.nsw.gov.au/__data/assets/pdf_file/0016/231514/Health_Care_in_People_with_Intellectual_Disability_Guidelines.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Health Care in People with Intellectual Disability Guidelines",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://ebm.bmj.com/content/19/2/41",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Suggestions for improving guideline utility and trustworthiness",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://watermark.silverchair.com/ehu283.pdf?token=AQECAHi208BE49Ooan9kkhW_Ercy7Dm3ZL_9Cf3qfKAc485ysgAAAs8wggLLBgkqhkiG9w0BBwagggK8MIICuAIBADCCArEGCSqGSIb3DQEHATAeBglghkgBZQMEAS4wEQQMtx6XSKYN_1ANj_lmAgEQgIICgi23Nu1mLZ0HDKSjjDBgMzlMtirz31-aHXeRDsT0CSB9UnnQ_5n2qIC3l-_qW0TuoHTRkucv7Im4XeAwHvcdkbPNg0c9Dh-aFTM6tPCuyedYp4WS80mCAvtyLBzudx9bUDzKniYBY8okDwE9Y7KttZ5eBYvnj2pwBdcMtYbbNiKNeKEu6Lt6BPzu6vvZhSMYNVcRxz0jFOmFgRFIIUrY0C7eLpiPGPwOlNgv3yyE46JP9wzcXlUv8I9Ff4_P8OU-me4j2ausYolcXv817hVRlfBMcFJahqAYDwmM8AsKvpDa-WEE9b2PHR0d1Uj0DNPgzjB7ZMfhSKAJiO85z8Q8a7M6D5SP7SYt5qXu6AqlljVSE3ckvC-AWOLrVQWr6MOpzk9t7ZuQvKtdIHaJhQQB9nYk9TD52uPYuF-l93r4iQLK2jHYh_BiSTKoAdGdlo1GkP4-DpIaJjFlfJ8wn4B36TeqjNo5iCU11GCGre65cN6CzJECjgd4V5fsYEmJxXrTL26pUNQTIJSZcCZs3Pdj6qPZKcbUzZpwxCLNWcfOFWW7R9wkuZOry20DxiZPs-KMslswRhBTOoSDK_QxGm0VJJTZEtHtFVNpVKCP1XG_m-nmGBkKFzF-Do8cMoH_HPNdFe3NZ5TwvjQv5Vmn8JnbnwfNETyMqJtiC_JPApRQrIBC8YzhIOcDWfa1yLo75J9uEm3zVLq9jS9PfsOWlJgSXtoSLKpPcaUdy_3AmY26RQOtxocot-QUZEwNKZanqmCdv5NgoNz_3qcFXKNrCVu5aBKUfjSt8DGtuHXvakmQq7dre7LTOeYdDZIQKfig4Rb1brL69Z3aP43LQymUsctAZcCdlg",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Diagnosis and Management of Acute Pulmonary Embolism",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://watermark.silverchair.com/ehu284.pdf?token=AQECAHi208BE49Ooan9kkhW_Ercy7Dm3ZL_9Cf3qfKAc485ysgAAAs8wggLLBgkqhkiG9w0BBwagggK8MIICuAIBADCCArEGCSqGSIb3DQEHATAeBglghkgBZQMEAS4wEQQMG4E3vVWWpfgPOp0qAgEQgIICgt1OdmBjlSCC1ZN2TbB9WQsMrWlyCnauBRs1rdH-0FzyRgyCo83nFbVVwAExA7WBVRCu5oHg6rTWB1FH4nC7fzjZBnd67rRcy1W1mJi_jThLhrUV520uetGV7qYfCy1r-omS-DtzvvhurFUzo2wdrrgctHabkEJlDy8XGjSEFKLaSkCzp07GSrLshwTieKveyv2ffdpa_kql5FDMEW4M8Z7t74afqX8uyc1d9v8kObBEowdHtukBMWcf8Pj_vUNtETAQxNNGxpp5B_aRHH2qBm8Nkmd7SCUsyxHzwJDfEoxpZoZzG6sgMIkUCZG3R-gk-dv6yMAMSVeTuJoQqPC_snAxZpEQW1RxGhelfsUMasEoIClb2-VX1X9082yFK4j2esXwKxJnnBmYy5V_tJBdBKcZvRZuBnYLUF5zgr4uUyRpdlN9l70MzbSm84adOHBvGwlmxF8TxC0btOSl2LGUdeMZMrNxoPnXa3Xu77aNsNKZtu79Uv-qnHqJi3ynlmzywsgWN-KemszvANCKLb3vcGlPfJBoPVb_-TCVGYH8yn-2-KCkHNu44s--QZQYFfAaJgXpCp8p8DtlGOGVfULTgiPIyIecdolz7BNpehUSorw0HrB5-ddiVP6Rh_LGNHlq2LMYbog9GSIexdpkMqjOX4YxQqxcmF5TsUjEOIogc0TVvGOGv_z1pzFMpIR5usm92BEh2AHo9G6YzsAoe-y8ljvpZGhT0NC4EExU_w0aBgamOEDOSP46AQQ-a1_ksNLzpehJDqaNjwcp3MCG-Y_1JLslcvtfo-V023kFgoi2hq2YPscpKzaKT8OOTNZ5N8ulY66rinW8IZDjmKDIOJDtG6YqDQ",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Hypertrophic Cardiomyopathy",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.accessdata.fda.gov/drugsatfda_docs/nda/2014/202293Orig1s000MedR.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Dapagliflozin (Farxiga)",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.accessdata.fda.gov/drugsatfda_docs/nda/2014/204684Orig1s000MedR.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Impavido (miltefosine)",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.accessdata.fda.gov/drugsatfda_docs/nda/2015/205353Orig1s000MedR.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Panobinostat (Farydak)",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.accessdata.fda.gov/drugsatfda_docs/nda/2015/205266Orig1s000MedR.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Sonidegib (Odomzo)",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.ema.europa.eu/en/documents/assessment-report/nerventra-epar-refusal-public-assessment-report_en.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Nerventra - laquinimod",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.ema.europa.eu/en/documents/assessment-report/sylvant-epar-public-assessment-report_en.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Sylvant - siltuximab",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.ema.europa.eu/en/documents/assessment-report/scenesse-epar-public-assessment-report_en.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Scenesse - afamelanotide",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.ema.europa.eu/en/documents/assessment-report/vimizim-epar-public-assessment-report_en.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Vimizim - elosulfase alfa",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.ema.europa.eu/en/documents/assessment-report/xigduo-epar-public-assessment-report_en.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Xigduo - dapagliflozin / metformin",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.ema.europa.eu/en/documents/assessment-report/vizamyl-epar-public-assessment-report_en.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Vizamyl - flutemetamol (18F)",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.ema.europa.eu/en/documents/assessment-report/envarsus-epar-public-assessment-report_en.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Envarsus - tacrolimus",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.ema.europa.eu/en/documents/assessment-report/gazyvaro-epar-public-assessment-report_en.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Gazyvaro - obinutuzumab",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.ema.europa.eu/en/documents/assessment-report/laventair-epar-public-assessment-report_en.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Laventair - umeclidinium bromide / vilanterol",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.ema.europa.eu/en/documents/assessment-report/harvoni-epar-public-assessment-report_en.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Harvoni - sofosbuvir / ledipasvir",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.ema.europa.eu/en/documents/assessment-report/ketoconazole-hra-epar-public-assessment-report_en.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Ketoconazole HRA",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.ema.europa.eu/en/documents/assessment-report/adempas-epar-public-assessment-report_en.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Adempas (riociguat)",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.ema.europa.eu/en/documents/assessment-report/anoro-epar-public-assessment-report_en.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Anoro (umeclidinium bromide / vilanterol trifenatate)",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.nice.org.uk/advice/esnm45/resources/erectile-dysfunction-avanafil-1502680985969605",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Erectile dysfunction: avanafil",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.nice.org.uk/advice/esnm50/resources/erectile-dysfunction-alprostadil-cream-1502681038037701",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Erectile dysfunction: Alprostadil cream",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.nice.org.uk/advice/mib16/resources/the-oncentra-prostate-v4.x-for-ultrasoundguided-realtime-hdr-brachytherapy-in-men-with-localised-prostate-cancer-63498988021957",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "The Oncentra Prostate v4.x for ultrasound-guided real-time HDR brachytherapy in men with localised prostate cancer",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.accessdata.fda.gov/drugsatfda_docs/nda/2015/125522Orig1s000MedR.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Evolocumab (Repatha)",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://prostatecanceruk.org/media/azpbdsne/treating-ed-after-radiotherapy-and-adt-for-prostate-cancer.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Treating erectile dysfunction after radical radiotherapy and androgen deprivation therapy (ADT) for prostate cancer",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://prostatecanceruk.org/media/mctemdi4/treating-ed-after-surgery-for-pelvic-cancers.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Treating erectile dysfunction after surgery for pelvic cancers",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.canceraustralia.gov.au/sites/default/files/publications/risk-factors-lung-cancer-systematic-review/pdf/risk_factors_for_lung_cancer_-_a_systematic_review.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Risk factors for lung cancer",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://acsearch.acr.org/docs/69490/Narrative/",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Hematuria",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.aapd.org/media/Policies_Guidelines/BP_CariesRiskAssessment.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Caries-risk Assessment and Management for Infants, Children, and Adolescents",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.orthopt.org/uploads/content_files/files/10.%20Nonarthritic%20Hip%20Joint%20Pain%20-%20June%202014.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Nonarthritic Hip Joint Pain",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.ahajournals.org/doi/10.1161/CIR.0000000000000025",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Assessment of the 12-Lead ECG as a Screening Test for Detection of Cardiovascular Disease in Healthy General Populations of Young People (12?25 Years of Age)",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.aium.org/resources/guidelines/usGuidedProcedures.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "AIUM Practice Parameter for the Performance of Selected Ultrasound-Guided Procedures",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.auanet.org/guidelines/guidelines/benign-prostatic-hyperplasia-(bph)-guideline/benign-prostatic-hyperplasia-(2010-reviewed-and-validity-confirmed-2014)",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Management of Benign Prostatic Hyperplasia (BPH)",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.auanet.org/guidelines/guidelines/overactive-bladder-(oab)-guideline",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Diagnosis and Treatment of Non-Neurogenic Overactive Bladder (OAB) in Adults: AUA/SUFU Guideline",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.auanet.org/guidelines/interstitial-cystitis/bladder-pain-syndrome-(2011-amended-2014)",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Diagnosis and Treatment Interstitial Cystitis/Bladder Pain Syndrome",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.auanet.org/guidelines/guidelines/cryptorchidism-guideline",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Evaluation and Treatment of Cryptorchidism",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.acpjournals.org/doi/10.7326/M14-0701",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Screening Pelvic Examination in Adult Women",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.auanet.org/guidelines/guidelines/kidney-stones-medical-management-guideline",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Medical Management of Kidney Stones",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://ascopubs.org/doi/full/10.1200/jco.2013.53.4495",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Screening, Assessment, and Management of Fatigue in Adult Survivors of Cancer Guideline Adaptation",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://ascopubs.org/doi/full/10.1200/JCO.2013.54.8404",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Systemic Therapy in Men with Metastatic Castration-Resistant Prostate Cancer (CRPC)",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://ascopubs.org/doi/full/10.1200/JCO.2014.58.8525",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Adjuvant and Salvage Radiotherapy After Prostatectomy Endorsement",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.ahajournals.org/doi/10.1161/CIR.0000000000000041",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.ahajournals.org/doi/10.1161/CIR.0000000000000040",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: Executive Summary",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://sufuorg.com/docs/guidelines/oab-amendment-061014.aspx",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Diagnosis and Treatment of Overactive Bladder (Non-Neurogenic) in Adults: AUA/SUFU Guideline",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.jvir.org/article/S1051-0443(14)00496-5/pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Position Statement: Prostate Artery Embolization for Treatment of Benign Disease of the Prostate",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://gi.org/wp-content/uploads/2014/08/Giardiello_et_al_Lynch-Syndrome_Aug_2014.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Guidelines on Genetic Evaluation and Management of Lynch Syndrome: A Consensus Statement by the US Multi-Society Task Force on Colorectal Cancer 2",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://gi.org/wp-content/uploads/2014/07/ACG_Guideline_Benign_Anorectal_Disorders_August_2014.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Management of Benign Anorectal Disorders",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://watermark.silverchair.com/arpa_2013-0610-cp.pdf?token=AQECAHi208BE49Ooan9kkhW_Ercy7Dm3ZL_9Cf3qfKAc485ysgAAAsQwggLABgkqhkiG9w0BBwagggKxMIICrQIBADCCAqYGCSqGSIb3DQEHATAeBglghkgBZQMEAS4wEQQM7xFgPDg1qvmMqWF4AgEQgIICd5auZZbDFre6-oJDiyAV9IMGri-NBXetxqScBGcpdNHfi3RU9k1EN8fpMKM7kamGpTg1za1y4F9o5Ary97lZUxH3H0e6uXd3igrqFj41FIS22nrXZjDhW0PtirQgizyO-L3oP4CP4BKaCcfPC-83lIH13G7RwIbGjV_eBUDCPiM1uj4Pamtn3eT8Frs1FRqcPNi2_ESo8UClOYd3VMjeDJkyf_Q9phEEy4bq0zuElPwFHvEP8m6qOxh3oj0_7altryWM6VlITp_t4EEsCRSF_9Wqqx_yxBQPYoI-uQkhcTrSC1BqpKl9ag_fWIqU4qR370eYM6z7qD0acn0tPcHBp8a35LKXKFLlfvn3BhZe8SdxLmurkO4kRXEh_Lm2KV0h81PtXYx_DMlE1ZlehgJVlUDtrGyOPwTrwuLu_tmIEJ9FfO5NPT0Fl8vzD_UxZYRMSUyPxViOCjQPeHcsJzJxZfAgaUPTIHDnuCNzs6Bq_6EhoHqaCe0aaxLkR9QG9-QIv1OipkybWqI1fq4r0Aev2Fw6ki9oRbj8oN6ieP6gaRmVwNyhbHtJcObz4YSnZfznQYd9_IgJPNfd_T8CtdiH7IMX-r2d266-eNvY4j9Z6nMsUD7eHcfseIRKG9TwdqywUVDDKn5czFEdBwoZWTZIevTBSCYjDr13v3iDk8uG-JP-uRISQezPtp5T-rYt4ljWzXb5xsnrpU-IqNEtU0LTih8oAG3xLcizE-5p3CAdhlLS_NDQXqUFiDpF-va-3t-VHCkdXsCjolp8SalJbfXNw79Jr8jErz33lr3yYZuLymKpJsmpJ3RkyR1y36mtGOKHGnWI2tOvmCU",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Principles of Analytic Validation of Immunohistochemical Assays",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://watermark.silverchair.com/gfu040.pdf?token=AQECAHi208BE49Ooan9kkhW_Ercy7Dm3ZL_9Cf3qfKAc485ysgAAAsYwggLCBgkqhkiG9w0BBwagggKzMIICrwIBADCCAqgGCSqGSIb3DQEHATAeBglghkgBZQMEAS4wEQQM5U5iy6DO2Ppt6tWcAgEQgIICeUZyxnFSkH4orhV3Zo-2uFhyOPfTiuObSy8kw-mxVgbbmI3DzwZ4aVlxQ4ILSG1DYmeOknWZmr4CIueJWS7hbrrFIdO__zNEJuOIXvG-jBt0mLKXKFVTRo-PKD6APdpRWkyK0HGk-VzdpIlKlzTBdLNY30mxHK__eGlB1Ysm3jLQhKz_bhNloWLFw-wI1rfOva7gozWAYOKcXlw2UOAAh_uE-InE7ZFlHa7jXCa_Jk6AtfDziSjBYf6cFm-je_zV7aIzbYnlpiDmkFIw-0IPtjG9JRc1xf0E7uUnGSVhs1B1GT_CZrCGlNHXkrJr2CmvvLcofOGe6jiyCv9YXBEU-7sqV1LQ4LRRNEBb7UnBEOXmjwjfksJFO2QXOQacWa-USYUeBTDAsY6Dc-rI_6EA_qAFCsLdyyL4bzIlbPOc6LSR_rcXBwSD9V4pNgh0gX8uVr0K0tDovZDCziGtlaK2W4sIriciTR5WuXC13BEnWmMqEMo6rYK9tP2D8uhUqfslsDCCT2am58Z0YJYys5UC6YWqHQkgHn1IMMbHi4zX17oAGroLzU3iWf-tZ-UkKRdYkW8DwUvbNPsNmb0MpRVI9z23uNWrIL8n6GB4j4z1XQRbJDGGijuZGIEQHc3VjBJlaXR50_KPStDmigyBj9Mj-tPDujtLxKmwr3sszq8YaUO11dxwMYXPxP9AdaQz3_bjF2xkZGqdrDLC3xdFi337ix4BLrBPOvqNUPcEYSBqnsPoQ28-fvIF1HG1Qs8qE1RdyhvXRN21rSJoWLZI7iFwmVRWNhSrfjSWdlKR4FNBQHLBVp-iYhOGD5LPx8PP2X_juyV8bxml0zK98A",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Clinical Practice guideline on the diagnosis and treatment of hyponatraemia",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://academic.oup.com/HTTPHandlers/Sigma/LoginHandler.ashx?error=login_required&state=cb668f3d-119a-4000-9edb-10d1b40f2d27redirecturl%3Dhttpszazjzjacademiczwoupzwcomzjjcemzjarticlezylookupzjdoizj10zw1210zjjczw2014zy2700",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Acromegaly",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://acsearch.acr.org/docs/69400/Narrative/",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Postradical Prostatectomy Irradiation in Prostate Cancer",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://jeccr.biomedcentral.com/articles/10.1186/s13046-014-0082-9",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Quantitative assessment of the influence of EPHX1 gene polymorphisms and cancer risk: a meta-analysis with 94,213 subjects",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://ashm.blob.core.windows.net/ashmpublic/HIV_Viral_Hepatitis_and_STIs_a_Guide_for_Clinical_Care_(4th_Edition).pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "HIV, viral hepatitis and STIs - a guide for primary care",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.canceraustralia.gov.au/sites/default/files/__migrated_guidelines/guideline_22.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Clinical guidance for responding to suffering in adults with cancer",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.bashh.org/documents/Sexual%20History%20Guidelines%202013%20final.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Guideline for consultations requiring sexual history taking",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.peelregion.ca/health/library/pdf/Alcohol_Impacts_Health.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Alcohol impacts health: A rapid Review of the Evidence",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3758937/",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "CUA-CUOG guidelines for the management of castration-resistant prostate cancer (CRPC): 2013 update",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.racgp.org.au/download/Documents/AFP/2013/March/201303yeoh.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Macroscopic haematuria - a urological approach",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "file:///Users/chutizzah/Downloads/3002398.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Aspirin for prophylactic use in the primary prevention of cardiovascular disease and cancer: a systematic review and overview of reviews",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.baus.org.uk/_userfiles/pages/files/Publications/MDT%20Prostate%20Cancer%20Guidance.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Prostate Cancer Multi-disciplinary Team",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.esmo.org/guidelines/guidelines-by-topic/gynaecological-cancers/newly-diagnosed-and-relapsed-epithelial-ovarian-carcinoma",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Newly Diagnosed and Relapsed Epithelial Ovarian Carcinoma",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.esmo.org/guidelines/guidelines-by-topic/genitourinary-cancers/penile-carcinoma",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Penile Carcinoma",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.cadth.ca/media/pdf/htis/aug-2013/RC465%20Green%20Light%20Laser%20for%20BPH%20_Final.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "GreenLight Laser for the Treatment of Benign Prostatic Hypertrophy",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.clinicalcorrelations.org/2013/06/26/primary-care-for-the-transgender-population/",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Primary Care for the Transgender Population",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.cadth.ca/media/pdf/htis/jun-2013/RB0590%20Portable%20BMD%20testing%20Final.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Portable Bone Mineral Density Scanners for Screening and Diagnosis of Osteoporosis: Uses, Limitations, and Guidelines",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.hsrd.research.va.gov/publications/esp/caregiver-interventions.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Effectiveness of Family and Caregiver Interventions on Patient Outcomes among Adults with Cancer or Memory-Related Disorders",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.clinicalcorrelations.org/2013/04/25/health-care-do-celebrities-know-best/",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Health Care: Do Celebrities Know Best?",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www2.gov.bc.ca/gov/content/health/practitioner-professional-resources/bc-guidelines/osteoporosis",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Osteoporosis - Diagnosis and Treatment",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://evidentlycochrane.wordpress.com/2013/03/28/out-of-the-ivory-tower-and-into-the-crowds-how-social-media-has-transformed-academic-conferences/",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Out of the ivory tower and into the crowds: how social media has transformed academic conferences",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www2.gov.bc.ca/gov/content/health/practitioner-professional-resources/bc-guidelines/osteoporosis",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Osteoporosis: Diagnosis, Treatment and Fracture Prevention",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://journals.aace.com/doi/pdf/10.4158/EP13155.GL",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Clinical Practice Guidelines for Healthy Eating for the Prevention and Treatment of Metabolic and Endocrine Diseases in Adults",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.sign.ac.uk/media/1108/sign136_2019.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Management of chronic pain",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://link.springer.com/article/10.1007/s00268-012-1787-6",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Guidelines for Perioperative Care in Elective Rectal/Pelvic Surgery: Enhanced Recovery After Surgery (ERAS) Society Recommendations",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://aci.health.nsw.gov.au/__data/assets/pdf_file/0004/191065/ACI_Neobladder_Jan13.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Neobladder - Clinical Guideline and Patient Information",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.accessdata.fda.gov/drugsatfda_docs/nda/2014/021883Orig1s000MedR.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Dalbavancin hydrochloride (HCl) (Dalvance)",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.accessdata.fda.gov/drugsatfda_docs/nda/2014/206256Orig1s000MedR.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Belinostat (Beleodaq)",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.accessdata.fda.gov/drugsatfda_docs/nda/2013/204824Orig2s000MedR.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Otrexup (methotrexate) auto-injector",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.ema.europa.eu/en/documents/assessment-report/balaxur-epar-refusal-public-assessment-report_en.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Balaxur (memantine hydrochloride / donepezil hydrochloride)",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.ema.europa.eu/en/documents/assessment-report/bosulif-epar-public-assessment-report_en.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Bosulif (bosutinib (as monohydrate))",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.ema.europa.eu/en/documents/assessment-report/istodax-epar-refusal-public-assessment-report_en.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Istodax - romidepsin",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.ema.europa.eu/en/documents/assessment-report/giotrif-epar-public-assessment-report_en.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Giotrif - afatinib",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.ema.europa.eu/en/documents/assessment-report/acrescent-epar-refusal-public-assessment-report_en.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Acrescent (memantine hydrochloride / donepezil hydrochloride)",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.ema.europa.eu/en/documents/assessment-report/relvar-ellipta-epar-public-assessment-report_en.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Relvar Ellipta - fluticasone furoate / vilanterol",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.ema.europa.eu/en/documents/assessment-report/provenge-epar-public-assessment-report_en.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Provenge - autologous peripheral-blood mononuclear cells activated with prostatic acid phosphatase granulocyte-macrophage colony-stimulating factor (sipuleucel-T)",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.ema.europa.eu/en/documents/assessment-report/lonquex-epar-public-assessment-report_en.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Lonquex - lipegfilgrastim",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.ema.europa.eu/en/documents/assessment-report/kadcyla-epar-public-assessment-report_en.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Kadcyla - trastuzumab emtansine",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.ema.europa.eu/en/documents/assessment-report/jetrea-epar-public-assessment-report_en.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Jetrea - ocriplasmin",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.ema.europa.eu/en/documents/assessment-report/opsumit-epar-public-assessment-report_en.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Opsumit - macitentan",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.ema.europa.eu/en/documents/assessment-report/stivarga-epar-public-assessment-report_en.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Stivarga - regorafenib",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.ema.europa.eu/en/documents/assessment-report/perjeta-epar-public-assessment-report_en.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Perjeta - pertuzumab",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.ema.europa.eu/en/documents/assessment-report/xofigo-epar-public-assessment-report_en.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Xofigo - radium Ra223 dichloride",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.ema.europa.eu/en/documents/assessment-report/xtandi-epar-public-assessment-report_en.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Xtandi - enzalutamide",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.nice.org.uk/guidance/cg164/resources/familial-breast-cancer-classification-care-and-managing-breast-cancer-and-related-risks-in-people-with-a-family-history-of-breast-cancer-35109691767493",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Familial breast cancer: classification, care and managing breast cancer and related risks in people with a family history of breast cancer",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.rcr.ac.uk/sites/default/files/publication/2013_PETCT_RCP_RCR.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Evidence-based indications for the use of PET-CT in the UK",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.rcr.ac.uk/sites/default/files/publication/RCR%2813%29_IO_0.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Interventional oncology: guidance for service delivery",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.iqwig.de/download/a13-06_abiraterone-acetate-new-therapeutic-indication_extract-of-dossier-assessment.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Abiraterone acetate (new therapeutic indication) - Benefit assessment according to Â¤ 35a Social Code Book V",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.iqwig.de/download/a13-33_enzalutamide_extract-of-dossier-assessment.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Enzalutamide - Benefit assessment according to Â¤35a Social Code Book V",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "http://www.has-sante.fr/portail/upload/docs/application/pdf/2014-03/methodological_choices_for_the_clinical_development_of_medical_devices.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Methodological Choices for the Clinical Development of Medical Devices",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://car.ca/wp-content/uploads/Ultrasound-Prostate-and-Surrounding-Structures-2013.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Ultrasound - Prostate and Surrounding Structures",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://acmedsci.ac.uk/viewFile/51e915f9f09fb.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Realising the potential of stratified medicine",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.worldgastroenterology.org/UserFiles/file/guidelines/common-gi-symptoms-english-2013.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Coping with Common GI Symptoms in the Community: A Global Perspective on Heartburn, Constipation, Bloating, and Abdominal Pain/Discomfort",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://acsearch.acr.org/docs/69350/Narrative/",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Definitive External Beam Irradiation in Stage T1 and T2 Prostate Cancer",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://acsearch.acr.org/docs/3082863/Narrative/",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "High-Dose-Rate Brachytherapy for Prostate Cancer",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://acsearch.acr.org/docs/69426/Narrative/",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Chronic Neck Pain",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.auanet.org/guidelines/renal-cancer-follow-up-for-clinically-localized-renal-neoplasms-guideline",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Follow-up for Clinically Localized Renal Neoplasms",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.auanet.org/guidelines/flexible-cystoscopes",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Joint AUA/SUNA White Paper on Reprocessing of Flexible Cystoscopes",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.auanet.org/guidelines/guidelines/prostate-specific-antigen-(psa)-best-practice-statement",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "PSA Testing for the Pretreatment Staging and Posttreatment Management of Prostate Cancer",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://n.neurology.org/content/80/22/2065",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Periprocedural management of antithrombotic medications in patients with ischemic cerebrovascular disease",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.ahajournals.org/doi/10.1161/01.cir.0000435708.67487.da",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Guide to the Assessment of Physical Activity: Clinical and Research Applications",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.ahajournals.org/doi/10.1161/CIR.0b013e31829d8654",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Cardiopulmonary Resuscitation Quality: Improving Cardiac Resuscitation Outcomes Both Inside and Outside the Hospital",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://deepblue.lib.umich.edu/bitstream/handle/2027.42/140217/sur.2013.9999.pdf?sequence=1",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Clinical Practice Guidelines for Antimicrobial Prophylaxis in Surgery",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.ahajournals.org/doi/10.1161/HYP.0b013e318293645f",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Beyond Medications and Diet: Alternative Approaches to Lowering Blood Pressure",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.astro.org/uploadedFiles/_MAIN_SITE/Patient_Care/Clinical_Practice_Statements/Content_Pieces/RadiationAfterProstatectomy.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Adjuvant and Salvage Radiation Therapy After Prostatectomy Guideline",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://journals.sagepub.com/doi/full/10.1177/0194599813487301",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Improving Voice Outcomes After Thyroid Surgery",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://academic.oup.com/jcem/article/98/12/4565/2833703?login=false",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Diagnosis and Treatment of Polycystic Ovary Syndrome",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.saudijhealthsci.org/article.asp?issn=2278-0521;year=2013;volume=2;issue=3;spage=184;epage=193;aulast=Kumar",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Reporting characteristics of cancer pain: A systematic review and quantitative analysis of articles published in cancer journals",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://ebm.bmj.com/content/18/3/83.full",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Citations of scientific results and conflicts of interest: the case of mammography screening",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.pmda.go.jp/files/000153609.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Xeljanz (tofacitinib citrate)",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.pmda.go.jp/files/000153885.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Lyxumia (lixisenatide)",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://ascopubs.org/doi/full/10.1200/jco.2013.50.7442",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Follow-Up Care, Surveillance Protocol, and Secondary Prevention Measures for Survivors of Colorectal Cancer Endorsement",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.pmda.go.jp/files/000153631.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Perjeta (pertuzumab (genetical recombination))",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.facs.org/media/314or1oq/geriatric_guidelines.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Geriatric Trauma Management",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.cadth.ca/media/pdf/htis/nov-2012/RC0400%20Robot-assisted%20prostatectomy%20and%20hysterectomy%20Final.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Robot-assisted Surgery for Prostatectomy and Hysterectomy: A Review of the Clinical and Cost-Effectiveness ? An Update",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.cadth.ca/media/pdf/htis/nov-2012/RB0543%20Detection%20of%20CTCs%20Final.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "The ?CellSearch? System for Detecting Circulating Tumour Cells in Advanced Ovarian Cancer: Clinical Benefit and Cost-Effectiveness",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://cuaj.ca/index.php/journal/article/view/10",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Guidelines for adult urinary incontinence collaborative consensus document for the Canadian Urological Association",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.racgp.org.au/download/Documents/AFP/2012/November/201211arnold.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Overactive bladder syndrome. Management and treatment options",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.racgp.org.au/download/Documents/Guidelines/Redbook8/redbook8.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Guidelines for preventive activities in general practice (8th edition)",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.cancercareontario.ca/",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Referral of Suspected Prostate Cancer by Family Physicians and Other Primary Care Providers",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "http://www.navarra.es/NR/rdonlyres/F5697AC2-06CB-440F-954A-55BD5D9A68A2/238297/Bit_v20n4_e1.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Medicalization of aging and the testosterone deficiency syndrome",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://onlinelibrary.wiley.com/doi/10.1111/hir.12004",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Utilisation of search filters in systematic reviews of prognosis questions",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.clinicalcorrelations.org/2012/09/28/how-to-get-your-patient-a-kidney/",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "How to Get Your Patient a Kidney",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.clinicalcorrelations.org/2012/09/20/what-is-andropause-is-testosterone-supplementation-the-answer-in-older-men/",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "What Is Andropause? Is Testosterone Supplementation the Answer in Older Men?",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.cancercareontario.ca/",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Risk Reduction of Prostate Cancer with Drugs or Nutritional Supplements",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.mja.com.au/journal/2012/196/11/vitamin-d-and-health-adults-australia-and-new-zealand-position-statement",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Vitamin D and health in adults in Australia and New Zealand: a position statement",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "http://www.hsrd.research.va.gov/publications/esp/myhealthevet.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Secure Messaging between Providers and Patients, and Patients? Access to Their Own Medical Record",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.hsrd.research.va.gov/publications/esp/nutritional-supplements.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Nutritional Supplements for Age-related Macular Degeneration",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.blood.gov.au/system/files/documents/pbm-module-2.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Patient blood management guidelines module 2. Perioperative",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://consensus.nih.gov/2011/docs/prostate/Final%20Statement.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Role of Active Surveillance in the Managementof Men With Localized Prostate Cancer",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.surgeons.org/media/18790137/2012-11-21_rpt_surgical_simulation_update.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Surgical simulation: skills transfer to the operating room: a systematic review",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.asrm.org/globalassets/asrm/asrm-content/news-and-publications/practice-guidelines/for-non-members/best-practices_of_asrm_and_eshre.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Best practices of ASRM and ESHRE: a journey through reproductive medicine",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.sign.ac.uk/media/1067/sign129.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Antithrombotics: indications and management",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.bapras.org.uk/docs/default-source/commissioning-and-policy/melanoma-guidelines--september-2012.pdf?sfvrsn=0",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Quality in melanoma care- A best practice pathway",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://watermark.silverchair.com/ehs092.pdf?token=AQECAHi208BE49Ooan9kkhW_Ercy7Dm3ZL_9Cf3qfKAc485ysgAAAs8wggLLBgkqhkiG9w0BBwagggK8MIICuAIBADCCArEGCSqGSIb3DQEHATAeBglghkgBZQMEAS4wEQQMzEQ08HTG-4zEzyowAgEQgIICgs5CxecS0JLy1axP6Y2xzVQJcbvju3SkKmKBYTJH5VSZx7uX27nY6YQdlrAbCXXjYobNjHh5Q08CtNRso7I8B174SW_VtkPChKrV2lVGB1GBTC2MKSfjDHZCms3mEtpY7a4l3M9UMULqHlbj7ereaudOQVu9RLv9Gerj0GsHQJproMulKT8qanFSVGplXyg1rDcjRkVfKXWILsSmbNkopHmx-Axnet4p4FIeJ3YX53FzVMycIsZVObx7yUUybHskltlX46oWIxZjAeMhp30lC9GUNPfU1yscJwUiAoM1dq4LjSB28fT8h0IR56xYNgrnFvmfGQnS3Qcx95gu4qk7xNq4kRRFGqmZy6F2eKdLt-NLpCGmLev4MOMKueD864NmiPcV2G5uXyLAktQNgl-Y3UGK3nuKKmGE5YJ5G0dJc-8X_qCBUelopG_LlVrUtOTqoTGhEkcAtN1JwIDJfoGUmvTnYmwffiDrQiMUvZOd_yqNcvFOnWYZfr_-yVBX5IAxYlmCFyG3WHGVXxfbzysdhHWZnwilnYO84FLBEg_9wqoPsetY5BfUmtFL_H3Svl_cbZG3A-qXWHxQtaPvLMnl0WiHj2DQ0h8sjS4cekKoS2DkcGC1Ri3QK_lDdI3UNckAooqBGg9UIlyTb2U3ht0Ba4IQ3BY8MKQqdUsrGTsNitT-ad9Ba2xTobcH0qi_S7nsEVWoke5RxeQ9KI9l-fu4EKtYuFWAGN_q6SZK2LmzQe5LO5WDlbRht1v4AvN2-ZtzeHyyUbdKXdyhoP22j8lN3h5IHWWauJ_mUJR1a4imGQIFFNDXs2_0N8ZK5wx1kZzA1OzBFsSf5ERiV3cRIdg5YzAH8g",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "CVD Prevention in clinical practice",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.surgeons.org/media/18790137/2012-11-21_rpt_surgical_simulation_update.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Surgical simulation for training: skills transfer to the operating room (update)",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.accessdata.fda.gov/drugsatfda_docs/nda/2012/202450Orig1s000MedR.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Aclidinium bromide (Tudorza Pressair)",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.accessdata.fda.gov/drugsatfda_docs/nda/2012/202611Orig1s000MedR.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Mirabegron (Myrbetriq)",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.accessdata.fda.gov/drugsatfda_docs/nda/2012/202834Orig1s000MedR.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Perampanel (Fycompa)",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.rxfiles.ca/rxfiles/uploads/documents/Post-Menopausal%20Hormone%20Tx%20-%20DOPS%20-%20KEEPS%20-%20Update.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Post-menopausal Hormone Treatment Update (DOPS, KEEPS)",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.ema.europa.eu/en/documents/assessment-report/zelboraf-epar-public-assessment-report_en.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Zelboraf - vemurafenib",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.accessdata.fda.gov/drugsatfda_docs/nda/2013/022426Orig1s000MedRedt.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Alogliptin and alogliptin/pioglitazone",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.nice.org.uk/guidance/cg151/resources/neutropenic-sepsis-prevention-and-management-in-people-with-cancer-35109626262469",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Neutropenic sepsis: prevention and management in people with cancer",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.nice.org.uk/guidance/cg148/resources/urinary-incontinence-in-neurological-disease-assessment-and-management-35109577553605",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Urinary incontinence in neurological disease: assessment and management",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.nice.org.uk/guidance/cg138/resources/patient-experience-in-adult-nhs-services-improving-the-experience-of-care-for-people-using-adult-nhs-services-35109517087429",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Patient experience in adult NHS services: improving the experience of care for people using adult NHS services",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.ema.europa.eu/en/documents/assessment-report/eylea-epar-public-assessment-report_en.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Eylea - aflibercept",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.accessdata.fda.gov/drugsatfda_docs/nda/2013/201292Orig1s000MedR.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Afatinib (BIBW 2992) (Gilotrif)",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.ema.europa.eu/en/documents/assessment-report/esmya-epar-public-assessment-report_en.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Esmya - ulipristal",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.ema.europa.eu/en/documents/assessment-report/forxiga-epar-public-assessment-report_en.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Forxiga - dapagliflozin",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.ema.europa.eu/en/documents/assessment-report/docetaxel-kabi-epar-public-assessment-report_en.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Docetaxel Kabi",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.ema.europa.eu/en/documents/assessment-report/dacogen-epar-public-assessment-report_en.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Dacogen - decitabine",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.ema.europa.eu/en/documents/assessment-report/jakavi-epar-public-assessment-report_en.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Jakavi - ruxolitinib",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.ema.europa.eu/en/documents/assessment-report/inlyta-epar-public-assessment-report_en.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Inlyta - axitinib",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.rcr.ac.uk/sites/default/files/publication/obca_12.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Consensus guidelines for the safe prescription and administration of oral bowel-cleansing agents",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.saxinstitute.org.au/wp-content/uploads/Best-practice-in-early-assessment-and-diagnosis-of-lung-cancer.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Early assessment and diagnosis of lung cancer",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "http://ebm.bmj.com/content/17/5/149.extract",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Randomised controlled trial: Lung cancer screening with chest radiography has no effect on lung cancer incidence or mortality",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.iqwig.de/download/a11-24_extract_cabazitaxel_benefit_assessment_35a_social_code_book_v.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Cabazitaxel - Benefit assessment according to Â¤ 35a Social Code Book V",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.journals.elsevier.com/annals-of-oncology",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Management of cancer pain",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.eanm.org/publications/guidelines/2012_published_OC_GL_Radionuclide_Imaging_of_Phaeochromocytoma_and_Paraganglioma.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "EANM 2012 Guidelines for Radionuclide Imaging of Phaeochromocytoma and Paraganglioma",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://onlinelibrary.wiley.com/doi/full/10.1111/j.1365-2141.2012.09179.x",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Diagnosis and management of myelofibrosis",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "http://www.msac.gov.au/internet/msac/publishing.nsf/Content/5F8AE15E631253A2CA25801000123B8F/$File/1158-PSD-Roboticimage-guidedsterotacticprecisebeamradiosurgeryandradiotherapy-Accessible%20(D13-1620678)%20(D13-1647459).pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Robotic image-guided stereotactic precise beam radiosurgery and radiotherapy",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://scai.org/Assets/35db1e3a-77a5-4b1f-b710-4a0ef0a22b03/635461151459400000/2012dec-accfexpertconsensusdocument-pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "ACCF Clinical Expert Consensus Document on Practical Clinical Considerations in the Interpretation of Troponin Elevations",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.ajkd.org/article/S0272-6386(12)00957-2/pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "KDOQI Clinical Practice Guideline For Diabetes: Update",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.gastrojournal.org/article/S0016-5085(12)00494-5/pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Nonalcoholic Fatty Liver Disease",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://nurses.uroweb.org/wp-content/uploads/EAUN_Paris_Guideline_2012_LR_online_file.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Catheterisation Indwelling catheters in adults ? Urethral and Suprapubic",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://acsearch.acr.org/docs/69466/Narrative/",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Clinically Suspected Adnexal Mass",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://sufuorg.com/docs/guidelines/uds-guideline-061014.aspx",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Adult Urodynamics: AUA/SUFU Guideline",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.ahajournals.org/doi/10.1161/CIR.0b013e31824607ee",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Evaluating Parents and Adult Caregivers as 'Agents of Change' for Treating Obese Children: Evidence for Parent Behavior Change Strategies and Research Gaps",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.ahajournals.org/doi/pdf/10.1161/CIR.0b013e31824f2173",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Decision Making in Advanced Heart Failure",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://watermark.silverchair.com/arpa_lgt200570.pdf?token=AQECAHi208BE49Ooan9kkhW_Ercy7Dm3ZL_9Cf3qfKAc485ysgAAArkwggK1BgkqhkiG9w0BBwagggKmMIICogIBADCCApsGCSqGSIb3DQEHATAeBglghkgBZQMEAS4wEQQMOh3oIH-JBDQg5NBgAgEQgIICbPOp3mkmG5bWDtvK6LjFyKdwfcGsmtr4YoyfqyyyeNUIqpqptlH-g0tGe31igXdjEJg6mRMKeJ-59b301bPQj-8d5TU9OucBABKLE-lnPwC3dp-zPbc0PD3E_Wk1bS1-te9lY1q_Y5giuwjhDoHThwGo4vELcRtihTsrr2bFqnsxxzZ0YdaYC8PD2Ypf7XVSD0vQBMrAkEahE77rHYQzE9_QEtnUNIx9GPZPJdhHkffELs2MBz48CzDoNmTq34UJramOyV78yZ9mV0Hc9McTUMp5Zo_xjjK1Qjax4pyVPfz22aXzigHnSSWbGYfRPll7GdQ3QIA8298e4wa6ANMoziCb4pIrrQysvn_P4qwoXdCpGRLNHZNQyBmOULFbY2PPeeahJg613Rp6rE0TYzxiB5SMaWFGId0hyX_uHsnba5pf2FUmbMFpwRwAbDG6QyrbG9GBYH6x_5ob_AsRvx-e5lnELLx99n9hH0E6n5KDs2OpVX1MaMFIr2PvAfSDiDGEbt2SVLgcOKcug3caOfr-cPzAM-CPV-vXjBjOYkdYuEVZCCeqBg1x5tVNQoAKcRjf0ZnaERInKfMjR6nsOECzLYJ01HGR4whlkbjSed8MzjzUUojuNGxh-7YzT1LryQloZKfpPy9-J4JgU5OczX-lPXMEFzl_GSpXNyTT8NSHEIdszFHjNXQcdOzjBLPS-4KzEQgXPYhmnxaX-w2b_hFh11wB6EU-bUioObzufEmZ96rFEJXYyaoRj2iIDi4qxn9ORTGV_5toDT6Ksx9q9a_HUbpnU5OxW-KTCrh9yZPvFRIvz9K-8pmn6oz61uUF",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "The Lower Anogenital Squamous Terminology Standardization Project for HPV-Associated Lesions",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://academic.oup.com/HTTPHandlers/Sigma/LoginHandler.ashx?error=login_required&state=8ef74f5f-5917-4585-a3a6-e1f98e9e967bredirecturl%3Dhttpszazjzjacademiczwoupzwcomzjjcemzjarticlezj97zj6zj1802zj2536476",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Osteoporosis in Men",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://gi.org/wp-content/uploads/2012/09/Lieberman_et_al_Surveillance_after_Polypectomy_Gastro_Sept2012.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Guidelines for Colonoscopy Surveillance After Screening and Polypectomy: A Consensus Update by the US Multi-Society Task Force on Colorectal Cancer 2",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.asge.org/docs/default-source/education/practice_guidelines/doc-e49cb8b8-9e3d-4678-9252-0a415efd6c2d.pdf?sfvrsn=12",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Guidelines for colonoscopy surveillance after screening and polypectomy: A Consensus Update by the US Multi-Society Task Force on Colorectal Cancer",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://pubs.asahq.org/anesthesiology/article/116/2/248/12956/Practice-Guidelines-for-Acute-Pain-Management-in",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Treatment/ management/ diagnosis",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Practice Guidelines for Acute Pain Management in the Perioperative Setting",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.pmda.go.jp/files/000153949.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Xalkori (crizotinib)",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.pmda.go.jp/files/000153594.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Tenelia (teneligliptin hydrobromide hydrate)",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.pmda.go.jp/files/000153897.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Seebri (glycopyrronium bromide)",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://www.ncceh.ca/sites/default/files/Household_Pets_Zoonoses_Jan_2012_0.pdf",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Household Pets and Zoonoses",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://ebm.bmj.com/content/17/2/50",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Intervention/ primary study/erratum/ conference abstract/ commentary/ clinic trial/ newsletter/ magazine/protocol/ literature review",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Cohort study: Cohort analysis finds that the proportion of people who meet high risk criteria for colorectal, breast or prostate cancer screening based on family history increases between age 30 and 50",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    },
    {
        "Source": "TRIP",
        "Type": "",
        "Date Access": "",
        "URL": "https://cps.ca/en/documents/position/vitamin-d",
        "Final Level 1 Consensus": "Exclude",
        "Exclusion Reason Final Level 1": "Not Prostate Cancer/ irrelevant/ not related to study objective",
        "Final Level 2 Consensus": "",
        "Exclusion Reason Final Level 2": "",
        "Title": "Vitamin D supplementation: Recommendations for Canadian mothers and infants",
        "Theme": "",
        "Research Paper Type": "",
        "Country/ Organisation": ""
    }
]